Index Sample Index Original Filename Sample Name Sample ID Sample Comment Sample Type Acquisition Date & Time Rack Number Plate Number Vial Number Dilution Factor Injection Volume Operator Name Acq. Method Name IS Component Name Component Index Component Comment IS Comment Mass Info IS Mass Info IS Name Component Group Name Conc. Units Failed Query IS Failed Query Peak Comment IS Peak Comment Actual Concentration IS Actual Concentration Concentration Ratio Expected RT IS Expected RT Integration Type IS Integration Type Area IS Area Corrected Area IS Corrected Area Area Ratio Height IS Height Corrected Height IS Corrected Height Height Ratio Area / Height IS Area / Height Corrected Area/Height IS Corrected Area/Height Region Height IS Region Height Quality IS Quality Retention Time IS Retention Time Start Time IS Start Time End Time IS End Time Total Width IS Total Width Width at 50% IS Width at 50% Signal / Noise IS Signal / Noise Baseline Delta / Height IS Baseline Delta / Height Modified Relative RT Used Calculated Concentration Accuracy SF Peak Width Confidence SF Model Source SF Candidate Model Quality SF Asymmetry SF Saturated SF Integration Quality SF Group Confidence SF Num Peaks Score_IMPAQT MSSimScore_IMPAQT HeightScore_IMPAQT RTminScore_IMPAQT RankScore_IMPAQT MSSim_IMPAQT MSSimSita_IMPAQT RTminDiff_IMPAQT RankSum_IMPAQT CosSimilarity_IMPAQT CosSimilaritySita_IMPAQT Height_IMPAQT InterfereTrans_IMPAQT InterfereTransAll_IMPAQT LScore_IMPAQT LRTminScore_IMPAQT LSNScore_IMPAQT LSNAllScore_IMPAQT HLSimScore_IMPAQT HLSim_IMPAQT HLSimSita_IMPAQT BaseLine_IMPAQT BaseLineUnitNum_IMPAQT BaseLineMaxCount_IMPAQT Symbol Description 1 1 C20140606_SFK034_02 C20140606_SFK034_02 TB456572.[MT7]-SC[CAM]PLQGSPGRPR.3y10_2.heavy 485.925 / 532.802 83336.0 18.8506498336792 38 12 10 6 10 0.8455724776832675 62.30303226922002 0.034999847412109375 3 0.8940218373441984 3.7570063006819185 83336.0 117.78899290565252 0.0 - - - - - - - 1188.142857142857 166 7 DMGDH dimethylglycine dehydrogenase 3 1 C20140606_SFK034_02 C20140606_SFK034_02 TB456572.[MT7]-SC[CAM]PLQGSPGRPR.3b4_1.heavy 485.925 / 602.309 65603.0 18.8506498336792 38 12 10 6 10 0.8455724776832675 62.30303226922002 0.034999847412109375 3 0.8940218373441984 3.7570063006819185 65603.0 147.5343147804501 0.0 - - - - - - - 727.3333333333334 131 12 DMGDH dimethylglycine dehydrogenase 5 1 C20140606_SFK034_02 C20140606_SFK034_02 TB456572.[MT7]-SC[CAM]PLQGSPGRPR.3y8_1.heavy 485.925 / 854.459 13093.0 18.8506498336792 38 12 10 6 10 0.8455724776832675 62.30303226922002 0.034999847412109375 3 0.8940218373441984 3.7570063006819185 13093.0 188.99460869565218 0.0 - - - - - - - 140.875 26 16 DMGDH dimethylglycine dehydrogenase 7 1 C20140606_SFK034_02 C20140606_SFK034_02 TB456572.[MT7]-SC[CAM]PLQGSPGRPR.3y5_1.heavy 485.925 / 582.347 70748.0 18.8506498336792 38 12 10 6 10 0.8455724776832675 62.30303226922002 0.034999847412109375 3 0.8940218373441984 3.7570063006819185 70748.0 135.01417543837482 0.0 - - - - - - - 658.3333333333334 141 9 DMGDH dimethylglycine dehydrogenase 9 2 C20140606_SFK034_02 C20140606_SFK034_02 TB326469.[MT7]-SQLVASQEK[MT7].2y4_1.heavy 639.369 / 635.348 10371.0 20.169599533081055 50 20 10 10 10 4.98734285921548 15.949016085617327 0.0 3 0.9926489312348951 14.385359635171467 10371.0 20.88897642574269 0.0 - - - - - - - 759.8461538461538 20 13 NIN ninein (GSK3B interacting protein) 11 2 C20140606_SFK034_02 C20140606_SFK034_02 TB326469.[MT7]-SQLVASQEK[MT7].2y5_1.heavy 639.369 / 706.385 17778.0 20.169599533081055 50 20 10 10 10 4.98734285921548 15.949016085617327 0.0 3 0.9926489312348951 14.385359635171467 17778.0 196.28111309523808 0.0 - - - - - - - 199.25 35 16 NIN ninein (GSK3B interacting protein) 13 2 C20140606_SFK034_02 C20140606_SFK034_02 TB326469.[MT7]-SQLVASQEK[MT7].2b4_1.heavy 639.369 / 572.352 14097.0 20.169599533081055 50 20 10 10 10 4.98734285921548 15.949016085617327 0.0 3 0.9926489312348951 14.385359635171467 14097.0 43.083215051202664 0.0 - - - - - - - 685.8181818181819 28 11 NIN ninein (GSK3B interacting protein) 15 2 C20140606_SFK034_02 C20140606_SFK034_02 TB326469.[MT7]-SQLVASQEK[MT7].2y6_1.heavy 639.369 / 805.454 11179.0 20.169599533081055 50 20 10 10 10 4.98734285921548 15.949016085617327 0.0 3 0.9926489312348951 14.385359635171467 11179.0 77.66938296178344 0.0 - - - - - - - 165.28 22 25 NIN ninein (GSK3B interacting protein) 17 3 C20140606_SFK034_02 C20140606_SFK034_02 TB558110.[MT7]-GILYVTDTK[MT7].2y4_1.heavy 649.384 / 608.337 29276.0 33.15609931945801 45 20 10 5 10 12.194127415046939 8.200668780662816 0.042201995849609375 3 0.9977049318297083 25.756181601723554 29276.0 12.275502936323203 0.0 - - - - - - - 1702.4285714285713 58 7 GLDN gliomedin 19 3 C20140606_SFK034_02 C20140606_SFK034_02 TB558110.[MT7]-GILYVTDTK[MT7].2y5_1.heavy 649.384 / 707.406 22333.0 33.15609931945801 45 20 10 5 10 12.194127415046939 8.200668780662816 0.042201995849609375 3 0.9977049318297083 25.756181601723554 22333.0 35.4342784429563 0.0 - - - - - - - 324.0 44 5 GLDN gliomedin 21 3 C20140606_SFK034_02 C20140606_SFK034_02 TB558110.[MT7]-GILYVTDTK[MT7].2b4_1.heavy 649.384 / 591.362 24994.0 33.15609931945801 45 20 10 5 10 12.194127415046939 8.200668780662816 0.042201995849609375 3 0.9977049318297083 25.756181601723554 24994.0 19.098082196837446 0.0 - - - - - - - 463.0 49 1 GLDN gliomedin 23 3 C20140606_SFK034_02 C20140606_SFK034_02 TB558110.[MT7]-GILYVTDTK[MT7].2y6_1.heavy 649.384 / 870.469 28928.0 33.15609931945801 45 20 10 5 10 12.194127415046939 8.200668780662816 0.042201995849609375 3 0.9977049318297083 25.756181601723554 28928.0 39.85100366456754 0.0 - - - - - - - 347.0 57 4 GLDN gliomedin 25 4 C20140606_SFK034_02 C20140606_SFK034_02 TB557259.[MT7]-TLLEGEESR.2y8_1.heavy 589.313 / 932.468 37987.0 25.860000610351562 48 18 10 10 10 10.780683041167475 9.275850112477723 0.0 3 0.989478031165185 12.02077102675705 37987.0 13.990600913397168 0.0 - - - - - - - 400.0 75 4 KRT1 keratin 1 27 4 C20140606_SFK034_02 C20140606_SFK034_02 TB557259.[MT7]-TLLEGEESR.2y5_1.heavy 589.313 / 577.258 36948.0 25.860000610351562 48 18 10 10 10 10.780683041167475 9.275850112477723 0.0 3 0.989478031165185 12.02077102675705 36948.0 27.356187080222618 0.0 - - - - - - - 680.0 73 2 KRT1 keratin 1 29 4 C20140606_SFK034_02 C20140606_SFK034_02 TB557259.[MT7]-TLLEGEESR.2y6_1.heavy 589.313 / 706.3 29750.0 25.860000610351562 48 18 10 10 10 10.780683041167475 9.275850112477723 0.0 3 0.989478031165185 12.02077102675705 29750.0 36.99601258962815 0.0 - - - - - - - 320.0 59 6 KRT1 keratin 1 31 4 C20140606_SFK034_02 C20140606_SFK034_02 TB557259.[MT7]-TLLEGEESR.2y7_1.heavy 589.313 / 819.384 23992.0 25.860000610351562 48 18 10 10 10 10.780683041167475 9.275850112477723 0.0 3 0.989478031165185 12.02077102675705 23992.0 27.994500319577604 0.0 - - - - - - - 480.0 47 1 KRT1 keratin 1 33 5 C20140606_SFK034_02 C20140606_SFK034_02 TB326526.[MT7]-VTFAFDLLGGK[MT7].2y4_1.heavy 728.426 / 518.342 18682.0 46.30979919433594 42 12 10 10 10 0.9032688156284185 66.96515631206182 0.0 3 0.8888153604156012 3.6663290151644574 18682.0 30.48296536377709 0.0 - - - - - - - 1161.142857142857 37 7 GLDN gliomedin 35 5 C20140606_SFK034_02 C20140606_SFK034_02 TB326526.[MT7]-VTFAFDLLGGK[MT7].2y5_1.heavy 728.426 / 631.426 17274.0 46.30979919433594 42 12 10 10 10 0.9032688156284185 66.96515631206182 0.0 3 0.8888153604156012 3.6663290151644574 17274.0 14.369969619412316 0.0 - - - - - - - 744.7272727272727 34 11 GLDN gliomedin 37 5 C20140606_SFK034_02 C20140606_SFK034_02 TB326526.[MT7]-VTFAFDLLGGK[MT7].2b4_1.heavy 728.426 / 563.331 29814.0 46.30979919433594 42 12 10 10 10 0.9032688156284185 66.96515631206182 0.0 3 0.8888153604156012 3.6663290151644574 29814.0 36.17208255159474 0.0 - - - - - - - 832.0 59 7 GLDN gliomedin 39 5 C20140606_SFK034_02 C20140606_SFK034_02 TB326526.[MT7]-VTFAFDLLGGK[MT7].2b6_1.heavy 728.426 / 825.426 15163.0 46.30979919433594 42 12 10 10 10 0.9032688156284185 66.96515631206182 0.0 3 0.8888153604156012 3.6663290151644574 15163.0 22.39475818452381 0.0 - - - - - - - 658.2857142857143 30 7 GLDN gliomedin 41 6 C20140606_SFK034_02 C20140606_SFK034_02 TB403940.[MT7]-AVPLYELAVEIR.2y8_1.heavy 758.946 / 992.541 32809.0 46.535301208496094 46 20 10 6 10 12.132757100570803 8.24214967555028 0.0391998291015625 3 0.9965834004020863 21.10773332429905 32809.0 62.1475397089397 0.0 - - - - - - - 318.25 65 8 NPHP3 nephronophthisis 3 (adolescent) 43 6 C20140606_SFK034_02 C20140606_SFK034_02 TB403940.[MT7]-AVPLYELAVEIR.2y9_1.heavy 758.946 / 1105.63 15330.0 46.535301208496094 46 20 10 6 10 12.132757100570803 8.24214967555028 0.0391998291015625 3 0.9965834004020863 21.10773332429905 15330.0 24.374415584415583 1.0 - - - - - - - 695.8 30 10 NPHP3 nephronophthisis 3 (adolescent) 45 6 C20140606_SFK034_02 C20140606_SFK034_02 TB403940.[MT7]-AVPLYELAVEIR.2y6_1.heavy 758.946 / 700.435 14934.0 46.535301208496094 46 20 10 6 10 12.132757100570803 8.24214967555028 0.0391998291015625 3 0.9965834004020863 21.10773332429905 14934.0 33.06939929328622 0.0 - - - - - - - 804.6666666666666 29 9 NPHP3 nephronophthisis 3 (adolescent) 47 6 C20140606_SFK034_02 C20140606_SFK034_02 TB403940.[MT7]-AVPLYELAVEIR.2y10_1.heavy 758.946 / 1202.68 124391.0 46.535301208496094 46 20 10 6 10 12.132757100570803 8.24214967555028 0.0391998291015625 3 0.9965834004020863 21.10773332429905 124391.0 264.5400435396023 0.0 - - - - - - - 328.2 248 5 NPHP3 nephronophthisis 3 (adolescent) 49 7 C20140606_SFK034_02 C20140606_SFK034_02 TB558605.[MT7]-AWIHTEDNK[MT7].3y3_1.heavy 467.917 / 520.285 152879.0 23.602100372314453 46 16 10 10 10 3.9251154422903696 25.476957676854557 0.0 3 0.9662155625993123 6.695356095812805 152879.0 86.29724516867637 0.0 - - - - - - - 994.0 305 1 NFYC nuclear transcription factor Y, gamma 51 7 C20140606_SFK034_02 C20140606_SFK034_02 TB558605.[MT7]-AWIHTEDNK[MT7].3y4_1.heavy 467.917 / 649.327 79544.0 23.602100372314453 46 16 10 10 10 3.9251154422903696 25.476957676854557 0.0 3 0.9662155625993123 6.695356095812805 79544.0 102.83625145342577 0.0 - - - - - - - 1224.2857142857142 159 7 NFYC nuclear transcription factor Y, gamma 53 7 C20140606_SFK034_02 C20140606_SFK034_02 TB558605.[MT7]-AWIHTEDNK[MT7].3b3_1.heavy 467.917 / 515.31 161758.0 23.602100372314453 46 16 10 10 10 3.9251154422903696 25.476957676854557 0.0 3 0.9662155625993123 6.695356095812805 161758.0 78.78271920060098 0.0 - - - - - - - 1345.3333333333333 323 3 NFYC nuclear transcription factor Y, gamma 55 7 C20140606_SFK034_02 C20140606_SFK034_02 TB558605.[MT7]-AWIHTEDNK[MT7].3y5_1.heavy 467.917 / 750.375 64020.0 23.602100372314453 46 16 10 10 10 3.9251154422903696 25.476957676854557 0.0 3 0.9662155625993123 6.695356095812805 64020.0 196.6447487901386 0.0 - - - - - - - 727.2857142857143 128 7 NFYC nuclear transcription factor Y, gamma 57 8 C20140606_SFK034_02 C20140606_SFK034_02 TB555359.[MT7]-AVEPLR.2y4_1.heavy 414.757 / 514.298 74765.0 22.097700119018555 48 18 10 10 10 6.95445618933873 14.379269532720802 0.0 3 0.9883701167378414 11.432807529484126 74765.0 54.391945195459954 0.0 - - - - - - - 1797.7142857142858 149 7 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 59 8 C20140606_SFK034_02 C20140606_SFK034_02 TB555359.[MT7]-AVEPLR.2b3_1.heavy 414.757 / 444.258 314754.0 22.097700119018555 48 18 10 10 10 6.95445618933873 14.379269532720802 0.0 3 0.9883701167378414 11.432807529484126 314754.0 61.25754009252921 0.0 - - - - - - - 987.0 629 1 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 61 8 C20140606_SFK034_02 C20140606_SFK034_02 TB555359.[MT7]-AVEPLR.2y5_1.heavy 414.757 / 613.367 271178.0 22.097700119018555 48 18 10 10 10 6.95445618933873 14.379269532720802 0.0 3 0.9883701167378414 11.432807529484126 271178.0 242.35482012234542 0.0 - - - - - - - 789.5714285714286 542 7 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 63 8 C20140606_SFK034_02 C20140606_SFK034_02 TB555359.[MT7]-AVEPLR.2b4_1.heavy 414.757 / 541.31 88386.0 22.097700119018555 48 18 10 10 10 6.95445618933873 14.379269532720802 0.0 3 0.9883701167378414 11.432807529484126 88386.0 14.845741061706967 0.0 - - - - - - - 2270.0 176 1 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 65 9 C20140606_SFK034_02 C20140606_SFK034_02 TB555358.[MT7]-SPPEPR.2y4_1.heavy 413.731 / 498.267 26038.0 16.153400421142578 43 13 10 10 10 0.854626283426726 74.00943822937865 0.0 3 0.9195846945506198 4.322537819556371 26038.0 35.69162115055902 0.0 - - - - - - - 837.2857142857143 52 7 CYB5R1;RIPK4 cytochrome b5 reductase 1;receptor-interacting serine-threonine kinase 4 67 9 C20140606_SFK034_02 C20140606_SFK034_02 TB555358.[MT7]-SPPEPR.2y5_1.heavy 413.731 / 595.32 209088.0 16.153400421142578 43 13 10 10 10 0.854626283426726 74.00943822937865 0.0 3 0.9195846945506198 4.322537819556371 209088.0 623.8246143693862 0.0 - - - - - - - 228.0 418 3 CYB5R1;RIPK4 cytochrome b5 reductase 1;receptor-interacting serine-threonine kinase 4 69 9 C20140606_SFK034_02 C20140606_SFK034_02 TB555358.[MT7]-SPPEPR.2b4_1.heavy 413.731 / 555.289 139083.0 16.153400421142578 43 13 10 10 10 0.854626283426726 74.00943822937865 0.0 3 0.9195846945506198 4.322537819556371 139083.0 112.09009926376423 0.0 - - - - - - - 391.0 278 1 CYB5R1;RIPK4 cytochrome b5 reductase 1;receptor-interacting serine-threonine kinase 4 71 9 C20140606_SFK034_02 C20140606_SFK034_02 TB555358.[MT7]-SPPEPR.2b5_1.heavy 413.731 / 652.342 6009.0 16.153400421142578 43 13 10 10 10 0.854626283426726 74.00943822937865 0.0 3 0.9195846945506198 4.322537819556371 6009.0 9.399744027303754 0.0 - - - - - - - 706.0909090909091 12 11 CYB5R1;RIPK4 cytochrome b5 reductase 1;receptor-interacting serine-threonine kinase 4 73 10 C20140606_SFK034_02 C20140606_SFK034_02 TB403945.[MT7]-LNK[MT7]PADFIGK[MT7].3y7_1.heavy 512.315 / 891.506 8606.0 29.493799209594727 39 11 10 10 8 1.0574966815082472 62.417631634074496 0.0 4 0.8664068066207193 3.3381998122463044 8606.0 43.94068783068783 0.0 - - - - - - - 195.25 17 16 DMGDH dimethylglycine dehydrogenase 75 10 C20140606_SFK034_02 C20140606_SFK034_02 TB403945.[MT7]-LNK[MT7]PADFIGK[MT7].3y3_1.heavy 512.315 / 461.32 24495.0 29.493799209594727 39 11 10 10 8 1.0574966815082472 62.417631634074496 0.0 4 0.8664068066207193 3.3381998122463044 24495.0 12.235775048207621 2.0 - - - - - - - 2813.75 59 8 DMGDH dimethylglycine dehydrogenase 77 10 C20140606_SFK034_02 C20140606_SFK034_02 TB403945.[MT7]-LNK[MT7]PADFIGK[MT7].3y4_1.heavy 512.315 / 608.389 34048.0 29.493799209594727 39 11 10 10 8 1.0574966815082472 62.417631634074496 0.0 4 0.8664068066207193 3.3381998122463044 34048.0 54.618954714313645 0.0 - - - - - - - 797.1428571428571 68 7 DMGDH dimethylglycine dehydrogenase 79 10 C20140606_SFK034_02 C20140606_SFK034_02 TB403945.[MT7]-LNK[MT7]PADFIGK[MT7].3y5_1.heavy 512.315 / 723.416 7850.0 29.493799209594727 39 11 10 10 8 1.0574966815082472 62.417631634074496 0.0 4 0.8664068066207193 3.3381998122463044 7850.0 11.415345496651437 0.0 - - - - - - - 1092.6666666666667 15 9 DMGDH dimethylglycine dehydrogenase 81 11 C20140606_SFK034_02 C20140606_SFK034_02 TB557878.[MT7]-NDIAMAITK[MT7].3y3_1.heavy 422.244 / 505.347 48628.0 30.94219970703125 48 18 10 10 10 2.843701429866222 35.165435776675174 0.0 3 0.9819976890059546 9.184268111585547 48628.0 30.80404811994596 0.0 - - - - - - - 874.0 97 1 NFYC nuclear transcription factor Y, gamma 83 11 C20140606_SFK034_02 C20140606_SFK034_02 TB557878.[MT7]-NDIAMAITK[MT7].3b4_1.heavy 422.244 / 558.3 99224.0 30.94219970703125 48 18 10 10 10 2.843701429866222 35.165435776675174 0.0 3 0.9819976890059546 9.184268111585547 99224.0 92.92236813778257 0.0 - - - - - - - 328.0 198 1 NFYC nuclear transcription factor Y, gamma 85 11 C20140606_SFK034_02 C20140606_SFK034_02 TB557878.[MT7]-NDIAMAITK[MT7].3b5_1.heavy 422.244 / 689.341 38029.0 30.94219970703125 48 18 10 10 10 2.843701429866222 35.165435776675174 0.0 3 0.9819976890059546 9.184268111585547 38029.0 108.79004200723122 1.0 - - - - - - - 286.875 77 8 NFYC nuclear transcription factor Y, gamma 87 11 C20140606_SFK034_02 C20140606_SFK034_02 TB557878.[MT7]-NDIAMAITK[MT7].3b3_1.heavy 422.244 / 487.263 50923.0 30.94219970703125 48 18 10 10 10 2.843701429866222 35.165435776675174 0.0 3 0.9819976890059546 9.184268111585547 50923.0 23.38648643153272 0.0 - - - - - - - 819.5 101 2 NFYC nuclear transcription factor Y, gamma 89 12 C20140606_SFK034_02 C20140606_SFK034_02 TB558602.[MT7]-ISQGTFADVYR.2b8_1.heavy 700.868 / 964.486 35997.0 33.21929931640625 48 18 10 10 10 3.846538299211138 25.997401357087323 0.0 3 0.9832076507856218 9.510361516746553 35997.0 80.71377018633541 0.0 - - - - - - - 312.14285714285717 71 7 IRAK2 interleukin-1 receptor-associated kinase 2 91 12 C20140606_SFK034_02 C20140606_SFK034_02 TB558602.[MT7]-ISQGTFADVYR.2y8_1.heavy 700.868 / 928.452 38643.0 33.21929931640625 48 18 10 10 10 3.846538299211138 25.997401357087323 0.0 3 0.9832076507856218 9.510361516746553 38643.0 19.133263846266257 1.0 - - - - - - - 359.375 82 8 IRAK2 interleukin-1 receptor-associated kinase 2 93 12 C20140606_SFK034_02 C20140606_SFK034_02 TB558602.[MT7]-ISQGTFADVYR.2y9_1.heavy 700.868 / 1056.51 31972.0 33.21929931640625 48 18 10 10 10 3.846538299211138 25.997401357087323 0.0 3 0.9832076507856218 9.510361516746553 31972.0 52.26726956521739 0.0 - - - - - - - 733.125 63 8 IRAK2 interleukin-1 receptor-associated kinase 2 95 12 C20140606_SFK034_02 C20140606_SFK034_02 TB558602.[MT7]-ISQGTFADVYR.2y10_1.heavy 700.868 / 1143.54 108682.0 33.21929931640625 48 18 10 10 10 3.846538299211138 25.997401357087323 0.0 3 0.9832076507856218 9.510361516746553 108682.0 116.8725275362319 0.0 - - - - - - - 306.6666666666667 217 3 IRAK2 interleukin-1 receptor-associated kinase 2 97 13 C20140606_SFK034_02 C20140606_SFK034_02 TB556495.[MT7]-ATVEETAR.2y5_1.heavy 510.776 / 605.289 64330.0 17.02589988708496 50 20 10 10 10 4.084969260670645 19.01487899381168 0.0 3 0.9943008655340599 16.339977095164983 64330.0 201.558041885897 0.0 - - - - - - - 683.6666666666666 128 9 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 99 13 C20140606_SFK034_02 C20140606_SFK034_02 TB556495.[MT7]-ATVEETAR.2b4_1.heavy 510.776 / 545.305 47210.0 17.02589988708496 50 20 10 10 10 4.084969260670645 19.01487899381168 0.0 3 0.9943008655340599 16.339977095164983 47210.0 174.03048569316866 0.0 - - - - - - - 334.93333333333334 94 15 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 101 13 C20140606_SFK034_02 C20140606_SFK034_02 TB556495.[MT7]-ATVEETAR.2y6_1.heavy 510.776 / 704.357 43570.0 17.02589988708496 50 20 10 10 10 4.084969260670645 19.01487899381168 0.0 3 0.9943008655340599 16.339977095164983 43570.0 137.41096290826295 0.0 - - - - - - - 621.625 87 8 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 103 13 C20140606_SFK034_02 C20140606_SFK034_02 TB556495.[MT7]-ATVEETAR.2y7_1.heavy 510.776 / 805.405 125380.0 17.02589988708496 50 20 10 10 10 4.084969260670645 19.01487899381168 0.0 3 0.9943008655340599 16.339977095164983 125380.0 249.0402201302715 0.0 - - - - - - - 781.75 250 12 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 105 14 C20140606_SFK034_02 C20140606_SFK034_02 TB556491.[MT7]-LLVEEK[MT7].2y4_1.heavy 509.823 / 648.369 57942.0 28.632299423217773 50 20 10 10 10 13.279604296786943 7.530344863076637 0.0 3 0.9963112705535113 20.313762871411242 57942.0 67.93444812913651 0.0 - - - - - - - 1365.125 115 8 HSD3B2;RIPK4 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2;receptor-interacting serine-threonine kinase 4 107 14 C20140606_SFK034_02 C20140606_SFK034_02 TB556491.[MT7]-LLVEEK[MT7].2y5_1.heavy 509.823 / 761.453 61366.0 28.632299423217773 50 20 10 10 10 13.279604296786943 7.530344863076637 0.0 3 0.9963112705535113 20.313762871411242 61366.0 35.55836534938125 0.0 - - - - - - - 771.3333333333334 122 3 HSD3B2;RIPK4 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2;receptor-interacting serine-threonine kinase 4 109 14 C20140606_SFK034_02 C20140606_SFK034_02 TB556491.[MT7]-LLVEEK[MT7].2b4_1.heavy 509.823 / 599.388 16198.0 28.632299423217773 50 20 10 10 10 13.279604296786943 7.530344863076637 0.0 3 0.9963112705535113 20.313762871411242 16198.0 22.983868200590344 0.0 - - - - - - - 1269.2857142857142 32 7 HSD3B2;RIPK4 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2;receptor-interacting serine-threonine kinase 4 111 14 C20140606_SFK034_02 C20140606_SFK034_02 TB556491.[MT7]-LLVEEK[MT7].2y3_1.heavy 509.823 / 549.3 54980.0 28.632299423217773 50 20 10 10 10 13.279604296786943 7.530344863076637 0.0 3 0.9963112705535113 20.313762871411242 54980.0 49.27252171533119 0.0 - - - - - - - 1308.857142857143 109 7 HSD3B2;RIPK4 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2;receptor-interacting serine-threonine kinase 4 113 15 C20140606_SFK034_02 C20140606_SFK034_02 TB557056.[MT7]-LQPLDFK[MT7].2y4_1.heavy 574.849 / 666.394 9923.0 35.67399978637695 44 14 10 10 10 0.6548202630062059 77.95629613783457 0.0 3 0.9355522976347317 4.835018625179567 9923.0 11.983713508130748 0.0 - - - - - - - 1214.125 19 8 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 115 15 C20140606_SFK034_02 C20140606_SFK034_02 TB557056.[MT7]-LQPLDFK[MT7].2y5_1.heavy 574.849 / 763.447 160139.0 35.67399978637695 44 14 10 10 10 0.6548202630062059 77.95629613783457 0.0 3 0.9355522976347317 4.835018625179567 160139.0 235.54167775085403 0.0 - - - - - - - 708.8571428571429 320 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 117 15 C20140606_SFK034_02 C20140606_SFK034_02 TB557056.[MT7]-LQPLDFK[MT7].2y3_1.heavy 574.849 / 553.31 19740.0 35.67399978637695 44 14 10 10 10 0.6548202630062059 77.95629613783457 0.0 3 0.9355522976347317 4.835018625179567 19740.0 3.5803730396577755 1.0 - - - - - - - 2810.75 49 8 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 119 15 C20140606_SFK034_02 C20140606_SFK034_02 TB557056.[MT7]-LQPLDFK[MT7].2b5_1.heavy 574.849 / 711.416 77483.0 35.67399978637695 44 14 10 10 10 0.6548202630062059 77.95629613783457 0.0 3 0.9355522976347317 4.835018625179567 77483.0 117.85572105263157 0.0 - - - - - - - 905.0 154 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 121 16 C20140606_SFK034_02 C20140606_SFK034_02 TB404000.[MT7]-FATTFYQHLADSK[MT7].3y3_1.heavy 606.321 / 493.274 30164.0 36.36069869995117 45 17 10 10 8 1.267580901788349 49.40458954540834 0.0 4 0.9704199335054828 7.15791282935345 30164.0 10.877392855977877 1.0 - - - - - - - 2169.0 65 1 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 123 16 C20140606_SFK034_02 C20140606_SFK034_02 TB404000.[MT7]-FATTFYQHLADSK[MT7].3y6_1.heavy 606.321 / 814.454 19814.0 36.36069869995117 45 17 10 10 8 1.267580901788349 49.40458954540834 0.0 4 0.9704199335054828 7.15791282935345 19814.0 13.400368383010523 0.0 - - - - - - - 394.1666666666667 39 6 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 125 16 C20140606_SFK034_02 C20140606_SFK034_02 TB404000.[MT7]-FATTFYQHLADSK[MT7].3y4_1.heavy 606.321 / 564.311 89507.0 36.36069869995117 45 17 10 10 8 1.267580901788349 49.40458954540834 0.0 4 0.9704199335054828 7.15791282935345 89507.0 56.19416715372671 0.0 - - - - - - - 1818.111111111111 179 9 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 127 16 C20140606_SFK034_02 C20140606_SFK034_02 TB404000.[MT7]-FATTFYQHLADSK[MT7].3b7_1.heavy 606.321 / 1003.5 30953.0 36.36069869995117 45 17 10 10 8 1.267580901788349 49.40458954540834 0.0 4 0.9704199335054828 7.15791282935345 30953.0 68.76633695587896 0.0 - - - - - - - 309.85714285714283 61 14 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 129 17 C20140606_SFK034_02 C20140606_SFK034_02 TB558100.[MT7]-WIEEEAVK[MT7].2b3_1.heavy 646.36 / 573.315 8399.0 31.83989906311035 48 18 10 10 10 3.521570209650157 22.653424279558205 0.0 3 0.9837819051329745 9.677735449332529 8399.0 4.8816868639810505 0.0 - - - - - - - 460.0 16 1 DMGDH dimethylglycine dehydrogenase 131 17 C20140606_SFK034_02 C20140606_SFK034_02 TB558100.[MT7]-WIEEEAVK[MT7].2y5_1.heavy 646.36 / 719.406 6673.0 31.83989906311035 48 18 10 10 10 3.521570209650157 22.653424279558205 0.0 3 0.9837819051329745 9.677735449332529 6673.0 9.92669205850085 0.0 - - - - - - - 345.0 13 4 DMGDH dimethylglycine dehydrogenase 133 17 C20140606_SFK034_02 C20140606_SFK034_02 TB558100.[MT7]-WIEEEAVK[MT7].2y6_1.heavy 646.36 / 848.448 9435.0 31.83989906311035 48 18 10 10 10 3.521570209650157 22.653424279558205 0.0 3 0.9837819051329745 9.677735449332529 9435.0 10.360673546985335 0.0 - - - - - - - 747.5 18 8 DMGDH dimethylglycine dehydrogenase 135 17 C20140606_SFK034_02 C20140606_SFK034_02 TB558100.[MT7]-WIEEEAVK[MT7].2y7_1.heavy 646.36 / 961.532 13807.0 31.83989906311035 48 18 10 10 10 3.521570209650157 22.653424279558205 0.0 3 0.9837819051329745 9.677735449332529 13807.0 35.55285116669465 0.0 - - - - - - - 702.7777777777778 27 9 DMGDH dimethylglycine dehydrogenase 137 18 C20140606_SFK034_02 C20140606_SFK034_02 TB456446.[MT7]-ILLVTDGAR.2y8_1.heavy 551.341 / 844.489 269017.0 33.98870086669922 47 17 10 10 10 3.259816845272424 25.054060679781088 0.0 3 0.9755943602607698 7.883698794751595 269017.0 310.69206167394765 0.0 - - - - - - - 873.6 538 5 LAMA5 laminin, alpha 5 139 18 C20140606_SFK034_02 C20140606_SFK034_02 TB456446.[MT7]-ILLVTDGAR.2y5_1.heavy 551.341 / 519.252 113147.0 33.98870086669922 47 17 10 10 10 3.259816845272424 25.054060679781088 0.0 3 0.9755943602607698 7.883698794751595 113147.0 32.224775602539175 0.0 - - - - - - - 1278.0 226 1 LAMA5 laminin, alpha 5 141 18 C20140606_SFK034_02 C20140606_SFK034_02 TB456446.[MT7]-ILLVTDGAR.2y6_1.heavy 551.341 / 618.321 168442.0 33.98870086669922 47 17 10 10 10 3.259816845272424 25.054060679781088 0.0 3 0.9755943602607698 7.883698794751595 168442.0 90.67678133577678 0.0 - - - - - - - 1385.0 336 1 LAMA5 laminin, alpha 5 143 18 C20140606_SFK034_02 C20140606_SFK034_02 TB456446.[MT7]-ILLVTDGAR.2y7_1.heavy 551.341 / 731.405 144896.0 33.98870086669922 47 17 10 10 10 3.259816845272424 25.054060679781088 0.0 3 0.9755943602607698 7.883698794751595 144896.0 102.97434796877899 0.0 - - - - - - - 1235.6 289 5 LAMA5 laminin, alpha 5 145 19 C20140606_SFK034_02 C20140606_SFK034_02 TB558104.[MT7]-IESVLSSSGK[MT7].2y8_1.heavy 647.876 / 908.517 6845.0 30.17639923095703 46 16 10 10 10 1.8303717163383857 39.82856627844117 0.0 3 0.9610459535209612 6.232554848296388 6845.0 -0.31672277097334217 2.0 - - - - - - - 290.4 18 5 GM2A GM2 ganglioside activator 147 19 C20140606_SFK034_02 C20140606_SFK034_02 TB558104.[MT7]-IESVLSSSGK[MT7].2y5_1.heavy 647.876 / 609.332 18254.0 30.17639923095703 46 16 10 10 10 1.8303717163383857 39.82856627844117 0.0 3 0.9610459535209612 6.232554848296388 18254.0 13.640996384089995 0.0 - - - - - - - 803.5 36 4 GM2A GM2 ganglioside activator 149 19 C20140606_SFK034_02 C20140606_SFK034_02 TB558104.[MT7]-IESVLSSSGK[MT7].2y9_1.heavy 647.876 / 1037.56 19499.0 30.17639923095703 46 16 10 10 10 1.8303717163383857 39.82856627844117 0.0 3 0.9610459535209612 6.232554848296388 19499.0 21.929480861170674 0.0 - - - - - - - 293.6666666666667 38 6 GM2A GM2 ganglioside activator 151 19 C20140606_SFK034_02 C20140606_SFK034_02 TB558104.[MT7]-IESVLSSSGK[MT7].2y6_1.heavy 647.876 / 722.417 23544.0 30.17639923095703 46 16 10 10 10 1.8303717163383857 39.82856627844117 0.0 3 0.9610459535209612 6.232554848296388 23544.0 37.82616170554259 0.0 - - - - - - - 345.6666666666667 47 3 GM2A GM2 ganglioside activator 153 20 C20140606_SFK034_02 C20140606_SFK034_02 TB556202.[MT7]-LDSELK[MT7].2y4_1.heavy 496.797 / 620.374 33025.0 25.519500732421875 50 20 10 10 10 9.151223421848213 10.927500661961071 0.0 3 0.9937699886192972 15.627597608799613 33025.0 21.111464939486993 0.0 - - - - - - - 859.0 66 1 GOLGA3;KRT1;KRT3 golgin A3;keratin 1;keratin 3 155 20 C20140606_SFK034_02 C20140606_SFK034_02 TB556202.[MT7]-LDSELK[MT7].2y5_1.heavy 496.797 / 735.401 35133.0 25.519500732421875 50 20 10 10 10 9.151223421848213 10.927500661961071 0.0 3 0.9937699886192972 15.627597608799613 35133.0 26.089307818299194 0.0 - - - - - - - 703.0 70 2 GOLGA3;KRT1;KRT3 golgin A3;keratin 1;keratin 3 157 20 C20140606_SFK034_02 C20140606_SFK034_02 TB556202.[MT7]-LDSELK[MT7].2b4_1.heavy 496.797 / 589.295 19128.0 25.519500732421875 50 20 10 10 10 9.151223421848213 10.927500661961071 0.0 3 0.9937699886192972 15.627597608799613 19128.0 6.057074614432144 1.0 - - - - - - - 1327.0 38 1 GOLGA3;KRT1;KRT3 golgin A3;keratin 1;keratin 3 159 20 C20140606_SFK034_02 C20140606_SFK034_02 TB556202.[MT7]-LDSELK[MT7].2y3_1.heavy 496.797 / 533.341 9369.0 25.519500732421875 50 20 10 10 10 9.151223421848213 10.927500661961071 0.0 3 0.9937699886192972 15.627597608799613 9369.0 2.125404598365269 1.0 - - - - - - - 1483.0 18 1 GOLGA3;KRT1;KRT3 golgin A3;keratin 1;keratin 3 161 21 C20140606_SFK034_02 C20140606_SFK034_02 TB558102.[MT7]-ETALDPDHPR.3b5_1.heavy 432.222 / 674.348 154220.0 20.076324939727783 47 20 10 7 10 11.260170341772488 8.880860321359826 0.028699874877929688 3 0.9977024508684504 25.742266377066947 154220.0 168.8997375420298 0.0 - - - - - - - 1282.1 308 10 NPHP3 nephronophthisis 3 (adolescent) 163 21 C20140606_SFK034_02 C20140606_SFK034_02 TB558102.[MT7]-ETALDPDHPR.3y4_1.heavy 432.222 / 524.258 97598.0 20.076324939727783 47 20 10 7 10 11.260170341772488 8.880860321359826 0.028699874877929688 3 0.9977024508684504 25.742266377066947 97598.0 127.26882127465396 1.0 - - - - - - - 1768.3333333333333 236 9 NPHP3 nephronophthisis 3 (adolescent) 165 21 C20140606_SFK034_02 C20140606_SFK034_02 TB558102.[MT7]-ETALDPDHPR.3b3_1.heavy 432.222 / 446.237 266433.0 20.076324939727783 47 20 10 7 10 11.260170341772488 8.880860321359826 0.028699874877929688 3 0.9977024508684504 25.742266377066947 266433.0 64.70262090452567 0.0 - - - - - - - 1928.0 532 1 NPHP3 nephronophthisis 3 (adolescent) 167 21 C20140606_SFK034_02 C20140606_SFK034_02 TB558102.[MT7]-ETALDPDHPR.3y5_1.heavy 432.222 / 621.31 149558.0 20.076324939727783 47 20 10 7 10 11.260170341772488 8.880860321359826 0.028699874877929688 3 0.9977024508684504 25.742266377066947 149558.0 188.28008969615803 0.0 - - - - - - - 862.875 299 8 NPHP3 nephronophthisis 3 (adolescent) 169 22 C20140606_SFK034_02 C20140606_SFK034_02 TB326470.[MT7]-RVLLQLELR.2y8_1.heavy 642.418 / 983.625 17454.0 36.02450180053711 30 10 4 10 6 1.7144612266301105 58.327361649675076 0.0 5 0.8234144507604392 2.89251991562779 17454.0 17.35998757541763 0.0 - - - - - - - 805.875 34 8 LRP3 low density lipoprotein receptor-related protein 3 171 22 C20140606_SFK034_02 C20140606_SFK034_02 TB326470.[MT7]-RVLLQLELR.2b7_1.heavy 642.418 / 996.632 46610.0 36.02450180053711 30 10 4 10 6 1.7144612266301105 58.327361649675076 0.0 5 0.8234144507604392 2.89251991562779 46610.0 102.19180047916275 0.0 - - - - - - - 807.7142857142857 93 7 LRP3 low density lipoprotein receptor-related protein 3 173 22 C20140606_SFK034_02 C20140606_SFK034_02 TB326470.[MT7]-RVLLQLELR.2b5_1.heavy 642.418 / 754.506 4859.0 36.02450180053711 30 10 4 10 6 1.7144612266301105 58.327361649675076 0.0 5 0.8234144507604392 2.89251991562779 4859.0 4.844401486401012 0.0 - - - - - - - 1317.5714285714287 9 7 LRP3 low density lipoprotein receptor-related protein 3 175 22 C20140606_SFK034_02 C20140606_SFK034_02 TB326470.[MT7]-RVLLQLELR.2y7_1.heavy 642.418 / 884.556 6248.0 36.02450180053711 30 10 4 10 6 1.7144612266301105 58.327361649675076 0.0 5 0.8234144507604392 2.89251991562779 6248.0 8.460167797713119 4.0 - - - - - - - 805.75 174 8 LRP3 low density lipoprotein receptor-related protein 3 177 23 C20140606_SFK034_02 C20140606_SFK034_02 TB560652.[MT7]-SLTFNETY[MT7]QDISELVYGAK[MT7].4y4_1.heavy 653.347 / 582.337 32264.0 45.214900970458984 32 8 10 10 4 1.1625408767815273 78.1399931274795 0.0 10 0.7516101149780845 2.423070196449517 32264.0 47.30841816230061 2.0 - - - - - - - 442.0 65 1 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 179 23 C20140606_SFK034_02 C20140606_SFK034_02 TB560652.[MT7]-SLTFNETY[MT7]QDISELVYGAK[MT7].4b4_1.heavy 653.347 / 593.341 2652.0 45.214900970458984 32 8 10 10 4 1.1625408767815273 78.1399931274795 0.0 10 0.7516101149780845 2.423070196449517 2652.0 3.920380147835269 4.0 - - - - - - - 331.75 12 4 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 181 23 C20140606_SFK034_02 C20140606_SFK034_02 TB560652.[MT7]-SLTFNETY[MT7]QDISELVYGAK[MT7].4b5_1.heavy 653.347 / 707.385 3536.0 45.214900970458984 32 8 10 10 4 1.1625408767815273 78.1399931274795 0.0 10 0.7516101149780845 2.423070196449517 3536.0 3.150891089108911 3.0 - - - - - - - 331.625 12 8 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 183 23 C20140606_SFK034_02 C20140606_SFK034_02 TB560652.[MT7]-SLTFNETY[MT7]QDISELVYGAK[MT7].4b6_1.heavy 653.347 / 836.427 3915.0 45.214900970458984 32 8 10 10 4 1.1625408767815273 78.1399931274795 0.0 10 0.7516101149780845 2.423070196449517 3915.0 2.28375 3.0 - - - - - - - 210.33333333333334 13 6 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 185 24 C20140606_SFK034_02 C20140606_SFK034_02 TB403738.[MT7]-VSGILVK[MT7].2y5_1.heavy 502.341 / 673.473 17032.0 30.13409996032715 35 15 2 10 8 2.2412402568599776 34.987998030767265 0.0 4 0.9507683216574496 5.539135532113095 17032.0 46.867221407712336 0.0 - - - - - - - 1222.375 34 8 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 187 24 C20140606_SFK034_02 C20140606_SFK034_02 TB403738.[MT7]-VSGILVK[MT7].2b4_1.heavy 502.341 / 501.315 54356.0 30.13409996032715 35 15 2 10 8 2.2412402568599776 34.987998030767265 0.0 4 0.9507683216574496 5.539135532113095 54356.0 15.276529882437366 0.0 - - - - - - - 1367.0 108 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 189 24 C20140606_SFK034_02 C20140606_SFK034_02 TB403738.[MT7]-VSGILVK[MT7].2y6_1.heavy 502.341 / 760.505 84320.0 30.13409996032715 35 15 2 10 8 2.2412402568599776 34.987998030767265 0.0 4 0.9507683216574496 5.539135532113095 84320.0 40.671738167392554 0.0 - - - - - - - 762.25 168 4 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 191 24 C20140606_SFK034_02 C20140606_SFK034_02 TB403738.[MT7]-VSGILVK[MT7].2b5_1.heavy 502.341 / 614.399 28387.0 30.13409996032715 35 15 2 10 8 2.2412402568599776 34.987998030767265 0.0 4 0.9507683216574496 5.539135532113095 28387.0 8.599371860682597 1.0 - - - - - - - 841.0 526 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 193 25 C20140606_SFK034_02 C20140606_SFK034_02 TB456640.[MT7]-DLGLLSQAIVPLQR.3y6_1.heavy 556.337 / 725.467 295483.0 44.56740188598633 46 16 10 10 10 2.5706146117353175 30.65981889751192 0.0 3 0.9623783656927197 6.342675294956518 295483.0 793.3646877638732 0.0 - - - - - - - 279.3333333333333 590 9 NPHP3 nephronophthisis 3 (adolescent) 195 25 C20140606_SFK034_02 C20140606_SFK034_02 TB456640.[MT7]-DLGLLSQAIVPLQR.3b4_1.heavy 556.337 / 543.326 502636.0 44.56740188598633 46 16 10 10 10 2.5706146117353175 30.65981889751192 0.0 3 0.9623783656927197 6.342675294956518 502636.0 575.7503644603048 0.0 - - - - - - - 251.33333333333334 1005 3 NPHP3 nephronophthisis 3 (adolescent) 197 25 C20140606_SFK034_02 C20140606_SFK034_02 TB456640.[MT7]-DLGLLSQAIVPLQR.3y4_1.heavy 556.337 / 513.314 774345.0 44.56740188598633 46 16 10 10 10 2.5706146117353175 30.65981889751192 0.0 3 0.9623783656927197 6.342675294956518 774345.0 630.5234476876469 0.0 - - - - - - - 1243.3333333333333 1548 9 NPHP3 nephronophthisis 3 (adolescent) 199 25 C20140606_SFK034_02 C20140606_SFK034_02 TB456640.[MT7]-DLGLLSQAIVPLQR.3y5_1.heavy 556.337 / 612.383 352065.0 44.56740188598633 46 16 10 10 10 2.5706146117353175 30.65981889751192 0.0 3 0.9623783656927197 6.342675294956518 352065.0 700.9101716319263 0.0 - - - - - - - 730.875 704 8 NPHP3 nephronophthisis 3 (adolescent) 201 26 C20140606_SFK034_02 C20140606_SFK034_02 TB558757.[MT7]-RLLC[CAM]PDPVC[CAM]R.3y6_1.heavy 477.256 / 743.351 13047.0 25.945100784301758 48 20 10 10 8 19.045432500056965 5.250602736362165 0.0 4 0.9989156165732579 37.47414053283104 13047.0 80.7890959669048 0.0 - - - - - - - 693.0 26 7 FAM75D4;FAM75D3;FAM75D1 family with sequence similarity 75, member D4;family with sequence similarity 75, member D3;family with sequence similarity 75, member D1 203 26 C20140606_SFK034_02 C20140606_SFK034_02 TB558757.[MT7]-RLLC[CAM]PDPVC[CAM]R.3b4_1.heavy 477.256 / 687.409 10621.0 25.945100784301758 48 20 10 10 8 19.045432500056965 5.250602736362165 0.0 4 0.9989156165732579 37.47414053283104 10621.0 12.472549407114625 0.0 - - - - - - - 752.6363636363636 21 11 FAM75D4;FAM75D3;FAM75D1 family with sequence similarity 75, member D4;family with sequence similarity 75, member D3;family with sequence similarity 75, member D1 205 26 C20140606_SFK034_02 C20140606_SFK034_02 TB558757.[MT7]-RLLC[CAM]PDPVC[CAM]R.3b3_1.heavy 477.256 / 527.379 13214.0 25.945100784301758 48 20 10 10 8 19.045432500056965 5.250602736362165 0.0 4 0.9989156165732579 37.47414053283104 13214.0 9.191317601808779 1.0 - - - - - - - 1696.5714285714287 55 7 FAM75D4;FAM75D3;FAM75D1 family with sequence similarity 75, member D4;family with sequence similarity 75, member D3;family with sequence similarity 75, member D1 207 26 C20140606_SFK034_02 C20140606_SFK034_02 TB558757.[MT7]-RLLC[CAM]PDPVC[CAM]R.3y4_1.heavy 477.256 / 531.271 164253.0 25.945100784301758 48 20 10 10 8 19.045432500056965 5.250602736362165 0.0 4 0.9989156165732579 37.47414053283104 164253.0 108.32364491373252 0.0 - - - - - - - 1233.5 328 4 FAM75D4;FAM75D3;FAM75D1 family with sequence similarity 75, member D4;family with sequence similarity 75, member D3;family with sequence similarity 75, member D1 209 27 C20140606_SFK034_02 C20140606_SFK034_02 TB555364.[MT7]-ALEAQR.2y4_1.heavy 416.244 / 503.257 42179.0 17.346099853515625 48 18 10 10 10 3.809445525482926 26.25053943705441 0.0 3 0.982895031235925 9.422805507114392 42179.0 21.226512002198277 0.0 - - - - - - - 1287.75 84 4 GLDN gliomedin 211 27 C20140606_SFK034_02 C20140606_SFK034_02 TB555364.[MT7]-ALEAQR.2b3_1.heavy 416.244 / 458.273 60693.0 17.346099853515625 48 18 10 10 10 3.809445525482926 26.25053943705441 0.0 3 0.982895031235925 9.422805507114392 60693.0 24.83196659451798 0.0 - - - - - - - 1853.0 121 3 GLDN gliomedin 213 27 C20140606_SFK034_02 C20140606_SFK034_02 TB555364.[MT7]-ALEAQR.2y5_1.heavy 416.244 / 616.341 121846.0 17.346099853515625 48 18 10 10 10 3.809445525482926 26.25053943705441 0.0 3 0.982895031235925 9.422805507114392 121846.0 95.90226742106461 0.0 - - - - - - - 1806.857142857143 243 7 GLDN gliomedin 215 27 C20140606_SFK034_02 C20140606_SFK034_02 TB555364.[MT7]-ALEAQR.2b4_1.heavy 416.244 / 529.31 50340.0 17.346099853515625 48 18 10 10 10 3.809445525482926 26.25053943705441 0.0 3 0.982895031235925 9.422805507114392 50340.0 23.776798638591025 0.0 - - - - - - - 1792.2857142857142 100 7 GLDN gliomedin 217 28 C20140606_SFK034_02 C20140606_SFK034_02 TPX_ECO57.AQTFTLVAK.2y7.peptide 489.78 / 779.47 3221180.0 29.821300506591797 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 3221180.0 8660.548872819114 0.0 - - - - - - - 308.5 6442 2 219 28 C20140606_SFK034_02 C20140606_SFK034_02 TPX_ECO57.AQTFTLVAK.2y6.peptide 489.78 / 678.42 1146640.0 29.821300506591797 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1146640.0 1248.1685868326786 0.0 - - - - - - - 309.0 2293 1 221 28 C20140606_SFK034_02 C20140606_SFK034_02 TPX_ECO57.AQTFTLVAK.2y5.peptide 489.78 / 531.35 1047000.0 29.821300506591797 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1047000.0 478.78764928924693 0.0 - - - - - - - 720.0 2094 1 223 29 C20140606_SFK034_02 C20140606_SFK034_02 TB560506.[MT7]-RATADIQQLLSWESLK[MT7].3b6_1.heavy 716.407 / 772.443 13725.0 42.77250099182129 37 11 10 6 10 1.0102274287901654 65.62364234208903 0.032001495361328125 3 0.8687075294641992 3.3680003522930355 13725.0 23.427118665559284 0.0 - - - - - - - 1164.111111111111 27 9 FAM75D1 family with sequence similarity 75, member D1 225 29 C20140606_SFK034_02 C20140606_SFK034_02 TB560506.[MT7]-RATADIQQLLSWESLK[MT7].3y6_1.heavy 716.407 / 893.485 37988.0 42.77250099182129 37 11 10 6 10 1.0102274287901654 65.62364234208903 0.032001495361328125 3 0.8687075294641992 3.3680003522930355 37988.0 54.29272227654059 0.0 - - - - - - - 771.0 75 12 FAM75D1 family with sequence similarity 75, member D1 227 29 C20140606_SFK034_02 C20140606_SFK034_02 TB560506.[MT7]-RATADIQQLLSWESLK[MT7].3b5_1.heavy 716.407 / 659.359 24324.0 42.77250099182129 37 11 10 6 10 1.0102274287901654 65.62364234208903 0.032001495361328125 3 0.8687075294641992 3.3680003522930355 24324.0 20.490893081436088 0.0 - - - - - - - 2221.125 48 8 FAM75D1 family with sequence similarity 75, member D1 229 29 C20140606_SFK034_02 C20140606_SFK034_02 TB560506.[MT7]-RATADIQQLLSWESLK[MT7].3b7_1.heavy 716.407 / 900.502 20281.0 42.77250099182129 37 11 10 6 10 1.0102274287901654 65.62364234208903 0.032001495361328125 3 0.8687075294641992 3.3680003522930355 20281.0 39.16970335185517 1.0 - - - - - - - 777.375 40 16 FAM75D1 family with sequence similarity 75, member D1 231 30 C20140606_SFK034_02 C20140606_SFK034_02 TB326445.[MT7]-EVAGLWIK[MT7].2y5_1.heavy 602.371 / 760.484 56212.0 37.49369812011719 46 16 10 10 10 2.0608101094223237 33.3282477264507 0.0 3 0.9671862016678395 6.794215798980665 56212.0 66.4092704970949 0.0 - - - - - - - 808.625 112 8 GM2A GM2 ganglioside activator 233 30 C20140606_SFK034_02 C20140606_SFK034_02 TB326445.[MT7]-EVAGLWIK[MT7].2b4_1.heavy 602.371 / 501.279 47375.0 37.49369812011719 46 16 10 10 10 2.0608101094223237 33.3282477264507 0.0 3 0.9671862016678395 6.794215798980665 47375.0 26.641544131094356 0.0 - - - - - - - 820.0 94 1 GM2A GM2 ganglioside activator 235 30 C20140606_SFK034_02 C20140606_SFK034_02 TB326445.[MT7]-EVAGLWIK[MT7].2y3_1.heavy 602.371 / 590.378 73522.0 37.49369812011719 46 16 10 10 10 2.0608101094223237 33.3282477264507 0.0 3 0.9671862016678395 6.794215798980665 73522.0 35.34518333493541 0.0 - - - - - - - 2186.4285714285716 147 7 GM2A GM2 ganglioside activator 237 30 C20140606_SFK034_02 C20140606_SFK034_02 TB326445.[MT7]-EVAGLWIK[MT7].2b5_1.heavy 602.371 / 614.363 N/A 37.49369812011719 46 16 10 10 10 2.0608101094223237 33.3282477264507 0.0 3 0.9671862016678395 6.794215798980665 56667.0 30.908966894639228 1.0 - - - - - - - 911.0 137 2 GM2A GM2 ganglioside activator 239 31 C20140606_SFK034_02 C20140606_SFK034_02 TB557237.[MT7]-RATVEETAR.2y8_1.heavy 588.826 / 876.442 3070.0 15.565299987792969 43 13 10 10 10 1.267918920649089 45.670743876699525 0.0 3 0.9131978307279598 4.158190496326743 3070.0 33.5183606557377 0.0 - - - - - - - 119.0 6 10 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 241 31 C20140606_SFK034_02 C20140606_SFK034_02 TB557237.[MT7]-RATVEETAR.2b6_1.heavy 588.826 / 830.449 3757.0 15.565299987792969 43 13 10 10 10 1.267918920649089 45.670743876699525 0.0 3 0.9131978307279598 4.158190496326743 3757.0 93.925 0.0 - - - - - - - 169.15384615384616 7 13 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 243 31 C20140606_SFK034_02 C20140606_SFK034_02 TB557237.[MT7]-RATVEETAR.2b5_1.heavy 588.826 / 701.406 1695.0 15.565299987792969 43 13 10 10 10 1.267918920649089 45.670743876699525 0.0 3 0.9131978307279598 4.158190496326743 1695.0 11.272187375942835 0.0 - - - - - - - 168.72727272727272 3 22 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 245 31 C20140606_SFK034_02 C20140606_SFK034_02 TB557237.[MT7]-RATVEETAR.2y7_1.heavy 588.826 / 805.405 596.0 15.565299987792969 43 13 10 10 10 1.267918920649089 45.670743876699525 0.0 3 0.9131978307279598 4.158190496326743 596.0 4.948391438184551 0.0 - - - - - - - 0.0 1 0 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 247 32 C20140606_SFK034_02 C20140606_SFK034_02 TB557235.[MT7]-QENAAVQK[MT7].2b3_1.heavy 588.335 / 516.253 N/A 16.430099487304688 41 15 10 6 10 2.400947444637688 33.17039953037939 0.03299903869628906 3 0.9564684735464302 5.893485736420977 4792.0 4.615344633572308 0.0 - - - - - - - 1241.875 9 8 NIN ninein (GSK3B interacting protein) 249 32 C20140606_SFK034_02 C20140606_SFK034_02 TB557235.[MT7]-QENAAVQK[MT7].2b4_1.heavy 588.335 / 587.291 4792.0 16.430099487304688 41 15 10 6 10 2.400947444637688 33.17039953037939 0.03299903869628906 3 0.9564684735464302 5.893485736420977 4792.0 18.604469011262353 0.0 - - - - - - - 225.78947368421052 9 19 NIN ninein (GSK3B interacting protein) 251 32 C20140606_SFK034_02 C20140606_SFK034_02 TB557235.[MT7]-QENAAVQK[MT7].2b5_1.heavy 588.335 / 658.328 6053.0 16.430099487304688 41 15 10 6 10 2.400947444637688 33.17039953037939 0.03299903869628906 3 0.9564684735464302 5.893485736420977 6053.0 46.745940594059405 0.0 - - - - - - - 192.14285714285714 12 21 NIN ninein (GSK3B interacting protein) 253 32 C20140606_SFK034_02 C20140606_SFK034_02 TB557235.[MT7]-QENAAVQK[MT7].2y7_1.heavy 588.335 / 903.502 9230.0 16.430099487304688 41 15 10 6 10 2.400947444637688 33.17039953037939 0.03299903869628906 3 0.9564684735464302 5.893485736420977 9230.0 26.409386313080645 0.0 - - - - - - - 212.3684210526316 18 19 NIN ninein (GSK3B interacting protein) 255 33 C20140606_SFK034_02 C20140606_SFK034_02 TB557998.[MT7]-LLC[CAM]PDPVC[CAM]R.2y8_1.heavy 637.329 / 1016.47 55433.0 30.65850067138672 50 20 10 10 10 49.96480753630441 2.0014086900532946 0.0 2 0.9993899690470832 49.96482305192843 55433.0 61.49775103603458 0.0 - - - - - - - 429.0 110 1 FAM75D4;FAM75D3;FAM75D1 family with sequence similarity 75, member D4;family with sequence similarity 75, member D3;family with sequence similarity 75, member D1 257 33 C20140606_SFK034_02 C20140606_SFK034_02 TB557998.[MT7]-LLC[CAM]PDPVC[CAM]R.2y7_1.heavy 637.329 / 903.381 35704.0 30.65850067138672 50 20 10 10 10 49.96480753630441 2.0014086900532946 0.0 2 0.9993899690470832 49.96482305192843 35704.0 69.1880621761658 0.0 - - - - - - - 750.5555555555555 71 9 FAM75D4;FAM75D3;FAM75D1 family with sequence similarity 75, member D4;family with sequence similarity 75, member D3;family with sequence similarity 75, member D1 259 34 C20140606_SFK034_02 C20140606_SFK034_02 TB557233.[MT7]-TANLNLETR.2y8_1.heavy 588.329 / 930.5 119442.0 25.604700088500977 45 15 10 10 10 7.349170005741417 13.606978736629667 0.0 3 0.9565673517587069 5.900239846025686 119442.0 284.30737111373475 0.0 - - - - - - - 359.27272727272725 238 11 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 261 34 C20140606_SFK034_02 C20140606_SFK034_02 TB557233.[MT7]-TANLNLETR.2b4_1.heavy 588.329 / 544.321 39760.0 25.604700088500977 45 15 10 10 10 7.349170005741417 13.606978736629667 0.0 3 0.9565673517587069 5.900239846025686 39760.0 13.814878638177044 0.0 - - - - - - - 2863.0 79 2 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 263 34 C20140606_SFK034_02 C20140606_SFK034_02 TB557233.[MT7]-TANLNLETR.2b5_1.heavy 588.329 / 658.364 34034.0 25.604700088500977 45 15 10 10 10 7.349170005741417 13.606978736629667 0.0 3 0.9565673517587069 5.900239846025686 34034.0 19.859372720641865 0.0 - - - - - - - 760.4285714285714 68 7 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 265 34 C20140606_SFK034_02 C20140606_SFK034_02 TB557233.[MT7]-TANLNLETR.2y7_1.heavy 588.329 / 859.463 35002.0 25.604700088500977 45 15 10 10 10 7.349170005741417 13.606978736629667 0.0 3 0.9565673517587069 5.900239846025686 35002.0 24.334531140535237 0.0 - - - - - - - 349.6666666666667 70 6 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 267 35 C20140606_SFK034_02 C20140606_SFK034_02 ODP2_ECOLI.AEAPAAAPAAK.2y7.peptide 484.26 / 599.35 2051200.0 16.055166880289715 23 -3 10 6 10 null 0.0 0.0355987548828125 3 0.0 0.0 2051200.0 3024.1069194897286 0.0 - - - - - - - 819.5555555555555 4102 9 269 35 C20140606_SFK034_02 C20140606_SFK034_02 ODP2_ECOLI.AEAPAAAPAAK.2y8.peptide 484.26 / 696.4 3090120.0 16.055166880289715 23 -3 10 6 10 null 0.0 0.0355987548828125 3 0.0 0.0 3090120.0 8580.682522647745 0.0 - - - - - - - 1296.0 6180 7 271 35 C20140606_SFK034_02 C20140606_SFK034_02 ODP2_ECOLI.AEAPAAAPAAK.2y6.peptide 484.26 / 528.31 1696330.0 16.055166880289715 23 -3 10 6 10 null 0.0 0.0355987548828125 3 0.0 0.0 1696330.0 2120.6190565235065 0.0 - - - - - - - 790.2857142857143 3392 7 273 36 C20140606_SFK034_02 C20140606_SFK034_02 TB557833.[MT7]-IVNAAGFWAR.2y8_1.heavy 624.852 / 892.442 47929.0 38.839298248291016 48 18 10 10 10 4.897376436940155 20.41909607881384 0.0 3 0.9834711106172783 9.586068138514138 47929.0 40.54377580839379 0.0 - - - - - - - 818.9 95 10 DMGDH dimethylglycine dehydrogenase 275 36 C20140606_SFK034_02 C20140606_SFK034_02 TB557833.[MT7]-IVNAAGFWAR.2y9_1.heavy 624.852 / 991.511 116288.0 38.839298248291016 48 18 10 10 10 4.897376436940155 20.41909607881384 0.0 3 0.9834711106172783 9.586068138514138 116288.0 77.55769157437831 0.0 - - - - - - - 345.0 232 1 DMGDH dimethylglycine dehydrogenase 277 36 C20140606_SFK034_02 C20140606_SFK034_02 TB557833.[MT7]-IVNAAGFWAR.2y6_1.heavy 624.852 / 707.362 30947.0 38.839298248291016 48 18 10 10 10 4.897376436940155 20.41909607881384 0.0 3 0.9834711106172783 9.586068138514138 30947.0 38.1507614213198 0.0 - - - - - - - 1206.875 61 8 DMGDH dimethylglycine dehydrogenase 279 36 C20140606_SFK034_02 C20140606_SFK034_02 TB557833.[MT7]-IVNAAGFWAR.2y7_1.heavy 624.852 / 778.399 20430.0 38.839298248291016 48 18 10 10 10 4.897376436940155 20.41909607881384 0.0 3 0.9834711106172783 9.586068138514138 20430.0 12.89896614626891 0.0 - - - - - - - 776.0 40 1 DMGDH dimethylglycine dehydrogenase 281 37 C20140606_SFK034_02 C20140606_SFK034_02 TB556619.[MT7]-GLLLFTAR.2y5_1.heavy 517.828 / 607.356 39532.0 41.635501861572266 50 20 10 10 10 10.522346797667812 9.503583366228163 0.0 3 0.9942440048665555 16.258992253062548 39532.0 64.736060649167 0.0 - - - - - - - 727.3636363636364 79 11 LAMA5 laminin, alpha 5 283 37 C20140606_SFK034_02 C20140606_SFK034_02 TB556619.[MT7]-GLLLFTAR.2b4_1.heavy 517.828 / 541.383 27162.0 41.635501861572266 50 20 10 10 10 10.522346797667812 9.503583366228163 0.0 3 0.9942440048665555 16.258992253062548 27162.0 43.60435957102388 0.0 - - - - - - - 706.0 54 10 LAMA5 laminin, alpha 5 285 37 C20140606_SFK034_02 C20140606_SFK034_02 TB556619.[MT7]-GLLLFTAR.2y6_1.heavy 517.828 / 720.44 27498.0 41.635501861572266 50 20 10 10 10 10.522346797667812 9.503583366228163 0.0 3 0.9942440048665555 16.258992253062548 27498.0 68.81583723625204 0.0 - - - - - - - 709.7777777777778 54 9 LAMA5 laminin, alpha 5 287 37 C20140606_SFK034_02 C20140606_SFK034_02 TB556619.[MT7]-GLLLFTAR.2y7_1.heavy 517.828 / 833.524 14925.0 41.635501861572266 50 20 10 10 10 10.522346797667812 9.503583366228163 0.0 3 0.9942440048665555 16.258992253062548 14925.0 112.04703959541138 0.0 - - - - - - - 186.07692307692307 29 13 LAMA5 laminin, alpha 5 289 38 C20140606_SFK034_02 C20140606_SFK034_02 TB456655.[MT7]-FDQFDFLIDIVPR.3y6_1.heavy 590.318 / 712.435 127104.0 53.925899505615234 42 12 10 10 10 1.5627139299607362 50.379139006400685 0.0 3 0.8937585706827263 3.752262803878944 127104.0 -2.8969572649572797 0.0 - - - - - - - 294.0 254 7 NFYC nuclear transcription factor Y, gamma 291 38 C20140606_SFK034_02 C20140606_SFK034_02 TB456655.[MT7]-FDQFDFLIDIVPR.3b5_1.heavy 590.318 / 797.359 146902.0 53.925899505615234 42 12 10 10 10 1.5627139299607362 50.379139006400685 0.0 3 0.8937585706827263 3.752262803878944 146902.0 193.19166314653148 0.0 - - - - - - - 319.3333333333333 293 3 NFYC nuclear transcription factor Y, gamma 293 38 C20140606_SFK034_02 C20140606_SFK034_02 TB456655.[MT7]-FDQFDFLIDIVPR.3b3_1.heavy 590.318 / 535.263 59719.0 53.925899505615234 42 12 10 10 10 1.5627139299607362 50.379139006400685 0.0 3 0.8937585706827263 3.752262803878944 59719.0 124.77048577797427 0.0 - - - - - - - 297.0 119 10 NFYC nuclear transcription factor Y, gamma 295 38 C20140606_SFK034_02 C20140606_SFK034_02 TB456655.[MT7]-FDQFDFLIDIVPR.3y5_1.heavy 590.318 / 599.351 247711.0 53.925899505615234 42 12 10 10 10 1.5627139299607362 50.379139006400685 0.0 3 0.8937585706827263 3.752262803878944 247711.0 0.0 0.0 - - - - - - - 397.5 495 2 NFYC nuclear transcription factor Y, gamma 297 39 C20140606_SFK034_02 C20140606_SFK034_02 TB403747.[MT7]-MVENLK[MT7].2y4_1.heavy 511.301 / 647.385 16455.0 25.604700088500977 43 13 10 10 10 1.0544319137706644 54.9139764351294 0.0 3 0.9183440813308953 4.289118502899316 16455.0 19.885457918255238 0.0 - - - - - - - 747.0 32 7 NIN ninein (GSK3B interacting protein) 299 39 C20140606_SFK034_02 C20140606_SFK034_02 TB403747.[MT7]-MVENLK[MT7].2y5_1.heavy 511.301 / 746.453 25067.0 25.604700088500977 43 13 10 10 10 1.0544319137706644 54.9139764351294 0.0 3 0.9183440813308953 4.289118502899316 25067.0 35.07490920388659 0.0 - - - - - - - 730.5 50 8 NIN ninein (GSK3B interacting protein) 301 39 C20140606_SFK034_02 C20140606_SFK034_02 TB403747.[MT7]-MVENLK[MT7].2b4_1.heavy 511.301 / 618.304 11303.0 25.604700088500977 43 13 10 10 10 1.0544319137706644 54.9139764351294 0.0 3 0.9183440813308953 4.289118502899316 11303.0 9.37793204085887 2.0 - - - - - - - 1268.6 46 10 NIN ninein (GSK3B interacting protein) 303 39 C20140606_SFK034_02 C20140606_SFK034_02 TB403747.[MT7]-MVENLK[MT7].2y3_1.heavy 511.301 / 518.342 19069.0 25.604700088500977 43 13 10 10 10 1.0544319137706644 54.9139764351294 0.0 3 0.9183440813308953 4.289118502899316 19069.0 15.906383378781749 0.0 - - - - - - - 807.5 38 2 NIN ninein (GSK3B interacting protein) 305 40 C20140606_SFK034_02 C20140606_SFK034_02 TB557170.[MT7]-SLVNLGGSK[MT7].2y5_1.heavy 581.855 / 605.374 24003.0 28.595199584960938 50 20 10 10 10 5.233430472653315 19.107925580083354 0.0 3 0.9918946456209666 13.698801936797885 24003.0 27.083982089552237 0.0 - - - - - - - 1151.125 48 8 KRT1 keratin 1 307 40 C20140606_SFK034_02 C20140606_SFK034_02 TB557170.[MT7]-SLVNLGGSK[MT7].2b4_1.heavy 581.855 / 558.337 35912.0 28.595199584960938 50 20 10 10 10 5.233430472653315 19.107925580083354 0.0 3 0.9918946456209666 13.698801936797885 35912.0 20.2473566053493 0.0 - - - - - - - 1834.4285714285713 71 7 KRT1 keratin 1 309 40 C20140606_SFK034_02 C20140606_SFK034_02 TB557170.[MT7]-SLVNLGGSK[MT7].2y6_1.heavy 581.855 / 719.417 48658.0 28.595199584960938 50 20 10 10 10 5.233430472653315 19.107925580083354 0.0 3 0.9918946456209666 13.698801936797885 48658.0 51.32064637799494 0.0 - - - - - - - 753.3 97 10 KRT1 keratin 1 311 40 C20140606_SFK034_02 C20140606_SFK034_02 TB557170.[MT7]-SLVNLGGSK[MT7].2y7_1.heavy 581.855 / 818.485 21677.0 28.595199584960938 50 20 10 10 10 5.233430472653315 19.107925580083354 0.0 3 0.9918946456209666 13.698801936797885 21677.0 46.56423020527859 0.0 - - - - - - - 651.0 43 8 KRT1 keratin 1 313 41 C20140606_SFK034_02 C20140606_SFK034_02 TB558039.[MT7]-SLAQPQSPFR.2y8_1.heavy 637.852 / 930.479 10143.0 29.067599296569824 34 13 9 6 6 1.5423158280573679 42.734404398065365 0.03380012512207031 5 0.9294107638460841 4.617476555308439 10143.0 42.887068965517244 0.0 - - - - - - - 676.2857142857143 20 7 FAM75D1 family with sequence similarity 75, member D1 315 41 C20140606_SFK034_02 C20140606_SFK034_02 TB558039.[MT7]-SLAQPQSPFR.2y9_1.heavy 637.852 / 1043.56 12655.0 29.067599296569824 34 13 9 6 6 1.5423158280573679 42.734404398065365 0.03380012512207031 5 0.9294107638460841 4.617476555308439 12655.0 11.309736594543745 0.0 - - - - - - - 316.0 25 11 FAM75D1 family with sequence similarity 75, member D1 317 41 C20140606_SFK034_02 C20140606_SFK034_02 TB558039.[MT7]-SLAQPQSPFR.2b4_1.heavy 637.852 / 544.321 23764.0 29.067599296569824 34 13 9 6 6 1.5423158280573679 42.734404398065365 0.03380012512207031 5 0.9294107638460841 4.617476555308439 23764.0 17.97436305732484 1.0 - - - - - - - 1763.0 50 8 FAM75D1 family with sequence similarity 75, member D1 319 41 C20140606_SFK034_02 C20140606_SFK034_02 TB558039.[MT7]-SLAQPQSPFR.2y6_1.heavy 637.852 / 731.383 23474.0 29.067599296569824 34 13 9 6 6 1.5423158280573679 42.734404398065365 0.03380012512207031 5 0.9294107638460841 4.617476555308439 23474.0 20.316161806208843 1.0 - - - - - - - 444.2 52 5 FAM75D1 family with sequence similarity 75, member D1 321 42 C20140606_SFK034_02 C20140606_SFK034_02 TB556377.[MT7]-LDEDVK[MT7].2b3_1.heavy 503.787 / 502.263 13427.0 22.51127529144287 42 20 10 6 6 15.7876613536615 6.334060362702665 0.032299041748046875 5 0.9956554639118714 18.71687353022875 13427.0 9.269886120996441 2.0 - - - - - - - 1829.142857142857 81 7 NFYC nuclear transcription factor Y, gamma 323 42 C20140606_SFK034_02 C20140606_SFK034_02 TB556377.[MT7]-LDEDVK[MT7].2y4_1.heavy 503.787 / 634.353 30133.0 22.51127529144287 42 20 10 6 6 15.7876613536615 6.334060362702665 0.032299041748046875 5 0.9956554639118714 18.71687353022875 30133.0 11.072951817692873 0.0 - - - - - - - 625.0 60 1 NFYC nuclear transcription factor Y, gamma 325 42 C20140606_SFK034_02 C20140606_SFK034_02 TB556377.[MT7]-LDEDVK[MT7].2y5_1.heavy 503.787 / 749.38 41895.0 22.51127529144287 42 20 10 6 6 15.7876613536615 6.334060362702665 0.032299041748046875 5 0.9956554639118714 18.71687353022875 41895.0 17.134097489696515 2.0 - - - - - - - 937.0 153 1 NFYC nuclear transcription factor Y, gamma 327 42 C20140606_SFK034_02 C20140606_SFK034_02 TB556377.[MT7]-LDEDVK[MT7].2b4_1.heavy 503.787 / 617.29 92638.0 22.51127529144287 42 20 10 6 6 15.7876613536615 6.334060362702665 0.032299041748046875 5 0.9956554639118714 18.71687353022875 92638.0 18.64508127568499 0.0 - - - - - - - 4580.0 185 1 NFYC nuclear transcription factor Y, gamma 329 43 C20140606_SFK034_02 C20140606_SFK034_02 TB556998.[MT7]-NSQNQEK[MT7].2y4_1.heavy 568.301 / 662.359 N/A N/A - - - - - - - - - 0.0 - - - - - - - NIN ninein (GSK3B interacting protein) 331 43 C20140606_SFK034_02 C20140606_SFK034_02 TB556998.[MT7]-NSQNQEK[MT7].2b4_1.heavy 568.301 / 588.286 N/A N/A - - - - - - - - - 0.0 - - - - - - - NIN ninein (GSK3B interacting protein) 333 43 C20140606_SFK034_02 C20140606_SFK034_02 TB556998.[MT7]-NSQNQEK[MT7].2b6_1.heavy 568.301 / 845.387 N/A N/A - - - - - - - - - 0.0 - - - - - - - NIN ninein (GSK3B interacting protein) 335 43 C20140606_SFK034_02 C20140606_SFK034_02 TB556998.[MT7]-NSQNQEK[MT7].2y6_1.heavy 568.301 / 877.45 N/A N/A - - - - - - - - - 0.0 - - - - - - - NIN ninein (GSK3B interacting protein) 337 44 C20140606_SFK034_02 C20140606_SFK034_02 TB556376.[MT7]-QISELK[MT7].2y4_1.heavy 503.313 / 620.374 60174.0 24.345199584960938 48 20 10 10 8 10.421472384458172 9.595573092832137 0.0 4 0.9982648663914033 29.623276499683683 60174.0 86.39948204916215 0.0 - - - - - - - 386.0 120 2 NIN ninein (GSK3B interacting protein) 339 44 C20140606_SFK034_02 C20140606_SFK034_02 TB556376.[MT7]-QISELK[MT7].2y5_1.heavy 503.313 / 733.458 49150.0 24.345199584960938 48 20 10 10 8 10.421472384458172 9.595573092832137 0.0 4 0.9982648663914033 29.623276499683683 49150.0 36.68209815030986 0.0 - - - - - - - 492.0 98 1 NIN ninein (GSK3B interacting protein) 341 44 C20140606_SFK034_02 C20140606_SFK034_02 TB556376.[MT7]-QISELK[MT7].2b4_1.heavy 503.313 / 602.327 20503.0 24.345199584960938 48 20 10 10 8 10.421472384458172 9.595573092832137 0.0 4 0.9982648663914033 29.623276499683683 20503.0 19.7515868328438 1.0 - - - - - - - 1354.2857142857142 85 7 NIN ninein (GSK3B interacting protein) 343 44 C20140606_SFK034_02 C20140606_SFK034_02 TB556376.[MT7]-QISELK[MT7].2y3_1.heavy 503.313 / 533.341 12849.0 24.345199584960938 48 20 10 10 8 10.421472384458172 9.595573092832137 0.0 4 0.9982648663914033 29.623276499683683 12849.0 5.603501986498225 2.0 - - - - - - - 1765.4285714285713 25 7 NIN ninein (GSK3B interacting protein) 345 45 C20140606_SFK034_02 C20140606_SFK034_02 TB557381.[MT7]-LYEALTPVH.2b3_1.heavy 593.833 / 550.299 N/A 34.70180130004883 42 12 10 10 10 1.1618470665218925 65.36826075427638 0.0 3 0.8850440926275801 3.6045060732861276 42339.0 8.069560453486716 0.0 - - - - - - - 1077.0 84 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 347 45 C20140606_SFK034_02 C20140606_SFK034_02 TB557381.[MT7]-LYEALTPVH.2b4_1.heavy 593.833 / 621.336 83385.0 34.70180130004883 42 12 10 10 10 1.1618470665218925 65.36826075427638 0.0 3 0.8850440926275801 3.6045060732861276 83385.0 110.59172494021891 0.0 - - - - - - - 862.0 166 4 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 349 45 C20140606_SFK034_02 C20140606_SFK034_02 TB557381.[MT7]-LYEALTPVH.2b6_1.heavy 593.833 / 835.468 60115.0 34.70180130004883 42 12 10 10 10 1.1618470665218925 65.36826075427638 0.0 3 0.8850440926275801 3.6045060732861276 60115.0 94.68312910529593 0.0 - - - - - - - 323.0 120 3 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 351 45 C20140606_SFK034_02 C20140606_SFK034_02 TB557381.[MT7]-LYEALTPVH.2b5_1.heavy 593.833 / 734.42 58176.0 34.70180130004883 42 12 10 10 10 1.1618470665218925 65.36826075427638 0.0 3 0.8850440926275801 3.6045060732861276 58176.0 71.75937130166591 0.0 - - - - - - - 431.0 116 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 353 46 C20140606_SFK034_02 C20140606_SFK034_02 TB456564.[MT7]-VAVTDLSPFGK[MT7].2y4_1.heavy 711.416 / 592.357 46018.0 37.01300048828125 43 13 10 10 10 1.5323779158335233 57.99481152868347 0.0 3 0.9124418031308777 4.139929993506861 46018.0 42.14689895470383 0.0 - - - - - - - 1158.5555555555557 92 9 DMGDH dimethylglycine dehydrogenase 355 46 C20140606_SFK034_02 C20140606_SFK034_02 TB456564.[MT7]-VAVTDLSPFGK[MT7].2y8_1.heavy 711.416 / 1008.55 45157.0 37.01300048828125 43 13 10 10 10 1.5323779158335233 57.99481152868347 0.0 3 0.9124418031308777 4.139929993506861 45157.0 49.30032520325203 0.0 - - - - - - - 300.57142857142856 90 7 DMGDH dimethylglycine dehydrogenase 357 46 C20140606_SFK034_02 C20140606_SFK034_02 TB456564.[MT7]-VAVTDLSPFGK[MT7].2y5_1.heavy 711.416 / 679.39 28032.0 37.01300048828125 43 13 10 10 10 1.5323779158335233 57.99481152868347 0.0 3 0.9124418031308777 4.139929993506861 28032.0 20.450851304471797 0.0 - - - - - - - 1257.2857142857142 56 7 DMGDH dimethylglycine dehydrogenase 359 46 C20140606_SFK034_02 C20140606_SFK034_02 TB456564.[MT7]-VAVTDLSPFGK[MT7].2b5_1.heavy 711.416 / 630.358 37790.0 37.01300048828125 43 13 10 10 10 1.5323779158335233 57.99481152868347 0.0 3 0.9124418031308777 4.139929993506861 37790.0 29.318016371529623 0.0 - - - - - - - 909.0 75 2 DMGDH dimethylglycine dehydrogenase 361 47 C20140606_SFK034_02 C20140606_SFK034_02 TB557383.[MT7]-GLIPVFALGR.2y8_1.heavy 593.875 / 872.535 42966.0 45.097900390625 50 20 10 10 10 6.571142590306944 15.218053576787307 0.0 3 0.9987732713975874 35.232520823291686 42966.0 109.97282083594685 0.0 - - - - - - - 296.1333333333333 85 15 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 363 47 C20140606_SFK034_02 C20140606_SFK034_02 TB557383.[MT7]-GLIPVFALGR.2y5_1.heavy 593.875 / 563.33 18396.0 45.097900390625 50 20 10 10 10 6.571142590306944 15.218053576787307 0.0 3 0.9987732713975874 35.232520823291686 18396.0 19.69135570774528 0.0 - - - - - - - 1289.6666666666667 36 9 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 365 47 C20140606_SFK034_02 C20140606_SFK034_02 TB557383.[MT7]-GLIPVFALGR.2y6_1.heavy 593.875 / 662.398 13705.0 45.097900390625 50 20 10 10 10 6.571142590306944 15.218053576787307 0.0 3 0.9987732713975874 35.232520823291686 13705.0 29.90483186952823 0.0 - - - - - - - 632.75 27 12 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 367 47 C20140606_SFK034_02 C20140606_SFK034_02 TB557383.[MT7]-GLIPVFALGR.2y7_1.heavy 593.875 / 759.451 496951.0 45.097900390625 50 20 10 10 10 6.571142590306944 15.218053576787307 0.0 3 0.9987732713975874 35.232520823291686 496951.0 715.0622409514219 0.0 - - - - - - - 784.8571428571429 993 7 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 369 48 C20140606_SFK034_02 C20140606_SFK034_02 TB556703.[MT7]-VANPC[CAM]VK[MT7].2y4_1.heavy 538.312 / 647.367 54441.0 20.205474376678467 47 20 10 7 10 4.644990245457597 21.528570506211814 0.028699874877929688 3 0.992370861645525 14.120436742953272 54441.0 165.52413937103904 0.0 - - - - - - - 651.5 108 8 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 371 48 C20140606_SFK034_02 C20140606_SFK034_02 TB556703.[MT7]-VANPC[CAM]VK[MT7].2y5_1.heavy 538.312 / 761.41 12677.0 20.205474376678467 47 20 10 7 10 4.644990245457597 21.528570506211814 0.028699874877929688 3 0.992370861645525 14.120436742953272 12677.0 74.65344444444445 0.0 - - - - - - - 183.75 25 24 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 373 48 C20140606_SFK034_02 C20140606_SFK034_02 TB556703.[MT7]-VANPC[CAM]VK[MT7].2y3_1.heavy 538.312 / 550.314 8317.0 20.205474376678467 47 20 10 7 10 4.644990245457597 21.528570506211814 0.028699874877929688 3 0.992370861645525 14.120436742953272 8317.0 6.941702605706014 0.0 - - - - - - - 653.2307692307693 16 13 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 375 48 C20140606_SFK034_02 C20140606_SFK034_02 TB556703.[MT7]-VANPC[CAM]VK[MT7].2y6_1.heavy 538.312 / 832.447 22253.0 20.205474376678467 47 20 10 7 10 4.644990245457597 21.528570506211814 0.028699874877929688 3 0.992370861645525 14.120436742953272 22253.0 65.63529031999359 0.0 - - - - - - - 685.25 44 8 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 377 49 C20140606_SFK034_02 C20140606_SFK034_02 TB456561.[MT7]-AEAESLYQSK[MT7].3y3_1.heavy 471.92 / 506.306 36491.0 25.347900390625 46 16 10 10 10 1.5876450892454095 41.672025938636295 0.0 3 0.9676284154143292 6.840719898007607 36491.0 39.86249707447812 0.0 - - - - - - - 1708.0 72 9 KRT1 keratin 1 379 49 C20140606_SFK034_02 C20140606_SFK034_02 TB456561.[MT7]-AEAESLYQSK[MT7].3b4_1.heavy 471.92 / 545.269 35486.0 25.347900390625 46 16 10 10 10 1.5876450892454095 41.672025938636295 0.0 3 0.9676284154143292 6.840719898007607 35486.0 11.116608375427546 0.0 - - - - - - - 1269.0 70 3 KRT1 keratin 1 381 49 C20140606_SFK034_02 C20140606_SFK034_02 TB456561.[MT7]-AEAESLYQSK[MT7].3b5_1.heavy 471.92 / 632.301 55886.0 25.347900390625 46 16 10 10 10 1.5876450892454095 41.672025938636295 0.0 3 0.9676284154143292 6.840719898007607 55886.0 61.274700927275006 0.0 - - - - - - - 709.375 111 8 KRT1 keratin 1 383 49 C20140606_SFK034_02 C20140606_SFK034_02 TB456561.[MT7]-AEAESLYQSK[MT7].3y4_1.heavy 471.92 / 669.369 23058.0 25.347900390625 46 16 10 10 10 1.5876450892454095 41.672025938636295 0.0 3 0.9676284154143292 6.840719898007607 23058.0 33.74108793534997 1.0 - - - - - - - 673.5 46 8 KRT1 keratin 1 385 50 C20140606_SFK034_02 C20140606_SFK034_02 TB326355.[MT7]-LEAEFVR.2y5_1.heavy 504.286 / 621.336 32514.0 32.00740051269531 37 17 2 10 8 2.1986967604169405 35.926786840867265 0.0 4 0.9754015283174563 7.852609781960684 32514.0 35.53644237374251 0.0 - - - - - - - 1190.0 65 8 LRP3 low density lipoprotein receptor-related protein 3 387 50 C20140606_SFK034_02 C20140606_SFK034_02 TB326355.[MT7]-LEAEFVR.2b4_1.heavy 504.286 / 587.316 28566.0 32.00740051269531 37 17 2 10 8 2.1986967604169405 35.926786840867265 0.0 4 0.9754015283174563 7.852609781960684 28566.0 11.389771666427443 0.0 - - - - - - - 1393.0 57 3 LRP3 low density lipoprotein receptor-related protein 3 389 50 C20140606_SFK034_02 C20140606_SFK034_02 TB326355.[MT7]-LEAEFVR.2y6_1.heavy 504.286 / 750.378 46913.0 32.00740051269531 37 17 2 10 8 2.1986967604169405 35.926786840867265 0.0 4 0.9754015283174563 7.852609781960684 46913.0 60.86113284492471 1.0 - - - - - - - 309.3333333333333 275 3 LRP3 low density lipoprotein receptor-related protein 3 391 50 C20140606_SFK034_02 C20140606_SFK034_02 TB326355.[MT7]-LEAEFVR.2b5_1.heavy 504.286 / 734.384 18812.0 32.00740051269531 37 17 2 10 8 2.1986967604169405 35.926786840867265 0.0 4 0.9754015283174563 7.852609781960684 18812.0 18.26853629206847 0.0 - - - - - - - 309.3333333333333 37 6 LRP3 low density lipoprotein receptor-related protein 3 393 51 C20140606_SFK034_02 C20140606_SFK034_02 TB456462.[MT7]-EFGLVFQR.2b4_1.heavy 570.32 / 591.326 38570.0 38.34040069580078 48 18 10 10 10 7.756833302640871 12.891858842184254 0.0 3 0.9899631552938534 12.308350405848433 38570.0 21.536840717479084 0.0 - - - - - - - 308.0 77 2 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 395 51 C20140606_SFK034_02 C20140606_SFK034_02 TB456462.[MT7]-EFGLVFQR.2y6_1.heavy 570.32 / 719.42 37073.0 38.34040069580078 48 18 10 10 10 7.756833302640871 12.891858842184254 0.0 3 0.9899631552938534 12.308350405848433 37073.0 42.39333180539682 0.0 - - - - - - - 1233.0 74 9 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 397 51 C20140606_SFK034_02 C20140606_SFK034_02 TB456462.[MT7]-EFGLVFQR.2b5_1.heavy 570.32 / 690.394 35753.0 38.34040069580078 48 18 10 10 10 7.756833302640871 12.891858842184254 0.0 3 0.9899631552938534 12.308350405848433 35753.0 50.57546094404433 0.0 - - - - - - - 704.3 71 10 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 399 51 C20140606_SFK034_02 C20140606_SFK034_02 TB456462.[MT7]-EFGLVFQR.2y7_1.heavy 570.32 / 866.488 82777.0 38.34040069580078 48 18 10 10 10 7.756833302640871 12.891858842184254 0.0 3 0.9899631552938534 12.308350405848433 82777.0 130.18548288160025 0.0 - - - - - - - 616.0 165 9 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 401 52 C20140606_SFK034_02 C20140606_SFK034_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y7.peptide 590.82 / 599.35 3430880.0 18.662799835205078 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 3430880.0 6074.425716405104 0.0 - - - - - - - 776.8 6861 5 403 52 C20140606_SFK034_02 C20140606_SFK034_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y9.peptide 590.82 / 741.43 2124550.0 18.662799835205078 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2124550.0 8640.211669028517 0.0 - - - - - - - 774.0 4249 7 405 52 C20140606_SFK034_02 C20140606_SFK034_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y11.peptide 590.82 / 909.52 2594940.0 18.662799835205078 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2594940.0 7164.069308347756 0.0 - - - - - - - 474.5 5189 2 407 53 C20140606_SFK034_02 C20140606_SFK034_02 TB456661.[MT7]-GINLWEMAEFLLK[MT7].3y3_1.heavy 618.014 / 517.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 409 53 C20140606_SFK034_02 C20140606_SFK034_02 TB456661.[MT7]-GINLWEMAEFLLK[MT7].3b6_1.heavy 618.014 / 857.464 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 411 53 C20140606_SFK034_02 C20140606_SFK034_02 TB456661.[MT7]-GINLWEMAEFLLK[MT7].3b4_1.heavy 618.014 / 542.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 413 53 C20140606_SFK034_02 C20140606_SFK034_02 TB456661.[MT7]-GINLWEMAEFLLK[MT7].3y4_1.heavy 618.014 / 664.451 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 415 54 C20140606_SFK034_02 C20140606_SFK034_02 TB403933.[MT7]-ALQLEELTLGK[MT7].2y4_1.heavy 751.955 / 562.368 35728.0 40.00640106201172 43 17 10 6 10 4.170863621111411 19.174401510036944 0.0388031005859375 3 0.978377050971285 8.377592389452472 35728.0 76.24456140350877 0.0 - - - - - - - 760.3333333333334 71 9 NPHP3 nephronophthisis 3 (adolescent) 417 54 C20140606_SFK034_02 C20140606_SFK034_02 TB403933.[MT7]-ALQLEELTLGK[MT7].2y8_1.heavy 751.955 / 1046.62 37439.0 40.00640106201172 43 17 10 6 10 4.170863621111411 19.174401510036944 0.0388031005859375 3 0.978377050971285 8.377592389452472 37439.0 33.33558681300124 0.0 - - - - - - - 1249.125 74 8 NPHP3 nephronophthisis 3 (adolescent) 419 54 C20140606_SFK034_02 C20140606_SFK034_02 TB403933.[MT7]-ALQLEELTLGK[MT7].2b6_1.heavy 751.955 / 828.458 20739.0 40.00640106201172 43 17 10 6 10 4.170863621111411 19.174401510036944 0.0388031005859375 3 0.978377050971285 8.377592389452472 20739.0 19.962304581495225 0.0 - - - - - - - 661.5555555555555 41 9 NPHP3 nephronophthisis 3 (adolescent) 421 54 C20140606_SFK034_02 C20140606_SFK034_02 TB403933.[MT7]-ALQLEELTLGK[MT7].2y7_1.heavy 751.955 / 933.537 29979.0 40.00640106201172 43 17 10 6 10 4.170863621111411 19.174401510036944 0.0388031005859375 3 0.978377050971285 8.377592389452472 29979.0 91.98102272727272 0.0 - - - - - - - 669.3333333333334 59 9 NPHP3 nephronophthisis 3 (adolescent) 423 55 C20140606_SFK034_02 C20140606_SFK034_02 TB558877.[MT7]-SLNPNRVTFK[MT7].3y3_1.heavy 488.624 / 539.331 43728.0 26.369750022888184 40 14 10 6 10 1.5641693913545769 42.62578487473517 0.03949928283691406 3 0.9344581356568604 4.794042795717942 43728.0 29.110428627121077 0.0 - - - - - - - 296.5 87 2 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 425 55 C20140606_SFK034_02 C20140606_SFK034_02 TB558877.[MT7]-SLNPNRVTFK[MT7].3y7_2.heavy 488.624 / 503.302 44660.0 26.369750022888184 40 14 10 6 10 1.5641693913545769 42.62578487473517 0.03949928283691406 3 0.9344581356568604 4.794042795717942 44660.0 20.69207702935271 0.0 - - - - - - - 1767.4285714285713 89 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 427 55 C20140606_SFK034_02 C20140606_SFK034_02 TB558877.[MT7]-SLNPNRVTFK[MT7].3y4_1.heavy 488.624 / 638.399 25593.0 26.369750022888184 40 14 10 6 10 1.5641693913545769 42.62578487473517 0.03949928283691406 3 0.9344581356568604 4.794042795717942 25593.0 7.6321379936450295 2.0 - - - - - - - 1218.375 51 8 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 429 55 C20140606_SFK034_02 C20140606_SFK034_02 TB558877.[MT7]-SLNPNRVTFK[MT7].3y9_2.heavy 488.624 / 616.865 41270.0 26.369750022888184 40 14 10 6 10 1.5641693913545769 42.62578487473517 0.03949928283691406 3 0.9344581356568604 4.794042795717942 41270.0 45.72684302178445 1.0 - - - - - - - 1186.4444444444443 82 9 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 431 56 C20140606_SFK034_02 C20140606_SFK034_02 TB557187.[MT7]-VMGFLADK[MT7].2y4_1.heavy 584.836 / 590.363 12293.0 37.031150817871094 39 13 10 6 10 1.0419044338005543 57.458162493977696 0.0363006591796875 3 0.9010655896755376 3.8908219293906248 12293.0 6.8340645503276924 0.0 - - - - - - - 290.0 24 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 433 56 C20140606_SFK034_02 C20140606_SFK034_02 TB557187.[MT7]-VMGFLADK[MT7].2b4_1.heavy 584.836 / 579.308 39202.0 37.031150817871094 39 13 10 6 10 1.0419044338005543 57.458162493977696 0.0363006591796875 3 0.9010655896755376 3.8908219293906248 39202.0 14.38829033125042 0.0 - - - - - - - 1742.0 78 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 435 56 C20140606_SFK034_02 C20140606_SFK034_02 TB557187.[MT7]-VMGFLADK[MT7].2y6_1.heavy 584.836 / 794.453 13358.0 37.031150817871094 39 13 10 6 10 1.0419044338005543 57.458162493977696 0.0363006591796875 3 0.9010655896755376 3.8908219293906248 13358.0 19.586293116126477 0.0 - - - - - - - 793.7 26 10 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 437 56 C20140606_SFK034_02 C20140606_SFK034_02 TB557187.[MT7]-VMGFLADK[MT7].2y7_1.heavy 584.836 / 925.493 24199.0 37.031150817871094 39 13 10 6 10 1.0419044338005543 57.458162493977696 0.0363006591796875 3 0.9010655896755376 3.8908219293906248 24199.0 59.29872526726625 1.0 - - - - - - - 1173.75 48 8 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 439 57 C20140606_SFK034_02 C20140606_SFK034_02 TB559665.[MT7]-DLGLLSQAIVPLQR.2y4_1.heavy 834.002 / 513.314 265713.0 44.56740188598633 47 17 10 10 10 4.408107108867711 22.685474179797442 0.0 3 0.9772686177710345 8.170023790591333 265713.0 358.1186443386243 0.0 - - - - - - - 751.6363636363636 531 11 NPHP3 nephronophthisis 3 (adolescent) 441 57 C20140606_SFK034_02 C20140606_SFK034_02 TB559665.[MT7]-DLGLLSQAIVPLQR.2y9_1.heavy 834.002 / 1011.59 197065.0 44.56740188598633 47 17 10 10 10 4.408107108867711 22.685474179797442 0.0 3 0.9772686177710345 8.170023790591333 197065.0 103.15658433074238 0.0 - - - - - - - 1285.857142857143 394 7 NPHP3 nephronophthisis 3 (adolescent) 443 57 C20140606_SFK034_02 C20140606_SFK034_02 TB559665.[MT7]-DLGLLSQAIVPLQR.2b4_1.heavy 834.002 / 543.326 175938.0 44.56740188598633 47 17 10 10 10 4.408107108867711 22.685474179797442 0.0 3 0.9772686177710345 8.170023790591333 175938.0 320.3765194291366 0.0 - - - - - - - 353.3076923076923 351 13 NPHP3 nephronophthisis 3 (adolescent) 445 57 C20140606_SFK034_02 C20140606_SFK034_02 TB559665.[MT7]-DLGLLSQAIVPLQR.2y10_1.heavy 834.002 / 1124.68 102084.0 44.56740188598633 47 17 10 10 10 4.408107108867711 22.685474179797442 0.0 3 0.9772686177710345 8.170023790591333 102084.0 211.97622681505032 0.0 - - - - - - - 770.75 204 12 NPHP3 nephronophthisis 3 (adolescent) 447 58 C20140606_SFK034_02 C20140606_SFK034_02 TB557615.[MT7]-LLYTGDFSR.2y8_1.heavy 608.328 / 958.463 174452.0 35.4369010925293 50 20 10 10 10 10.08028309979795 9.92035630447764 0.0 3 0.9917250666430786 13.557517764016332 174452.0 179.09873085666428 0.0 - - - - - - - 318.0 348 3 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 449 58 C20140606_SFK034_02 C20140606_SFK034_02 TB557615.[MT7]-LLYTGDFSR.2b6_1.heavy 608.328 / 807.437 61653.0 35.4369010925293 50 20 10 10 10 10.08028309979795 9.92035630447764 0.0 3 0.9917250666430786 13.557517764016332 61653.0 100.18632775789945 0.0 - - - - - - - 265.0 123 4 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 451 58 C20140606_SFK034_02 C20140606_SFK034_02 TB557615.[MT7]-LLYTGDFSR.2y6_1.heavy 608.328 / 682.315 68444.0 35.4369010925293 50 20 10 10 10 10.08028309979795 9.92035630447764 0.0 3 0.9917250666430786 13.557517764016332 68444.0 66.77894376910757 0.0 - - - - - - - 1233.375 136 8 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 453 58 C20140606_SFK034_02 C20140606_SFK034_02 TB557615.[MT7]-LLYTGDFSR.2y7_1.heavy 608.328 / 845.379 107919.0 35.4369010925293 50 20 10 10 10 10.08028309979795 9.92035630447764 0.0 3 0.9917250666430786 13.557517764016332 107919.0 94.91522986032177 0.0 - - - - - - - 318.0 215 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 455 59 C20140606_SFK034_02 C20140606_SFK034_02 OPPA_ECOLI.LAIAASSLWK.2y7.peptide 530.31 / 762.41 3574.0 38.68283462524414 21 -3 10 6 8 null 0.0 0.03440093994140625 4 0.0 0.0 3574.0 0.4857628270472307 1.0 - - - - - - - 1281.2857142857142 7 7 457 59 C20140606_SFK034_02 C20140606_SFK034_02 OPPA_ECOLI.LAIAASSLWK.2y8.peptide 530.31 / 875.5 1331.0 38.68283462524414 21 -3 10 6 8 null 0.0 0.03440093994140625 4 0.0 0.0 1331.0 0.9497451580020387 7.0 - - - - - - - 345.8125 6 16 459 59 C20140606_SFK034_02 C20140606_SFK034_02 OPPA_ECOLI.LAIAASSLWK.2y6.peptide 530.31 / 691.38 1822.0 38.68283462524414 21 -3 10 6 8 null 0.0 0.03440093994140625 4 0.0 0.0 1822.0 0.5475582268970699 9.0 - - - - - - - 771.0 3 9 461 60 C20140606_SFK034_02 C20140606_SFK034_02 TB558648.[MT7]-SK[MT7]LPGIVAEGR.3y7_1.heavy 472.292 / 701.394 53801.0 27.02304983139038 40 14 10 6 10 1.970101335845604 39.91499035532817 0.03899955749511719 3 0.9383367047691878 4.944150355780298 53801.0 61.3877418841771 0.0 - - - - - - - 348.0 107 2 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 463 60 C20140606_SFK034_02 C20140606_SFK034_02 TB558648.[MT7]-SK[MT7]LPGIVAEGR.3b3_1.heavy 472.292 / 617.422 46662.0 27.02304983139038 40 14 10 6 10 1.970101335845604 39.91499035532817 0.03899955749511719 3 0.9383367047691878 4.944150355780298 46662.0 65.72512438458152 0.0 - - - - - - - 87.0 93 1 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 465 60 C20140606_SFK034_02 C20140606_SFK034_02 TB558648.[MT7]-SK[MT7]LPGIVAEGR.3y8_1.heavy 472.292 / 798.447 82877.0 27.02304983139038 40 14 10 6 10 1.970101335845604 39.91499035532817 0.03899955749511719 3 0.9383367047691878 4.944150355780298 82877.0 179.3365295259252 0.0 - - - - - - - 241.66666666666666 165 9 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 467 60 C20140606_SFK034_02 C20140606_SFK034_02 TB558648.[MT7]-SK[MT7]LPGIVAEGR.3y5_1.heavy 472.292 / 531.289 147647.0 27.02304983139038 40 14 10 6 10 1.970101335845604 39.91499035532817 0.03899955749511719 3 0.9383367047691878 4.944150355780298 147647.0 93.39141323153184 0.0 - - - - - - - 1236.4 295 5 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 469 61 C20140606_SFK034_02 C20140606_SFK034_02 TB559661.[MT7]-INQHLQEELENR.3y7_1.heavy 556.292 / 917.432 80895.0 28.704500198364258 48 18 10 10 10 3.7783226548868702 26.466770875340764 0.0 3 0.9834668070132517 9.584816968100366 80895.0 93.05554345209083 0.0 - - - - - - - 765.25 161 8 NIN ninein (GSK3B interacting protein) 471 61 C20140606_SFK034_02 C20140606_SFK034_02 TB559661.[MT7]-INQHLQEELENR.3y6_1.heavy 556.292 / 789.374 75244.0 28.704500198364258 48 18 10 10 10 3.7783226548868702 26.466770875340764 0.0 3 0.9834668070132517 9.584816968100366 75244.0 83.01255457227138 0.0 - - - - - - - 718.0 150 8 NIN ninein (GSK3B interacting protein) 473 61 C20140606_SFK034_02 C20140606_SFK034_02 TB559661.[MT7]-INQHLQEELENR.3b4_1.heavy 556.292 / 637.354 100200.0 28.704500198364258 48 18 10 10 10 3.7783226548868702 26.466770875340764 0.0 3 0.9834668070132517 9.584816968100366 100200.0 72.05074882258228 0.0 - - - - - - - 329.5 200 4 NIN ninein (GSK3B interacting protein) 475 61 C20140606_SFK034_02 C20140606_SFK034_02 TB559661.[MT7]-INQHLQEELENR.3b3_1.heavy 556.292 / 500.295 128546.0 28.704500198364258 48 18 10 10 10 3.7783226548868702 26.466770875340764 0.0 3 0.9834668070132517 9.584816968100366 128546.0 69.87128034646382 0.0 - - - - - - - 1777.625 257 8 NIN ninein (GSK3B interacting protein) 477 62 C20140606_SFK034_02 C20140606_SFK034_02 TB403908.[MT7]-VQNLEDTVQNVNLQMSR.3b6_1.heavy 711.368 / 843.433 38146.0 37.661773681640625 44 18 10 6 10 7.527329801876871 13.28492342331884 0.038299560546875 3 0.9878917478566575 11.20424129910081 38146.0 35.629541479024525 0.0 - - - - - - - 1263.25 76 8 NIN ninein (GSK3B interacting protein) 479 62 C20140606_SFK034_02 C20140606_SFK034_02 TB403908.[MT7]-VQNLEDTVQNVNLQMSR.3y6_1.heavy 711.368 / 748.377 67097.0 37.661773681640625 44 18 10 6 10 7.527329801876871 13.28492342331884 0.038299560546875 3 0.9878917478566575 11.20424129910081 67097.0 68.62992827415374 0.0 - - - - - - - 227.5 134 2 NIN ninein (GSK3B interacting protein) 481 62 C20140606_SFK034_02 C20140606_SFK034_02 TB403908.[MT7]-VQNLEDTVQNVNLQMSR.3b4_1.heavy 711.368 / 599.363 52440.0 37.661773681640625 44 18 10 6 10 7.527329801876871 13.28492342331884 0.038299560546875 3 0.9878917478566575 11.20424129910081 52440.0 26.633377980176796 0.0 - - - - - - - 318.5 104 2 NIN ninein (GSK3B interacting protein) 483 62 C20140606_SFK034_02 C20140606_SFK034_02 TB403908.[MT7]-VQNLEDTVQNVNLQMSR.3y9_1.heavy 711.368 / 1089.55 55535.0 37.661773681640625 44 18 10 6 10 7.527329801876871 13.28492342331884 0.038299560546875 3 0.9878917478566575 11.20424129910081 55535.0 73.8372563254713 0.0 - - - - - - - 702.0 111 7 NIN ninein (GSK3B interacting protein) 485 63 C20140606_SFK034_02 C20140606_SFK034_02 TB556777.[MT7]-IYEDSLGR.2b4_1.heavy 548.791 / 665.326 50836.0 27.28689956665039 50 20 10 10 10 4.2459096977704895 23.552078851914725 0.0 3 0.9913461520729986 13.256963144688303 50836.0 44.871099365750524 0.0 - - - - - - - 752.5 101 8 NPHP3 nephronophthisis 3 (adolescent) 487 63 C20140606_SFK034_02 C20140606_SFK034_02 TB556777.[MT7]-IYEDSLGR.2y6_1.heavy 548.791 / 676.326 25203.0 27.28689956665039 50 20 10 10 10 4.2459096977704895 23.552078851914725 0.0 3 0.9913461520729986 13.256963144688303 25203.0 22.996923449612403 0.0 - - - - - - - 678.4444444444445 50 9 NPHP3 nephronophthisis 3 (adolescent) 489 63 C20140606_SFK034_02 C20140606_SFK034_02 TB556777.[MT7]-IYEDSLGR.2b5_1.heavy 548.791 / 752.358 12300.0 27.28689956665039 50 20 10 10 10 4.2459096977704895 23.552078851914725 0.0 3 0.9913461520729986 13.256963144688303 12300.0 19.16908914728682 0.0 - - - - - - - 659.3333333333334 24 9 NPHP3 nephronophthisis 3 (adolescent) 491 63 C20140606_SFK034_02 C20140606_SFK034_02 TB556777.[MT7]-IYEDSLGR.2y7_1.heavy 548.791 / 839.389 127822.0 27.28689956665039 50 20 10 10 10 4.2459096977704895 23.552078851914725 0.0 3 0.9913461520729986 13.256963144688303 127822.0 106.46886375766817 0.0 - - - - - - - 344.0 255 2 NPHP3 nephronophthisis 3 (adolescent) 493 64 C20140606_SFK034_02 C20140606_SFK034_02 TB558546.[MT7]-LEETIENLK[MT7].3y3_1.heavy 459.601 / 518.342 155335.0 36.15355110168457 42 16 10 6 10 1.8625912463787553 37.82558408661485 0.036899566650390625 3 0.968734763704334 6.96134957575078 155335.0 76.42225384308452 0.0 - - - - - - - 779.0 310 2 FMN1 formin 1 495 64 C20140606_SFK034_02 C20140606_SFK034_02 TB558546.[MT7]-LEETIENLK[MT7].3b4_1.heavy 459.601 / 617.326 154920.0 36.15355110168457 42 16 10 6 10 1.8625912463787553 37.82558408661485 0.036899566650390625 3 0.968734763704334 6.96134957575078 154920.0 95.12768392524194 0.0 - - - - - - - 416.0 309 1 FMN1 formin 1 497 64 C20140606_SFK034_02 C20140606_SFK034_02 TB558546.[MT7]-LEETIENLK[MT7].3y4_1.heavy 459.601 / 647.385 96214.0 36.15355110168457 42 16 10 6 10 1.8625912463787553 37.82558408661485 0.036899566650390625 3 0.968734763704334 6.96134957575078 96214.0 119.57346555466513 0.0 - - - - - - - 727.0 192 8 FMN1 formin 1 499 64 C20140606_SFK034_02 C20140606_SFK034_02 TB558546.[MT7]-LEETIENLK[MT7].3b3_1.heavy 459.601 / 516.279 117099.0 36.15355110168457 42 16 10 6 10 1.8625912463787553 37.82558408661485 0.036899566650390625 3 0.968734763704334 6.96134957575078 117099.0 91.28207594351471 0.0 - - - - - - - 762.0 234 3 FMN1 formin 1 501 65 C20140606_SFK034_02 C20140606_SFK034_02 TB558548.[MT7]-ANRPFLVFIR.3y7_1.heavy 459.614 / 891.545 16403.0 39.32852554321289 39 13 10 6 10 1.7149872284856134 58.309472128432745 0.0381011962890625 3 0.9144424149685424 4.188774018527591 16403.0 293.8836317725994 0.0 - - - - - - - 194.44444444444446 32 9 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 503 65 C20140606_SFK034_02 C20140606_SFK034_02 TB558548.[MT7]-ANRPFLVFIR.3b6_1.heavy 459.614 / 843.496 10408.0 39.32852554321289 39 13 10 6 10 1.7149872284856134 58.309472128432745 0.0381011962890625 3 0.9144424149685424 4.188774018527591 10408.0 101.45743329341317 0.0 - - - - - - - 166.42857142857142 20 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 505 65 C20140606_SFK034_02 C20140606_SFK034_02 TB558548.[MT7]-ANRPFLVFIR.3y4_1.heavy 459.614 / 534.34 67278.0 39.32852554321289 39 13 10 6 10 1.7149872284856134 58.309472128432745 0.0381011962890625 3 0.9144424149685424 4.188774018527591 67278.0 171.34933422298457 0.0 - - - - - - - 274.8 134 10 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 507 65 C20140606_SFK034_02 C20140606_SFK034_02 TB558548.[MT7]-ANRPFLVFIR.3y5_1.heavy 459.614 / 647.424 35804.0 39.32852554321289 39 13 10 6 10 1.7149872284856134 58.309472128432745 0.0381011962890625 3 0.9144424149685424 4.188774018527591 35804.0 66.03451364027782 0.0 - - - - - - - 874.25 71 12 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 509 66 C20140606_SFK034_02 C20140606_SFK034_02 TB558644.[MT7]-SASASHQADIK[MT7].3y3_1.heavy 468.256 / 519.326 14980.0 16.375099182128906 43 13 10 10 10 2.8575762090052415 34.99469224472976 0.0 3 0.9013343539457329 3.8962081648605884 14980.0 28.56977065143041 0.0 - - - - - - - 817.6428571428571 29 14 LBR lamin B receptor 511 66 C20140606_SFK034_02 C20140606_SFK034_02 TB558644.[MT7]-SASASHQADIK[MT7].3b4_1.heavy 468.256 / 461.248 9281.0 16.375099182128906 43 13 10 10 10 2.8575762090052415 34.99469224472976 0.0 3 0.9013343539457329 3.8962081648605884 9281.0 8.542094015054312 2.0 - - - - - - - 1248.25 38 8 LBR lamin B receptor 513 66 C20140606_SFK034_02 C20140606_SFK034_02 TB558644.[MT7]-SASASHQADIK[MT7].3b5_1.heavy 468.256 / 548.28 20428.0 16.375099182128906 43 13 10 10 10 2.8575762090052415 34.99469224472976 0.0 3 0.9013343539457329 3.8962081648605884 20428.0 13.588419867361779 0.0 - - - - - - - 1261.125 40 8 LBR lamin B receptor 515 66 C20140606_SFK034_02 C20140606_SFK034_02 TB558644.[MT7]-SASASHQADIK[MT7].3y4_1.heavy 468.256 / 590.363 20781.0 16.375099182128906 43 13 10 10 10 2.8575762090052415 34.99469224472976 0.0 3 0.9013343539457329 3.8962081648605884 20781.0 15.386704017005204 0.0 - - - - - - - 691.0 41 10 LBR lamin B receptor 517 67 C20140606_SFK034_02 C20140606_SFK034_02 TB456675.[MT7]-NQQLDLENTELSQK[MT7].2b3_1.heavy 974.515 / 515.269 6652.0 30.091699600219727 48 18 10 10 10 4.754982416581088 21.030571985143464 0.0 3 0.9828923995054963 9.422078625940808 6652.0 36.08452921100181 0.0 - - - - - - - 228.33333333333334 13 12 NIN ninein (GSK3B interacting protein) 519 67 C20140606_SFK034_02 C20140606_SFK034_02 TB456675.[MT7]-NQQLDLENTELSQK[MT7].2y9_1.heavy 974.515 / 1205.65 3815.0 30.091699600219727 48 18 10 10 10 4.754982416581088 21.030571985143464 0.0 3 0.9828923995054963 9.422078625940808 3815.0 16.2918395834642 0.0 - - - - - - - 237.64285714285714 7 14 NIN ninein (GSK3B interacting protein) 521 67 C20140606_SFK034_02 C20140606_SFK034_02 TB456675.[MT7]-NQQLDLENTELSQK[MT7].2y3_1.heavy 974.515 / 506.306 6065.0 30.091699600219727 48 18 10 10 10 4.754982416581088 21.030571985143464 0.0 3 0.9828923995054963 9.422078625940808 6065.0 21.086539410033545 0.0 - - - - - - - 293.3636363636364 12 11 NIN ninein (GSK3B interacting protein) 523 67 C20140606_SFK034_02 C20140606_SFK034_02 TB456675.[MT7]-NQQLDLENTELSQK[MT7].2b5_1.heavy 974.515 / 743.38 9978.0 30.091699600219727 48 18 10 10 10 4.754982416581088 21.030571985143464 0.0 3 0.9828923995054963 9.422078625940808 9978.0 34.62040211324136 0.0 - - - - - - - 287.1875 19 16 NIN ninein (GSK3B interacting protein) 525 68 C20140606_SFK034_02 C20140606_SFK034_02 TB558647.[MT7]-EEAGTLLQHLR.3b4_1.heavy 470.932 / 531.253 88676.0 32.88650131225586 45 15 10 10 10 5.035933040478446 19.85729341438967 0.0 3 0.9543574430289712 5.754552127033009 88676.0 67.50240234649263 0.0 - - - - - - - 858.8 177 5 C17orf76 chromosome 17 open reading frame 76 527 68 C20140606_SFK034_02 C20140606_SFK034_02 TB558647.[MT7]-EEAGTLLQHLR.3b5_1.heavy 470.932 / 632.301 128604.0 32.88650131225586 45 15 10 10 10 5.035933040478446 19.85729341438967 0.0 3 0.9543574430289712 5.754552127033009 128604.0 241.52782815326873 0.0 - - - - - - - 290.0 257 4 C17orf76 chromosome 17 open reading frame 76 529 68 C20140606_SFK034_02 C20140606_SFK034_02 TB558647.[MT7]-EEAGTLLQHLR.3y4_1.heavy 470.932 / 553.32 250592.0 32.88650131225586 45 15 10 10 10 5.035933040478446 19.85729341438967 0.0 3 0.9543574430289712 5.754552127033009 250592.0 202.81173242856386 0.0 - - - - - - - 232.0 501 2 C17orf76 chromosome 17 open reading frame 76 531 68 C20140606_SFK034_02 C20140606_SFK034_02 TB558647.[MT7]-EEAGTLLQHLR.3y5_1.heavy 470.932 / 666.405 127907.0 32.88650131225586 45 15 10 10 10 5.035933040478446 19.85729341438967 0.0 3 0.9543574430289712 5.754552127033009 127907.0 371.7290592723973 0.0 - - - - - - - 348.0 255 6 C17orf76 chromosome 17 open reading frame 76 533 69 C20140606_SFK034_02 C20140606_SFK034_02 TB559265.[MT7]-FHC[CAM]ANLTSWPR.3y6_1.heavy 511.59 / 759.415 23188.0 31.965599060058594 50 20 10 10 10 7.556198251764562 13.234168383108198 0.0 3 0.9904788126908775 12.637804387053329 23188.0 33.883356425402106 0.0 - - - - - - - 1092.7142857142858 46 7 CRBN cereblon 535 69 C20140606_SFK034_02 C20140606_SFK034_02 TB559265.[MT7]-FHC[CAM]ANLTSWPR.3b5_1.heavy 511.59 / 774.347 34434.0 31.965599060058594 50 20 10 10 10 7.556198251764562 13.234168383108198 0.0 3 0.9904788126908775 12.637804387053329 34434.0 78.88244343170375 0.0 - - - - - - - 348.0 68 9 CRBN cereblon 537 69 C20140606_SFK034_02 C20140606_SFK034_02 TB559265.[MT7]-FHC[CAM]ANLTSWPR.3y4_1.heavy 511.59 / 545.283 124981.0 31.965599060058594 50 20 10 10 10 7.556198251764562 13.234168383108198 0.0 3 0.9904788126908775 12.637804387053329 124981.0 61.71345425394034 0.0 - - - - - - - 812.0 249 1 CRBN cereblon 539 69 C20140606_SFK034_02 C20140606_SFK034_02 TB559265.[MT7]-FHC[CAM]ANLTSWPR.3y5_1.heavy 511.59 / 646.331 108402.0 31.965599060058594 50 20 10 10 10 7.556198251764562 13.234168383108198 0.0 3 0.9904788126908775 12.637804387053329 108402.0 98.0685524305793 0.0 - - - - - - - 116.0 216 1 CRBN cereblon 541 70 C20140606_SFK034_02 C20140606_SFK034_02 TB456671.[MT7]-NLVDPITHDLIISLAR.4y4_1.heavy 484.285 / 446.272 72709.0 46.035301208496094 39 9 10 10 10 0.677901921396275 75.65160115136987 0.0 3 0.8103121399562213 2.7875683024240896 72709.0 208.03009605991537 0.0 - - - - - - - 279.1 145 10 C17orf76 chromosome 17 open reading frame 76 543 70 C20140606_SFK034_02 C20140606_SFK034_02 TB456671.[MT7]-NLVDPITHDLIISLAR.4y5_1.heavy 484.285 / 559.356 21000.0 46.035301208496094 39 9 10 10 10 0.677901921396275 75.65160115136987 0.0 3 0.8103121399562213 2.7875683024240896 21000.0 45.99162039734154 0.0 - - - - - - - 248.84615384615384 42 13 C17orf76 chromosome 17 open reading frame 76 545 70 C20140606_SFK034_02 C20140606_SFK034_02 TB456671.[MT7]-NLVDPITHDLIISLAR.4b4_1.heavy 484.285 / 586.332 16242.0 46.035301208496094 39 9 10 10 10 0.677901921396275 75.65160115136987 0.0 3 0.8103121399562213 2.7875683024240896 16242.0 80.14425196850394 0.0 - - - - - - - 241.875 32 16 C17orf76 chromosome 17 open reading frame 76 547 70 C20140606_SFK034_02 C20140606_SFK034_02 TB456671.[MT7]-NLVDPITHDLIISLAR.4b5_1.heavy 484.285 / 683.385 2030.0 46.035301208496094 39 9 10 10 10 0.677901921396275 75.65160115136987 0.0 3 0.8103121399562213 2.7875683024240896 2030.0 10.675797762121839 0.0 - - - - - - - 172.9090909090909 4 11 C17orf76 chromosome 17 open reading frame 76 549 71 C20140606_SFK034_02 C20140606_SFK034_02 TB557613.[MT7]-VSNIPVTAIR.2y8_1.heavy 607.373 / 883.536 16111.0 30.98430061340332 50 20 10 10 10 8.762023384933913 11.412888964887674 0.0 3 0.9962018335987813 20.018789820235085 16111.0 26.738197430161083 0.0 - - - - - - - 740.4285714285714 32 7 DMGDH dimethylglycine dehydrogenase 551 71 C20140606_SFK034_02 C20140606_SFK034_02 TB557613.[MT7]-VSNIPVTAIR.2b4_1.heavy 607.373 / 558.337 100609.0 30.98430061340332 50 20 10 10 10 8.762023384933913 11.412888964887674 0.0 3 0.9962018335987813 20.018789820235085 100609.0 27.727370200197743 0.0 - - - - - - - 1127.0 201 1 DMGDH dimethylglycine dehydrogenase 553 71 C20140606_SFK034_02 C20140606_SFK034_02 TB557613.[MT7]-VSNIPVTAIR.2y9_1.heavy 607.373 / 970.568 139140.0 30.98430061340332 50 20 10 10 10 8.762023384933913 11.412888964887674 0.0 3 0.9962018335987813 20.018789820235085 139140.0 130.81097445677864 0.0 - - - - - - - 360.6 278 5 DMGDH dimethylglycine dehydrogenase 555 71 C20140606_SFK034_02 C20140606_SFK034_02 TB557613.[MT7]-VSNIPVTAIR.2y6_1.heavy 607.373 / 656.409 165504.0 30.98430061340332 50 20 10 10 10 8.762023384933913 11.412888964887674 0.0 3 0.9962018335987813 20.018789820235085 165504.0 93.02121395307624 0.0 - - - - - - - 375.6666666666667 331 3 DMGDH dimethylglycine dehydrogenase 557 72 C20140606_SFK034_02 C20140606_SFK034_02 TB559262.[MT7]-TSAAYLPEDFIR.2y8_1.heavy 763.902 / 1052.54 45408.0 39.562599182128906 50 20 10 10 10 6.973402781712651 14.340201352235708 0.0 3 0.9930208171997137 14.764106663278225 45408.0 44.605428169036415 0.0 - - - - - - - 766.5555555555555 90 9 IRAK2 interleukin-1 receptor-associated kinase 2 559 72 C20140606_SFK034_02 C20140606_SFK034_02 TB559262.[MT7]-TSAAYLPEDFIR.2y6_1.heavy 763.902 / 776.394 57040.0 39.562599182128906 50 20 10 10 10 6.973402781712651 14.340201352235708 0.0 3 0.9930208171997137 14.764106663278225 57040.0 129.25916925380443 0.0 - - - - - - - 280.6666666666667 114 6 IRAK2 interleukin-1 receptor-associated kinase 2 561 72 C20140606_SFK034_02 C20140606_SFK034_02 TB559262.[MT7]-TSAAYLPEDFIR.2b5_1.heavy 763.902 / 638.327 42840.0 39.562599182128906 50 20 10 10 10 6.973402781712651 14.340201352235708 0.0 3 0.9930208171997137 14.764106663278225 42840.0 52.21391613051606 0.0 - - - - - - - 1253.5 85 8 IRAK2 interleukin-1 receptor-associated kinase 2 563 72 C20140606_SFK034_02 C20140606_SFK034_02 TB559262.[MT7]-TSAAYLPEDFIR.2y7_1.heavy 763.902 / 889.478 29122.0 39.562599182128906 50 20 10 10 10 6.973402781712651 14.340201352235708 0.0 3 0.9930208171997137 14.764106663278225 29122.0 34.613786216020436 0.0 - - - - - - - 401.0 58 9 IRAK2 interleukin-1 receptor-associated kinase 2 565 73 C20140606_SFK034_02 C20140606_SFK034_02 TB456402.[MT7]-IALLGGGK[MT7].2y4_1.heavy 508.839 / 462.279 626508.0 33.3494987487793 50 20 10 10 10 6.196948216054581 16.136975251935723 0.0 3 0.9911710338533696 13.124639840448781 626508.0 514.0213363636364 0.0 - - - - - - - 1335.7142857142858 1253 7 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 567 73 C20140606_SFK034_02 C20140606_SFK034_02 TB456402.[MT7]-IALLGGGK[MT7].2y5_1.heavy 508.839 / 575.363 355000.0 33.3494987487793 50 20 10 10 10 6.196948216054581 16.136975251935723 0.0 3 0.9911710338533696 13.124639840448781 355000.0 212.05726105617634 0.0 - - - - - - - 1705.0 710 6 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 569 73 C20140606_SFK034_02 C20140606_SFK034_02 TB456402.[MT7]-IALLGGGK[MT7].2y6_1.heavy 508.839 / 688.447 127611.0 33.3494987487793 50 20 10 10 10 6.196948216054581 16.136975251935723 0.0 3 0.9911710338533696 13.124639840448781 127611.0 114.38586000000001 0.0 - - - - - - - 440.0 255 1 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 571 73 C20140606_SFK034_02 C20140606_SFK034_02 TB456402.[MT7]-IALLGGGK[MT7].2y7_1.heavy 508.839 / 759.484 227169.0 33.3494987487793 50 20 10 10 10 6.196948216054581 16.136975251935723 0.0 3 0.9911710338533696 13.124639840448781 227169.0 114.82360363636363 0.0 - - - - - - - 990.0 454 1 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 573 74 C20140606_SFK034_02 C20140606_SFK034_02 TB559657.[MT7]-LATTPVRVDEFK[MT7].3b9_2.heavy 555.326 / 549.325 160780.0 31.797000885009766 46 16 10 10 10 2.7952300360473057 35.775230914951294 0.0 3 0.967666161294544 6.844733382441962 160780.0 49.29732962921573 0.0 - - - - - - - 1857.0 321 1 DMGDH dimethylglycine dehydrogenase 575 74 C20140606_SFK034_02 C20140606_SFK034_02 TB559657.[MT7]-LATTPVRVDEFK[MT7].3b4_1.heavy 555.326 / 531.326 47944.0 31.797000885009766 46 16 10 10 10 2.7952300360473057 35.775230914951294 0.0 3 0.967666161294544 6.844733382441962 47944.0 22.015270321592652 0.0 - - - - - - - 813.0 95 2 DMGDH dimethylglycine dehydrogenase 577 74 C20140606_SFK034_02 C20140606_SFK034_02 TB559657.[MT7]-LATTPVRVDEFK[MT7].3y11_2.heavy 555.326 / 703.892 291378.0 31.797000885009766 46 16 10 10 10 2.7952300360473057 35.775230914951294 0.0 3 0.967666161294544 6.844733382441962 291378.0 257.15820751334195 0.0 - - - - - - - 435.0 582 4 DMGDH dimethylglycine dehydrogenase 579 74 C20140606_SFK034_02 C20140606_SFK034_02 TB559657.[MT7]-LATTPVRVDEFK[MT7].3y4_1.heavy 555.326 / 682.353 56186.0 31.797000885009766 46 16 10 10 10 2.7952300360473057 35.775230914951294 0.0 3 0.967666161294544 6.844733382441962 56186.0 44.37168956293736 0.0 - - - - - - - 232.0 112 1 DMGDH dimethylglycine dehydrogenase 581 75 C20140606_SFK034_02 C20140606_SFK034_02 TB559523.[MT7]-SLDLDSIIAEVK[MT7].3y3_1.heavy 530.978 / 519.326 110400.0 45.885501861572266 44 14 10 10 10 1.5944982621884283 49.793311116998325 0.0 3 0.9313900128906066 4.684397980436659 110400.0 194.4314960629921 0.0 - - - - - - - 682.5 220 12 KRT1 keratin 1 583 75 C20140606_SFK034_02 C20140606_SFK034_02 TB559523.[MT7]-SLDLDSIIAEVK[MT7].3b6_1.heavy 530.978 / 775.395 80498.0 45.885501861572266 44 14 10 10 10 1.5944982621884283 49.793311116998325 0.0 3 0.9313900128906066 4.684397980436659 80498.0 281.90445201054837 0.0 - - - - - - - 209.2 160 10 KRT1 keratin 1 585 75 C20140606_SFK034_02 C20140606_SFK034_02 TB559523.[MT7]-SLDLDSIIAEVK[MT7].3b5_1.heavy 530.978 / 688.363 67928.0 45.885501861572266 44 14 10 10 10 1.5944982621884283 49.793311116998325 0.0 3 0.9313900128906066 4.684397980436659 67928.0 221.29782180730035 0.0 - - - - - - - 680.0 135 7 KRT1 keratin 1 587 75 C20140606_SFK034_02 C20140606_SFK034_02 TB559523.[MT7]-SLDLDSIIAEVK[MT7].3y4_1.heavy 530.978 / 590.363 165695.0 45.885501861572266 44 14 10 10 10 1.5944982621884283 49.793311116998325 0.0 3 0.9313900128906066 4.684397980436659 165695.0 331.661540335102 0.0 - - - - - - - 221.875 331 8 KRT1 keratin 1 589 76 C20140606_SFK034_02 C20140606_SFK034_02 TB559659.[MT7]-LATTPVRVDEFK[MT7].4y4_1.heavy 416.746 / 682.353 9643.0 31.797000885009766 35 9 6 10 10 1.1402303026527973 70.87731391179085 0.0 3 0.8126082860615985 2.8051715616988475 9643.0 19.507927870176694 0.0 - - - - - - - 290.5 19 8 DMGDH dimethylglycine dehydrogenase 591 76 C20140606_SFK034_02 C20140606_SFK034_02 TB559659.[MT7]-LATTPVRVDEFK[MT7].4y7_2.heavy 416.746 / 518.799 95621.0 31.797000885009766 35 9 6 10 10 1.1402303026527973 70.87731391179085 0.0 3 0.8126082860615985 2.8051715616988475 95621.0 85.04413805802359 0.0 - - - - - - - 395.4 191 5 DMGDH dimethylglycine dehydrogenase 593 76 C20140606_SFK034_02 C20140606_SFK034_02 TB559659.[MT7]-LATTPVRVDEFK[MT7].4b9_2.heavy 416.746 / 549.325 42524.0 31.797000885009766 35 9 6 10 10 1.1402303026527973 70.87731391179085 0.0 3 0.8126082860615985 2.8051715616988475 42524.0 28.97924031777557 0.0 - - - - - - - 310.0 85 3 DMGDH dimethylglycine dehydrogenase 595 76 C20140606_SFK034_02 C20140606_SFK034_02 TB559659.[MT7]-LATTPVRVDEFK[MT7].4b3_1.heavy 416.746 / 430.278 N/A 31.797000885009766 35 9 6 10 10 1.1402303026527973 70.87731391179085 0.0 3 0.8126082860615985 2.8051715616988475 91787.0 33.573963030232434 2.0 - - - - - - - 1556.8 300 5 DMGDH dimethylglycine dehydrogenase 597 77 C20140606_SFK034_02 C20140606_SFK034_02 TB559903.[MT7]-DDSLPSNPIDFSYR.2y4_1.heavy 885.427 / 572.283 19912.0 37.4536018371582 41 11 10 10 10 0.7665552573309035 84.33994113204729 0.0 3 0.8524943914301994 3.172993366223238 19912.0 29.29804821773378 0.0 - - - - - - - 691.25 39 8 CRBN cereblon 599 77 C20140606_SFK034_02 C20140606_SFK034_02 TB559903.[MT7]-DDSLPSNPIDFSYR.2b4_1.heavy 885.427 / 575.279 42313.0 37.4536018371582 41 11 10 10 10 0.7665552573309035 84.33994113204729 0.0 3 0.8524943914301994 3.172993366223238 42313.0 73.71958546626372 0.0 - - - - - - - 737.1428571428571 84 7 CRBN cereblon 601 77 C20140606_SFK034_02 C20140606_SFK034_02 TB559903.[MT7]-DDSLPSNPIDFSYR.2y10_1.heavy 885.427 / 1195.57 43696.0 37.4536018371582 41 11 10 10 10 0.7665552573309035 84.33994113204729 0.0 3 0.8524943914301994 3.172993366223238 43696.0 16.217286526421535 1.0 - - - - - - - 277.0 92 1 CRBN cereblon 603 77 C20140606_SFK034_02 C20140606_SFK034_02 TB559903.[MT7]-DDSLPSNPIDFSYR.2y7_1.heavy 885.427 / 897.446 13920.0 37.4536018371582 41 11 10 10 10 0.7665552573309035 84.33994113204729 0.0 3 0.8524943914301994 3.172993366223238 13920.0 31.62129042082691 0.0 - - - - - - - 311.125 27 8 CRBN cereblon 605 78 C20140606_SFK034_02 C20140606_SFK034_02 TB559650.[MT7]-RALQLEELTLGK[MT7].3b6_1.heavy 553.673 / 855.517 12975.0 35.488932291666664 30 14 0 6 10 2.625197306751113 38.0923749018156 0.03910064697265625 3 0.9441464901762258 5.197502486867678 12975.0 27.81649010315026 0.0 - - - - - - - 659.125 25 8 NPHP3 nephronophthisis 3 (adolescent) 607 78 C20140606_SFK034_02 C20140606_SFK034_02 TB559650.[MT7]-RALQLEELTLGK[MT7].3b4_1.heavy 553.673 / 613.39 N/A 35.488932291666664 30 14 0 6 10 2.625197306751113 38.0923749018156 0.03910064697265625 3 0.9441464901762258 5.197502486867678 22679.0 15.056655700719723 2.0 - - - - - - - 808.6666666666666 1046 3 NPHP3 nephronophthisis 3 (adolescent) 609 78 C20140606_SFK034_02 C20140606_SFK034_02 TB559650.[MT7]-RALQLEELTLGK[MT7].3y4_1.heavy 553.673 / 562.368 61181.0 35.488932291666664 30 14 0 6 10 2.625197306751113 38.0923749018156 0.03910064697265625 3 0.9441464901762258 5.197502486867678 61181.0 40.82467632485997 0.0 - - - - - - - 1133.875 122 8 NPHP3 nephronophthisis 3 (adolescent) 611 78 C20140606_SFK034_02 C20140606_SFK034_02 TB559650.[MT7]-RALQLEELTLGK[MT7].3b7_1.heavy 553.673 / 984.56 25527.0 35.488932291666664 30 14 0 6 10 2.625197306751113 38.0923749018156 0.03910064697265625 3 0.9441464901762258 5.197502486867678 25527.0 42.86980693716523 0.0 - - - - - - - 272.3333333333333 51 12 NPHP3 nephronophthisis 3 (adolescent) 613 79 C20140606_SFK034_02 C20140606_SFK034_02 TB456549.[MT7]-LEETIENLK[MT7].2y4_1.heavy 688.897 / 647.385 26413.0 36.14740117390951 38 20 2 6 10 8.488632470055233 11.780460557429379 0.036899566650390625 3 0.996304075097401 20.293967004994055 26413.0 22.599050465426103 0.0 - - - - - - - 1662.0 52 7 FMN1 formin 1 615 79 C20140606_SFK034_02 C20140606_SFK034_02 TB456549.[MT7]-LEETIENLK[MT7].2b3_1.heavy 688.897 / 516.279 34798.0 36.14740117390951 38 20 2 6 10 8.488632470055233 11.780460557429379 0.036899566650390625 3 0.996304075097401 20.293967004994055 34798.0 19.992363224583222 0.0 - - - - - - - 733.5 69 2 FMN1 formin 1 617 79 C20140606_SFK034_02 C20140606_SFK034_02 TB456549.[MT7]-LEETIENLK[MT7].2y8_1.heavy 688.897 / 1119.6 N/A 36.14740117390951 38 20 2 6 10 8.488632470055233 11.780460557429379 0.036899566650390625 3 0.996304075097401 20.293967004994055 48215.0 11.984523929002883 1.0 - - - - - - - 681.5 250 4 FMN1 formin 1 619 79 C20140606_SFK034_02 C20140606_SFK034_02 TB456549.[MT7]-LEETIENLK[MT7].2b4_1.heavy 688.897 / 617.326 22849.0 36.14740117390951 38 20 2 6 10 8.488632470055233 11.780460557429379 0.036899566650390625 3 0.996304075097401 20.293967004994055 22849.0 17.92494376954413 0.0 - - - - - - - 2276.0 45 7 FMN1 formin 1 621 80 C20140606_SFK034_02 C20140606_SFK034_02 TB556966.[MT7]-NVC[CAM]VQTDR.2b3_1.heavy 568.286 / 518.251 7078.0 18.466700553894043 44 18 10 6 10 7.949697089767997 12.579095639846372 0.037601470947265625 3 0.9892704387291484 11.903709118007244 7078.0 11.59983420187461 0.0 - - - - - - - 1177.75 14 8 FMN1 formin 1 623 80 C20140606_SFK034_02 C20140606_SFK034_02 TB556966.[MT7]-NVC[CAM]VQTDR.2y5_1.heavy 568.286 / 618.321 3890.0 18.466700553894043 44 18 10 6 10 7.949697089767997 12.579095639846372 0.037601470947265625 3 0.9892704387291484 11.903709118007244 3890.0 44.37937194220048 0.0 - - - - - - - 234.3684210526316 7 19 FMN1 formin 1 625 80 C20140606_SFK034_02 C20140606_SFK034_02 TB556966.[MT7]-NVC[CAM]VQTDR.2y6_1.heavy 568.286 / 778.351 10312.0 18.466700553894043 44 18 10 6 10 7.949697089767997 12.579095639846372 0.037601470947265625 3 0.9892704387291484 11.903709118007244 10312.0 39.99336358479864 0.0 - - - - - - - 217.8235294117647 20 17 FMN1 formin 1 627 80 C20140606_SFK034_02 C20140606_SFK034_02 TB556966.[MT7]-NVC[CAM]VQTDR.2y7_1.heavy 568.286 / 877.42 11765.0 18.466700553894043 44 18 10 6 10 7.949697089767997 12.579095639846372 0.037601470947265625 3 0.9892704387291484 11.903709118007244 11765.0 26.93033930602958 0.0 - - - - - - - 177.68421052631578 23 19 FMN1 formin 1 629 81 C20140606_SFK034_02 C20140606_SFK034_02 TB556620.[MT7]-FADGEVVR.2y5_1.heavy 518.781 / 559.32 196783.0 25.860000610351562 50 20 10 10 10 4.198827440873745 23.81617282638096 0.0 3 0.9905978201365999 12.71766052126337 196783.0 113.96612987064032 0.0 - - - - - - - 846.0 393 3 LBR lamin B receptor 631 81 C20140606_SFK034_02 C20140606_SFK034_02 TB556620.[MT7]-FADGEVVR.2y6_1.heavy 518.781 / 674.347 37408.0 25.860000610351562 50 20 10 10 10 4.198827440873745 23.81617282638096 0.0 3 0.9905978201365999 12.71766052126337 37408.0 62.996194640943195 0.0 - - - - - - - 388.5 74 4 LBR lamin B receptor 633 81 C20140606_SFK034_02 C20140606_SFK034_02 TB556620.[MT7]-FADGEVVR.2b5_1.heavy 518.781 / 664.306 74817.0 25.860000610351562 50 20 10 10 10 4.198827440873745 23.81617282638096 0.0 3 0.9905978201365999 12.71766052126337 74817.0 73.83014094539405 0.0 - - - - - - - 1350.6 149 10 LBR lamin B receptor 635 81 C20140606_SFK034_02 C20140606_SFK034_02 TB556620.[MT7]-FADGEVVR.2y7_1.heavy 518.781 / 745.384 138828.0 25.860000610351562 50 20 10 10 10 4.198827440873745 23.81617282638096 0.0 3 0.9905978201365999 12.71766052126337 138828.0 254.4829291398257 0.0 - - - - - - - 1181.142857142857 277 7 LBR lamin B receptor 637 82 C20140606_SFK034_02 C20140606_SFK034_02 EFTU1_ECO24.FESEVYILSK.2y8.peptide 607.82 / 938.52 2134520.0 35.00400161743164 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2134520.0 97.3232349531147 1.0 - - - - - - - 4887.0 4483 1 639 82 C20140606_SFK034_02 C20140606_SFK034_02 EFTU1_ECO24.FESEVYILSK.2y6.peptide 607.82 / 722.44 406391.0 35.00400161743164 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 406391.0 258.26754858827474 0.0 - - - - - - - 1434.0 812 2 641 82 C20140606_SFK034_02 C20140606_SFK034_02 EFTU1_ECO24.FESEVYILSK.2y5.peptide 607.82 / 623.38 600048.0 35.00400161743164 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 600048.0 67.67105679641882 0.0 - - - - - - - 1594.0 1200 1 643 83 C20140606_SFK034_02 C20140606_SFK034_02 TB403918.[MT7]-GASAPPQDPASSAR.2b8_1.heavy 728.369 / 868.428 7159.0 17.962675094604492 36 10 10 6 10 1.239522441293487 48.00613711678879 0.03730010986328125 3 0.8460629694862719 3.10424075338052 7159.0 3.2147196918449894 0.0 - - - - - - - 204.42857142857142 14 7 GLDN gliomedin 645 83 C20140606_SFK034_02 C20140606_SFK034_02 TB403918.[MT7]-GASAPPQDPASSAR.2y9_1.heavy 728.369 / 928.448 4960.0 17.962675094604492 36 10 10 6 10 1.239522441293487 48.00613711678879 0.03730010986328125 3 0.8460629694862719 3.10424075338052 4960.0 9.424240952149624 0.0 - - - - - - - 279.09090909090907 9 11 GLDN gliomedin 647 83 C20140606_SFK034_02 C20140606_SFK034_02 TB403918.[MT7]-GASAPPQDPASSAR.2y6_1.heavy 728.369 / 588.31 20556.0 17.962675094604492 36 10 10 6 10 1.239522441293487 48.00613711678879 0.03730010986328125 3 0.8460629694862719 3.10424075338052 20556.0 16.082616892783044 0.0 - - - - - - - 869.0 41 2 GLDN gliomedin 649 83 C20140606_SFK034_02 C20140606_SFK034_02 TB403918.[MT7]-GASAPPQDPASSAR.2y10_1.heavy 728.369 / 1025.5 30629.0 17.962675094604492 36 10 10 6 10 1.239522441293487 48.00613711678879 0.03730010986328125 3 0.8460629694862719 3.10424075338052 30629.0 28.60623517963409 0.0 - - - - - - - 818.0 61 1 GLDN gliomedin 651 84 C20140606_SFK034_02 C20140606_SFK034_02 TB559528.[MT7]-DDLYVSDAFHK[MT7].3y3_1.heavy 533.275 / 575.342 25241.0 31.40679931640625 50 20 10 10 10 16.820064225951704 5.945280508840736 0.0 3 0.9912164271710574 13.158560003664997 25241.0 14.702759151232243 0.0 - - - - - - - 337.0 50 1 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 653 84 C20140606_SFK034_02 C20140606_SFK034_02 TB559528.[MT7]-DDLYVSDAFHK[MT7].3b4_1.heavy 533.275 / 651.311 85593.0 31.40679931640625 50 20 10 10 10 16.820064225951704 5.945280508840736 0.0 3 0.9912164271710574 13.158560003664997 85593.0 87.72524222457336 0.0 - - - - - - - 785.0 171 1 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 655 84 C20140606_SFK034_02 C20140606_SFK034_02 TB559528.[MT7]-DDLYVSDAFHK[MT7].3b5_1.heavy 533.275 / 750.379 16154.0 31.40679931640625 50 20 10 10 10 16.820064225951704 5.945280508840736 0.0 3 0.9912164271710574 13.158560003664997 16154.0 18.24065388833933 0.0 - - - - - - - 400.85714285714283 32 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 657 84 C20140606_SFK034_02 C20140606_SFK034_02 TB559528.[MT7]-DDLYVSDAFHK[MT7].3b7_1.heavy 533.275 / 952.438 14023.0 31.40679931640625 50 20 10 10 10 16.820064225951704 5.945280508840736 0.0 3 0.9912164271710574 13.158560003664997 14023.0 42.99386809269163 1.0 - - - - - - - 240.42857142857142 114 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 659 85 C20140606_SFK034_02 C20140606_SFK034_02 TB558551.[MT7]-SPETALEAFK[MT7].3y3_1.heavy 460.925 / 509.32 102523.0 36.172000885009766 50 20 10 10 10 15.220153421808254 6.5702360041072 0.0 3 0.996204157921737 20.024921858642156 102523.0 91.15568345172754 0.0 - - - - - - - 209.0 205 1 FMN1 formin 1 661 85 C20140606_SFK034_02 C20140606_SFK034_02 TB558551.[MT7]-SPETALEAFK[MT7].3b4_1.heavy 460.925 / 559.284 32782.0 36.172000885009766 50 20 10 10 10 15.220153421808254 6.5702360041072 0.0 3 0.996204157921737 20.024921858642156 32782.0 12.42733439744613 1.0 - - - - - - - 365.5 65 2 FMN1 formin 1 663 85 C20140606_SFK034_02 C20140606_SFK034_02 TB558551.[MT7]-SPETALEAFK[MT7].3b5_1.heavy 460.925 / 630.321 98661.0 36.172000885009766 50 20 10 10 10 15.220153421808254 6.5702360041072 0.0 3 0.996204157921737 20.024921858642156 98661.0 180.97764313442082 0.0 - - - - - - - 790.5714285714286 197 7 FMN1 formin 1 665 85 C20140606_SFK034_02 C20140606_SFK034_02 TB558551.[MT7]-SPETALEAFK[MT7].3y4_1.heavy 460.925 / 638.363 45937.0 36.172000885009766 50 20 10 10 10 15.220153421808254 6.5702360041072 0.0 3 0.996204157921737 20.024921858642156 45937.0 81.13500664156888 0.0 - - - - - - - 313.5 91 4 FMN1 formin 1 667 86 C20140606_SFK034_02 C20140606_SFK034_02 TB557829.[MT7]-LQQENSILR.2y8_1.heavy 622.858 / 987.522 145536.0 28.3710994720459 47 17 10 10 10 4.763150178378979 20.994509149411815 0.0 3 0.9796479617295109 8.63612830299071 145536.0 138.81220231898624 0.0 - - - - - - - 710.0 291 7 NIN;RRBP1 ninein (GSK3B interacting protein);ribosome binding protein 1 homolog 180kDa (dog) 669 86 C20140606_SFK034_02 C20140606_SFK034_02 TB557829.[MT7]-LQQENSILR.2y5_1.heavy 622.858 / 602.362 40319.0 28.3710994720459 47 17 10 10 10 4.763150178378979 20.994509149411815 0.0 3 0.9796479617295109 8.63612830299071 40319.0 19.00705267143687 0.0 - - - - - - - 1473.0 80 1 NIN;RRBP1 ninein (GSK3B interacting protein);ribosome binding protein 1 homolog 180kDa (dog) 671 86 C20140606_SFK034_02 C20140606_SFK034_02 TB557829.[MT7]-LQQENSILR.2y6_1.heavy 622.858 / 731.405 31666.0 28.3710994720459 47 17 10 10 10 4.763150178378979 20.994509149411815 0.0 3 0.9796479617295109 8.63612830299071 31666.0 59.533000940698514 0.0 - - - - - - - 684.8888888888889 63 9 NIN;RRBP1 ninein (GSK3B interacting protein);ribosome binding protein 1 homolog 180kDa (dog) 673 86 C20140606_SFK034_02 C20140606_SFK034_02 TB557829.[MT7]-LQQENSILR.2y7_1.heavy 622.858 / 859.463 54127.0 28.3710994720459 47 17 10 10 10 4.763150178378979 20.994509149411815 0.0 3 0.9796479617295109 8.63612830299071 54127.0 173.23254830917875 0.0 - - - - - - - 241.5 108 8 NIN;RRBP1 ninein (GSK3B interacting protein);ribosome binding protein 1 homolog 180kDa (dog) 675 87 C20140606_SFK034_02 C20140606_SFK034_02 TB558964.[MT7]-VAAC[CAM]LPIDDVLR.2y4_1.heavy 743.414 / 502.298 51921.0 41.58525085449219 40 14 10 6 10 1.9057611795583402 41.47968313216888 0.0343017578125 3 0.935399126557131 4.829220078589413 51921.0 38.608454228274894 0.0 - - - - - - - 844.0 103 3 CRBN cereblon 677 87 C20140606_SFK034_02 C20140606_SFK034_02 TB558964.[MT7]-VAAC[CAM]LPIDDVLR.2b4_1.heavy 743.414 / 546.283 73922.0 41.58525085449219 40 14 10 6 10 1.9057611795583402 41.47968313216888 0.0343017578125 3 0.935399126557131 4.829220078589413 73922.0 75.03354056698056 0.0 - - - - - - - 454.0 147 1 CRBN cereblon 679 87 C20140606_SFK034_02 C20140606_SFK034_02 TB558964.[MT7]-VAAC[CAM]LPIDDVLR.2y11_1.heavy 743.414 / 1242.65 49130.0 41.58525085449219 40 14 10 6 10 1.9057611795583402 41.47968313216888 0.0343017578125 3 0.935399126557131 4.829220078589413 49130.0 68.30392778534744 0.0 - - - - - - - 367.6666666666667 98 3 CRBN cereblon 681 87 C20140606_SFK034_02 C20140606_SFK034_02 TB558964.[MT7]-VAAC[CAM]LPIDDVLR.2y7_1.heavy 743.414 / 827.462 119223.0 41.58525085449219 40 14 10 6 10 1.9057611795583402 41.47968313216888 0.0343017578125 3 0.935399126557131 4.829220078589413 119223.0 150.63733221832655 0.0 - - - - - - - 389.0 238 1 CRBN cereblon 683 88 C20140606_SFK034_02 C20140606_SFK034_02 TB558966.[MT7]-VAAC[CAM]LPIDDVLR.3y7_1.heavy 495.945 / 827.462 74611.0 41.56809997558594 47 17 10 10 10 2.123531282869809 31.39424749918031 0.0 3 0.9744455115630622 7.703703557884351 74611.0 414.32723741883115 0.0 - - - - - - - 277.5 149 12 CRBN cereblon 685 88 C20140606_SFK034_02 C20140606_SFK034_02 TB558966.[MT7]-VAAC[CAM]LPIDDVLR.3y6_1.heavy 495.945 / 730.409 33203.0 41.56809997558594 47 17 10 10 10 2.123531282869809 31.39424749918031 0.0 3 0.9744455115630622 7.703703557884351 33203.0 87.91848426159052 0.0 - - - - - - - 232.9090909090909 66 11 CRBN cereblon 687 88 C20140606_SFK034_02 C20140606_SFK034_02 TB558966.[MT7]-VAAC[CAM]LPIDDVLR.3b4_1.heavy 495.945 / 546.283 99609.0 41.56809997558594 47 17 10 10 10 2.123531282869809 31.39424749918031 0.0 3 0.9744455115630622 7.703703557884351 99609.0 118.37532734237509 0.0 - - - - - - - 333.2 199 5 CRBN cereblon 689 88 C20140606_SFK034_02 C20140606_SFK034_02 TB558966.[MT7]-VAAC[CAM]LPIDDVLR.3y5_1.heavy 495.945 / 617.325 99481.0 41.56809997558594 47 17 10 10 10 2.123531282869809 31.39424749918031 0.0 3 0.9744455115630622 7.703703557884351 99481.0 155.55650611221128 0.0 - - - - - - - 1181.4285714285713 198 7 CRBN cereblon 691 89 C20140606_SFK034_02 C20140606_SFK034_02 TB556130.[MT7]-SISISVAR.2b6_1.heavy 488.799 / 731.442 6601.0 28.010499954223633 48 18 10 10 10 3.313572778960951 30.178905571332393 0.0 3 0.988565602838344 11.530311451836772 6601.0 7.990231704534413 0.0 - - - - - - - 708.4166666666666 13 12 KRT1 keratin 1 693 89 C20140606_SFK034_02 C20140606_SFK034_02 TB556130.[MT7]-SISISVAR.2b7_1.heavy 488.799 / 802.479 14648.0 28.010499954223633 48 18 10 10 10 3.313572778960951 30.178905571332393 0.0 3 0.988565602838344 11.530311451836772 14648.0 23.662717378361 0.0 - - - - - - - 874.25 29 12 KRT1 keratin 1 695 89 C20140606_SFK034_02 C20140606_SFK034_02 TB556130.[MT7]-SISISVAR.2y7_1.heavy 488.799 / 745.457 101093.0 28.010499954223633 48 18 10 10 10 3.313572778960951 30.178905571332393 0.0 3 0.988565602838344 11.530311451836772 101093.0 136.1551160610746 0.0 - - - - - - - 756.4545454545455 202 11 KRT1 keratin 1 697 90 C20140606_SFK034_02 C20140606_SFK034_02 TB558278.[MT7]-LHGRPLGAPTR.3y10_2.heavy 440.266 / 531.302 142822.0 19.2549991607666 41 11 10 10 10 1.101661830450969 60.00660705028025 0.0 3 0.8630077224407957 3.295542893936795 142822.0 77.10879530274472 0.0 - - - - - - - 1346.5 285 2 LAMA5 laminin, alpha 5 699 90 C20140606_SFK034_02 C20140606_SFK034_02 TB558278.[MT7]-LHGRPLGAPTR.3y7_1.heavy 440.266 / 711.415 49059.0 19.2549991607666 41 11 10 10 10 1.101661830450969 60.00660705028025 0.0 3 0.8630077224407957 3.295542893936795 49059.0 170.8182451253482 0.0 - - - - - - - 304.1666666666667 98 18 LAMA5 laminin, alpha 5 701 90 C20140606_SFK034_02 C20140606_SFK034_02 TB558278.[MT7]-LHGRPLGAPTR.3y6_1.heavy 440.266 / 614.362 9740.0 19.2549991607666 41 11 10 10 10 1.101661830450969 60.00660705028025 0.0 3 0.8630077224407957 3.295542893936795 9740.0 10.057854884824994 1.0 - - - - - - - 756.7142857142857 19 7 LAMA5 laminin, alpha 5 703 90 C20140606_SFK034_02 C20140606_SFK034_02 TB558278.[MT7]-LHGRPLGAPTR.3y5_1.heavy 440.266 / 501.278 44166.0 19.2549991607666 41 11 10 10 10 1.101661830450969 60.00660705028025 0.0 3 0.8630077224407957 3.295542893936795 44166.0 33.5105309686559 0.0 - - - - - - - 1820.857142857143 88 7 LAMA5 laminin, alpha 5 705 91 C20140606_SFK034_02 C20140606_SFK034_02 TB456512.[MT7]-ELFESDLDR.2y8_1.heavy 634.318 / 994.484 29738.0 33.943199157714844 42 20 6 10 6 5.10424048856456 19.591553380769973 0.0 5 0.9912589389360655 13.19056611098773 29738.0 14.244329081041256 0.0 - - - - - - - 999.0 59 1 DMGDH dimethylglycine dehydrogenase 707 91 C20140606_SFK034_02 C20140606_SFK034_02 TB456512.[MT7]-ELFESDLDR.2y5_1.heavy 634.318 / 605.289 12539.0 33.943199157714844 42 20 6 10 6 5.10424048856456 19.591553380769973 0.0 5 0.9912589389360655 13.19056611098773 12539.0 3.6159134425143775 3.0 - - - - - - - 2330.0 92 4 DMGDH dimethylglycine dehydrogenase 709 91 C20140606_SFK034_02 C20140606_SFK034_02 TB456512.[MT7]-ELFESDLDR.2b6_1.heavy 634.318 / 865.406 11762.0 33.943199157714844 42 20 6 10 6 5.10424048856456 19.591553380769973 0.0 5 0.9912589389360655 13.19056611098773 11762.0 5.491699640228197 1.0 - - - - - - - 888.0 24 2 DMGDH dimethylglycine dehydrogenase 711 91 C20140606_SFK034_02 C20140606_SFK034_02 TB456512.[MT7]-ELFESDLDR.2y7_1.heavy 634.318 / 881.4 20306.0 33.943199157714844 42 20 6 10 6 5.10424048856456 19.591553380769973 0.0 5 0.9912589389360655 13.19056611098773 20306.0 6.919259650083562 0.0 - - - - - - - 333.0 40 1 DMGDH dimethylglycine dehydrogenase 713 92 C20140606_SFK034_02 C20140606_SFK034_02 TB456511.[MT7]-YPAPVTSLK[MT7].2y6_1.heavy 632.381 / 788.5 13807.0 30.359700202941895 28 7 10 5 6 0.8475791439164562 82.63423636318922 0.04080009460449219 5 0.7432319958567831 2.3813756248541327 13807.0 10.84408984312352 1.0 - - - - - - - 311.0 41 1 DMGDH dimethylglycine dehydrogenase 715 92 C20140606_SFK034_02 C20140606_SFK034_02 TB456511.[MT7]-YPAPVTSLK[MT7].2y4_1.heavy 632.381 / 592.379 4879.0 30.359700202941895 28 7 10 5 6 0.8475791439164562 82.63423636318922 0.04080009460449219 5 0.7432319958567831 2.3813756248541327 4879.0 2.3308495958998616 9.0 - - - - - - - 810.0 11 5 DMGDH dimethylglycine dehydrogenase 717 92 C20140606_SFK034_02 C20140606_SFK034_02 TB456511.[MT7]-YPAPVTSLK[MT7].2y8_1.heavy 632.381 / 956.59 45159.0 30.359700202941895 28 7 10 5 6 0.8475791439164562 82.63423636318922 0.04080009460449219 5 0.7432319958567831 2.3813756248541327 45159.0 70.46821848750636 0.0 - - - - - - - 311.3333333333333 90 3 DMGDH dimethylglycine dehydrogenase 719 92 C20140606_SFK034_02 C20140606_SFK034_02 TB456511.[MT7]-YPAPVTSLK[MT7].2b6_1.heavy 632.381 / 773.431 1038.0 30.359700202941895 28 7 10 5 6 0.8475791439164562 82.63423636318922 0.04080009460449219 5 0.7432319958567831 2.3813756248541327 1038.0 0.8692233075109465 29.0 - - - - - - - 643.7 29 10 DMGDH dimethylglycine dehydrogenase 721 93 C20140606_SFK034_02 C20140606_SFK034_02 TB456519.[MT7]-IESVLSSSGK[MT7].3y3_1.heavy 432.253 / 435.268 208831.0 30.17639923095703 42 20 6 10 6 190.0765620320275 0.526103791708681 0.0 5 0.998673326937153 33.87914086346564 208831.0 214.76416822676964 0.0 - - - - - - - 1680.7142857142858 417 7 GM2A GM2 ganglioside activator 723 93 C20140606_SFK034_02 C20140606_SFK034_02 TB456519.[MT7]-IESVLSSSGK[MT7].3b4_1.heavy 432.253 / 573.336 226986.0 30.17639923095703 42 20 6 10 6 190.0765620320275 0.526103791708681 0.0 5 0.998673326937153 33.87914086346564 226986.0 37.769553904508754 0.0 - - - - - - - 253.5 453 2 GM2A GM2 ganglioside activator 725 93 C20140606_SFK034_02 C20140606_SFK034_02 TB456519.[MT7]-IESVLSSSGK[MT7].3y4_1.heavy 432.253 / 522.3 127997.0 30.17639923095703 42 20 6 10 6 190.0765620320275 0.526103791708681 0.0 5 0.998673326937153 33.87914086346564 127997.0 88.11361099024826 2.0 - - - - - - - 710.0 689 1 GM2A GM2 ganglioside activator 727 93 C20140606_SFK034_02 C20140606_SFK034_02 TB456519.[MT7]-IESVLSSSGK[MT7].3y5_1.heavy 432.253 / 609.332 110146.0 30.17639923095703 42 20 6 10 6 190.0765620320275 0.526103791708681 0.0 5 0.998673326937153 33.87914086346564 110146.0 62.34609957727484 0.0 - - - - - - - 687.4444444444445 220 9 GM2A GM2 ganglioside activator 729 94 C20140606_SFK034_02 C20140606_SFK034_02 TB559125.[MT7]-GDQGPPGPPGPPGPPGPPGPPGSR.3b4_1.heavy 757.386 / 502.238 46812.0 26.340150356292725 44 18 10 6 10 3.302415603829641 24.080897544117327 0.03940010070800781 3 0.9812315971371204 8.994294648612 46812.0 52.120498029997506 0.0 - - - - - - - 774.8888888888889 93 9 GLDN gliomedin 731 94 C20140606_SFK034_02 C20140606_SFK034_02 TB559125.[MT7]-GDQGPPGPPGPPGPPGPPGPPGSR.3y13_1.heavy 757.386 / 1169.61 38705.0 26.340150356292725 44 18 10 6 10 3.302415603829641 24.080897544117327 0.03940010070800781 3 0.9812315971371204 8.994294648612 38705.0 96.00170619130988 0.0 - - - - - - - 261.6 77 5 GLDN gliomedin 733 94 C20140606_SFK034_02 C20140606_SFK034_02 TB559125.[MT7]-GDQGPPGPPGPPGPPGPPGPPGSR.3b7_1.heavy 757.386 / 753.365 70698.0 26.340150356292725 44 18 10 6 10 3.302415603829641 24.080897544117327 0.03940010070800781 3 0.9812315971371204 8.994294648612 70698.0 354.5040472601741 0.0 - - - - - - - 218.0 141 4 GLDN gliomedin 735 94 C20140606_SFK034_02 C20140606_SFK034_02 TB559125.[MT7]-GDQGPPGPPGPPGPPGPPGPPGSR.3y10_1.heavy 757.386 / 918.479 28506.0 26.340150356292725 44 18 10 6 10 3.302415603829641 24.080897544117327 0.03940010070800781 3 0.9812315971371204 8.994294648612 28506.0 62.111697247706424 0.0 - - - - - - - 747.2857142857143 57 7 GLDN gliomedin 737 95 C20140606_SFK034_02 C20140606_SFK034_02 TB326581.[MT7]-TFSVLEPGGPGGC[CAM]AAR.2y12_1.heavy 860.434 / 1141.54 19501.0 33.59910011291504 42 17 10 5 10 4.441257417050191 22.516145904107113 0.046802520751953125 3 0.9714639356475588 7.288314948077728 19501.0 30.887133142766604 0.0 - - - - - - - 203.63636363636363 39 11 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 739 95 C20140606_SFK034_02 C20140606_SFK034_02 TB326581.[MT7]-TFSVLEPGGPGGC[CAM]AAR.2b4_1.heavy 860.434 / 579.326 27795.0 33.59910011291504 42 17 10 5 10 4.441257417050191 22.516145904107113 0.046802520751953125 3 0.9714639356475588 7.288314948077728 27795.0 69.21874179622785 0.0 - - - - - - - 261.3333333333333 55 15 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 741 95 C20140606_SFK034_02 C20140606_SFK034_02 TB326581.[MT7]-TFSVLEPGGPGGC[CAM]AAR.2b6_1.heavy 860.434 / 821.453 39899.0 33.59910011291504 42 17 10 5 10 4.441257417050191 22.516145904107113 0.046802520751953125 3 0.9714639356475588 7.288314948077728 39899.0 257.3841741071428 0.0 - - - - - - - 261.3333333333333 79 9 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 743 95 C20140606_SFK034_02 C20140606_SFK034_02 TB326581.[MT7]-TFSVLEPGGPGGC[CAM]AAR.2y10_1.heavy 860.434 / 899.415 79349.0 33.59910011291504 42 17 10 5 10 4.441257417050191 22.516145904107113 0.046802520751953125 3 0.9714639356475588 7.288314948077728 79349.0 223.7456847400528 0.0 - - - - - - - 242.66666666666666 158 6 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 745 96 C20140606_SFK034_02 C20140606_SFK034_02 TB456695.[MT7]-VQSSTLVSSLEAELSEVK[MT7].4y5_1.heavy 549.307 / 719.442 9208.0 48.587799072265625 48 18 10 10 10 5.2744563128465805 18.959300081116954 0.0 3 0.9869432765177611 10.788761502407572 9208.0 31.055507527298566 0.0 - - - - - - - 268.2857142857143 18 7 NIN ninein (GSK3B interacting protein) 747 96 C20140606_SFK034_02 C20140606_SFK034_02 TB456695.[MT7]-VQSSTLVSSLEAELSEVK[MT7].4y4_1.heavy 549.307 / 606.358 23930.0 48.587799072265625 48 18 10 10 10 5.2744563128465805 18.959300081116954 0.0 3 0.9869432765177611 10.788761502407572 23930.0 92.65063893959837 0.0 - - - - - - - 212.23076923076923 47 13 NIN ninein (GSK3B interacting protein) 749 96 C20140606_SFK034_02 C20140606_SFK034_02 TB456695.[MT7]-VQSSTLVSSLEAELSEVK[MT7].4b5_1.heavy 549.307 / 647.348 13314.0 48.587799072265625 48 18 10 10 10 5.2744563128465805 18.959300081116954 0.0 3 0.9869432765177611 10.788761502407572 13314.0 21.87539540180605 0.0 - - - - - - - 275.7 26 10 NIN ninein (GSK3B interacting protein) 751 96 C20140606_SFK034_02 C20140606_SFK034_02 TB456695.[MT7]-VQSSTLVSSLEAELSEVK[MT7].4b6_1.heavy 549.307 / 760.432 9091.0 48.587799072265625 48 18 10 10 10 5.2744563128465805 18.959300081116954 0.0 3 0.9869432765177611 10.788761502407572 9091.0 27.299611932061055 0.0 - - - - - - - 180.35714285714286 18 14 NIN ninein (GSK3B interacting protein) 753 97 C20140606_SFK034_02 C20140606_SFK034_02 SUCC_ECO24.LVQQFTK.2y4.peptide 432.25 / 523.29 1649930.0 22.36989974975586 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1649930.0 583.6203217569775 0.0 - - - - - - - 667.0 3299 3 755 97 C20140606_SFK034_02 C20140606_SFK034_02 SUCC_ECO24.LVQQFTK.2y6.peptide 432.25 / 750.41 2447070.0 22.36989974975586 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2447070.0 5891.965046508321 0.0 - - - - - - - 236.4375 4894 16 757 97 C20140606_SFK034_02 C20140606_SFK034_02 SUCC_ECO24.LVQQFTK.2y5.peptide 432.25 / 651.35 6530640.0 22.36989974975586 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 6530640.0 8221.271370815753 0.0 - - - - - - - 787.0 13061 9 759 98 C20140606_SFK034_02 C20140606_SFK034_02 TB456696.[MT7]-VQSSTLVSSLEAELSEVK[MT7].3b6_1.heavy 732.073 / 760.432 68154.0 48.604949951171875 40 14 10 6 10 2.028201862508022 39.198876025458354 0.0343017578125 3 0.9377622822883508 4.921040409170044 68154.0 71.96223816344157 0.0 - - - - - - - 272.35714285714283 136 14 NIN ninein (GSK3B interacting protein) 761 98 C20140606_SFK034_02 C20140606_SFK034_02 TB456696.[MT7]-VQSSTLVSSLEAELSEVK[MT7].3b5_1.heavy 732.073 / 647.348 48153.0 48.604949951171875 40 14 10 6 10 2.028201862508022 39.198876025458354 0.0343017578125 3 0.9377622822883508 4.921040409170044 48153.0 52.80348779800485 0.0 - - - - - - - 721.4 96 10 NIN ninein (GSK3B interacting protein) 763 98 C20140606_SFK034_02 C20140606_SFK034_02 TB456696.[MT7]-VQSSTLVSSLEAELSEVK[MT7].3y4_1.heavy 732.073 / 606.358 112084.0 48.604949951171875 40 14 10 6 10 2.028201862508022 39.198876025458354 0.0343017578125 3 0.9377622822883508 4.921040409170044 112084.0 71.56678209302501 0.0 - - - - - - - 358.55555555555554 224 9 NIN ninein (GSK3B interacting protein) 765 98 C20140606_SFK034_02 C20140606_SFK034_02 TB456696.[MT7]-VQSSTLVSSLEAELSEVK[MT7].3b7_1.heavy 732.073 / 859.5 57421.0 48.604949951171875 40 14 10 6 10 2.028201862508022 39.198876025458354 0.0343017578125 3 0.9377622822883508 4.921040409170044 57421.0 64.26977877797121 0.0 - - - - - - - 289.46666666666664 114 15 NIN ninein (GSK3B interacting protein) 767 99 C20140606_SFK034_02 C20140606_SFK034_02 TB560092.[MT7]-NITDELGVLGVAGPQAR.3b4_1.heavy 618.678 / 588.311 63901.0 40.819400787353516 44 14 10 10 10 2.5179487731081727 39.71486674709404 0.0 3 0.9360075520279069 4.852375302313412 63901.0 44.75833193135367 0.0 - - - - - - - 2201.1 127 10 DMGDH dimethylglycine dehydrogenase 769 99 C20140606_SFK034_02 C20140606_SFK034_02 TB560092.[MT7]-NITDELGVLGVAGPQAR.3b5_1.heavy 618.678 / 717.354 92195.0 40.819400787353516 44 14 10 10 10 2.5179487731081727 39.71486674709404 0.0 3 0.9360075520279069 4.852375302313412 92195.0 104.68809057971015 0.0 - - - - - - - 774.3333333333334 184 9 DMGDH dimethylglycine dehydrogenase 771 99 C20140606_SFK034_02 C20140606_SFK034_02 TB560092.[MT7]-NITDELGVLGVAGPQAR.3y8_1.heavy 618.678 / 755.416 217582.0 40.819400787353516 44 14 10 10 10 2.5179487731081727 39.71486674709404 0.0 3 0.9360075520279069 4.852375302313412 217582.0 301.0378978402955 0.0 - - - - - - - 793.5 435 4 DMGDH dimethylglycine dehydrogenase 773 99 C20140606_SFK034_02 C20140606_SFK034_02 TB560092.[MT7]-NITDELGVLGVAGPQAR.3b7_1.heavy 618.678 / 887.459 218755.0 40.819400787353516 44 14 10 10 10 2.5179487731081727 39.71486674709404 0.0 3 0.9360075520279069 4.852375302313412 218755.0 322.26012434123845 0.0 - - - - - - - 828.0 437 8 DMGDH dimethylglycine dehydrogenase 775 100 C20140606_SFK034_02 C20140606_SFK034_02 TB560089.[MT7]-NITDELGVLGVAGPQAR.2y9_1.heavy 927.514 / 868.5 36589.0 40.819400787353516 48 18 10 10 10 3.60646436146492 23.217357429525975 0.0 3 0.9823343184701988 9.271622659341025 36589.0 82.42044147113955 0.0 - - - - - - - 770.6 73 10 DMGDH dimethylglycine dehydrogenase 777 100 C20140606_SFK034_02 C20140606_SFK034_02 TB560089.[MT7]-NITDELGVLGVAGPQAR.2b4_1.heavy 927.514 / 588.311 45614.0 40.819400787353516 48 18 10 10 10 3.60646436146492 23.217357429525975 0.0 3 0.9823343184701988 9.271622659341025 45614.0 129.9465303054755 0.0 - - - - - - - 682.6666666666666 91 12 DMGDH dimethylglycine dehydrogenase 779 100 C20140606_SFK034_02 C20140606_SFK034_02 TB560089.[MT7]-NITDELGVLGVAGPQAR.2b5_1.heavy 927.514 / 717.354 32562.0 40.819400787353516 48 18 10 10 10 3.60646436146492 23.217357429525975 0.0 3 0.9823343184701988 9.271622659341025 32562.0 185.45503597122303 0.0 - - - - - - - 284.09090909090907 65 11 DMGDH dimethylglycine dehydrogenase 781 100 C20140606_SFK034_02 C20140606_SFK034_02 TB560089.[MT7]-NITDELGVLGVAGPQAR.2y11_1.heavy 927.514 / 1024.59 57556.0 40.819400787353516 48 18 10 10 10 3.60646436146492 23.217357429525975 0.0 3 0.9823343184701988 9.271622659341025 57556.0 181.3999192792793 0.0 - - - - - - - 298.5 115 10 DMGDH dimethylglycine dehydrogenase 783 101 C20140606_SFK034_02 C20140606_SFK034_02 TB555780.[MT7]-VLESIEIFK[MT7].3b6_1.heavy 455.946 / 815.463 7751.0 42.73242473602295 43 17 10 6 10 2.9477134951688626 26.939477805710496 0.032100677490234375 3 0.9712312228955827 7.258634973287479 7751.0 67.03567567567568 0.0 - - - - - - - 147.6 15 5 FAM75D1 family with sequence similarity 75, member D1 785 101 C20140606_SFK034_02 C20140606_SFK034_02 TB555780.[MT7]-VLESIEIFK[MT7].3y3_1.heavy 455.946 / 551.367 24298.0 42.73242473602295 43 17 10 6 10 2.9477134951688626 26.939477805710496 0.032100677490234375 3 0.9712312228955827 7.258634973287479 24298.0 62.52290243902439 0.0 - - - - - - - 259.6521739130435 48 23 FAM75D1 family with sequence similarity 75, member D1 787 101 C20140606_SFK034_02 C20140606_SFK034_02 TB555780.[MT7]-VLESIEIFK[MT7].3b4_1.heavy 455.946 / 573.336 31249.0 42.73242473602295 43 17 10 6 10 2.9477134951688626 26.939477805710496 0.032100677490234375 3 0.9712312228955827 7.258634973287479 31249.0 135.92044715447153 0.0 - - - - - - - 743.3333333333334 62 12 FAM75D1 family with sequence similarity 75, member D1 789 101 C20140606_SFK034_02 C20140606_SFK034_02 TB555780.[MT7]-VLESIEIFK[MT7].3b3_1.heavy 455.946 / 486.304 16855.0 42.73242473602295 43 17 10 6 10 2.9477134951688626 26.939477805710496 0.032100677490234375 3 0.9712312228955827 7.258634973287479 16855.0 38.08306707883871 0.0 - - - - - - - 288.3157894736842 33 19 FAM75D1 family with sequence similarity 75, member D1 791 102 C20140606_SFK034_02 C20140606_SFK034_02 TB326288.[MT7]-LVSANR.2y4_1.heavy 402.246 / 447.231 154825.0 19.320199966430664 48 20 10 10 8 6.74155587283514 14.833371092116353 0.0 4 0.9966831140988422 21.422837248894343 154825.0 57.998343064171074 0.0 - - - - - - - 2253.0 309 9 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 793 102 C20140606_SFK034_02 C20140606_SFK034_02 TB326288.[MT7]-LVSANR.2y5_1.heavy 402.246 / 546.299 356493.0 19.320199966430664 48 20 10 10 8 6.74155587283514 14.833371092116353 0.0 4 0.9966831140988422 21.422837248894343 356493.0 23.07472876633808 0.0 - - - - - - - 2832.0 712 2 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 795 102 C20140606_SFK034_02 C20140606_SFK034_02 TB326288.[MT7]-LVSANR.2b4_1.heavy 402.246 / 515.331 30435.0 19.320199966430664 48 20 10 10 8 6.74155587283514 14.833371092116353 0.0 4 0.9966831140988422 21.422837248894343 30435.0 11.62162977140046 2.0 - - - - - - - 1439.0 70 1 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 797 102 C20140606_SFK034_02 C20140606_SFK034_02 TB326288.[MT7]-LVSANR.2b5_1.heavy 402.246 / 629.374 44146.0 19.320199966430664 48 20 10 10 8 6.74155587283514 14.833371092116353 0.0 4 0.9966831140988422 21.422837248894343 44146.0 10.227473228148432 1.0 - - - - - - - 2208.625 250 8 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 799 103 C20140606_SFK034_02 C20140606_SFK034_02 TB456521.[MT7]-GILYVTDTK[MT7].3y3_1.heavy 433.258 / 507.289 60378.0 33.1349983215332 50 20 10 10 10 7.49884188085174 13.335392529791775 0.0 3 0.9952989304307928 17.992592598852685 60378.0 70.8515560354275 0.0 - - - - - - - 1236.857142857143 120 7 GLDN gliomedin 801 103 C20140606_SFK034_02 C20140606_SFK034_02 TB456521.[MT7]-GILYVTDTK[MT7].3b4_1.heavy 433.258 / 591.362 82078.0 33.1349983215332 50 20 10 10 10 7.49884188085174 13.335392529791775 0.0 3 0.9952989304307928 17.992592598852685 82078.0 24.31657310890864 1.0 - - - - - - - 450.0 170 1 GLDN gliomedin 803 103 C20140606_SFK034_02 C20140606_SFK034_02 TB456521.[MT7]-GILYVTDTK[MT7].3b5_1.heavy 433.258 / 690.431 14279.0 33.1349983215332 50 20 10 10 10 7.49884188085174 13.335392529791775 0.0 3 0.9952989304307928 17.992592598852685 14279.0 22.10450177935943 0.0 - - - - - - - 287.3333333333333 28 9 GLDN gliomedin 805 103 C20140606_SFK034_02 C20140606_SFK034_02 TB456521.[MT7]-GILYVTDTK[MT7].3y4_1.heavy 433.258 / 608.337 57792.0 33.1349983215332 50 20 10 10 10 7.49884188085174 13.335392529791775 0.0 3 0.9952989304307928 17.992592598852685 57792.0 39.50310623306677 0.0 - - - - - - - 225.0 115 1 GLDN gliomedin 807 104 C20140606_SFK034_02 C20140606_SFK034_02 TB556126.[MT7]-LLSLLK[MT7].2y4_1.heavy 487.846 / 604.415 134637.0 41.8253755569458 46 20 10 6 10 9.840995846446647 10.161573235101775 0.032100677490234375 3 0.9966249758186667 21.237417437002065 134637.0 539.6092657080551 0.0 - - - - - - - 275.6666666666667 269 9 FAM75D1 family with sequence similarity 75, member D1 809 104 C20140606_SFK034_02 C20140606_SFK034_02 TB556126.[MT7]-LLSLLK[MT7].2y5_1.heavy 487.846 / 717.499 144561.0 41.8253755569458 46 20 10 6 10 9.840995846446647 10.161573235101775 0.032100677490234375 3 0.9966249758186667 21.237417437002065 144561.0 312.7359582101392 0.0 - - - - - - - 718.4285714285714 289 7 FAM75D1 family with sequence similarity 75, member D1 811 104 C20140606_SFK034_02 C20140606_SFK034_02 TB556126.[MT7]-LLSLLK[MT7].2b4_1.heavy 487.846 / 571.394 27032.0 41.8253755569458 46 20 10 6 10 9.840995846446647 10.161573235101775 0.032100677490234375 3 0.9966249758186667 21.237417437002065 27032.0 41.77736917852771 0.0 - - - - - - - 326.2857142857143 54 7 FAM75D1 family with sequence similarity 75, member D1 813 104 C20140606_SFK034_02 C20140606_SFK034_02 TB556126.[MT7]-LLSLLK[MT7].2y3_1.heavy 487.846 / 517.383 45053.0 41.8253755569458 46 20 10 6 10 9.840995846446647 10.161573235101775 0.032100677490234375 3 0.9966249758186667 21.237417437002065 45053.0 54.91335753207191 0.0 - - - - - - - 712.8333333333334 90 12 FAM75D1 family with sequence similarity 75, member D1 815 105 C20140606_SFK034_02 C20140606_SFK034_02 TB326412.[MT7]-SLNNQFASFIDK[MT7].3y3_1.heavy 557.97 / 519.326 93010.0 38.957298278808594 46 16 10 10 10 3.501230002604736 22.601689466787278 0.0 3 0.9671639831154877 6.791904021600311 93010.0 13.201404640854676 0.0 - - - - - - - 1699.0 186 1 KRT1 keratin 1 817 105 C20140606_SFK034_02 C20140606_SFK034_02 TB326412.[MT7]-SLNNQFASFIDK[MT7].3b4_1.heavy 557.97 / 573.311 40347.0 38.957298278808594 46 16 10 10 10 3.501230002604736 22.601689466787278 0.0 3 0.9671639831154877 6.791904021600311 40347.0 24.274252930120753 0.0 - - - - - - - 1206.0 80 5 KRT1 keratin 1 819 105 C20140606_SFK034_02 C20140606_SFK034_02 TB326412.[MT7]-SLNNQFASFIDK[MT7].3b5_1.heavy 557.97 / 701.37 88169.0 38.957298278808594 46 16 10 10 10 3.501230002604736 22.601689466787278 0.0 3 0.9671639831154877 6.791904021600311 88169.0 81.8974582806732 0.0 - - - - - - - 679.6666666666666 176 3 KRT1 keratin 1 821 105 C20140606_SFK034_02 C20140606_SFK034_02 TB326412.[MT7]-SLNNQFASFIDK[MT7].3y5_1.heavy 557.97 / 753.426 61073.0 38.957298278808594 46 16 10 10 10 3.501230002604736 22.601689466787278 0.0 3 0.9671639831154877 6.791904021600311 61073.0 58.28796097009131 0.0 - - - - - - - 425.0 122 1 KRT1 keratin 1 823 106 C20140606_SFK034_02 C20140606_SFK034_02 TB556326.[MT7]-VQGVSITR.2b4_1.heavy 502.304 / 528.326 8045.0 24.43049955368042 36 20 6 6 4 4.340718488907965 23.037660759511255 0.03880119323730469 7 0.990943533651218 12.958498144438227 8045.0 4.794325752127403 0.0 - - - - - - - 1264.3333333333333 16 9 IRAK2 interleukin-1 receptor-associated kinase 2 825 106 C20140606_SFK034_02 C20140606_SFK034_02 TB556326.[MT7]-VQGVSITR.2y6_1.heavy 502.304 / 632.373 21380.0 24.43049955368042 36 20 6 6 4 4.340718488907965 23.037660759511255 0.03880119323730469 7 0.990943533651218 12.958498144438227 21380.0 9.231934347080479 1.0 - - - - - - - 217.0 108 1 IRAK2 interleukin-1 receptor-associated kinase 2 827 106 C20140606_SFK034_02 C20140606_SFK034_02 TB556326.[MT7]-VQGVSITR.2b5_1.heavy 502.304 / 615.358 8842.0 24.43049955368042 36 20 6 6 4 4.340718488907965 23.037660759511255 0.03880119323730469 7 0.990943533651218 12.958498144438227 8842.0 1.9318997240110396 8.0 - - - - - - - 1196.0 41 2 IRAK2 interleukin-1 receptor-associated kinase 2 829 106 C20140606_SFK034_02 C20140606_SFK034_02 TB556326.[MT7]-VQGVSITR.2y7_1.heavy 502.304 / 760.431 37396.0 24.43049955368042 36 20 6 6 4 4.340718488907965 23.037660759511255 0.03880119323730469 7 0.990943533651218 12.958498144438227 37396.0 78.92986687517543 0.0 - - - - - - - 1263.2857142857142 74 7 IRAK2 interleukin-1 receptor-associated kinase 2 831 107 C20140606_SFK034_02 C20140606_SFK034_02 TB558537.[MT7]-HVEALPLYER.3y3_1.heavy 457.59 / 467.225 96758.0 29.528900146484375 50 20 10 10 10 5.273346386306514 15.051203436867493 0.0 3 0.9913040041343868 13.224750457350137 96758.0 62.27778903108667 0.0 - - - - - - - 493.0 193 2 NPHP3 nephronophthisis 3 (adolescent) 833 107 C20140606_SFK034_02 C20140606_SFK034_02 TB558537.[MT7]-HVEALPLYER.3b4_1.heavy 457.59 / 581.316 153610.0 29.528900146484375 50 20 10 10 10 5.273346386306514 15.051203436867493 0.0 3 0.9913040041343868 13.224750457350137 153610.0 73.79987421516651 1.0 - - - - - - - 886.8 307 5 NPHP3 nephronophthisis 3 (adolescent) 835 107 C20140606_SFK034_02 C20140606_SFK034_02 TB558537.[MT7]-HVEALPLYER.3b3_1.heavy 457.59 / 510.279 69859.0 29.528900146484375 50 20 10 10 10 5.273346386306514 15.051203436867493 0.0 3 0.9913040041343868 13.224750457350137 69859.0 41.98557603793863 0.0 - - - - - - - 886.6 139 5 NPHP3 nephronophthisis 3 (adolescent) 837 107 C20140606_SFK034_02 C20140606_SFK034_02 TB558537.[MT7]-HVEALPLYER.3y5_1.heavy 457.59 / 677.362 152921.0 29.528900146484375 50 20 10 10 10 5.273346386306514 15.051203436867493 0.0 3 0.9913040041343868 13.224750457350137 152921.0 245.90041672129917 0.0 - - - - - - - 751.375 305 8 NPHP3 nephronophthisis 3 (adolescent) 839 108 C20140606_SFK034_02 C20140606_SFK034_02 TB557005.[MT7]-AWSDDTSQLGPDK[MT7].3y3_1.heavy 569.952 / 503.295 166060.0 28.245850563049316 39 13 10 6 10 1.4277105971310435 55.13155153918258 0.03610038757324219 3 0.900283347031283 3.8752685853655597 166060.0 26.878533457536818 0.0 - - - - - - - 2191.0 332 1 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 841 108 C20140606_SFK034_02 C20140606_SFK034_02 TB557005.[MT7]-AWSDDTSQLGPDK[MT7].3b4_1.heavy 569.952 / 604.285 43272.0 28.245850563049316 39 13 10 6 10 1.4277105971310435 55.13155153918258 0.03610038757324219 3 0.900283347031283 3.8752685853655597 43272.0 27.90674357144826 1.0 - - - - - - - 867.5 89 2 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 843 108 C20140606_SFK034_02 C20140606_SFK034_02 TB557005.[MT7]-AWSDDTSQLGPDK[MT7].3b5_1.heavy 569.952 / 719.312 79607.0 28.245850563049316 39 13 10 6 10 1.4277105971310435 55.13155153918258 0.03610038757324219 3 0.900283347031283 3.8752685853655597 79607.0 24.159634535601036 0.0 - - - - - - - 1241.6 159 5 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 845 108 C20140606_SFK034_02 C20140606_SFK034_02 TB557005.[MT7]-AWSDDTSQLGPDK[MT7].3y4_1.heavy 569.952 / 560.316 308110.0 28.245850563049316 39 13 10 6 10 1.4277105971310435 55.13155153918258 0.03610038757324219 3 0.900283347031283 3.8752685853655597 308110.0 36.350642291094374 0.0 - - - - - - - 2647.0 616 1 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 847 109 C20140606_SFK034_02 C20140606_SFK034_02 TB558534.[MT7]-TQSDGIQQAK[MT7].3b6_1.heavy 455.252 / 746.38 41747.0 17.972000122070312 48 18 10 10 10 3.867928401379442 25.85363264850932 0.0 3 0.984036985764129 9.75496016637774 41747.0 140.98558593321854 0.0 - - - - - - - 359.6666666666667 83 12 CRBN cereblon 849 109 C20140606_SFK034_02 C20140606_SFK034_02 TB558534.[MT7]-TQSDGIQQAK[MT7].3b4_1.heavy 455.252 / 576.275 46984.0 17.972000122070312 48 18 10 10 10 3.867928401379442 25.85363264850932 0.0 3 0.984036985764129 9.75496016637774 46984.0 37.02753319368353 0.0 - - - - - - - 1136.0 93 7 CRBN cereblon 851 109 C20140606_SFK034_02 C20140606_SFK034_02 TB558534.[MT7]-TQSDGIQQAK[MT7].3b5_1.heavy 455.252 / 633.296 220373.0 17.972000122070312 48 18 10 10 10 3.867928401379442 25.85363264850932 0.0 3 0.984036985764129 9.75496016637774 220373.0 226.64012034426202 0.0 - - - - - - - 1814.857142857143 440 7 CRBN cereblon 853 109 C20140606_SFK034_02 C20140606_SFK034_02 TB558534.[MT7]-TQSDGIQQAK[MT7].3y4_1.heavy 455.252 / 618.369 22013.0 17.972000122070312 48 18 10 10 10 3.867928401379442 25.85363264850932 0.0 3 0.984036985764129 9.75496016637774 22013.0 42.63686348016245 0.0 - - - - - - - 339.2 44 5 CRBN cereblon 855 110 C20140606_SFK034_02 C20140606_SFK034_02 TB456526.[MT7]-WLLSDYVK[MT7].3y3_1.heavy 437.923 / 553.347 69552.0 41.89759826660156 44 14 10 10 10 2.5423979852332077 39.33294495229364 0.0 3 0.9409239756163192 5.0523702120907705 69552.0 208.76009717582753 0.0 - - - - - - - 687.5 139 8 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 857 110 C20140606_SFK034_02 C20140606_SFK034_02 TB456526.[MT7]-WLLSDYVK[MT7].3b4_1.heavy 437.923 / 644.389 14363.0 41.89759826660156 44 14 10 10 10 2.5423979852332077 39.33294495229364 0.0 3 0.9409239756163192 5.0523702120907705 14363.0 58.52517937505984 0.0 - - - - - - - 232.05882352941177 28 17 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 859 110 C20140606_SFK034_02 C20140606_SFK034_02 TB456526.[MT7]-WLLSDYVK[MT7].3b5_1.heavy 437.923 / 759.416 87603.0 41.89759826660156 44 14 10 10 10 2.5423979852332077 39.33294495229364 0.0 3 0.9409239756163192 5.0523702120907705 87603.0 1503.805185963521 0.0 - - - - - - - 183.16666666666666 175 12 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 861 110 C20140606_SFK034_02 C20140606_SFK034_02 TB456526.[MT7]-WLLSDYVK[MT7].3b3_1.heavy 437.923 / 557.357 74922.0 41.89759826660156 44 14 10 10 10 2.5423979852332077 39.33294495229364 0.0 3 0.9409239756163192 5.0523702120907705 74922.0 267.44064432989694 0.0 - - - - - - - 684.0 149 7 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 863 111 C20140606_SFK034_02 C20140606_SFK034_02 TB558532.[MT7]-LRSEIDNVK[MT7].3b6_1.heavy 454.605 / 858.48 14550.0 24.576900482177734 43 13 10 10 10 3.702438908987646 27.00922350325637 0.0 3 0.9224630005128757 4.403124366096993 14550.0 41.591184507544256 0.0 - - - - - - - 208.64705882352942 29 17 KRT1 keratin 1 865 111 C20140606_SFK034_02 C20140606_SFK034_02 TB558532.[MT7]-LRSEIDNVK[MT7].3y3_1.heavy 454.605 / 504.326 74524.0 24.576900482177734 43 13 10 10 10 3.702438908987646 27.00922350325637 0.0 3 0.9224630005128757 4.403124366096993 74524.0 43.24856682310231 0.0 - - - - - - - 1255.5 149 2 KRT1 keratin 1 867 111 C20140606_SFK034_02 C20140606_SFK034_02 TB558532.[MT7]-LRSEIDNVK[MT7].3b4_1.heavy 454.605 / 630.369 36708.0 24.576900482177734 43 13 10 10 10 3.702438908987646 27.00922350325637 0.0 3 0.9224630005128757 4.403124366096993 36708.0 40.94266168541209 0.0 - - - - - - - 1190.875 73 8 KRT1 keratin 1 869 111 C20140606_SFK034_02 C20140606_SFK034_02 TB558532.[MT7]-LRSEIDNVK[MT7].3y4_1.heavy 454.605 / 619.353 37890.0 24.576900482177734 43 13 10 10 10 3.702438908987646 27.00922350325637 0.0 3 0.9224630005128757 4.403124366096993 37890.0 38.603359827016796 0.0 - - - - - - - 1264.875 75 8 KRT1 keratin 1 871 112 C20140606_SFK034_02 C20140606_SFK034_02 TNAA_ECO24.GLTFTYEPK.2y7.peptide 528.27 / 885.44 1355610.0 32.13370132446289 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1355610.0 577.2675945142172 0.0 - - - - - - - 309.3333333333333 2711 3 873 112 C20140606_SFK034_02 C20140606_SFK034_02 TNAA_ECO24.GLTFTYEPK.2y6.peptide 528.27 / 784.39 1190340.0 32.13370132446289 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1190340.0 1056.234485172706 0.0 - - - - - - - 813.0 2380 1 875 112 C20140606_SFK034_02 C20140606_SFK034_02 TNAA_ECO24.GLTFTYEPK.2y5.peptide 528.27 / 637.32 2292140.0 32.13370132446289 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2292140.0 682.5117930441705 0.0 - - - - - - - 813.0 4584 2 877 113 C20140606_SFK034_02 C20140606_SFK034_02 TB558676.[MT7]-VAVTDLSPFGK[MT7].3b6_1.heavy 474.613 / 743.442 31394.0 37.01300048828125 47 17 10 10 10 2.6471602684420055 30.016302657282868 0.0 3 0.975256247341829 7.829427201144392 31394.0 95.04897850565101 0.0 - - - - - - - 598.1428571428571 62 7 DMGDH dimethylglycine dehydrogenase 879 113 C20140606_SFK034_02 C20140606_SFK034_02 TB558676.[MT7]-VAVTDLSPFGK[MT7].3y3_1.heavy 474.613 / 495.305 166104.0 37.01300048828125 47 17 10 10 10 2.6471602684420055 30.016302657282868 0.0 3 0.975256247341829 7.829427201144392 166104.0 110.05955748126576 0.0 - - - - - - - 1250.4285714285713 332 7 DMGDH dimethylglycine dehydrogenase 881 113 C20140606_SFK034_02 C20140606_SFK034_02 TB558676.[MT7]-VAVTDLSPFGK[MT7].3b5_1.heavy 474.613 / 630.358 222899.0 37.01300048828125 47 17 10 10 10 2.6471602684420055 30.016302657282868 0.0 3 0.975256247341829 7.829427201144392 222899.0 173.27875102675 0.0 - - - - - - - 780.0 445 5 DMGDH dimethylglycine dehydrogenase 883 113 C20140606_SFK034_02 C20140606_SFK034_02 TB558676.[MT7]-VAVTDLSPFGK[MT7].3y4_1.heavy 474.613 / 592.357 193883.0 37.01300048828125 47 17 10 10 10 2.6471602684420055 30.016302657282868 0.0 3 0.975256247341829 7.829427201144392 193883.0 221.85659094167465 0.0 - - - - - - - 815.2857142857143 387 7 DMGDH dimethylglycine dehydrogenase 885 114 C20140606_SFK034_02 C20140606_SFK034_02 TB558776.[MT7]-VTFAFDLLGGK[MT7].3b6_1.heavy 485.953 / 825.426 69037.0 46.30979919433594 43 13 10 10 10 1.0935991390339181 54.61722810597608 0.0 3 0.9255029573265511 4.4932348349721005 69037.0 1144.832316576087 0.0 - - - - - - - 237.57142857142858 138 7 GLDN gliomedin 887 114 C20140606_SFK034_02 C20140606_SFK034_02 TB558776.[MT7]-VTFAFDLLGGK[MT7].3b4_1.heavy 485.953 / 563.331 101765.0 46.30979919433594 43 13 10 10 10 1.0935991390339181 54.61722810597608 0.0 3 0.9255029573265511 4.4932348349721005 101765.0 370.20776362945264 0.0 - - - - - - - 216.0 203 8 GLDN gliomedin 889 114 C20140606_SFK034_02 C20140606_SFK034_02 TB558776.[MT7]-VTFAFDLLGGK[MT7].3y4_1.heavy 485.953 / 518.342 77219.0 46.30979919433594 43 13 10 10 10 1.0935991390339181 54.61722810597608 0.0 3 0.9255029573265511 4.4932348349721005 77219.0 249.40718091605126 0.0 - - - - - - - 229.16666666666666 154 12 GLDN gliomedin 891 114 C20140606_SFK034_02 C20140606_SFK034_02 TB558776.[MT7]-VTFAFDLLGGK[MT7].3b3_1.heavy 485.953 / 492.294 46664.0 46.30979919433594 43 13 10 10 10 1.0935991390339181 54.61722810597608 0.0 3 0.9255029573265511 4.4932348349721005 46664.0 265.3150489373602 0.0 - - - - - - - 234.55555555555554 93 9 GLDN gliomedin 893 115 C20140606_SFK034_02 C20140606_SFK034_02 TB558674.[MT7]-LALDLEIATYR.2y8_1.heavy 711.41 / 980.505 38242.0 42.756500244140625 48 18 10 10 10 4.352409987939562 22.97577670235523 0.0 3 0.984408944823061 9.870945102490955 38242.0 53.62049691041412 0.0 - - - - - - - 1192.8 76 10 KRT1 keratin 1 895 115 C20140606_SFK034_02 C20140606_SFK034_02 TB558674.[MT7]-LALDLEIATYR.2b4_1.heavy 711.41 / 557.341 44944.0 42.756500244140625 48 18 10 10 10 4.352409987939562 22.97577670235523 0.0 3 0.984408944823061 9.870945102490955 44944.0 27.337780593541858 0.0 - - - - - - - 1696.0 89 12 KRT1 keratin 1 897 115 C20140606_SFK034_02 C20140606_SFK034_02 TB558674.[MT7]-LALDLEIATYR.2y10_1.heavy 711.41 / 1164.63 43345.0 42.756500244140625 48 18 10 10 10 4.352409987939562 22.97577670235523 0.0 3 0.984408944823061 9.870945102490955 43345.0 62.69909728296773 0.0 - - - - - - - 777.2142857142857 86 14 KRT1 keratin 1 899 115 C20140606_SFK034_02 C20140606_SFK034_02 TB558674.[MT7]-LALDLEIATYR.2y7_1.heavy 711.41 / 865.478 37935.0 42.756500244140625 48 18 10 10 10 4.352409987939562 22.97577670235523 0.0 3 0.984408944823061 9.870945102490955 37935.0 45.68843695212908 0.0 - - - - - - - 1206.5 75 8 KRT1 keratin 1 901 116 C20140606_SFK034_02 C20140606_SFK034_02 TB456426.[MT7]-FVNVISAR.2b3_1.heavy 525.315 / 505.289 96034.0 32.88650131225586 47 17 10 10 10 10.677464914086036 9.365518950858547 0.0 3 0.9787973607093998 8.460520026617612 96034.0 15.971680585010692 0.0 - - - - - - - 1941.0 192 1 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 903 116 C20140606_SFK034_02 C20140606_SFK034_02 TB456426.[MT7]-FVNVISAR.2b4_1.heavy 525.315 / 604.357 112477.0 32.88650131225586 47 17 10 10 10 10.677464914086036 9.365518950858547 0.0 3 0.9787973607093998 8.460520026617612 112477.0 45.81255382894195 0.0 - - - - - - - 1142.0 224 2 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 905 116 C20140606_SFK034_02 C20140606_SFK034_02 TB456426.[MT7]-FVNVISAR.2y6_1.heavy 525.315 / 659.383 177451.0 32.88650131225586 47 17 10 10 10 10.677464914086036 9.365518950858547 0.0 3 0.9787973607093998 8.460520026617612 177451.0 110.83759559758595 0.0 - - - - - - - 742.0 354 2 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 907 116 C20140606_SFK034_02 C20140606_SFK034_02 TB456426.[MT7]-FVNVISAR.2y7_1.heavy 525.315 / 758.452 256470.0 32.88650131225586 47 17 10 10 10 10.677464914086036 9.365518950858547 0.0 3 0.9787973607093998 8.460520026617612 256470.0 185.96797114819316 0.0 - - - - - - - 799.5 512 2 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 909 117 C20140606_SFK034_02 C20140606_SFK034_02 TB560087.[MT7]-GQLVLFHADGQTEQR.3y7_1.heavy 614.991 / 833.375 74352.0 31.152299880981445 47 17 10 10 10 4.426327490184518 22.592092478867023 0.0 3 0.9723580083293675 7.405803730638079 74352.0 41.973225443140294 0.0 - - - - - - - 246.75 148 4 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 911 117 C20140606_SFK034_02 C20140606_SFK034_02 TB560087.[MT7]-GQLVLFHADGQTEQR.3y6_1.heavy 614.991 / 718.348 56175.0 31.152299880981445 47 17 10 10 10 4.426327490184518 22.592092478867023 0.0 3 0.9723580083293675 7.405803730638079 56175.0 42.8439531544413 0.0 - - - - - - - 821.6666666666666 112 6 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 913 117 C20140606_SFK034_02 C20140606_SFK034_02 TB560087.[MT7]-GQLVLFHADGQTEQR.3b4_1.heavy 614.991 / 542.342 108517.0 31.152299880981445 47 17 10 10 10 4.426327490184518 22.592092478867023 0.0 3 0.9723580083293675 7.405803730638079 108517.0 43.96537650477376 0.0 - - - - - - - 1369.0 217 2 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 915 117 C20140606_SFK034_02 C20140606_SFK034_02 TB560087.[MT7]-GQLVLFHADGQTEQR.3y8_1.heavy 614.991 / 904.412 106327.0 31.152299880981445 47 17 10 10 10 4.426327490184518 22.592092478867023 0.0 3 0.9723580083293675 7.405803730638079 106327.0 172.62772967153694 0.0 - - - - - - - 807.875 212 8 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 917 118 C20140606_SFK034_02 C20140606_SFK034_02 TB556644.[MT7]-GFPDWK[MT7].2y4_1.heavy 519.287 / 689.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM75D1 family with sequence similarity 75, member D1 919 118 C20140606_SFK034_02 C20140606_SFK034_02 TB556644.[MT7]-GFPDWK[MT7].2b4_1.heavy 519.287 / 561.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM75D1 family with sequence similarity 75, member D1 921 118 C20140606_SFK034_02 C20140606_SFK034_02 TB556644.[MT7]-GFPDWK[MT7].2b4_2.heavy 519.287 / 281.143 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM75D1 family with sequence similarity 75, member D1 923 118 C20140606_SFK034_02 C20140606_SFK034_02 TB556644.[MT7]-GFPDWK[MT7].2y3_1.heavy 519.287 / 592.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM75D1 family with sequence similarity 75, member D1 925 119 C20140606_SFK034_02 C20140606_SFK034_02 TB556680.[MT7]-VWELSK[MT7].2b3_1.heavy 525.315 / 559.3 13956.0 32.30419921875 46 18 10 10 8 4.99858670738407 20.005654768832326 0.0 4 0.9841576672091857 9.792143697727559 13956.0 8.292393123020139 2.0 - - - - - - - 775.3333333333334 30 3 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 927 119 C20140606_SFK034_02 C20140606_SFK034_02 TB556680.[MT7]-VWELSK[MT7].2y4_1.heavy 525.315 / 620.374 17445.0 32.30419921875 46 18 10 10 8 4.99858670738407 20.005654768832326 0.0 4 0.9841576672091857 9.792143697727559 17445.0 9.563257241799695 1.0 - - - - - - - 930.0 37 1 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 929 119 C20140606_SFK034_02 C20140606_SFK034_02 TB556680.[MT7]-VWELSK[MT7].2y5_1.heavy 525.315 / 806.453 29076.0 32.30419921875 46 18 10 10 8 4.99858670738407 20.005654768832326 0.0 4 0.9841576672091857 9.792143697727559 29076.0 13.337506546720121 1.0 - - - - - - - 282.42857142857144 60 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 931 119 C20140606_SFK034_02 C20140606_SFK034_02 TB556680.[MT7]-VWELSK[MT7].2y3_1.heavy 525.315 / 491.331 26284.0 32.30419921875 46 18 10 10 8 4.99858670738407 20.005654768832326 0.0 4 0.9841576672091857 9.792143697727559 26284.0 5.8061376358917345 0.0 - - - - - - - 1163.0 52 1 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 933 120 C20140606_SFK034_02 C20140606_SFK034_02 TB559823.[MT7]-FLEQQNQVLQTK[MT7].3b4_1.heavy 588.668 / 662.363 84048.0 31.75309944152832 44 14 10 10 10 2.11117942080969 38.98309582114142 0.0 3 0.9478485351743603 5.380509219334856 84048.0 39.597919909418984 0.0 - - - - - - - 1708.142857142857 168 7 KRT77;KRT1;KRT2 keratin 77;keratin 1;keratin 2 935 120 C20140606_SFK034_02 C20140606_SFK034_02 TB559823.[MT7]-FLEQQNQVLQTK[MT7].3b5_1.heavy 588.668 / 790.422 56419.0 31.75309944152832 44 14 10 10 10 2.11117942080969 38.98309582114142 0.0 3 0.9478485351743603 5.380509219334856 56419.0 69.86442106336341 0.0 - - - - - - - 1243.857142857143 112 7 KRT77;KRT1;KRT2 keratin 77;keratin 1;keratin 2 937 120 C20140606_SFK034_02 C20140606_SFK034_02 TB559823.[MT7]-FLEQQNQVLQTK[MT7].3y4_1.heavy 588.668 / 633.405 251796.0 31.75309944152832 44 14 10 10 10 2.11117942080969 38.98309582114142 0.0 3 0.9478485351743603 5.380509219334856 251796.0 216.4987540895127 0.0 - - - - - - - 270.6666666666667 503 3 KRT77;KRT1;KRT2 keratin 77;keratin 1;keratin 2 939 120 C20140606_SFK034_02 C20140606_SFK034_02 TB559823.[MT7]-FLEQQNQVLQTK[MT7].3b3_1.heavy 588.668 / 534.304 141164.0 31.75309944152832 44 14 10 10 10 2.11117942080969 38.98309582114142 0.0 3 0.9478485351743603 5.380509219334856 141164.0 38.74660778506316 0.0 - - - - - - - 3206.625 282 8 KRT77;KRT1;KRT2 keratin 77;keratin 1;keratin 2 941 121 C20140606_SFK034_02 C20140606_SFK034_02 TB559418.[MT7]-GDVSNDVLLAGAK[MT7].3b6_1.heavy 516.294 / 732.328 68811.0 31.2362003326416 43 13 10 10 10 1.2713859547107813 56.18344829855577 0.0 3 0.9279650297326804 4.570340077731502 68811.0 64.77012978401807 0.0 - - - - - - - 281.5 137 4 GLDN gliomedin 943 121 C20140606_SFK034_02 C20140606_SFK034_02 TB559418.[MT7]-GDVSNDVLLAGAK[MT7].3b8_1.heavy 516.294 / 944.481 18808.0 31.2362003326416 43 13 10 10 10 1.2713859547107813 56.18344829855577 0.0 3 0.9279650297326804 4.570340077731502 18808.0 92.8448292709174 0.0 - - - - - - - 225.28571428571428 37 7 GLDN gliomedin 945 121 C20140606_SFK034_02 C20140606_SFK034_02 TB559418.[MT7]-GDVSNDVLLAGAK[MT7].3y5_1.heavy 516.294 / 603.395 44485.0 31.2362003326416 43 13 10 10 10 1.2713859547107813 56.18344829855577 0.0 3 0.9279650297326804 4.570340077731502 44485.0 38.92836457175391 0.0 - - - - - - - 638.0 88 3 GLDN gliomedin 947 121 C20140606_SFK034_02 C20140606_SFK034_02 TB559418.[MT7]-GDVSNDVLLAGAK[MT7].3b7_1.heavy 516.294 / 831.396 43246.0 31.2362003326416 43 13 10 10 10 1.2713859547107813 56.18344829855577 0.0 3 0.9279650297326804 4.570340077731502 43246.0 56.56201115805388 0.0 - - - - - - - 360.0 86 5 GLDN gliomedin 949 122 C20140606_SFK034_02 C20140606_SFK034_02 CH10_ECO24.SAGGIVLTGSAAAK.2y7.peptide 601.84 / 605.33 1394580.0 26.23259925842285 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1394580.0 667.6201963307674 0.0 - - - - - - - 8507.0 2789 1 951 122 C20140606_SFK034_02 C20140606_SFK034_02 CH10_ECO24.SAGGIVLTGSAAAK.2y8.peptide 601.84 / 718.41 1863370.0 26.23259925842285 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1863370.0 1691.3907631424804 0.0 - - - - - - - 13271.0 3726 1 953 122 C20140606_SFK034_02 C20140606_SFK034_02 CH10_ECO24.SAGGIVLTGSAAAK.2y9.peptide 601.84 / 817.48 2316540.0 26.23259925842285 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2316540.0 1485.193757960123 0.0 - - - - - - - 14206.0 4633 1 955 123 C20140606_SFK034_02 C20140606_SFK034_02 TB556936.[MT7]-FDTISEK[MT7].2y4_1.heavy 564.313 / 620.374 17964.0 26.350000381469727 44 14 10 10 10 2.5813041261837197 38.740107756246104 0.0 3 0.9326383771763765 4.728109456370769 17964.0 25.635606563476344 0.0 - - - - - - - 1154.0 35 8 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 957 123 C20140606_SFK034_02 C20140606_SFK034_02 TB556936.[MT7]-FDTISEK[MT7].2y5_1.heavy 564.313 / 721.421 32906.0 26.350000381469727 44 14 10 10 10 2.5813041261837197 38.740107756246104 0.0 3 0.9326383771763765 4.728109456370769 32906.0 26.02296374410923 0.0 - - - - - - - 718.1111111111111 65 9 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 959 123 C20140606_SFK034_02 C20140606_SFK034_02 TB556936.[MT7]-FDTISEK[MT7].2y3_1.heavy 564.313 / 507.289 40041.0 26.350000381469727 44 14 10 10 10 2.5813041261837197 38.740107756246104 0.0 3 0.9326383771763765 4.728109456370769 40041.0 26.89120883645597 0.0 - - - - - - - 1343.0 80 2 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 961 123 C20140606_SFK034_02 C20140606_SFK034_02 TB556936.[MT7]-FDTISEK[MT7].2y6_1.heavy 564.313 / 836.448 31311.0 26.350000381469727 44 14 10 10 10 2.5813041261837197 38.740107756246104 0.0 3 0.9326383771763765 4.728109456370769 31311.0 96.65192254812098 0.0 - - - - - - - 671.5714285714286 62 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 963 124 C20140606_SFK034_02 C20140606_SFK034_02 TB556683.[MT7]-AEELYER.2y4_1.heavy 527.27 / 580.309 17430.0 23.75380039215088 46 20 10 6 10 8.462665433115982 11.81660799311307 0.03420066833496094 3 0.9954159380649035 18.220953049057613 17430.0 19.541640655086447 0.0 - - - - - - - 1228.375 34 8 NPHP3 nephronophthisis 3 (adolescent) 965 124 C20140606_SFK034_02 C20140606_SFK034_02 TB556683.[MT7]-AEELYER.2y5_1.heavy 527.27 / 709.352 19779.0 23.75380039215088 46 20 10 6 10 8.462665433115982 11.81660799311307 0.03420066833496094 3 0.9954159380649035 18.220953049057613 19779.0 10.768062965156705 0.0 - - - - - - - 1769.125 39 8 NPHP3 nephronophthisis 3 (adolescent) 967 124 C20140606_SFK034_02 C20140606_SFK034_02 TB556683.[MT7]-AEELYER.2b4_1.heavy 527.27 / 587.316 27690.0 23.75380039215088 46 20 10 6 10 8.462665433115982 11.81660799311307 0.03420066833496094 3 0.9954159380649035 18.220953049057613 27690.0 35.12003768351085 0.0 - - - - - - - 1677.5714285714287 55 7 NPHP3 nephronophthisis 3 (adolescent) 969 124 C20140606_SFK034_02 C20140606_SFK034_02 TB556683.[MT7]-AEELYER.2y6_1.heavy 527.27 / 838.394 27567.0 23.75380039215088 46 20 10 6 10 8.462665433115982 11.81660799311307 0.03420066833496094 3 0.9954159380649035 18.220953049057613 27567.0 15.1046416840848 0.0 - - - - - - - 362.14285714285717 55 7 NPHP3 nephronophthisis 3 (adolescent) 971 125 C20140606_SFK034_02 C20140606_SFK034_02 TB556939.[MT7]-VLLQLELR.2y5_1.heavy 564.367 / 658.388 16821.0 41.200324058532715 46 20 10 6 10 19.370014053163473 5.162618866746159 0.039096832275390625 3 0.9990701999938342 40.47006864820449 16821.0 29.17803300628951 0.0 - - - - - - - 715.0 33 8 LRP3 low density lipoprotein receptor-related protein 3 973 125 C20140606_SFK034_02 C20140606_SFK034_02 TB556939.[MT7]-VLLQLELR.2b4_1.heavy 564.367 / 598.404 15119.0 41.200324058532715 46 20 10 6 10 19.370014053163473 5.162618866746159 0.039096832275390625 3 0.9990701999938342 40.47006864820449 15119.0 11.189764568541207 0.0 - - - - - - - 295.3333333333333 30 3 LRP3 low density lipoprotein receptor-related protein 3 975 125 C20140606_SFK034_02 C20140606_SFK034_02 TB556939.[MT7]-VLLQLELR.2y6_1.heavy 564.367 / 771.472 22338.0 41.200324058532715 46 20 10 6 10 19.370014053163473 5.162618866746159 0.039096832275390625 3 0.9990701999938342 40.47006864820449 22338.0 37.49390334292498 0.0 - - - - - - - 723.5 44 8 LRP3 low density lipoprotein receptor-related protein 3 977 125 C20140606_SFK034_02 C20140606_SFK034_02 TB556939.[MT7]-VLLQLELR.2y7_1.heavy 564.367 / 884.556 50873.0 41.200324058532715 46 20 10 6 10 19.370014053163473 5.162618866746159 0.039096832275390625 3 0.9990701999938342 40.47006864820449 50873.0 253.7148482612139 0.0 - - - - - - - 262.64285714285717 101 14 LRP3 low density lipoprotein receptor-related protein 3 979 126 C20140606_SFK034_02 C20140606_SFK034_02 TB559550.[MT7]-WELLQQVDTSTR.2b3_1.heavy 810.429 / 573.315 70850.0 39.4370002746582 47 17 10 10 10 2.9032806008413905 27.493739815635095 0.0 3 0.9737914887676207 7.606556326175084 70850.0 58.68026373355768 0.0 - - - - - - - 328.0 141 2 KRT1 keratin 1 981 126 C20140606_SFK034_02 C20140606_SFK034_02 TB559550.[MT7]-WELLQQVDTSTR.2y8_1.heavy 810.429 / 934.459 61431.0 39.4370002746582 47 17 10 10 10 2.9032806008413905 27.493739815635095 0.0 3 0.9737914887676207 7.606556326175084 61431.0 172.88412558446402 0.0 - - - - - - - 204.83333333333334 122 6 KRT1 keratin 1 983 126 C20140606_SFK034_02 C20140606_SFK034_02 TB559550.[MT7]-WELLQQVDTSTR.2y9_1.heavy 810.429 / 1047.54 73389.0 39.4370002746582 47 17 10 10 10 2.9032806008413905 27.493739815635095 0.0 3 0.9737914887676207 7.606556326175084 73389.0 99.59285788084945 0.0 - - - - - - - 843.6 146 10 KRT1 keratin 1 985 126 C20140606_SFK034_02 C20140606_SFK034_02 TB559550.[MT7]-WELLQQVDTSTR.2y10_1.heavy 810.429 / 1160.63 39234.0 39.4370002746582 47 17 10 10 10 2.9032806008413905 27.493739815635095 0.0 3 0.9737914887676207 7.606556326175084 39234.0 60.82637779998066 0.0 - - - - - - - 368.5 78 6 KRT1 keratin 1 987 127 C20140606_SFK034_02 C20140606_SFK034_02 TB560179.[MT7]-NLVDPITHDLIISLAR.3y7_1.heavy 645.378 / 785.524 164628.0 46.035301208496094 48 18 10 10 10 5.237008088679741 19.09487216874056 0.0 3 0.98433042459332 9.846117594603225 164628.0 380.3366122228232 0.0 - - - - - - - 628.5714285714286 329 7 C17orf76 chromosome 17 open reading frame 76 989 127 C20140606_SFK034_02 C20140606_SFK034_02 TB560179.[MT7]-NLVDPITHDLIISLAR.3y6_1.heavy 645.378 / 672.44 152450.0 46.035301208496094 48 18 10 10 10 5.237008088679741 19.09487216874056 0.0 3 0.98433042459332 9.846117594603225 152450.0 585.8862745098039 0.0 - - - - - - - 297.5 304 6 C17orf76 chromosome 17 open reading frame 76 991 127 C20140606_SFK034_02 C20140606_SFK034_02 TB560179.[MT7]-NLVDPITHDLIISLAR.3b4_1.heavy 645.378 / 586.332 754604.0 46.035301208496094 48 18 10 10 10 5.237008088679741 19.09487216874056 0.0 3 0.98433042459332 9.846117594603225 754604.0 638.8150480621309 0.0 - - - - - - - 765.25 1509 4 C17orf76 chromosome 17 open reading frame 76 993 127 C20140606_SFK034_02 C20140606_SFK034_02 TB560179.[MT7]-NLVDPITHDLIISLAR.3y8_1.heavy 645.378 / 900.551 255104.0 46.035301208496094 48 18 10 10 10 5.237008088679741 19.09487216874056 0.0 3 0.98433042459332 9.846117594603225 255104.0 729.3356548125219 0.0 - - - - - - - 344.4 510 5 C17orf76 chromosome 17 open reading frame 76 995 128 C20140606_SFK034_02 C20140606_SFK034_02 TB556023.[MT7]-RQEEVR.2b3_1.heavy 480.771 / 558.312 2145.0 13.402700424194336 50 20 10 10 10 3.3233076407953086 22.63844442875861 0.0 3 0.9935328511399643 15.33810155816702 2145.0 21.101762213640285 0.0 - - - - - - - 131.4090909090909 4 22 NFYC nuclear transcription factor Y, gamma 997 128 C20140606_SFK034_02 C20140606_SFK034_02 TB556023.[MT7]-RQEEVR.2y5_1.heavy 480.771 / 660.331 3277.0 13.402700424194336 50 20 10 10 10 3.3233076407953086 22.63844442875861 0.0 3 0.9935328511399643 15.33810155816702 3277.0 8.797315436241611 0.0 - - - - - - - 110.4 6 20 NFYC nuclear transcription factor Y, gamma 999 128 C20140606_SFK034_02 C20140606_SFK034_02 TB556023.[MT7]-RQEEVR.2b4_1.heavy 480.771 / 687.354 10160.0 13.402700424194336 50 20 10 10 10 3.3233076407953086 22.63844442875861 0.0 3 0.9935328511399643 15.33810155816702 10160.0 104.08502887188395 0.0 - - - - - - - 127.61111111111111 20 18 NFYC nuclear transcription factor Y, gamma 1001 128 C20140606_SFK034_02 C20140606_SFK034_02 TB556023.[MT7]-RQEEVR.2b5_1.heavy 480.771 / 786.423 1490.0 13.402700424194336 50 20 10 10 10 3.3233076407953086 22.63844442875861 0.0 3 0.9935328511399643 15.33810155816702 1490.0 12.399978495779798 1.0 - - - - - - - 96.38461538461539 2 13 NFYC nuclear transcription factor Y, gamma 1003 129 C20140606_SFK034_02 C20140606_SFK034_02 TB556020.[MT7]-AELTHSR.2y4_1.heavy 479.265 / 500.258 4710.0 15.52560043334961 50 20 10 10 10 9.49140746912807 10.535845218452783 0.0 3 0.9948660519311642 17.216729462439037 4710.0 4.3333684002797614 0.0 - - - - - - - 708.0 9 11 NIN ninein (GSK3B interacting protein) 1005 129 C20140606_SFK034_02 C20140606_SFK034_02 TB556020.[MT7]-AELTHSR.2y5_1.heavy 479.265 / 613.342 5887.0 15.52560043334961 50 20 10 10 10 9.49140746912807 10.535845218452783 0.0 3 0.9948660519311642 17.216729462439037 5887.0 22.635318916173397 0.0 - - - - - - - 685.7142857142857 11 7 NIN ninein (GSK3B interacting protein) 1007 129 C20140606_SFK034_02 C20140606_SFK034_02 TB556020.[MT7]-AELTHSR.2b4_1.heavy 479.265 / 559.321 3261.0 15.52560043334961 50 20 10 10 10 9.49140746912807 10.535845218452783 0.0 3 0.9948660519311642 17.216729462439037 3261.0 10.072852551616673 1.0 - - - - - - - 730.25 6 8 NIN ninein (GSK3B interacting protein) 1009 129 C20140606_SFK034_02 C20140606_SFK034_02 TB556020.[MT7]-AELTHSR.2y6_1.heavy 479.265 / 742.384 7608.0 15.52560043334961 50 20 10 10 10 9.49140746912807 10.535845218452783 0.0 3 0.9948660519311642 17.216729462439037 7608.0 37.499814776703026 0.0 - - - - - - - 247.76470588235293 15 17 NIN ninein (GSK3B interacting protein) 1011 130 C20140606_SFK034_02 C20140606_SFK034_02 TB559620.[MT7]-K[MT7]ATEDEGSEQK[MT7].3y6_1.heavy 551.96 / 821.412 2221.0 14.443424940109253 40 18 10 2 10 15.291021602413517 6.539785411343355 0.08750057220458984 3 0.9808620839150779 8.90676470444129 2221.0 3.2300243480801543 0.0 - - - - - - - 176.06666666666666 4 15 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1013 130 C20140606_SFK034_02 C20140606_SFK034_02 TB559620.[MT7]-K[MT7]ATEDEGSEQK[MT7].3y5_1.heavy 551.96 / 692.37 4404.0 14.443424940109253 40 18 10 2 10 15.291021602413517 6.539785411343355 0.08750057220458984 3 0.9808620839150779 8.90676470444129 4404.0 10.074561211038823 0.0 - - - - - - - 275.0 8 11 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1015 130 C20140606_SFK034_02 C20140606_SFK034_02 TB559620.[MT7]-K[MT7]ATEDEGSEQK[MT7].3b5_1.heavy 551.96 / 833.461 1187.0 14.443424940109253 40 18 10 2 10 15.291021602413517 6.539785411343355 0.08750057220458984 3 0.9808620839150779 8.90676470444129 1187.0 5.617886327920377 1.0 - - - - - - - 216.91666666666666 2 12 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1017 130 C20140606_SFK034_02 C20140606_SFK034_02 TB559620.[MT7]-K[MT7]ATEDEGSEQK[MT7].3y4_1.heavy 551.96 / 635.348 2145.0 14.443424940109253 40 18 10 2 10 15.291021602413517 6.539785411343355 0.08750057220458984 3 0.9808620839150779 8.90676470444129 2145.0 10.675460564822943 0.0 - - - - - - - 705.5714285714286 4 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1019 131 C20140606_SFK034_02 C20140606_SFK034_02 TB559622.[MT7]-LTSEDLSDDVFK[MT7].3b6_1.heavy 552.957 / 803.427 20756.0 36.651798248291016 48 18 10 10 10 4.468983627860922 22.376452528617783 0.0 3 0.9806045825900089 8.847251060480747 20756.0 29.22246307962354 0.0 - - - - - - - 861.4285714285714 41 7 DMGDH dimethylglycine dehydrogenase 1021 131 C20140606_SFK034_02 C20140606_SFK034_02 TB559622.[MT7]-LTSEDLSDDVFK[MT7].3y3_1.heavy 552.957 / 537.352 27576.0 36.651798248291016 48 18 10 10 10 4.468983627860922 22.376452528617783 0.0 3 0.9806045825900089 8.847251060480747 27576.0 19.957727626459143 0.0 - - - - - - - 1708.2857142857142 55 7 DMGDH dimethylglycine dehydrogenase 1023 131 C20140606_SFK034_02 C20140606_SFK034_02 TB559622.[MT7]-LTSEDLSDDVFK[MT7].3b4_1.heavy 552.957 / 575.316 14134.0 36.651798248291016 48 18 10 10 10 4.468983627860922 22.376452528617783 0.0 3 0.9806045825900089 8.847251060480747 14134.0 8.020806884469263 0.0 - - - - - - - 494.0 28 2 DMGDH dimethylglycine dehydrogenase 1025 131 C20140606_SFK034_02 C20140606_SFK034_02 TB559622.[MT7]-LTSEDLSDDVFK[MT7].3b5_1.heavy 552.957 / 690.343 83519.0 36.651798248291016 48 18 10 10 10 4.468983627860922 22.376452528617783 0.0 3 0.9806045825900089 8.847251060480747 83519.0 64.5619218584142 0.0 - - - - - - - 444.5 167 2 DMGDH dimethylglycine dehydrogenase 1027 132 C20140606_SFK034_02 C20140606_SFK034_02 TB558282.[MT7]-YEELQITAGR.2b3_1.heavy 662.355 / 566.258 28136.0 30.98430061340332 44 14 10 10 10 2.8689116629062767 34.85642353264289 0.0 3 0.9402332998861012 5.02279672955656 28136.0 27.695388785788346 0.0 - - - - - - - 174.4 56 5 KRT1;KRT6B keratin 1;keratin 6B 1029 132 C20140606_SFK034_02 C20140606_SFK034_02 TB558282.[MT7]-YEELQITAGR.2y8_1.heavy 662.355 / 887.495 17558.0 30.98430061340332 44 14 10 10 10 2.8689116629062767 34.85642353264289 0.0 3 0.9402332998861012 5.02279672955656 17558.0 41.014157007590356 0.0 - - - - - - - 218.0 35 7 KRT1;KRT6B keratin 1;keratin 6B 1031 132 C20140606_SFK034_02 C20140606_SFK034_02 TB558282.[MT7]-YEELQITAGR.2y9_1.heavy 662.355 / 1016.54 58016.0 30.98430061340332 44 14 10 10 10 2.8689116629062767 34.85642353264289 0.0 3 0.9402332998861012 5.02279672955656 58016.0 137.70513984032297 0.0 - - - - - - - 681.25 116 8 KRT1;KRT6B keratin 1;keratin 6B 1033 132 C20140606_SFK034_02 C20140606_SFK034_02 TB558282.[MT7]-YEELQITAGR.2y7_1.heavy 662.355 / 758.452 19630.0 30.98430061340332 44 14 10 10 10 2.8689116629062767 34.85642353264289 0.0 3 0.9402332998861012 5.02279672955656 19630.0 17.469761346179407 0.0 - - - - - - - 283.4 39 5 KRT1;KRT6B keratin 1;keratin 6B 1035 133 C20140606_SFK034_02 C20140606_SFK034_02 TB555956.[MT7]-IPEATNR.2y4_1.heavy 472.768 / 461.247 94495.0 20.522899627685547 50 20 10 10 10 10.256654842227304 9.749767496152216 0.0 3 0.9964806297352583 20.797083574614277 94495.0 34.321985477201196 0.0 - - - - - - - 2876.0 188 2 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1037 133 C20140606_SFK034_02 C20140606_SFK034_02 TB555956.[MT7]-IPEATNR.2b3_1.heavy 472.768 / 484.289 18153.0 20.522899627685547 50 20 10 10 10 10.256654842227304 9.749767496152216 0.0 3 0.9964806297352583 20.797083574614277 18153.0 26.17642956716171 0.0 - - - - - - - 1216.75 36 12 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1039 133 C20140606_SFK034_02 C20140606_SFK034_02 TB555956.[MT7]-IPEATNR.2y5_1.heavy 472.768 / 590.289 34509.0 20.522899627685547 50 20 10 10 10 10.256654842227304 9.749767496152216 0.0 3 0.9964806297352583 20.797083574614277 34509.0 121.97227311623624 0.0 - - - - - - - 818.6428571428571 69 14 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1041 133 C20140606_SFK034_02 C20140606_SFK034_02 TB555956.[MT7]-IPEATNR.2y6_1.heavy 472.768 / 687.342 862752.0 20.522899627685547 50 20 10 10 10 10.256654842227304 9.749767496152216 0.0 3 0.9964806297352583 20.797083574614277 862752.0 642.3487295977391 0.0 - - - - - - - 315.0 1725 1 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1043 134 C20140606_SFK034_02 C20140606_SFK034_02 TB559553.[MT7]-QININNPFVFK[MT7].3b6_1.heavy 541.315 / 841.465 48876.0 41.05379867553711 43 13 10 10 10 1.8472457748885809 42.45145619862741 0.0 3 0.927228714506349 4.546872820307402 48876.0 188.82676396796296 0.0 - - - - - - - 240.9375 97 16 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1045 134 C20140606_SFK034_02 C20140606_SFK034_02 TB559553.[MT7]-QININNPFVFK[MT7].3y3_1.heavy 541.315 / 537.352 144426.0 41.05379867553711 43 13 10 10 10 1.8472457748885809 42.45145619862741 0.0 3 0.927228714506349 4.546872820307402 144426.0 77.57897502188219 0.0 - - - - - - - 780.3333333333334 288 6 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1047 134 C20140606_SFK034_02 C20140606_SFK034_02 TB559553.[MT7]-QININNPFVFK[MT7].3b4_1.heavy 541.315 / 613.379 53075.0 41.05379867553711 43 13 10 10 10 1.8472457748885809 42.45145619862741 0.0 3 0.927228714506349 4.546872820307402 53075.0 50.861960388060055 0.0 - - - - - - - 808.875 106 8 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1049 134 C20140606_SFK034_02 C20140606_SFK034_02 TB559553.[MT7]-QININNPFVFK[MT7].3b3_1.heavy 541.315 / 500.295 96651.0 41.05379867553711 43 13 10 10 10 1.8472457748885809 42.45145619862741 0.0 3 0.927228714506349 4.546872820307402 96651.0 152.67953702839327 0.0 - - - - - - - 748.625 193 8 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1051 135 C20140606_SFK034_02 C20140606_SFK034_02 TB558092.[MT7]-RVLLQLELR.3b4_1.heavy 428.614 / 626.447 55417.0 36.02450180053711 45 15 10 10 10 3.144849278642631 31.79802627716444 0.0 3 0.9544473779429796 5.76027386191981 55417.0 107.73187381382488 0.0 - - - - - - - 682.8888888888889 110 9 LRP3 low density lipoprotein receptor-related protein 3 1053 135 C20140606_SFK034_02 C20140606_SFK034_02 TB558092.[MT7]-RVLLQLELR.3b3_1.heavy 428.614 / 513.363 65417.0 36.02450180053711 45 15 10 10 10 3.144849278642631 31.79802627716444 0.0 3 0.9544473779429796 5.76027386191981 65417.0 167.0836658763326 0.0 - - - - - - - 1172.0 130 8 LRP3 low density lipoprotein receptor-related protein 3 1055 135 C20140606_SFK034_02 C20140606_SFK034_02 TB558092.[MT7]-RVLLQLELR.3y4_1.heavy 428.614 / 530.33 156877.0 36.02450180053711 45 15 10 10 10 3.144849278642631 31.79802627716444 0.0 3 0.9544473779429796 5.76027386191981 156877.0 199.71502725010555 0.0 - - - - - - - 365.0 313 4 LRP3 low density lipoprotein receptor-related protein 3 1057 135 C20140606_SFK034_02 C20140606_SFK034_02 TB558092.[MT7]-RVLLQLELR.3y5_1.heavy 428.614 / 658.388 63126.0 36.02450180053711 45 15 10 10 10 3.144849278642631 31.79802627716444 0.0 3 0.9544473779429796 5.76027386191981 63126.0 175.20983213429255 0.0 - - - - - - - 291.9 126 10 LRP3 low density lipoprotein receptor-related protein 3 1059 136 C20140606_SFK034_02 C20140606_SFK034_02 TB556690.[MT7]-DVPSLDK[MT7].2y4_1.heavy 531.308 / 606.358 53324.0 25.38949966430664 48 18 10 10 10 2.715838675353576 28.14391611714968 0.0 3 0.9823960387507156 9.287909883261275 53324.0 33.00208411259226 0.0 - - - - - - - 892.6666666666666 106 3 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1061 136 C20140606_SFK034_02 C20140606_SFK034_02 TB556690.[MT7]-DVPSLDK[MT7].2y5_1.heavy 531.308 / 703.411 411390.0 25.38949966430664 48 18 10 10 10 2.715838675353576 28.14391611714968 0.0 3 0.9823960387507156 9.287909883261275 411390.0 223.05572943203316 0.0 - - - - - - - 590.5 822 2 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1063 136 C20140606_SFK034_02 C20140606_SFK034_02 TB556690.[MT7]-DVPSLDK[MT7].2y3_1.heavy 531.308 / 519.326 25284.0 25.38949966430664 48 18 10 10 10 2.715838675353576 28.14391611714968 0.0 3 0.9823960387507156 9.287909883261275 25284.0 14.458378840692106 1.0 - - - - - - - 1575.0 50 1 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1065 136 C20140606_SFK034_02 C20140606_SFK034_02 TB556690.[MT7]-DVPSLDK[MT7].2y6_1.heavy 531.308 / 802.479 54033.0 25.38949966430664 48 18 10 10 10 2.715838675353576 28.14391611714968 0.0 3 0.9823960387507156 9.287909883261275 54033.0 25.281434854157535 0.0 - - - - - - - 473.0 108 2 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1067 137 C20140606_SFK034_02 C20140606_SFK034_02 TB456599.[MT7]-C[CAM]PDLSDFQQK[MT7].3b6_1.heavy 509.257 / 832.363 20965.0 29.24530029296875 41 18 9 6 8 6.7934102891684285 14.72014728146809 0.033599853515625 4 0.9894963950175316 12.031293106552274 20965.0 19.471460386217462 0.0 - - - - - - - 313.3333333333333 41 6 NIN ninein (GSK3B interacting protein) 1069 137 C20140606_SFK034_02 C20140606_SFK034_02 TB456599.[MT7]-C[CAM]PDLSDFQQK[MT7].3b4_1.heavy 509.257 / 630.304 9025.0 29.24530029296875 41 18 9 6 8 6.7934102891684285 14.72014728146809 0.033599853515625 4 0.9894963950175316 12.031293106552274 9025.0 0.0 6.0 - - - - - - - 376.0 51 2 NIN ninein (GSK3B interacting protein) 1071 137 C20140606_SFK034_02 C20140606_SFK034_02 TB456599.[MT7]-C[CAM]PDLSDFQQK[MT7].3b5_1.heavy 509.257 / 717.336 3667.0 29.24530029296875 41 18 9 6 8 6.7934102891684285 14.72014728146809 0.033599853515625 4 0.9894963950175316 12.031293106552274 3667.0 2.790095381001384 5.0 - - - - - - - 1692.0 8 7 NIN ninein (GSK3B interacting protein) 1073 137 C20140606_SFK034_02 C20140606_SFK034_02 TB456599.[MT7]-C[CAM]PDLSDFQQK[MT7].3b3_1.heavy 509.257 / 517.22 22376.0 29.24530029296875 41 18 9 6 8 6.7934102891684285 14.72014728146809 0.033599853515625 4 0.9894963950175316 12.031293106552274 22376.0 8.880818330605564 1.0 - - - - - - - 658.0 44 1 NIN ninein (GSK3B interacting protein) 1075 138 C20140606_SFK034_02 C20140606_SFK034_02 TB456598.[MT7]-AAQIFITELTLR.2y8_1.heavy 760.452 / 992.578 171268.0 47.054901123046875 48 18 10 10 10 3.359679322797093 23.608087246313517 0.0 3 0.9857216051710863 10.315839247455125 171268.0 343.8472924136158 0.0 - - - - - - - 266.6666666666667 342 6 NFYC nuclear transcription factor Y, gamma 1077 138 C20140606_SFK034_02 C20140606_SFK034_02 TB456598.[MT7]-AAQIFITELTLR.2b4_1.heavy 760.452 / 528.326 132015.0 47.054901123046875 48 18 10 10 10 3.359679322797093 23.608087246313517 0.0 3 0.9857216051710863 10.315839247455125 132015.0 142.99613071404696 0.0 - - - - - - - 332.8 264 5 NFYC nuclear transcription factor Y, gamma 1079 138 C20140606_SFK034_02 C20140606_SFK034_02 TB456598.[MT7]-AAQIFITELTLR.2y9_1.heavy 760.452 / 1105.66 85538.0 47.054901123046875 48 18 10 10 10 3.359679322797093 23.608087246313517 0.0 3 0.9857216051710863 10.315839247455125 85538.0 152.97050274745766 0.0 - - - - - - - 695.0 171 8 NFYC nuclear transcription factor Y, gamma 1081 138 C20140606_SFK034_02 C20140606_SFK034_02 TB456598.[MT7]-AAQIFITELTLR.2y7_1.heavy 760.452 / 845.509 57537.0 47.054901123046875 48 18 10 10 10 3.359679322797093 23.608087246313517 0.0 3 0.9857216051710863 10.315839247455125 57537.0 77.53225559044678 0.0 - - - - - - - 752.7777777777778 115 9 NFYC nuclear transcription factor Y, gamma 1083 139 C20140606_SFK034_02 C20140606_SFK034_02 TB555539.[MT7]-VEIITR.2y4_1.heavy 437.778 / 502.335 27430.0 26.69930076599121 34 18 0 10 6 5.099754689305326 19.608786322547942 0.0 6 0.9802961247510712 8.777500200270923 27430.0 10.665363719626834 1.0 - - - - - - - 1363.0 402 2 FMN1 formin 1 1085 139 C20140606_SFK034_02 C20140606_SFK034_02 TB555539.[MT7]-VEIITR.2b3_1.heavy 437.778 / 486.304 30497.0 26.69930076599121 34 18 0 10 6 5.099754689305326 19.608786322547942 0.0 6 0.9802961247510712 8.777500200270923 30497.0 11.519304013501976 1.0 - - - - - - - 596.0 60 1 FMN1 formin 1 1087 139 C20140606_SFK034_02 C20140606_SFK034_02 TB555539.[MT7]-VEIITR.2y5_1.heavy 437.778 / 631.377 64060.0 26.69930076599121 34 18 0 10 6 5.099754689305326 19.608786322547942 0.0 6 0.9802961247510712 8.777500200270923 64060.0 72.29068468192244 2.0 - - - - - - - 426.0 690 1 FMN1 formin 1 1089 139 C20140606_SFK034_02 C20140606_SFK034_02 TB555539.[MT7]-VEIITR.2b4_1.heavy 437.778 / 599.388 14226.0 26.69930076599121 34 18 0 10 6 5.099754689305326 19.608786322547942 0.0 6 0.9802961247510712 8.777500200270923 14226.0 13.904155199821954 1.0 - - - - - - - 783.8 33 5 FMN1 formin 1 1091 140 C20140606_SFK034_02 C20140606_SFK034_02 TPX_ECO57.DLSDVTLGQFAGK.2y7.peptide 675.85 / 720.4 871202.0 37.53369903564453 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 871202.0 133.65534996103162 0.0 - - - - - - - 1497.0 1742 1 1093 140 C20140606_SFK034_02 C20140606_SFK034_02 TPX_ECO57.DLSDVTLGQFAGK.2y8.peptide 675.85 / 821.45 1788770.0 37.53369903564453 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1788770.0 154.1550678126939 0.0 - - - - - - - 2157.5 3577 2 1095 140 C20140606_SFK034_02 C20140606_SFK034_02 TPX_ECO57.DLSDVTLGQFAGK.2y6.peptide 675.85 / 607.32 1803190.0 37.53369903564453 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1803190.0 197.4534023088931 0.0 - - - - - - - 2378.0 3606 1 1097 141 C20140606_SFK034_02 C20140606_SFK034_02 TB556697.[MT7]-VQELPLAR.2b3_1.heavy 535.328 / 501.279 115866.0 30.091699600219727 50 20 10 10 10 9.246782739018213 10.814572248792514 0.0 3 0.9961342185343296 19.842834650346802 115866.0 32.179686496724614 0.0 - - - - - - - 2051.0 231 1 NFYC nuclear transcription factor Y, gamma 1099 141 C20140606_SFK034_02 C20140606_SFK034_02 TB556697.[MT7]-VQELPLAR.2y5_1.heavy 535.328 / 569.377 103767.0 30.091699600219727 50 20 10 10 10 9.246782739018213 10.814572248792514 0.0 3 0.9961342185343296 19.842834650346802 103767.0 43.401925079982604 0.0 - - - - - - - 1179.0 207 2 NFYC nuclear transcription factor Y, gamma 1101 141 C20140606_SFK034_02 C20140606_SFK034_02 TB556697.[MT7]-VQELPLAR.2b4_1.heavy 535.328 / 614.363 107458.0 30.091699600219727 50 20 10 10 10 9.246782739018213 10.814572248792514 0.0 3 0.9961342185343296 19.842834650346802 107458.0 -0.3725068942891687 2.0 - - - - - - - 1196.3333333333333 245 3 NFYC nuclear transcription factor Y, gamma 1103 141 C20140606_SFK034_02 C20140606_SFK034_02 TB556697.[MT7]-VQELPLAR.2y7_1.heavy 535.328 / 826.478 233681.0 30.091699600219727 50 20 10 10 10 9.246782739018213 10.814572248792514 0.0 3 0.9961342185343296 19.842834650346802 233681.0 552.2431816511167 0.0 - - - - - - - 307.6666666666667 467 3 NFYC nuclear transcription factor Y, gamma 1105 142 C20140606_SFK034_02 C20140606_SFK034_02 TB558598.[MT7]-GFHPDPEALK[MT7].3y3_1.heavy 466.926 / 475.336 100811.0 27.937400817871094 35 17 0 10 8 2.7081226068290656 29.566360563319876 0.0 4 0.9773009060731435 8.175854630177682 100811.0 41.1245124649473 0.0 - - - - - - - 1828.6666666666667 201 3 C17orf97 chromosome 17 open reading frame 97 1107 142 C20140606_SFK034_02 C20140606_SFK034_02 TB558598.[MT7]-GFHPDPEALK[MT7].3y4_1.heavy 466.926 / 604.379 47752.0 27.937400817871094 35 17 0 10 8 2.7081226068290656 29.566360563319876 0.0 4 0.9773009060731435 8.175854630177682 47752.0 32.959037640962315 0.0 - - - - - - - 854.0 95 2 C17orf97 chromosome 17 open reading frame 97 1109 142 C20140606_SFK034_02 C20140606_SFK034_02 TB558598.[MT7]-GFHPDPEALK[MT7].3b3_1.heavy 466.926 / 486.258 134534.0 27.937400817871094 35 17 0 10 8 2.7081226068290656 29.566360563319876 0.0 4 0.9773009060731435 8.175854630177682 134534.0 81.56971292370146 0.0 - - - - - - - 1289.0 269 3 C17orf97 chromosome 17 open reading frame 97 1111 142 C20140606_SFK034_02 C20140606_SFK034_02 TB558598.[MT7]-GFHPDPEALK[MT7].3y5_1.heavy 466.926 / 701.431 92357.0 27.937400817871094 35 17 0 10 8 2.7081226068290656 29.566360563319876 0.0 4 0.9773009060731435 8.175854630177682 92357.0 121.62105144278945 1.0 - - - - - - - 390.0 2755 3 C17orf97 chromosome 17 open reading frame 97 1113 143 C20140606_SFK034_02 C20140606_SFK034_02 TB556695.[MT7]-SFLAELSR.2y4_1.heavy 533.804 / 504.278 65806.0 38.6599006652832 48 18 10 10 10 4.813986704223639 20.772803529403845 0.0 3 0.9874879248315526 11.021579253883786 65806.0 14.49920006856422 0.0 - - - - - - - 1634.5 131 2 GLDN gliomedin 1115 143 C20140606_SFK034_02 C20140606_SFK034_02 TB556695.[MT7]-SFLAELSR.2y5_1.heavy 533.804 / 575.315 149632.0 38.6599006652832 48 18 10 10 10 4.813986704223639 20.772803529403845 0.0 3 0.9874879248315526 11.021579253883786 149632.0 209.3848826772265 0.0 - - - - - - - 353.0 299 1 GLDN gliomedin 1117 143 C20140606_SFK034_02 C20140606_SFK034_02 TB556695.[MT7]-SFLAELSR.2b4_1.heavy 533.804 / 563.331 56708.0 38.6599006652832 48 18 10 10 10 4.813986704223639 20.772803529403845 0.0 3 0.9874879248315526 11.021579253883786 56708.0 54.20720893378894 0.0 - - - - - - - 412.3333333333333 113 3 GLDN gliomedin 1119 143 C20140606_SFK034_02 C20140606_SFK034_02 TB556695.[MT7]-SFLAELSR.2y7_1.heavy 533.804 / 835.467 152193.0 38.6599006652832 48 18 10 10 10 4.813986704223639 20.772803529403845 0.0 3 0.9874879248315526 11.021579253883786 152193.0 946.0917799808121 0.0 - - - - - - - 215.88888888888889 304 9 GLDN gliomedin 1121 144 C20140606_SFK034_02 C20140606_SFK034_02 TB456508.[MT7]-DLEGSYYLR.2b3_1.heavy 630.323 / 502.263 17485.0 31.75309944152832 40 16 4 10 10 3.2858182046929674 24.088596716994658 0.0 3 0.9640572477177862 6.4900379405829085 17485.0 10.880181777677453 0.0 - - - - - - - 1289.857142857143 34 7 DMGDH dimethylglycine dehydrogenase 1123 144 C20140606_SFK034_02 C20140606_SFK034_02 TB456508.[MT7]-DLEGSYYLR.2y8_1.heavy 630.323 / 1000.51 33255.0 31.75309944152832 40 16 4 10 10 3.2858182046929674 24.088596716994658 0.0 3 0.9640572477177862 6.4900379405829085 33255.0 49.38633134760303 0.0 - - - - - - - 1175.5714285714287 66 7 DMGDH dimethylglycine dehydrogenase 1125 144 C20140606_SFK034_02 C20140606_SFK034_02 TB456508.[MT7]-DLEGSYYLR.2y6_1.heavy 630.323 / 758.383 23656.0 31.75309944152832 40 16 4 10 10 3.2858182046929674 24.088596716994658 0.0 3 0.9640572477177862 6.4900379405829085 23656.0 20.97377884755653 0.0 - - - - - - - 718.1428571428571 47 7 DMGDH dimethylglycine dehydrogenase 1127 144 C20140606_SFK034_02 C20140606_SFK034_02 TB456508.[MT7]-DLEGSYYLR.2y7_1.heavy 630.323 / 887.426 11656.0 31.75309944152832 40 16 4 10 10 3.2858182046929674 24.088596716994658 0.0 3 0.9640572477177862 6.4900379405829085 11656.0 13.148235097337842 2.0 - - - - - - - 1257.25 130 8 DMGDH dimethylglycine dehydrogenase 1129 145 C20140606_SFK034_02 C20140606_SFK034_02 TB326504.[MT7]-ALLPSPLFLIR.2y8_1.heavy 692.446 / 942.577 33111.0 50.53730010986328 45 20 10 5 10 4.912877610691798 20.35466948787244 0.044403076171875 3 0.9963837511804675 20.516451790586103 33111.0 143.16910252197488 0.0 - - - - - - - 264.4782608695652 66 23 FAM75D1 family with sequence similarity 75, member D1 1131 145 C20140606_SFK034_02 C20140606_SFK034_02 TB326504.[MT7]-ALLPSPLFLIR.2y9_1.heavy 692.446 / 1055.66 6445.0 50.53730010986328 45 20 10 5 10 4.912877610691798 20.35466948787244 0.044403076171875 3 0.9963837511804675 20.516451790586103 6445.0 19.570067354229934 0.0 - - - - - - - 657.6363636363636 12 11 FAM75D1 family with sequence similarity 75, member D1 1133 145 C20140606_SFK034_02 C20140606_SFK034_02 TB326504.[MT7]-ALLPSPLFLIR.2y6_1.heavy 692.446 / 758.492 N/A 50.53730010986328 45 20 10 5 10 4.912877610691798 20.35466948787244 0.044403076171875 3 0.9963837511804675 20.516451790586103 10522.0 3.1420253305309065 1.0 - - - - - - - 695.5384615384615 29 13 FAM75D1 family with sequence similarity 75, member D1 1135 145 C20140606_SFK034_02 C20140606_SFK034_02 TB326504.[MT7]-ALLPSPLFLIR.2y10_1.heavy 692.446 / 1168.75 2926.0 50.53730010986328 45 20 10 5 10 4.912877610691798 20.35466948787244 0.044403076171875 3 0.9963837511804675 20.516451790586103 2926.0 0.0 0.0 - - - - - - - 198.41935483870967 5 31 FAM75D1 family with sequence similarity 75, member D1 1137 146 C20140606_SFK034_02 C20140606_SFK034_02 TB456700.[MT7]-SALLPTIPDTEDEISPDK[MT7].3y7_1.heavy 743.73 / 947.48 N/A N/A - - - - - - - - - 0.0 - - - - - - - CRBN cereblon 1139 146 C20140606_SFK034_02 C20140606_SFK034_02 TB456700.[MT7]-SALLPTIPDTEDEISPDK[MT7].3y3_1.heavy 743.73 / 503.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - CRBN cereblon 1141 146 C20140606_SFK034_02 C20140606_SFK034_02 TB456700.[MT7]-SALLPTIPDTEDEISPDK[MT7].3b4_1.heavy 743.73 / 529.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - CRBN cereblon 1143 146 C20140606_SFK034_02 C20140606_SFK034_02 TB456700.[MT7]-SALLPTIPDTEDEISPDK[MT7].3y4_1.heavy 743.73 / 590.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - CRBN cereblon 1145 147 C20140606_SFK034_02 C20140606_SFK034_02 TB556285.[MT7]-QLLQAER.2y4_1.heavy 501.297 / 503.257 22996.0 23.94029998779297 50 20 10 10 10 11.536228997354083 8.66834387761683 0.0 3 0.9954789660542033 18.3476196417093 22996.0 16.860487030174696 0.0 - - - - - - - 1799.375 45 8 NIN ninein (GSK3B interacting protein) 1147 147 C20140606_SFK034_02 C20140606_SFK034_02 TB556285.[MT7]-QLLQAER.2y5_1.heavy 501.297 / 616.341 39999.0 23.94029998779297 50 20 10 10 10 11.536228997354083 8.66834387761683 0.0 3 0.9954789660542033 18.3476196417093 39999.0 23.43733504525813 0.0 - - - - - - - 1219.0 79 7 NIN ninein (GSK3B interacting protein) 1149 147 C20140606_SFK034_02 C20140606_SFK034_02 TB556285.[MT7]-QLLQAER.2b4_1.heavy 501.297 / 627.395 22345.0 23.94029998779297 50 20 10 10 10 11.536228997354083 8.66834387761683 0.0 3 0.9954789660542033 18.3476196417093 22345.0 29.189776310964433 0.0 - - - - - - - 1349.142857142857 44 7 NIN ninein (GSK3B interacting protein) 1151 147 C20140606_SFK034_02 C20140606_SFK034_02 TB556285.[MT7]-QLLQAER.2y6_1.heavy 501.297 / 729.425 71595.0 23.94029998779297 50 20 10 10 10 11.536228997354083 8.66834387761683 0.0 3 0.9954789660542033 18.3476196417093 71595.0 143.46174833674513 0.0 - - - - - - - 787.25 143 12 NIN ninein (GSK3B interacting protein) 1153 148 C20140606_SFK034_02 C20140606_SFK034_02 TB456706.[MT7]-MLFLEQPLPQAAVALWVK[MT7].3b6_1.heavy 781.456 / 906.487 3029.0 53.02970027923584 41 18 10 3 10 4.627416976346115 21.61032829139198 0.06380081176757812 3 0.9871970114018871 10.895376526171129 3029.0 0.0 2.0 - - - - - - - 746.75 6 8 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1155 148 C20140606_SFK034_02 C20140606_SFK034_02 TB456706.[MT7]-MLFLEQPLPQAAVALWVK[MT7].3b4_1.heavy 781.456 / 649.386 1812.0 53.02970027923584 41 18 10 3 10 4.627416976346115 21.61032829139198 0.06380081176757812 3 0.9871970114018871 10.895376526171129 1812.0 2.7848402532746865 2.0 - - - - - - - 237.73333333333332 5 15 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1157 148 C20140606_SFK034_02 C20140606_SFK034_02 TB456706.[MT7]-MLFLEQPLPQAAVALWVK[MT7].3b5_1.heavy 781.456 / 778.429 1897.0 53.02970027923584 41 18 10 3 10 4.627416976346115 21.61032829139198 0.06380081176757812 3 0.9871970114018871 10.895376526171129 1897.0 3.654113454113454 0.0 - - - - - - - 211.41176470588235 3 17 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1159 148 C20140606_SFK034_02 C20140606_SFK034_02 TB456706.[MT7]-MLFLEQPLPQAAVALWVK[MT7].3b3_1.heavy 781.456 / 536.302 3199.0 53.02970027923584 41 18 10 3 10 4.627416976346115 21.61032829139198 0.06380081176757812 3 0.9871970114018871 10.895376526171129 3199.0 5.14944812362031 1.0 - - - - - - - 232.52631578947367 6 19 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1161 149 C20140606_SFK034_02 C20140606_SFK034_02 TB560166.[MT7]-RTNWFEPVGSEYK[MT7].3y7_1.heavy 634.331 / 923.495 15944.0 33.393699645996094 44 14 10 10 10 10.281838325724816 9.725887222891195 0.0 3 0.9413516316237737 5.0709420682649275 15944.0 18.036282090287152 0.0 - - - - - - - 731.5 31 8 DMGDH dimethylglycine dehydrogenase 1163 149 C20140606_SFK034_02 C20140606_SFK034_02 TB560166.[MT7]-RTNWFEPVGSEYK[MT7].3b6_1.heavy 634.331 / 978.491 20189.0 33.393699645996094 44 14 10 10 10 10.281838325724816 9.725887222891195 0.0 3 0.9413516316237737 5.0709420682649275 20189.0 33.428409586056645 0.0 - - - - - - - 768.8 40 10 DMGDH dimethylglycine dehydrogenase 1165 149 C20140606_SFK034_02 C20140606_SFK034_02 TB560166.[MT7]-RTNWFEPVGSEYK[MT7].3b3_1.heavy 634.331 / 516.301 6080.0 33.393699645996094 44 14 10 10 10 10.281838325724816 9.725887222891195 0.0 3 0.9413516316237737 5.0709420682649275 6080.0 3.961181878775217 5.0 - - - - - - - 459.0 13 1 DMGDH dimethylglycine dehydrogenase 1167 149 C20140606_SFK034_02 C20140606_SFK034_02 TB560166.[MT7]-RTNWFEPVGSEYK[MT7].3y5_1.heavy 634.331 / 727.374 32233.0 33.393699645996094 44 14 10 10 10 10.281838325724816 9.725887222891195 0.0 3 0.9413516316237737 5.0709420682649275 32233.0 58.32567579684431 0.0 - - - - - - - 459.0 64 2 DMGDH dimethylglycine dehydrogenase 1169 150 C20140606_SFK034_02 C20140606_SFK034_02 TB556030.[MT7]-AGNAFIAR.2y4_1.heavy 482.278 / 506.309 7939.0 24.78019905090332 48 18 10 10 10 13.469822294269445 7.424002916693538 0.0 3 0.9873041852896701 10.941365649202798 7939.0 6.473942188893979 4.0 - - - - - - - 2268.1428571428573 15 7 GLDN gliomedin 1171 150 C20140606_SFK034_02 C20140606_SFK034_02 TB556030.[MT7]-AGNAFIAR.2y5_1.heavy 482.278 / 577.346 13184.0 24.78019905090332 48 18 10 10 10 13.469822294269445 7.424002916693538 0.0 3 0.9873041852896701 10.941365649202798 13184.0 2.1294568948112254 1.0 - - - - - - - 1250.5 26 6 GLDN gliomedin 1173 150 C20140606_SFK034_02 C20140606_SFK034_02 TB556030.[MT7]-AGNAFIAR.2b5_1.heavy 482.278 / 605.316 19885.0 24.78019905090332 48 18 10 10 10 13.469822294269445 7.424002916693538 0.0 3 0.9873041852896701 10.941365649202798 19885.0 29.397043294614573 0.0 - - - - - - - 1831.4285714285713 39 7 GLDN gliomedin 1175 150 C20140606_SFK034_02 C20140606_SFK034_02 TB556030.[MT7]-AGNAFIAR.2y7_1.heavy 482.278 / 748.41 22798.0 24.78019905090332 48 18 10 10 10 13.469822294269445 7.424002916693538 0.0 3 0.9873041852896701 10.941365649202798 22798.0 33.51807959148292 0.0 - - - - - - - 708.6363636363636 45 11 GLDN gliomedin 1177 151 C20140606_SFK034_02 C20140606_SFK034_02 TB456709.[MT7]-SLTFNETYQDISELVYGAK[MT7].3b6_1.heavy 822.76 / 836.427 33477.0 50.105499267578125 44 14 10 10 10 2.130982217203718 36.75070639201624 0.0 3 0.941044667396392 5.057591102116937 33477.0 85.37887424215334 0.0 - - - - - - - 279.1578947368421 66 19 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1179 151 C20140606_SFK034_02 C20140606_SFK034_02 TB456709.[MT7]-SLTFNETYQDISELVYGAK[MT7].3b5_1.heavy 822.76 / 707.385 20059.0 50.105499267578125 44 14 10 10 10 2.130982217203718 36.75070639201624 0.0 3 0.941044667396392 5.057591102116937 20059.0 72.76183058343972 0.0 - - - - - - - 713.1818181818181 40 11 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1181 151 C20140606_SFK034_02 C20140606_SFK034_02 TB456709.[MT7]-SLTFNETYQDISELVYGAK[MT7].3y4_1.heavy 822.76 / 582.337 130341.0 50.105499267578125 44 14 10 10 10 2.130982217203718 36.75070639201624 0.0 3 0.941044667396392 5.057591102116937 130341.0 102.68134218582165 0.0 - - - - - - - 401.2857142857143 260 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1183 151 C20140606_SFK034_02 C20140606_SFK034_02 TB456709.[MT7]-SLTFNETYQDISELVYGAK[MT7].3y5_1.heavy 822.76 / 681.405 49480.0 50.105499267578125 44 14 10 10 10 2.130982217203718 36.75070639201624 0.0 3 0.941044667396392 5.057591102116937 49480.0 99.52749719355667 0.0 - - - - - - - 646.2 98 10 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1185 152 C20140606_SFK034_02 C20140606_SFK034_02 TB556536.[MT7]-RELPVLR.2b3_1.heavy 513.831 / 543.337 5036.0 25.881250381469727 41 18 10 5 8 36.787030808581285 2.718349315016559 0.042499542236328125 4 0.9879667378595595 11.239169440724169 5036.0 4.452375407652225 2.0 - - - - - - - 1722.142857142857 20 7 DMGDH dimethylglycine dehydrogenase 1187 152 C20140606_SFK034_02 C20140606_SFK034_02 TB556536.[MT7]-RELPVLR.2y5_1.heavy 513.831 / 597.408 7679.0 25.881250381469727 41 18 10 5 8 36.787030808581285 2.718349315016559 0.042499542236328125 4 0.9879667378595595 11.239169440724169 7679.0 5.276572365807425 1.0 - - - - - - - 963.3333333333334 15 3 DMGDH dimethylglycine dehydrogenase 1189 152 C20140606_SFK034_02 C20140606_SFK034_02 TB556536.[MT7]-RELPVLR.2y6_1.heavy 513.831 / 726.451 9247.0 25.881250381469727 41 18 10 5 8 36.787030808581285 2.718349315016559 0.042499542236328125 4 0.9879667378595595 11.239169440724169 9247.0 22.077612456747406 0.0 - - - - - - - 302.77777777777777 18 9 DMGDH dimethylglycine dehydrogenase 1191 152 C20140606_SFK034_02 C20140606_SFK034_02 TB556536.[MT7]-RELPVLR.2b5_1.heavy 513.831 / 739.458 9495.0 25.881250381469727 41 18 10 5 8 36.787030808581285 2.718349315016559 0.042499542236328125 4 0.9879667378595595 11.239169440724169 9495.0 19.9330871517955 1.0 - - - - - - - 394.3333333333333 20 9 DMGDH dimethylglycine dehydrogenase 1193 153 C20140606_SFK034_02 C20140606_SFK034_02 TB456399.[MT7]-IETINFHEVK[MT7].3y3_1.heavy 506.624 / 519.326 116142.0 31.624799728393555 48 18 10 10 10 5.438030034536493 18.389012080644648 0.0 3 0.9804997145500113 8.823352090605098 116142.0 46.03826038382442 0.0 - - - - - - - 872.0 232 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1195 153 C20140606_SFK034_02 C20140606_SFK034_02 TB456399.[MT7]-IETINFHEVK[MT7].3b4_1.heavy 506.624 / 601.368 31625.0 31.624799728393555 48 18 10 10 10 5.438030034536493 18.389012080644648 0.0 3 0.9804997145500113 8.823352090605098 31625.0 10.87593077406681 1.0 - - - - - - - 327.0 73 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1197 153 C20140606_SFK034_02 C20140606_SFK034_02 TB456399.[MT7]-IETINFHEVK[MT7].3b5_1.heavy 506.624 / 715.411 79391.0 31.624799728393555 48 18 10 10 10 5.438030034536493 18.389012080644648 0.0 3 0.9804997145500113 8.823352090605098 79391.0 96.44063350268475 0.0 - - - - - - - 795.7 158 10 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1199 153 C20140606_SFK034_02 C20140606_SFK034_02 TB456399.[MT7]-IETINFHEVK[MT7].3y4_1.heavy 506.624 / 656.385 47438.0 31.624799728393555 48 18 10 10 10 5.438030034536493 18.389012080644648 0.0 3 0.9804997145500113 8.823352090605098 47438.0 33.34884023949894 0.0 - - - - - - - 981.0 94 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1201 154 C20140606_SFK034_02 C20140606_SFK034_02 TB559818.[MT7]-EEIENLQAQFELR.3y6_1.heavy 588.308 / 763.41 53637.0 39.89789962768555 48 18 10 10 10 6.5492375353714865 15.268952982681487 0.0 3 0.9899830541210682 12.320590216184552 53637.0 48.42391035772839 0.0 - - - - - - - 1213.75 107 8 FMN1 formin 1 1203 154 C20140606_SFK034_02 C20140606_SFK034_02 TB559818.[MT7]-EEIENLQAQFELR.3b4_1.heavy 588.308 / 645.321 28360.0 39.89789962768555 48 18 10 10 10 6.5492375353714865 15.268952982681487 0.0 3 0.9899830541210682 12.320590216184552 28360.0 46.54846070470211 0.0 - - - - - - - 1292.888888888889 56 9 FMN1 formin 1 1205 154 C20140606_SFK034_02 C20140606_SFK034_02 TB559818.[MT7]-EEIENLQAQFELR.3b5_1.heavy 588.308 / 759.364 49706.0 39.89789962768555 48 18 10 10 10 6.5492375353714865 15.268952982681487 0.0 3 0.9899830541210682 12.320590216184552 49706.0 71.72547827595373 0.0 - - - - - - - 1255.0 99 7 FMN1 formin 1 1207 154 C20140606_SFK034_02 C20140606_SFK034_02 TB559818.[MT7]-EEIENLQAQFELR.3b3_1.heavy 588.308 / 516.279 36528.0 39.89789962768555 48 18 10 10 10 6.5492375353714865 15.268952982681487 0.0 3 0.9899830541210682 12.320590216184552 36528.0 10.868347180604502 0.0 - - - - - - - 1310.0 73 3 FMN1 formin 1 1209 155 C20140606_SFK034_02 C20140606_SFK034_02 TB560575.[MT7]-LHDC[CAM]LLNLFVSQNLYK[MT7].4b7_1.heavy 567.063 / 1010.52 7294.0 45.61790084838867 44 14 10 10 10 1.7705251261632202 37.66692364673774 0.0 3 0.949120063904858 5.447914251746267 7294.0 54.572737901848996 0.0 - - - - - - - 201.35294117647058 14 17 NPHP3 nephronophthisis 3 (adolescent) 1211 155 C20140606_SFK034_02 C20140606_SFK034_02 TB560575.[MT7]-LHDC[CAM]LLNLFVSQNLYK[MT7].4b4_1.heavy 567.063 / 670.31 3742.0 45.61790084838867 44 14 10 10 10 1.7705251261632202 37.66692364673774 0.0 3 0.949120063904858 5.447914251746267 3742.0 13.095183867836534 1.0 - - - - - - - 238.8235294117647 9 17 NPHP3 nephronophthisis 3 (adolescent) 1213 155 C20140606_SFK034_02 C20140606_SFK034_02 TB560575.[MT7]-LHDC[CAM]LLNLFVSQNLYK[MT7].4b5_1.heavy 567.063 / 783.394 4630.0 45.61790084838867 44 14 10 10 10 1.7705251261632202 37.66692364673774 0.0 3 0.949120063904858 5.447914251746267 4630.0 16.37711015431836 0.0 - - - - - - - 306.0 9 17 NPHP3 nephronophthisis 3 (adolescent) 1215 155 C20140606_SFK034_02 C20140606_SFK034_02 TB560575.[MT7]-LHDC[CAM]LLNLFVSQNLYK[MT7].4b3_1.heavy 567.063 / 510.279 5265.0 45.61790084838867 44 14 10 10 10 1.7705251261632202 37.66692364673774 0.0 3 0.949120063904858 5.447914251746267 5265.0 6.099586574445991 0.0 - - - - - - - 707.4615384615385 10 13 NPHP3 nephronophthisis 3 (adolescent) 1217 156 C20140606_SFK034_02 C20140606_SFK034_02 TB560190.[MT7]-NQQLDLENTELSQK[MT7].3y3_1.heavy 650.012 / 506.306 250520.0 30.091699600219727 42 12 10 10 10 1.0478680972410603 55.34946595892228 0.0 3 0.8849237366467486 3.6025829064839967 250520.0 44.56864687437611 0.0 - - - - - - - 1974.0 501 1 NIN ninein (GSK3B interacting protein) 1219 156 C20140606_SFK034_02 C20140606_SFK034_02 TB560190.[MT7]-NQQLDLENTELSQK[MT7].3b5_1.heavy 650.012 / 743.38 142456.0 30.091699600219727 42 12 10 10 10 1.0478680972410603 55.34946595892228 0.0 3 0.8849237366467486 3.6025829064839967 142456.0 18.773066954887067 1.0 - - - - - - - 1779.375 327 8 NIN ninein (GSK3B interacting protein) 1221 156 C20140606_SFK034_02 C20140606_SFK034_02 TB560190.[MT7]-NQQLDLENTELSQK[MT7].3y4_1.heavy 650.012 / 619.39 148171.0 30.091699600219727 42 12 10 10 10 1.0478680972410603 55.34946595892228 0.0 3 0.8849237366467486 3.6025829064839967 148171.0 32.191570123899126 0.0 - - - - - - - 1714.5 296 2 NIN ninein (GSK3B interacting protein) 1223 156 C20140606_SFK034_02 C20140606_SFK034_02 TB560190.[MT7]-NQQLDLENTELSQK[MT7].3b3_1.heavy 650.012 / 515.269 76372.0 30.091699600219727 42 12 10 10 10 1.0478680972410603 55.34946595892228 0.0 3 0.8849237366467486 3.6025829064839967 76372.0 33.74280624780625 0.0 - - - - - - - 623.0 152 1 NIN ninein (GSK3B interacting protein) 1225 157 C20140606_SFK034_02 C20140606_SFK034_02 TB559012.[MT7]-TYFNLAVDEK[MT7].3y3_1.heavy 496.604 / 535.284 132605.0 35.873600006103516 44 14 10 10 10 2.7797199068413354 35.974847593055685 0.0 3 0.9396828992876569 4.999592908681246 132605.0 111.504192357075 0.0 - - - - - - - 665.6666666666666 265 3 GLDN gliomedin 1227 157 C20140606_SFK034_02 C20140606_SFK034_02 TB559012.[MT7]-TYFNLAVDEK[MT7].3b4_1.heavy 496.604 / 670.332 133866.0 35.873600006103516 44 14 10 10 10 2.7797199068413354 35.974847593055685 0.0 3 0.9396828992876569 4.999592908681246 133866.0 191.25917102830707 0.0 - - - - - - - 1321.0 267 7 GLDN gliomedin 1229 157 C20140606_SFK034_02 C20140606_SFK034_02 TB559012.[MT7]-TYFNLAVDEK[MT7].3b5_1.heavy 496.604 / 783.416 34570.0 35.873600006103516 44 14 10 10 10 2.7797199068413354 35.974847593055685 0.0 3 0.9396828992876569 4.999592908681246 34570.0 63.479015857242565 0.0 - - - - - - - 735.5 69 8 GLDN gliomedin 1231 157 C20140606_SFK034_02 C20140606_SFK034_02 TB559012.[MT7]-TYFNLAVDEK[MT7].3y4_1.heavy 496.604 / 634.353 81013.0 35.873600006103516 44 14 10 10 10 2.7797199068413354 35.974847593055685 0.0 3 0.9396828992876569 4.999592908681246 81013.0 119.95248882905156 0.0 - - - - - - - 1231.0 162 7 GLDN gliomedin 1233 158 C20140606_SFK034_02 C20140606_SFK034_02 TB557420.[MT7]-VGMVQELLR.2y8_1.heavy 594.848 / 945.519 54099.0 40.02577590942383 43 17 10 6 10 4.723023119311987 21.17287963107985 0.0386962890625 3 0.9751401494722765 7.811047455814549 54099.0 121.61289872055079 0.0 - - - - - - - 700.7272727272727 108 11 C17orf76 chromosome 17 open reading frame 76 1235 158 C20140606_SFK034_02 C20140606_SFK034_02 TB557420.[MT7]-VGMVQELLR.2b4_1.heavy 594.848 / 531.308 7244.0 40.02577590942383 43 17 10 6 10 4.723023119311987 21.17287963107985 0.0386962890625 3 0.9751401494722765 7.811047455814549 7244.0 6.525451029704167 0.0 - - - - - - - 770.8571428571429 14 7 C17orf76 chromosome 17 open reading frame 76 1237 158 C20140606_SFK034_02 C20140606_SFK034_02 TB557420.[MT7]-VGMVQELLR.2b6_1.heavy 594.848 / 788.409 6088.0 40.02577590942383 43 17 10 6 10 4.723023119311987 21.17287963107985 0.0386962890625 3 0.9751401494722765 7.811047455814549 6088.0 7.765630595576121 0.0 - - - - - - - 713.125 12 8 C17orf76 chromosome 17 open reading frame 76 1239 158 C20140606_SFK034_02 C20140606_SFK034_02 TB557420.[MT7]-VGMVQELLR.2b5_1.heavy 594.848 / 659.367 6011.0 40.02577590942383 43 17 10 6 10 4.723023119311987 21.17287963107985 0.0386962890625 3 0.9751401494722765 7.811047455814549 6011.0 4.15748217678825 0.0 - - - - - - - 732.25 12 8 C17orf76 chromosome 17 open reading frame 76 1241 159 C20140606_SFK034_02 C20140606_SFK034_02 ENO_ECO24.IQLVGDDLFVTNTK.2y8.peptide 781.92 / 937.5 1119490.0 40.55059814453125 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1119490.0 162.30989128734743 0.0 - - - - - - - 1191.0 2238 1 1243 159 C20140606_SFK034_02 C20140606_SFK034_02 ENO_ECO24.IQLVGDDLFVTNTK.2y6.peptide 781.92 / 709.39 1524990.0 40.55059814453125 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1524990.0 190.44886726063112 0.0 - - - - - - - 1331.0 3049 2 1245 159 C20140606_SFK034_02 C20140606_SFK034_02 ENO_ECO24.IQLVGDDLFVTNTK.2y5.peptide 781.92 / 562.32 2100250.0 40.55059814453125 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2100250.0 211.82962050782191 0.0 - - - - - - - 1401.0 4200 1 1247 160 C20140606_SFK034_02 C20140606_SFK034_02 TB404062.[MT7]-VQILPEC[CAM]VLPSTMSAVQLESLNK[MT7].4y5_1.heavy 711.892 / 734.417 6372.0 45.49470138549805 46 18 10 10 8 4.777252470278108 20.93253405009564 0.0 4 0.9862767617572545 10.52291720612909 6372.0 12.156102169922644 0.0 - - - - - - - 742.25 12 8 CRBN cereblon 1249 160 C20140606_SFK034_02 C20140606_SFK034_02 TB404062.[MT7]-VQILPEC[CAM]VLPSTMSAVQLESLNK[MT7].4b7_1.heavy 711.892 / 984.531 5011.0 45.49470138549805 46 18 10 10 8 4.777252470278108 20.93253405009564 0.0 4 0.9862767617572545 10.52291720612909 5011.0 6.405769108914109 0.0 - - - - - - - 689.2857142857143 10 7 CRBN cereblon 1251 160 C20140606_SFK034_02 C20140606_SFK034_02 TB404062.[MT7]-VQILPEC[CAM]VLPSTMSAVQLESLNK[MT7].4b4_1.heavy 711.892 / 598.404 31179.0 45.49470138549805 46 18 10 10 8 4.777252470278108 20.93253405009564 0.0 4 0.9862767617572545 10.52291720612909 31179.0 7.365344248467946 1.0 - - - - - - - 186.0 64 1 CRBN cereblon 1253 160 C20140606_SFK034_02 C20140606_SFK034_02 TB404062.[MT7]-VQILPEC[CAM]VLPSTMSAVQLESLNK[MT7].4y3_1.heavy 711.892 / 518.342 5877.0 45.49470138549805 46 18 10 10 8 4.777252470278108 20.93253405009564 0.0 4 0.9862767617572545 10.52291720612909 5877.0 9.399608113373315 1.0 - - - - - - - 769.6666666666666 17 9 CRBN cereblon 1255 161 C20140606_SFK034_02 C20140606_SFK034_02 TB555566.[MT7]-IQISDR.2y4_1.heavy 438.257 / 490.262 36006.0 23.83970069885254 34 20 0 10 4 3.0863335607795803 24.30159520135117 0.0 7 0.9949468063293049 17.353870295583967 36006.0 36.35240026519337 0.0 - - - - - - - 1260.5 72 4 FMN1 formin 1 1257 161 C20140606_SFK034_02 C20140606_SFK034_02 TB555566.[MT7]-IQISDR.2y5_1.heavy 438.257 / 618.321 138725.0 23.83970069885254 34 20 0 10 4 3.0863335607795803 24.30159520135117 0.0 7 0.9949468063293049 17.353870295583967 138725.0 11.356329661874222 3.0 - - - - - - - 1713.0 1474 2 FMN1 formin 1 1259 161 C20140606_SFK034_02 C20140606_SFK034_02 TB555566.[MT7]-IQISDR.2b4_1.heavy 438.257 / 586.368 7628.0 23.83970069885254 34 20 0 10 4 3.0863335607795803 24.30159520135117 0.0 7 0.9949468063293049 17.353870295583967 7628.0 4.580535395155807 3.0 - - - - - - - 2241.0 31 9 FMN1 formin 1 1261 161 C20140606_SFK034_02 C20140606_SFK034_02 TB555566.[MT7]-IQISDR.2b5_1.heavy 438.257 / 701.395 37816.0 23.83970069885254 34 20 0 10 4 3.0863335607795803 24.30159520135117 0.0 7 0.9949468063293049 17.353870295583967 37816.0 25.195000214512078 1.0 - - - - - - - 194.0 89 2 FMN1 formin 1 1263 162 C20140606_SFK034_02 C20140606_SFK034_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y7.peptide 503.96 / 728.39 682471.0 35.51499938964844 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 682471.0 617.620814479638 0.0 - - - - - - - 828.625 1364 8 1265 162 C20140606_SFK034_02 C20140606_SFK034_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y6.peptide 503.96 / 631.34 136602.0 35.51499938964844 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 136602.0 130.80349457058244 0.0 - - - - - - - 1143.3333333333333 273 12 1267 162 C20140606_SFK034_02 C20140606_SFK034_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y5.peptide 503.96 / 516.31 119205.0 35.51499938964844 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 119205.0 42.429655301611085 0.0 - - - - - - - 1174.0 238 12 1269 163 C20140606_SFK034_02 C20140606_SFK034_02 TB558168.[MT7]-WLLSDYVK[MT7].2y5_1.heavy 656.381 / 755.406 55876.0 41.89759826660156 45 15 10 10 10 1.9480153671548905 44.9813519154456 0.0 3 0.952827569013809 5.659734439384932 55876.0 31.168682154076645 0.0 - - - - - - - 563.3333333333334 111 3 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1271 163 C20140606_SFK034_02 C20140606_SFK034_02 TB558168.[MT7]-WLLSDYVK[MT7].2y3_1.heavy 656.381 / 553.347 62575.0 41.89759826660156 45 15 10 10 10 1.9480153671548905 44.9813519154456 0.0 3 0.952827569013809 5.659734439384932 62575.0 44.60260871541255 0.0 - - - - - - - 390.0 125 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1273 163 C20140606_SFK034_02 C20140606_SFK034_02 TB558168.[MT7]-WLLSDYVK[MT7].2y6_1.heavy 656.381 / 868.49 45533.0 41.89759826660156 45 15 10 10 10 1.9480153671548905 44.9813519154456 0.0 3 0.952827569013809 5.659734439384932 45533.0 83.81115099537767 0.0 - - - - - - - 768.8181818181819 91 11 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1275 163 C20140606_SFK034_02 C20140606_SFK034_02 TB558168.[MT7]-WLLSDYVK[MT7].2y7_1.heavy 656.381 / 981.574 58738.0 41.89759826660156 45 15 10 10 10 1.9480153671548905 44.9813519154456 0.0 3 0.952827569013809 5.659734439384932 58738.0 51.898004574167004 0.0 - - - - - - - 1319.5714285714287 117 7 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1277 164 C20140606_SFK034_02 C20140606_SFK034_02 TB403896.[MT7]-ATEDEGSEQK[MT7].2y9_1.heavy 691.338 / 1166.53 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1279 164 C20140606_SFK034_02 C20140606_SFK034_02 TB403896.[MT7]-ATEDEGSEQK[MT7].2b4_1.heavy 691.338 / 561.264 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1281 164 C20140606_SFK034_02 C20140606_SFK034_02 TB403896.[MT7]-ATEDEGSEQK[MT7].2y6_1.heavy 691.338 / 821.412 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1283 164 C20140606_SFK034_02 C20140606_SFK034_02 TB403896.[MT7]-ATEDEGSEQK[MT7].2y7_1.heavy 691.338 / 936.439 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1285 165 C20140606_SFK034_02 C20140606_SFK034_02 TB404068.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNRK[MT7].4b8_1.heavy 857.69 / 901.511 19564.0 51.575599670410156 46 16 10 10 10 1.8086664743454133 38.53670376317177 0.0 3 0.9646511424374088 6.544658473238472 19564.0 24.515758058848768 0.0 - - - - - - - 748.3571428571429 39 14 IRAK2 interleukin-1 receptor-associated kinase 2 1287 165 C20140606_SFK034_02 C20140606_SFK034_02 TB404068.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNRK[MT7].4b7_1.heavy 857.69 / 814.479 13629.0 51.575599670410156 46 16 10 10 10 1.8086664743454133 38.53670376317177 0.0 3 0.9646511424374088 6.544658473238472 13629.0 21.100933547824006 0.0 - - - - - - - 761.3125 27 16 IRAK2 interleukin-1 receptor-associated kinase 2 1289 165 C20140606_SFK034_02 C20140606_SFK034_02 TB404068.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNRK[MT7].4b10_1.heavy 857.69 / 1161.66 14538.0 51.575599670410156 46 16 10 10 10 1.8086664743454133 38.53670376317177 0.0 3 0.9646511424374088 6.544658473238472 14538.0 25.874714086343353 0.0 - - - - - - - 713.7857142857143 29 14 IRAK2 interleukin-1 receptor-associated kinase 2 1291 165 C20140606_SFK034_02 C20140606_SFK034_02 TB404068.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNRK[MT7].4b4_1.heavy 857.69 / 571.394 15163.0 51.575599670410156 46 16 10 10 10 1.8086664743454133 38.53670376317177 0.0 3 0.9646511424374088 6.544658473238472 15163.0 25.29793433587306 0.0 - - - - - - - 1322.5714285714287 30 7 IRAK2 interleukin-1 receptor-associated kinase 2 1293 166 C20140606_SFK034_02 C20140606_SFK034_02 TB404069.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNRK[MT7].3y6_1.heavy 1143.25 / 950.529 2470.0 51.56722450256348 43 17 10 6 10 9.315312349784163 10.735013088671902 0.03350067138671875 3 0.9784519937936591 8.392200984982239 2470.0 14.017866050469484 0.0 - - - - - - - 168.26923076923077 4 26 IRAK2 interleukin-1 receptor-associated kinase 2 1295 166 C20140606_SFK034_02 C20140606_SFK034_02 TB404069.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNRK[MT7].3b10_1.heavy 1143.25 / 1161.66 2470.0 51.56722450256348 43 17 10 6 10 9.315312349784163 10.735013088671902 0.03350067138671875 3 0.9784519937936591 8.392200984982239 2470.0 12.915535423596857 0.0 - - - - - - - 209.37037037037038 4 27 IRAK2 interleukin-1 receptor-associated kinase 2 1297 166 C20140606_SFK034_02 C20140606_SFK034_02 TB404069.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNRK[MT7].3b8_1.heavy 1143.25 / 901.511 2186.0 51.56722450256348 43 17 10 6 10 9.315312349784163 10.735013088671902 0.03350067138671875 3 0.9784519937936591 8.392200984982239 2186.0 19.523678541839274 0.0 - - - - - - - 167.22222222222223 4 27 IRAK2 interleukin-1 receptor-associated kinase 2 1299 166 C20140606_SFK034_02 C20140606_SFK034_02 TB404069.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNRK[MT7].3b7_1.heavy 1143.25 / 814.479 3067.0 51.56722450256348 43 17 10 6 10 9.315312349784163 10.735013088671902 0.03350067138671875 3 0.9784519937936591 8.392200984982239 3067.0 14.58618539430415 0.0 - - - - - - - 155.1153846153846 6 26 IRAK2 interleukin-1 receptor-associated kinase 2 1301 167 C20140606_SFK034_02 C20140606_SFK034_02 TB556803.[MT7]-DVVLLEK[MT7].2y4_1.heavy 552.349 / 646.426 1744.0 33.52880096435547 38 8 10 10 10 3.146483387686122 31.781512145067623 0.0 3 0.7654230833938287 2.496545161145496 1744.0 0.4776896378768219 38.0 - - - - - - - 116.0 299 1 DMGDH dimethylglycine dehydrogenase 1303 167 C20140606_SFK034_02 C20140606_SFK034_02 TB556803.[MT7]-DVVLLEK[MT7].2y5_1.heavy 552.349 / 745.494 89198.0 33.52880096435547 38 8 10 10 10 3.146483387686122 31.781512145067623 0.0 3 0.7654230833938287 2.496545161145496 89198.0 111.93379121287758 0.0 - - - - - - - 116.0 178 1 DMGDH dimethylglycine dehydrogenase 1305 167 C20140606_SFK034_02 C20140606_SFK034_02 TB556803.[MT7]-DVVLLEK[MT7].2b4_1.heavy 552.349 / 571.357 191537.0 33.52880096435547 38 8 10 10 10 3.146483387686122 31.781512145067623 0.0 3 0.7654230833938287 2.496545161145496 191537.0 119.98345987081282 0.0 - - - - - - - 1163.0 383 1 DMGDH dimethylglycine dehydrogenase 1307 167 C20140606_SFK034_02 C20140606_SFK034_02 TB556803.[MT7]-DVVLLEK[MT7].2y3_1.heavy 552.349 / 533.341 313530.0 33.52880096435547 38 8 10 10 10 3.146483387686122 31.781512145067623 0.0 3 0.7654230833938287 2.496545161145496 313530.0 81.71138880128876 0.0 - - - - - - - 1705.6666666666667 627 3 DMGDH dimethylglycine dehydrogenase 1309 168 C20140606_SFK034_02 C20140606_SFK034_02 TB555809.[MT7]-C[CAM]LPVER.2y4_1.heavy 459.253 / 500.283 50021.0 23.187950134277344 46 20 10 6 10 4.677885593951556 21.377179495218666 0.030498504638671875 3 0.9913632794429919 13.270120491688967 50021.0 24.72636630275101 0.0 - - - - - - - 2165.375 100 8 LRP3 low density lipoprotein receptor-related protein 3 1311 168 C20140606_SFK034_02 C20140606_SFK034_02 TB555809.[MT7]-C[CAM]LPVER.2y5_1.heavy 459.253 / 613.367 37250.0 23.187950134277344 46 20 10 6 10 4.677885593951556 21.377179495218666 0.030498504638671875 3 0.9913632794429919 13.270120491688967 37250.0 46.16482989707029 0.0 - - - - - - - 1292.4285714285713 74 7 LRP3 low density lipoprotein receptor-related protein 3 1313 168 C20140606_SFK034_02 C20140606_SFK034_02 TB555809.[MT7]-C[CAM]LPVER.2b4_1.heavy 459.253 / 614.345 19216.0 23.187950134277344 46 20 10 6 10 4.677885593951556 21.377179495218666 0.030498504638671875 3 0.9913632794429919 13.270120491688967 19216.0 18.266901217861975 0.0 - - - - - - - 1188.4 38 10 LRP3 low density lipoprotein receptor-related protein 3 1315 168 C20140606_SFK034_02 C20140606_SFK034_02 TB555809.[MT7]-C[CAM]LPVER.2b5_1.heavy 459.253 / 743.388 8041.0 23.187950134277344 46 20 10 6 10 4.677885593951556 21.377179495218666 0.030498504638671875 3 0.9913632794429919 13.270120491688967 8041.0 12.939945944590068 0.0 - - - - - - - 721.5 16 10 LRP3 low density lipoprotein receptor-related protein 3 1317 169 C20140606_SFK034_02 C20140606_SFK034_02 TB556801.[MT7]-QLQNAGGK[MT7].2y5_1.heavy 552.324 / 590.338 9196.0 16.792400360107422 48 18 10 10 10 3.8861997435488513 25.732079306011347 0.0 3 0.9846266665060868 9.940778368848942 9196.0 43.30795804833562 0.0 - - - - - - - 613.0 18 10 NIN ninein (GSK3B interacting protein) 1319 169 C20140606_SFK034_02 C20140606_SFK034_02 TB556801.[MT7]-QLQNAGGK[MT7].2b4_1.heavy 552.324 / 628.354 5313.0 16.792400360107422 48 18 10 10 10 3.8861997435488513 25.732079306011347 0.0 3 0.9846266665060868 9.940778368848942 5313.0 34.89911764705882 1.0 - - - - - - - 200.30769230769232 14 13 NIN ninein (GSK3B interacting protein) 1321 169 C20140606_SFK034_02 C20140606_SFK034_02 TB556801.[MT7]-QLQNAGGK[MT7].2y6_1.heavy 552.324 / 718.396 6897.0 16.792400360107422 48 18 10 10 10 3.8861997435488513 25.732079306011347 0.0 3 0.9846266665060868 9.940778368848942 6897.0 43.275294117647064 0.0 - - - - - - - 183.1818181818182 13 22 NIN ninein (GSK3B interacting protein) 1323 169 C20140606_SFK034_02 C20140606_SFK034_02 TB556801.[MT7]-QLQNAGGK[MT7].2y7_1.heavy 552.324 / 831.481 15071.0 16.792400360107422 48 18 10 10 10 3.8861997435488513 25.732079306011347 0.0 3 0.9846266665060868 9.940778368848942 15071.0 38.2176701218281 0.0 - - - - - - - 213.1764705882353 30 17 NIN ninein (GSK3B interacting protein) 1325 170 C20140606_SFK034_02 C20140606_SFK034_02 TB559166.[MT7]-WTTTQYTEAK[MT7].3b5_1.heavy 506.268 / 762.39 25462.0 27.434799194335938 50 20 10 10 10 7.3911225911722225 13.52974446932291 0.0 3 0.9924764659466188 14.219317844573338 25462.0 66.68045372699942 0.0 - - - - - - - 304.27272727272725 50 11 DMGDH dimethylglycine dehydrogenase 1327 170 C20140606_SFK034_02 C20140606_SFK034_02 TB559166.[MT7]-WTTTQYTEAK[MT7].3b3_1.heavy 506.268 / 533.284 18590.0 27.434799194335938 50 20 10 10 10 7.3911225911722225 13.52974446932291 0.0 3 0.9924764659466188 14.219317844573338 18590.0 9.397274858767492 0.0 - - - - - - - 793.0 37 3 DMGDH dimethylglycine dehydrogenase 1329 170 C20140606_SFK034_02 C20140606_SFK034_02 TB559166.[MT7]-WTTTQYTEAK[MT7].3y4_1.heavy 506.268 / 592.342 57267.0 27.434799194335938 50 20 10 10 10 7.3911225911722225 13.52974446932291 0.0 3 0.9924764659466188 14.219317844573338 57267.0 40.634105960264904 0.0 - - - - - - - 264.0 114 1 DMGDH dimethylglycine dehydrogenase 1331 170 C20140606_SFK034_02 C20140606_SFK034_02 TB559166.[MT7]-WTTTQYTEAK[MT7].3y5_1.heavy 506.268 / 755.406 14361.0 27.434799194335938 50 20 10 10 10 7.3911225911722225 13.52974446932291 0.0 3 0.9924764659466188 14.219317844573338 14361.0 28.43368355059094 0.0 - - - - - - - 724.5555555555555 28 9 DMGDH dimethylglycine dehydrogenase 1333 171 C20140606_SFK034_02 C20140606_SFK034_02 TB560040.[MT7]-HDLAESFPFWASK[MT7].3b4_1.heavy 608.317 / 581.316 6386.0 40.70349884033203 37 16 10 3 8 3.6031451842998696 27.75353056427869 0.07540130615234375 4 0.9614943806349378 6.268978852192635 6386.0 5.422095630060898 0.0 - - - - - - - 1219.8 12 10 FAM75D4;FAM75D3;FAM75D1 family with sequence similarity 75, member D4;family with sequence similarity 75, member D3;family with sequence similarity 75, member D1 1335 171 C20140606_SFK034_02 C20140606_SFK034_02 TB560040.[MT7]-HDLAESFPFWASK[MT7].3b5_1.heavy 608.317 / 710.359 6745.0 40.70349884033203 37 16 10 3 8 3.6031451842998696 27.75353056427869 0.07540130615234375 4 0.9614943806349378 6.268978852192635 6745.0 13.01412695468617 0.0 - - - - - - - 1148.090909090909 13 11 FAM75D4;FAM75D3;FAM75D1 family with sequence similarity 75, member D4;family with sequence similarity 75, member D3;family with sequence similarity 75, member D1 1337 171 C20140606_SFK034_02 C20140606_SFK034_02 TB560040.[MT7]-HDLAESFPFWASK[MT7].3b3_1.heavy 608.317 / 510.279 6745.0 40.70349884033203 37 16 10 3 8 3.6031451842998696 27.75353056427869 0.07540130615234375 4 0.9614943806349378 6.268978852192635 6745.0 4.414200903325745 2.0 - - - - - - - 1230.142857142857 17 7 FAM75D4;FAM75D3;FAM75D1 family with sequence similarity 75, member D4;family with sequence similarity 75, member D3;family with sequence similarity 75, member D1 1339 171 C20140606_SFK034_02 C20140606_SFK034_02 TB560040.[MT7]-HDLAESFPFWASK[MT7].3y4_1.heavy 608.317 / 635.363 17579.0 40.70349884033203 37 16 10 3 8 3.6031451842998696 27.75353056427869 0.07540130615234375 4 0.9614943806349378 6.268978852192635 17579.0 26.796788688790294 0.0 - - - - - - - 1178.857142857143 35 7 FAM75D4;FAM75D3;FAM75D1 family with sequence similarity 75, member D4;family with sequence similarity 75, member D3;family with sequence similarity 75, member D1 1341 172 C20140606_SFK034_02 C20140606_SFK034_02 TB556805.[MT7]-VDLVLEK[MT7].2y4_1.heavy 552.349 / 632.41 157969.0 33.52880096435547 50 20 10 10 10 17.843194815090097 5.604377525230482 0.0 3 0.9993838691448301 49.7168482928816 157969.0 91.70029223402126 0.0 - - - - - - - 342.0 315 1 GM2A GM2 ganglioside activator 1343 172 C20140606_SFK034_02 C20140606_SFK034_02 TB556805.[MT7]-VDLVLEK[MT7].2b4_1.heavy 552.349 / 571.357 158995.0 33.52880096435547 50 20 10 10 10 17.843194815090097 5.604377525230482 0.0 3 0.9993838691448301 49.7168482928816 158995.0 148.27771163976854 0.0 - - - - - - - 912.0 317 1 GM2A GM2 ganglioside activator 1345 172 C20140606_SFK034_02 C20140606_SFK034_02 TB556805.[MT7]-VDLVLEK[MT7].2y3_1.heavy 552.349 / 533.341 289020.0 33.52880096435547 50 20 10 10 10 17.843194815090097 5.604377525230482 0.0 3 0.9993838691448301 49.7168482928816 289020.0 177.56031959341362 0.0 - - - - - - - 1255.0 578 1 GM2A GM2 ganglioside activator 1347 172 C20140606_SFK034_02 C20140606_SFK034_02 TB556805.[MT7]-VDLVLEK[MT7].2y6_1.heavy 552.349 / 860.521 164926.0 33.52880096435547 50 20 10 10 10 17.843194815090097 5.604377525230482 0.0 3 0.9993838691448301 49.7168482928816 164926.0 162.2315531222899 0.0 - - - - - - - 798.0 329 5 GM2A GM2 ganglioside activator 1349 173 C20140606_SFK034_02 C20140606_SFK034_02 TB560469.[MT7]-EQLQDMGLVDLFSPEK[MT7].3y3_1.heavy 713.041 / 517.31 45454.0 46.58440017700195 45 15 10 10 10 3.8964800693395647 22.454909238915256 0.0 3 0.9506027280695353 5.529765648879974 45454.0 47.36383705247316 0.0 - - - - - - - 384.0 90 1 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1351 173 C20140606_SFK034_02 C20140606_SFK034_02 TB560469.[MT7]-EQLQDMGLVDLFSPEK[MT7].3b5_1.heavy 713.041 / 758.38 18284.0 46.58440017700195 45 15 10 10 10 3.8964800693395647 22.454909238915256 0.0 3 0.9506027280695353 5.529765648879974 18284.0 31.959153633854644 0.0 - - - - - - - 663.0 36 8 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1353 173 C20140606_SFK034_02 C20140606_SFK034_02 TB560469.[MT7]-EQLQDMGLVDLFSPEK[MT7].3y4_1.heavy 713.041 / 604.342 33307.0 46.58440017700195 45 15 10 10 10 3.8964800693395647 22.454909238915256 0.0 3 0.9506027280695353 5.529765648879974 33307.0 56.715833555418726 0.0 - - - - - - - 341.3333333333333 66 3 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1355 173 C20140606_SFK034_02 C20140606_SFK034_02 TB560469.[MT7]-EQLQDMGLVDLFSPEK[MT7].3b7_1.heavy 713.041 / 946.442 36312.0 46.58440017700195 45 15 10 10 10 3.8964800693395647 22.454909238915256 0.0 3 0.9506027280695353 5.529765648879974 36312.0 69.0377434237311 0.0 - - - - - - - 281.6 72 5 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1357 174 C20140606_SFK034_02 C20140606_SFK034_02 TB556809.[MT7]-TFEVTPIR.2b3_1.heavy 553.82 / 522.268 37540.0 31.624799728393555 50 20 10 10 10 3.7475574187657466 21.175792015535272 0.0 3 0.9916903681038169 13.529142842107996 37540.0 16.200741329097166 0.0 - - - - - - - 1259.0 75 3 LBR lamin B receptor 1359 174 C20140606_SFK034_02 C20140606_SFK034_02 TB556809.[MT7]-TFEVTPIR.2y5_1.heavy 553.82 / 585.372 41660.0 31.624799728393555 50 20 10 10 10 3.7475574187657466 21.175792015535272 0.0 3 0.9916903681038169 13.529142842107996 41660.0 28.088972202779253 0.0 - - - - - - - 687.0 83 1 LBR lamin B receptor 1361 174 C20140606_SFK034_02 C20140606_SFK034_02 TB556809.[MT7]-TFEVTPIR.2y6_1.heavy 553.82 / 714.414 27125.0 31.624799728393555 50 20 10 10 10 3.7475574187657466 21.175792015535272 0.0 3 0.9916903681038169 13.529142842107996 27125.0 17.291215391696117 0.0 - - - - - - - 1308.2857142857142 54 7 LBR lamin B receptor 1363 174 C20140606_SFK034_02 C20140606_SFK034_02 TB556809.[MT7]-TFEVTPIR.2y7_1.heavy 553.82 / 861.483 63177.0 31.624799728393555 50 20 10 10 10 3.7475574187657466 21.175792015535272 0.0 3 0.9916903681038169 13.529142842107996 63177.0 173.80572052401746 0.0 - - - - - - - 654.1428571428571 126 7 LBR lamin B receptor 1365 175 C20140606_SFK034_02 C20140606_SFK034_02 TB556676.[MT7]-LQELNQR.2y4_1.heavy 522.8 / 530.305 116176.0 24.026249885559082 46 20 10 6 10 12.303951115717044 8.127470522234129 0.03569984436035156 3 0.9980236483384269 27.756116755996647 116176.0 124.98654607626736 0.0 - - - - - - - 1185.0 232 7 NIN ninein (GSK3B interacting protein) 1367 175 C20140606_SFK034_02 C20140606_SFK034_02 TB556676.[MT7]-LQELNQR.2b3_1.heavy 522.8 / 515.295 115711.0 24.026249885559082 46 20 10 6 10 12.303951115717044 8.127470522234129 0.03569984436035156 3 0.9980236483384269 27.756116755996647 115711.0 63.522723358449944 0.0 - - - - - - - 1782.0 231 7 NIN ninein (GSK3B interacting protein) 1369 175 C20140606_SFK034_02 C20140606_SFK034_02 TB556676.[MT7]-LQELNQR.2y5_1.heavy 522.8 / 659.347 109939.0 24.026249885559082 46 20 10 6 10 12.303951115717044 8.127470522234129 0.03569984436035156 3 0.9980236483384269 27.756116755996647 109939.0 86.35632572298326 1.0 - - - - - - - 1336.5714285714287 219 7 NIN ninein (GSK3B interacting protein) 1371 175 C20140606_SFK034_02 C20140606_SFK034_02 TB556676.[MT7]-LQELNQR.2y6_1.heavy 522.8 / 787.406 304671.0 24.026249885559082 46 20 10 6 10 12.303951115717044 8.127470522234129 0.03569984436035156 3 0.9980236483384269 27.756116755996647 304671.0 357.27022259898115 0.0 - - - - - - - 796.125 609 8 NIN ninein (GSK3B interacting protein) 1373 176 C20140606_SFK034_02 C20140606_SFK034_02 TB556411.[MT7]-DTTQQK[MT7].2y4_1.heavy 504.782 / 648.38 216.0 14.076349973678589 33 11 10 2 10 3.4768453181548966 28.761705180795424 0.0840005874633789 3 0.8604072577489347 3.263956902474321 216.0 1.05 6.0 - - - - - - - 0.0 0 0 FMN1 formin 1 1375 176 C20140606_SFK034_02 C20140606_SFK034_02 TB556411.[MT7]-DTTQQK[MT7].2b5_1.heavy 504.782 / 718.349 1154.0 14.076349973678589 33 11 10 2 10 3.4768453181548966 28.761705180795424 0.0840005874633789 3 0.8604072577489347 3.263956902474321 1154.0 12.904025717111772 0.0 - - - - - - - 168.33333333333334 2 15 FMN1 formin 1 1377 176 C20140606_SFK034_02 C20140606_SFK034_02 TB556411.[MT7]-DTTQQK[MT7].2y5_1.heavy 504.782 / 749.427 1395.0 14.076349973678589 33 11 10 2 10 3.4768453181548966 28.761705180795424 0.0840005874633789 3 0.8604072577489347 3.263956902474321 1395.0 7.880844155844156 1.0 - - - - - - - 165.57894736842104 2 19 FMN1 formin 1 1379 176 C20140606_SFK034_02 C20140606_SFK034_02 TB556411.[MT7]-DTTQQK[MT7].2b4_1.heavy 504.782 / 590.29 914.0 14.076349973678589 33 11 10 2 10 3.4768453181548966 28.761705180795424 0.0840005874633789 3 0.8604072577489347 3.263956902474321 914.0 4.554492382271468 1.0 - - - - - - - 0.0 1 0 FMN1 formin 1 1381 177 C20140606_SFK034_02 C20140606_SFK034_02 TB559440.[MT7]-LPVTVGFSGC[CAM]VK[MT7].3b6_1.heavy 517.965 / 711.452 21422.0 36.86909866333008 50 20 10 10 10 5.014022070433698 15.992537231987104 0.0 3 0.9911825318278239 13.13320693939421 21422.0 49.54425999189574 0.0 - - - - - - - 682.4 42 10 LAMA5 laminin, alpha 5 1383 177 C20140606_SFK034_02 C20140606_SFK034_02 TB559440.[MT7]-LPVTVGFSGC[CAM]VK[MT7].3b4_1.heavy 517.965 / 555.362 18199.0 36.86909866333008 50 20 10 10 10 5.014022070433698 15.992537231987104 0.0 3 0.9911825318278239 13.13320693939421 18199.0 17.11422787356013 0.0 - - - - - - - 746.25 36 8 LAMA5 laminin, alpha 5 1385 177 C20140606_SFK034_02 C20140606_SFK034_02 TB559440.[MT7]-LPVTVGFSGC[CAM]VK[MT7].3y4_1.heavy 517.965 / 607.335 28436.0 36.86909866333008 50 20 10 10 10 5.014022070433698 15.992537231987104 0.0 3 0.9911825318278239 13.13320693939421 28436.0 31.573827881730455 0.0 - - - - - - - 777.2 56 10 LAMA5 laminin, alpha 5 1387 177 C20140606_SFK034_02 C20140606_SFK034_02 TB559440.[MT7]-LPVTVGFSGC[CAM]VK[MT7].3y5_1.heavy 517.965 / 694.367 22180.0 36.86909866333008 50 20 10 10 10 5.014022070433698 15.992537231987104 0.0 3 0.9911825318278239 13.13320693939421 22180.0 58.45092945235736 0.0 - - - - - - - 704.0 44 7 LAMA5 laminin, alpha 5 1389 178 C20140606_SFK034_02 C20140606_SFK034_02 TB559839.[MT7]-IQEMFPLLNMNK[MT7].3b4_1.heavy 589.324 / 646.335 13576.0 47.48682498931885 37 14 10 3 10 2.4599244414215025 36.25617294845206 0.07539749145507812 3 0.9305627091050176 4.656079087033807 13576.0 51.16296639414833 0.0 - - - - - - - 776.6 27 10 DMGDH dimethylglycine dehydrogenase 1391 178 C20140606_SFK034_02 C20140606_SFK034_02 TB559839.[MT7]-IQEMFPLLNMNK[MT7].3b5_1.heavy 589.324 / 793.404 14051.0 47.48682498931885 37 14 10 3 10 2.4599244414215025 36.25617294845206 0.07539749145507812 3 0.9305627091050176 4.656079087033807 14051.0 35.531649574747114 0.0 - - - - - - - 279.05882352941177 28 17 DMGDH dimethylglycine dehydrogenase 1393 178 C20140606_SFK034_02 C20140606_SFK034_02 TB559839.[MT7]-IQEMFPLLNMNK[MT7].3y4_1.heavy 589.324 / 650.341 12153.0 47.48682498931885 37 14 10 3 10 2.4599244414215025 36.25617294845206 0.07539749145507812 3 0.9305627091050176 4.656079087033807 12153.0 45.80020113347706 0.0 - - - - - - - 250.63636363636363 24 22 DMGDH dimethylglycine dehydrogenase 1395 178 C20140606_SFK034_02 C20140606_SFK034_02 TB559839.[MT7]-IQEMFPLLNMNK[MT7].3b3_1.heavy 589.324 / 515.295 7233.0 47.48682498931885 37 14 10 3 10 2.4599244414215025 36.25617294845206 0.07539749145507812 3 0.9305627091050176 4.656079087033807 7233.0 -0.9137006274295424 2.0 - - - - - - - 1151.857142857143 16 7 DMGDH dimethylglycine dehydrogenase 1397 179 C20140606_SFK034_02 C20140606_SFK034_02 TB559170.[MT7]-AVPLYELAVEIR.3y6_1.heavy 506.3 / 700.435 28226.0 46.545101165771484 48 18 10 10 10 3.943439567380675 25.35857296436835 0.0 3 0.9841518071428226 9.79032833794099 28226.0 112.0219375 0.0 - - - - - - - 307.2 56 10 NPHP3 nephronophthisis 3 (adolescent) 1399 179 C20140606_SFK034_02 C20140606_SFK034_02 TB559170.[MT7]-AVPLYELAVEIR.3b4_1.heavy 506.3 / 525.352 66116.0 46.545101165771484 48 18 10 10 10 3.943439567380675 25.35857296436835 0.0 3 0.9841518071428226 9.79032833794099 66116.0 349.7654464285714 0.0 - - - - - - - 234.66666666666666 132 9 NPHP3 nephronophthisis 3 (adolescent) 1401 179 C20140606_SFK034_02 C20140606_SFK034_02 TB559170.[MT7]-AVPLYELAVEIR.3y4_1.heavy 506.3 / 516.314 55619.0 46.545101165771484 48 18 10 10 10 3.943439567380675 25.35857296436835 0.0 3 0.9841518071428226 9.79032833794099 55619.0 130.40640891335227 0.0 - - - - - - - 358.4 111 5 NPHP3 nephronophthisis 3 (adolescent) 1403 179 C20140606_SFK034_02 C20140606_SFK034_02 TB559170.[MT7]-AVPLYELAVEIR.3y5_1.heavy 506.3 / 587.351 76165.0 46.545101165771484 48 18 10 10 10 3.943439567380675 25.35857296436835 0.0 3 0.9841518071428226 9.79032833794099 76165.0 221.86456473214287 0.0 - - - - - - - 320.0 152 7 NPHP3 nephronophthisis 3 (adolescent) 1405 180 C20140606_SFK034_02 C20140606_SFK034_02 TB559549.[MT7]-WELLQQVDTSTR.3y6_1.heavy 540.622 / 678.342 79639.0 39.4370002746582 48 18 10 10 10 5.999248307865191 16.66875496200033 0.0 3 0.985552600393635 10.25517953437033 79639.0 137.41443686368777 0.0 - - - - - - - 346.25 159 4 KRT1 keratin 1 1407 180 C20140606_SFK034_02 C20140606_SFK034_02 TB559549.[MT7]-WELLQQVDTSTR.3b4_1.heavy 540.622 / 686.399 80860.0 39.4370002746582 48 18 10 10 10 5.999248307865191 16.66875496200033 0.0 3 0.985552600393635 10.25517953437033 80860.0 129.46871416871414 0.0 - - - - - - - 787.2222222222222 161 9 KRT1 keratin 1 1409 180 C20140606_SFK034_02 C20140606_SFK034_02 TB559549.[MT7]-WELLQQVDTSTR.3b3_1.heavy 540.622 / 573.315 221979.0 39.4370002746582 48 18 10 10 10 5.999248307865191 16.66875496200033 0.0 3 0.985552600393635 10.25517953437033 221979.0 170.80349163978883 0.0 - - - - - - - 1221.25 443 4 KRT1 keratin 1 1411 180 C20140606_SFK034_02 C20140606_SFK034_02 TB559549.[MT7]-WELLQQVDTSTR.3y5_1.heavy 540.622 / 579.273 198853.0 39.4370002746582 48 18 10 10 10 5.999248307865191 16.66875496200033 0.0 3 0.985552600393635 10.25517953437033 198853.0 170.25300676059638 0.0 - - - - - - - 461.6666666666667 397 3 KRT1 keratin 1 1413 181 C20140606_SFK034_02 C20140606_SFK034_02 TB555942.[MT7]-DTPDNAR.2y5_1.heavy 466.731 / 572.279 1061.0 13.830549716949463 26 17 0 5 4 2.598731948629349 30.77698779660825 0.04500007629394531 10 0.9702557646816704 7.1380332572158025 1061.0 23.872500000000002 5.0 - - - - - - - 639.25 5 8 NPHP3 nephronophthisis 3 (adolescent) 1415 181 C20140606_SFK034_02 C20140606_SFK034_02 TB555942.[MT7]-DTPDNAR.2b4_1.heavy 466.731 / 573.264 868.0 13.830549716949463 26 17 0 5 4 2.598731948629349 30.77698779660825 0.04500007629394531 10 0.9702557646816704 7.1380332572158025 868.0 3.5907526057942376 6.0 - - - - - - - 687.625 103 8 NPHP3 nephronophthisis 3 (adolescent) 1417 181 C20140606_SFK034_02 C20140606_SFK034_02 TB555942.[MT7]-DTPDNAR.2y6_1.heavy 466.731 / 673.326 900.0 13.830549716949463 26 17 0 5 4 2.598731948629349 30.77698779660825 0.04500007629394531 10 0.9702557646816704 7.1380332572158025 900.0 9.025423728813559 0.0 - - - - - - - 0.0 1 0 NPHP3 nephronophthisis 3 (adolescent) 1419 181 C20140606_SFK034_02 C20140606_SFK034_02 TB555942.[MT7]-DTPDNAR.2b5_1.heavy 466.731 / 687.307 482.0 13.830549716949463 26 17 0 5 4 2.598731948629349 30.77698779660825 0.04500007629394531 10 0.9702557646816704 7.1380332572158025 482.0 1.0272022084195995 7.0 - - - - - - - 244.72222222222223 2 18 NPHP3 nephronophthisis 3 (adolescent) 1421 182 C20140606_SFK034_02 C20140606_SFK034_02 TB557580.[MT7]-EQFLQLQR.2b3_1.heavy 603.342 / 549.279 27498.0 32.67890167236328 44 14 10 10 10 1.9759734112755414 43.16622036311077 0.0 3 0.9490728655452774 5.445367325591065 27498.0 13.58202124243688 0.0 - - - - - - - 870.0 54 2 NIN ninein (GSK3B interacting protein) 1423 182 C20140606_SFK034_02 C20140606_SFK034_02 TB557580.[MT7]-EQFLQLQR.2y5_1.heavy 603.342 / 657.404 27382.0 32.67890167236328 44 14 10 10 10 1.9759734112755414 43.16622036311077 0.0 3 0.9490728655452774 5.445367325591065 27382.0 26.639711410647372 0.0 - - - - - - - 1232.5 54 8 NIN ninein (GSK3B interacting protein) 1425 182 C20140606_SFK034_02 C20140606_SFK034_02 TB557580.[MT7]-EQFLQLQR.2y6_1.heavy 603.342 / 804.473 32139.0 32.67890167236328 44 14 10 10 10 1.9759734112755414 43.16622036311077 0.0 3 0.9490728655452774 5.445367325591065 32139.0 14.58939239499747 1.0 - - - - - - - 739.5 68 8 NIN ninein (GSK3B interacting protein) 1427 182 C20140606_SFK034_02 C20140606_SFK034_02 TB557580.[MT7]-EQFLQLQR.2y7_1.heavy 603.342 / 932.531 78434.0 32.67890167236328 44 14 10 10 10 1.9759734112755414 43.16622036311077 0.0 3 0.9490728655452774 5.445367325591065 78434.0 70.6368953091022 0.0 - - - - - - - 754.0 156 2 NIN ninein (GSK3B interacting protein) 1429 183 C20140606_SFK034_02 C20140606_SFK034_02 TB559074.[MT7]-FRIEDGFSLK[MT7].3b6_1.heavy 500.62 / 862.454 34392.0 36.135101318359375 38 8 10 10 10 1.284139398486249 70.34474288861634 0.0 3 0.7870323631631649 2.6252947979242025 34392.0 66.78109513646193 0.0 - - - - - - - 264.72727272727275 68 11 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1431 183 C20140606_SFK034_02 C20140606_SFK034_02 TB559074.[MT7]-FRIEDGFSLK[MT7].3b5_1.heavy 500.62 / 805.432 26288.0 36.135101318359375 38 8 10 10 10 1.284139398486249 70.34474288861634 0.0 3 0.7870323631631649 2.6252947979242025 26288.0 120.0653846153846 0.0 - - - - - - - 254.22222222222223 52 9 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1433 183 C20140606_SFK034_02 C20140606_SFK034_02 TB559074.[MT7]-FRIEDGFSLK[MT7].3b5_2.heavy 500.62 / 403.22 177779.0 36.135101318359375 38 8 10 10 10 1.284139398486249 70.34474288861634 0.0 3 0.7870323631631649 2.6252947979242025 177779.0 9.982657942251931 0.0 - - - - - - - 1351.0 355 1 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1435 183 C20140606_SFK034_02 C20140606_SFK034_02 TB559074.[MT7]-FRIEDGFSLK[MT7].3y5_1.heavy 500.62 / 695.421 48938.0 36.135101318359375 38 8 10 10 10 1.284139398486249 70.34474288861634 0.0 3 0.7870323631631649 2.6252947979242025 48938.0 42.351921576359985 0.0 - - - - - - - 353.6 97 5 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1437 184 C20140606_SFK034_02 C20140606_SFK034_02 TB559076.[MT7]-ALQLEELTLGK[MT7].3b6_1.heavy 501.639 / 828.458 95947.0 39.996700286865234 40 14 10 6 10 1.8929211559706627 37.27601530930939 0.0388031005859375 3 0.941188838135273 5.063848626648096 95947.0 167.84834891623197 0.0 - - - - - - - 228.42857142857142 191 7 NPHP3 nephronophthisis 3 (adolescent) 1439 184 C20140606_SFK034_02 C20140606_SFK034_02 TB559076.[MT7]-ALQLEELTLGK[MT7].3b4_1.heavy 501.639 / 570.373 113842.0 39.996700286865234 40 14 10 6 10 1.8929211559706627 37.27601530930939 0.0388031005859375 3 0.941188838135273 5.063848626648096 113842.0 140.92112250072444 0.0 - - - - - - - 279.1666666666667 227 6 NPHP3 nephronophthisis 3 (adolescent) 1441 184 C20140606_SFK034_02 C20140606_SFK034_02 TB559076.[MT7]-ALQLEELTLGK[MT7].3b5_1.heavy 501.639 / 699.416 97851.0 39.996700286865234 40 14 10 6 10 1.8929211559706627 37.27601530930939 0.0388031005859375 3 0.941188838135273 5.063848626648096 97851.0 132.76596254944246 0.0 - - - - - - - 282.7142857142857 195 7 NPHP3 nephronophthisis 3 (adolescent) 1443 184 C20140606_SFK034_02 C20140606_SFK034_02 TB559076.[MT7]-ALQLEELTLGK[MT7].3y4_1.heavy 501.639 / 562.368 170572.0 39.996700286865234 40 14 10 6 10 1.8929211559706627 37.27601530930939 0.0388031005859375 3 0.941188838135273 5.063848626648096 170572.0 155.91288350900305 0.0 - - - - - - - 342.75 341 4 NPHP3 nephronophthisis 3 (adolescent) 1445 185 C20140606_SFK034_02 C20140606_SFK034_02 TB559078.[MT7]-AQEESTGLLSGLR.2b4_1.heavy 752.908 / 602.29 56667.0 34.91640090942383 47 17 10 10 10 2.5553197224653457 31.24489165788132 0.0 3 0.9732712922280027 7.531843174096504 56667.0 50.41896736750801 0.0 - - - - - - - 287.0 113 3 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1447 185 C20140606_SFK034_02 C20140606_SFK034_02 TB559078.[MT7]-AQEESTGLLSGLR.2y9_1.heavy 752.908 / 903.526 65286.0 34.91640090942383 47 17 10 10 10 2.5553197224653457 31.24489165788132 0.0 3 0.9732712922280027 7.531843174096504 65286.0 72.32833800932548 0.0 - - - - - - - 341.0 130 6 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1449 185 C20140606_SFK034_02 C20140606_SFK034_02 TB559078.[MT7]-AQEESTGLLSGLR.2y10_1.heavy 752.908 / 1032.57 98360.0 34.91640090942383 47 17 10 10 10 2.5553197224653457 31.24489165788132 0.0 3 0.9732712922280027 7.531843174096504 98360.0 225.57874253765465 0.0 - - - - - - - 1185.0 196 7 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1451 185 C20140606_SFK034_02 C20140606_SFK034_02 TB559078.[MT7]-AQEESTGLLSGLR.2y11_1.heavy 752.908 / 1161.61 59468.0 34.91640090942383 47 17 10 10 10 2.5553197224653457 31.24489165788132 0.0 3 0.9732712922280027 7.531843174096504 59468.0 115.55500353101328 0.0 - - - - - - - 723.4285714285714 118 7 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1453 186 C20140606_SFK034_02 C20140606_SFK034_02 TB559176.[MT7]-FC[CAM]NTVHDIVNR.3y6_1.heavy 506.925 / 753.4 125104.0 29.60099983215332 50 20 10 10 10 7.028861102694043 14.227055925414675 0.0 3 0.995515315846656 18.4218821214766 125104.0 127.62653850176636 0.0 - - - - - - - 700.6666666666666 250 6 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1455 186 C20140606_SFK034_02 C20140606_SFK034_02 TB559176.[MT7]-FC[CAM]NTVHDIVNR.3b4_1.heavy 506.925 / 667.299 105888.0 29.60099983215332 50 20 10 10 10 7.028861102694043 14.227055925414675 0.0 3 0.995515315846656 18.4218821214766 105888.0 207.31506112404819 0.0 - - - - - - - 400.0 211 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1457 186 C20140606_SFK034_02 C20140606_SFK034_02 TB559176.[MT7]-FC[CAM]NTVHDIVNR.3y4_1.heavy 506.925 / 501.314 178849.0 29.60099983215332 50 20 10 10 10 7.028861102694043 14.227055925414675 0.0 3 0.995515315846656 18.4218821214766 178849.0 38.8419065258531 0.0 - - - - - - - 3303.0 357 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1459 186 C20140606_SFK034_02 C20140606_SFK034_02 TB559176.[MT7]-FC[CAM]NTVHDIVNR.3y5_1.heavy 506.925 / 616.341 246105.0 29.60099983215332 50 20 10 10 10 7.028861102694043 14.227055925414675 0.0 3 0.995515315846656 18.4218821214766 246105.0 119.00235813321413 0.0 - - - - - - - 300.0 492 1 CPSF3 cleavage and polyadenylation specific factor 3, 73kDa 1461 187 C20140606_SFK034_02 C20140606_SFK034_02 TB559318.[MT7]-EVPLNTIIFMGR.3y6_1.heavy 511.957 / 736.417 9604.0 44.860575675964355 46 20 10 6 10 5.414566724218102 18.468698437628106 0.034297943115234375 3 0.9958841608590022 19.230213395573294 9604.0 41.32209785021284 0.0 - - - - - - - 195.08333333333334 19 12 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1463 187 C20140606_SFK034_02 C20140606_SFK034_02 TB559318.[MT7]-EVPLNTIIFMGR.3b4_1.heavy 511.957 / 583.357 24873.0 44.860575675964355 46 20 10 6 10 5.414566724218102 18.468698437628106 0.034297943115234375 3 0.9958841608590022 19.230213395573294 24873.0 75.52620965436546 0.0 - - - - - - - 288.6875 49 16 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1465 187 C20140606_SFK034_02 C20140606_SFK034_02 TB559318.[MT7]-EVPLNTIIFMGR.3b5_1.heavy 511.957 / 697.4 12560.0 44.860575675964355 46 20 10 6 10 5.414566724218102 18.468698437628106 0.034297943115234375 3 0.9958841608590022 19.230213395573294 12560.0 136.36173582515045 0.0 - - - - - - - 168.4 25 15 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1467 187 C20140606_SFK034_02 C20140606_SFK034_02 TB559318.[MT7]-EVPLNTIIFMGR.3y5_1.heavy 511.957 / 623.333 74310.0 44.860575675964355 46 20 10 6 10 5.414566724218102 18.468698437628106 0.034297943115234375 3 0.9958841608590022 19.230213395573294 74310.0 195.35925209341033 0.0 - - - - - - - 241.6153846153846 148 13 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1469 188 C20140606_SFK034_02 C20140606_SFK034_02 TB560554.[MT7]-FLDGDELTLADC[CAM]NLLPK[MT7].3y3_1.heavy 741.392 / 501.352 76673.0 44.4109001159668 42 12 10 10 10 0.8525046667755539 77.39831460671147 0.0 3 0.8857042339100524 3.615108052968283 76673.0 53.84259477989342 0.0 - - - - - - - 1220.0 153 1 CLIC5;CLIC6 chloride intracellular channel 5;chloride intracellular channel 6 1471 188 C20140606_SFK034_02 C20140606_SFK034_02 TB560554.[MT7]-FLDGDELTLADC[CAM]NLLPK[MT7].3b6_1.heavy 741.392 / 821.38 83870.0 44.4109001159668 42 12 10 10 10 0.8525046667755539 77.39831460671147 0.0 3 0.8857042339100524 3.615108052968283 83870.0 50.066230804975305 0.0 - - - - - - - 366.0 167 1 CLIC5;CLIC6 chloride intracellular channel 5;chloride intracellular channel 6 1473 188 C20140606_SFK034_02 C20140606_SFK034_02 TB560554.[MT7]-FLDGDELTLADC[CAM]NLLPK[MT7].3b5_1.heavy 741.392 / 692.337 50871.0 44.4109001159668 42 12 10 10 10 0.8525046667755539 77.39831460671147 0.0 3 0.8857042339100524 3.615108052968283 50871.0 40.721859605911334 0.0 - - - - - - - 1784.25 101 8 CLIC5;CLIC6 chloride intracellular channel 5;chloride intracellular channel 6 1475 188 C20140606_SFK034_02 C20140606_SFK034_02 TB560554.[MT7]-FLDGDELTLADC[CAM]NLLPK[MT7].3b7_1.heavy 741.392 / 934.464 49224.0 44.4109001159668 42 12 10 10 10 0.8525046667755539 77.39831460671147 0.0 3 0.8857042339100524 3.615108052968283 49224.0 47.38029567223846 0.0 - - - - - - - 427.0 98 1 CLIC5;CLIC6 chloride intracellular channel 5;chloride intracellular channel 6 1477 189 C20140606_SFK034_02 C20140606_SFK034_02 TB556192.[MT7]-AAELYK[MT7].2y4_1.heavy 491.794 / 696.405 11638.0 23.381099700927734 46 20 8 10 8 5.334913402802053 18.744446713507486 0.0 4 0.9911723176124058 13.12559553490541 11638.0 9.85395197734592 0.0 - - - - - - - 743.8666666666667 23 15 NPHP3 nephronophthisis 3 (adolescent) 1479 189 C20140606_SFK034_02 C20140606_SFK034_02 TB556192.[MT7]-AAELYK[MT7].2y5_1.heavy 491.794 / 767.442 25568.0 23.381099700927734 46 20 8 10 8 5.334913402802053 18.744446713507486 0.0 4 0.9911723176124058 13.12559553490541 25568.0 30.488118901400355 1.0 - - - - - - - 723.7777777777778 82 9 NPHP3 nephronophthisis 3 (adolescent) 1481 189 C20140606_SFK034_02 C20140606_SFK034_02 TB556192.[MT7]-AAELYK[MT7].2b4_1.heavy 491.794 / 529.31 24905.0 23.381099700927734 46 20 8 10 8 5.334913402802053 18.744446713507486 0.0 4 0.9911723176124058 13.12559553490541 24905.0 11.14411926073118 0.0 - - - - - - - 1731.4285714285713 49 7 NPHP3 nephronophthisis 3 (adolescent) 1483 189 C20140606_SFK034_02 C20140606_SFK034_02 TB556192.[MT7]-AAELYK[MT7].2y3_1.heavy 491.794 / 567.362 29910.0 23.381099700927734 46 20 8 10 8 5.334913402802053 18.744446713507486 0.0 4 0.9911723176124058 13.12559553490541 29910.0 14.089659250012852 0.0 - - - - - - - 1278.2 59 5 NPHP3 nephronophthisis 3 (adolescent) 1485 190 C20140606_SFK034_02 C20140606_SFK034_02 TB559181.[MT7]-AAQIFITELTLR.3y6_1.heavy 507.304 / 732.425 161643.0 47.054901123046875 50 20 10 10 10 4.615414175371881 21.666527899837426 0.0 3 0.990550948307108 12.686028734875737 161643.0 1335.9438719153034 0.0 - - - - - - - 218.16666666666666 323 6 NFYC nuclear transcription factor Y, gamma 1487 190 C20140606_SFK034_02 C20140606_SFK034_02 TB559181.[MT7]-AAQIFITELTLR.3b4_1.heavy 507.304 / 528.326 202100.0 47.054901123046875 50 20 10 10 10 4.615414175371881 21.666527899837426 0.0 3 0.990550948307108 12.686028734875737 202100.0 327.2588672332563 0.0 - - - - - - - 176.5 404 6 NFYC nuclear transcription factor Y, gamma 1489 190 C20140606_SFK034_02 C20140606_SFK034_02 TB559181.[MT7]-AAQIFITELTLR.3y4_1.heavy 507.304 / 502.335 107658.0 47.054901123046875 50 20 10 10 10 4.615414175371881 21.666527899837426 0.0 3 0.990550948307108 12.686028734875737 107658.0 240.53373412983336 0.0 - - - - - - - 249.22222222222223 215 9 NFYC nuclear transcription factor Y, gamma 1491 190 C20140606_SFK034_02 C20140606_SFK034_02 TB559181.[MT7]-AAQIFITELTLR.3y5_1.heavy 507.304 / 631.377 72375.0 47.054901123046875 50 20 10 10 10 4.615414175371881 21.666527899837426 0.0 3 0.990550948307108 12.686028734875737 72375.0 852.2926506024096 0.0 - - - - - - - 124.5 144 8 NFYC nuclear transcription factor Y, gamma 1493 191 C20140606_SFK034_02 C20140606_SFK034_02 TB456347.[MT7]-SDLPTSSDSK[MT7].3y3_1.heavy 442.233 / 493.274 41941.0 19.566150665283203 47 20 10 7 10 11.42301429881058 8.754256747311652 0.027099609375 3 0.9978869105974179 26.842745195404117 41941.0 28.84017589111292 0.0 - - - - - - - 1733.7142857142858 83 7 IRAK2 interleukin-1 receptor-associated kinase 2 1495 191 C20140606_SFK034_02 C20140606_SFK034_02 TB456347.[MT7]-SDLPTSSDSK[MT7].3y4_1.heavy 442.233 / 580.306 21622.0 19.566150665283203 47 20 10 7 10 11.42301429881058 8.754256747311652 0.027099609375 3 0.9978869105974179 26.842745195404117 21622.0 26.365295997079915 0.0 - - - - - - - 704.0 43 9 IRAK2 interleukin-1 receptor-associated kinase 2 1497 191 C20140606_SFK034_02 C20140606_SFK034_02 TB456347.[MT7]-SDLPTSSDSK[MT7].3b3_1.heavy 442.233 / 460.252 109729.0 19.566150665283203 47 20 10 7 10 11.42301429881058 8.754256747311652 0.027099609375 3 0.9978869105974179 26.842745195404117 109729.0 54.914786705193336 0.0 - - - - - - - 944.0 219 1 IRAK2 interleukin-1 receptor-associated kinase 2 1499 191 C20140606_SFK034_02 C20140606_SFK034_02 TB456347.[MT7]-SDLPTSSDSK[MT7].3y5_1.heavy 442.233 / 667.338 17172.0 19.566150665283203 47 20 10 7 10 11.42301429881058 8.754256747311652 0.027099609375 3 0.9978869105974179 26.842745195404117 17172.0 34.22664265707314 0.0 - - - - - - - 680.0 34 15 IRAK2 interleukin-1 receptor-associated kinase 2 1501 192 C20140606_SFK034_02 C20140606_SFK034_02 TB556786.[MT7]-LNDLEDALQQAK[MT7].3b6_1.heavy 549.305 / 844.417 82513.0 38.350125312805176 42 16 10 6 10 3.1043994205886474 32.21234978230935 0.038898468017578125 3 0.9669571166515797 6.7704919846370295 82513.0 151.14420386197224 0.0 - - - - - - - 782.7777777777778 165 9 KRT1 keratin 1 1503 192 C20140606_SFK034_02 C20140606_SFK034_02 TB556786.[MT7]-LNDLEDALQQAK[MT7].3b4_1.heavy 549.305 / 600.347 66926.0 38.350125312805176 42 16 10 6 10 3.1043994205886474 32.21234978230935 0.038898468017578125 3 0.9669571166515797 6.7704919846370295 66926.0 76.84878233438486 0.0 - - - - - - - 1673.0 133 7 KRT1 keratin 1 1505 192 C20140606_SFK034_02 C20140606_SFK034_02 TB556786.[MT7]-LNDLEDALQQAK[MT7].3b5_1.heavy 549.305 / 729.39 25538.0 38.350125312805176 42 16 10 6 10 3.1043994205886474 32.21234978230935 0.038898468017578125 3 0.9669571166515797 6.7704919846370295 25538.0 50.15733675892535 0.0 - - - - - - - 645.4444444444445 51 9 KRT1 keratin 1 1507 192 C20140606_SFK034_02 C20140606_SFK034_02 TB556786.[MT7]-LNDLEDALQQAK[MT7].3b7_1.heavy 549.305 / 915.454 77053.0 38.350125312805176 42 16 10 6 10 3.1043994205886474 32.21234978230935 0.038898468017578125 3 0.9669571166515797 6.7704919846370295 77053.0 198.54320579108744 0.0 - - - - - - - 715.375 154 8 KRT1 keratin 1 1509 193 C20140606_SFK034_02 C20140606_SFK034_02 TB559724.[MT7]-TAHSPNVFLQQGQR.3y7_1.heavy 576.308 / 876.469 44064.0 26.23259925842285 45 15 10 10 10 1.8363086817767738 37.36954214705022 0.0 3 0.9597845238208712 6.133374230149653 44064.0 181.7912576111485 0.0 - - - - - - - 628.375 88 8 NPHP3 nephronophthisis 3 (adolescent) 1511 193 C20140606_SFK034_02 C20140606_SFK034_02 TB559724.[MT7]-TAHSPNVFLQQGQR.3y6_1.heavy 576.308 / 729.4 49677.0 26.23259925842285 45 15 10 10 10 1.8363086817767738 37.36954214705022 0.0 3 0.9597845238208712 6.133374230149653 49677.0 46.04697022332506 0.0 - - - - - - - 764.5 99 8 NPHP3 nephronophthisis 3 (adolescent) 1513 193 C20140606_SFK034_02 C20140606_SFK034_02 TB559724.[MT7]-TAHSPNVFLQQGQR.3b4_1.heavy 576.308 / 541.285 N/A 26.23259925842285 45 15 10 10 10 1.8363086817767738 37.36954214705022 0.0 3 0.9597845238208712 6.133374230149653 35185.0 5.631812332299867 1.0 - - - - - - - 2848.0 70 1 NPHP3 nephronophthisis 3 (adolescent) 1515 193 C20140606_SFK034_02 C20140606_SFK034_02 TB559724.[MT7]-TAHSPNVFLQQGQR.3y5_1.heavy 576.308 / 616.316 63667.0 26.23259925842285 45 15 10 10 10 1.8363086817767738 37.36954214705022 0.0 3 0.9597845238208712 6.133374230149653 63667.0 64.98845177120484 0.0 - - - - - - - 377.0 127 2 NPHP3 nephronophthisis 3 (adolescent) 1517 194 C20140606_SFK034_02 C20140606_SFK034_02 TB403973.[MT7]-K[MT7]ATEDEGSEQK[MT7].2y5_1.heavy 827.436 / 692.37 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1519 194 C20140606_SFK034_02 C20140606_SFK034_02 TB403973.[MT7]-K[MT7]ATEDEGSEQK[MT7].2y9_1.heavy 827.436 / 1166.53 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1521 194 C20140606_SFK034_02 C20140606_SFK034_02 TB403973.[MT7]-K[MT7]ATEDEGSEQK[MT7].2b6_1.heavy 827.436 / 962.503 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1523 194 C20140606_SFK034_02 C20140606_SFK034_02 TB403973.[MT7]-K[MT7]ATEDEGSEQK[MT7].2b5_1.heavy 827.436 / 833.461 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1525 195 C20140606_SFK034_02 C20140606_SFK034_02 TB557572.[MT7]-GAGLHRPHGR.3b4_1.heavy 401.231 / 443.273 7918.0 13.95419979095459 46 20 10 10 6 6.409910350863181 15.600842215606596 0.0 5 0.9965318496407922 20.95018268996316 7918.0 20.135258112094395 1.0 - - - - - - - 772.8333333333334 24 12 C17orf76 chromosome 17 open reading frame 76 1527 195 C20140606_SFK034_02 C20140606_SFK034_02 TB557572.[MT7]-GAGLHRPHGR.3b5_1.heavy 401.231 / 580.332 2247.0 13.95419979095459 46 20 10 10 6 6.409910350863181 15.600842215606596 0.0 5 0.9965318496407922 20.95018268996316 2247.0 11.761842105263158 1.0 - - - - - - - 214.0 5 20 C17orf76 chromosome 17 open reading frame 76 1529 195 C20140606_SFK034_02 C20140606_SFK034_02 TB557572.[MT7]-GAGLHRPHGR.3y4_1.heavy 401.231 / 466.252 20828.0 13.95419979095459 46 20 10 10 6 6.409910350863181 15.600842215606596 0.0 5 0.9965318496407922 20.95018268996316 20828.0 43.38951341217985 0.0 - - - - - - - 299.5 41 10 C17orf76 chromosome 17 open reading frame 76 1531 195 C20140606_SFK034_02 C20140606_SFK034_02 TB557572.[MT7]-GAGLHRPHGR.3y9_2.heavy 401.231 / 500.781 3388.0 13.95419979095459 46 20 10 10 6 6.409910350863181 15.600842215606596 0.0 5 0.9965318496407922 20.95018268996316 3388.0 11.589796980739198 3.0 - - - - - - - 221.94444444444446 11 18 C17orf76 chromosome 17 open reading frame 76 1533 196 C20140606_SFK034_02 C20140606_SFK034_02 TB559719.[MT7]-TFSVLEPGGPGGC[CAM]AAR.3y6_1.heavy 573.958 / 591.267 56886.0 33.59910011291504 39 14 10 5 10 1.5975262007824553 44.75890148116437 0.046802520751953125 3 0.9493909955461599 5.462602969690997 56886.0 55.61139709775607 0.0 - - - - - - - 907.0 113 2 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1535 196 C20140606_SFK034_02 C20140606_SFK034_02 TB559719.[MT7]-TFSVLEPGGPGGC[CAM]AAR.3b4_1.heavy 573.958 / 579.326 92808.0 33.59910011291504 39 14 10 5 10 1.5975262007824553 44.75890148116437 0.046802520751953125 3 0.9493909955461599 5.462602969690997 92808.0 22.35144234953905 0.0 - - - - - - - 1246.6666666666667 185 3 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1537 196 C20140606_SFK034_02 C20140606_SFK034_02 TB559719.[MT7]-TFSVLEPGGPGGC[CAM]AAR.3y10_1.heavy 573.958 / 899.415 65952.0 33.59910011291504 39 14 10 5 10 1.5975262007824553 44.75890148116437 0.046802520751953125 3 0.9493909955461599 5.462602969690997 65952.0 134.30889034568804 0.0 - - - - - - - 377.6666666666667 131 3 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1539 196 C20140606_SFK034_02 C20140606_SFK034_02 TB559719.[MT7]-TFSVLEPGGPGGC[CAM]AAR.3y9_1.heavy 573.958 / 802.362 61419.0 33.59910011291504 39 14 10 5 10 1.5975262007824553 44.75890148116437 0.046802520751953125 3 0.9493909955461599 5.462602969690997 61419.0 77.97655784732812 0.0 - - - - - - - 396.5 122 2 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1541 197 C20140606_SFK034_02 C20140606_SFK034_02 TB557636.[MT7]-LTVAY[MT7]HAR.3y6_1.heavy 406.911 / 860.486 N/A 20.812400817871094 27 11 0 10 6 1.231337918269882 69.26790427056143 0.0 5 0.8562407686788807 3.215132322685544 0.0 0.0 2.0 - - - - - - - 0.0 0 0 LRP3 low density lipoprotein receptor-related protein 3 1543 197 C20140606_SFK034_02 C20140606_SFK034_02 TB557636.[MT7]-LTVAY[MT7]HAR.3y7_2.heavy 406.911 / 481.27 43586.0 20.812400817871094 27 11 0 10 6 1.231337918269882 69.26790427056143 0.0 5 0.8562407686788807 3.215132322685544 43586.0 39.33398027458502 2.0 - - - - - - - 2308.777777777778 498 9 LRP3 low density lipoprotein receptor-related protein 3 1545 197 C20140606_SFK034_02 C20140606_SFK034_02 TB557636.[MT7]-LTVAY[MT7]HAR.3b5_2.heavy 406.911 / 418.76 10705.0 20.812400817871094 27 11 0 10 6 1.231337918269882 69.26790427056143 0.0 5 0.8562407686788807 3.215132322685544 10705.0 13.032173913043476 0.0 - - - - - - - 1246.0 21 12 LRP3 low density lipoprotein receptor-related protein 3 1547 197 C20140606_SFK034_02 C20140606_SFK034_02 TB557636.[MT7]-LTVAY[MT7]HAR.3y5_1.heavy 406.911 / 761.417 7724.0 20.812400817871094 27 11 0 10 6 1.231337918269882 69.26790427056143 0.0 5 0.8562407686788807 3.215132322685544 7724.0 43.32280442804428 0.0 - - - - - - - 175.6153846153846 15 26 LRP3 low density lipoprotein receptor-related protein 3 1549 198 C20140606_SFK034_02 C20140606_SFK034_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y7.peptide 661.38 / 836.43 1427970.0 44.1467653910319 24 -3 10 7 10 null 0.0 0.028900146484375 3 0.0 0.0 1427970.0 1536.807694585338 0.0 - - - - - - - 489.0 2855 1 1551 198 C20140606_SFK034_02 C20140606_SFK034_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y9.peptide 661.38 / 502.76 2557280.0 44.1467653910319 24 -3 10 7 10 null 0.0 0.028900146484375 3 0.0 0.0 2557280.0 1000.6847421804438 0.0 - - - - - - - 1650.0 5114 1 1553 198 C20140606_SFK034_02 C20140606_SFK034_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y17.peptide 661.38 / 906.51 2730640.0 44.1467653910319 24 -3 10 7 10 null 0.0 0.028900146484375 3 0.0 0.0 2730640.0 981.2141012717175 0.0 - - - - - - - 702.5 5461 2 1555 199 C20140606_SFK034_02 C20140606_SFK034_02 TB559717.[MT7]-SSNVLLDQNLTPK[MT7].3b6_1.heavy 572.996 / 758.453 31079.0 32.720401763916016 50 20 10 10 10 38.88107579746923 2.571945295981471 0.0 3 0.9997190414784088 73.6259813571293 31079.0 34.837135421507575 0.0 - - - - - - - 348.0 62 2 IRAK2 interleukin-1 receptor-associated kinase 2 1557 199 C20140606_SFK034_02 C20140606_SFK034_02 TB559717.[MT7]-SSNVLLDQNLTPK[MT7].3b4_1.heavy 572.996 / 532.285 132896.0 32.720401763916016 50 20 10 10 10 38.88107579746923 2.571945295981471 0.0 3 0.9997190414784088 73.6259813571293 132896.0 24.459524688350097 0.0 - - - - - - - 1739.0 265 1 IRAK2 interleukin-1 receptor-associated kinase 2 1559 199 C20140606_SFK034_02 C20140606_SFK034_02 TB559717.[MT7]-SSNVLLDQNLTPK[MT7].3b5_1.heavy 572.996 / 645.369 82219.0 32.720401763916016 50 20 10 10 10 38.88107579746923 2.571945295981471 0.0 3 0.9997190414784088 73.6259813571293 82219.0 42.819661962083 0.0 - - - - - - - 1797.25 164 4 IRAK2 interleukin-1 receptor-associated kinase 2 1561 199 C20140606_SFK034_02 C20140606_SFK034_02 TB559717.[MT7]-SSNVLLDQNLTPK[MT7].3b7_1.heavy 572.996 / 873.48 19598.0 32.720401763916016 50 20 10 10 10 38.88107579746923 2.571945295981471 0.0 3 0.9997190414784088 73.6259813571293 19598.0 21.172567795414842 0.0 - - - - - - - 377.0 39 4 IRAK2 interleukin-1 receptor-associated kinase 2 1563 200 C20140606_SFK034_02 C20140606_SFK034_02 TB557579.[MT7]-EVAGLWIK[MT7].3y3_1.heavy 401.916 / 590.378 65539.0 37.49369812011719 48 18 10 10 10 6.973474244755357 14.340054396158195 0.0 3 0.985008565854492 10.066922463155791 65539.0 169.03384979663718 0.0 - - - - - - - 239.54545454545453 131 11 GM2A GM2 ganglioside activator 1565 200 C20140606_SFK034_02 C20140606_SFK034_02 TB557579.[MT7]-EVAGLWIK[MT7].3b4_1.heavy 401.916 / 501.279 311873.0 37.49369812011719 48 18 10 10 10 6.973474244755357 14.340054396158195 0.0 3 0.985008565854492 10.066922463155791 311873.0 378.82645661565783 0.0 - - - - - - - 235.25 623 4 GM2A GM2 ganglioside activator 1567 200 C20140606_SFK034_02 C20140606_SFK034_02 TB557579.[MT7]-EVAGLWIK[MT7].3b5_1.heavy 401.916 / 614.363 139552.0 37.49369812011719 48 18 10 10 10 6.973474244755357 14.340054396158195 0.0 3 0.985008565854492 10.066922463155791 139552.0 702.4578406569162 0.0 - - - - - - - 240.44444444444446 279 9 GM2A GM2 ganglioside activator 1569 200 C20140606_SFK034_02 C20140606_SFK034_02 TB557579.[MT7]-EVAGLWIK[MT7].3b3_1.heavy 401.916 / 444.258 65256.0 37.49369812011719 48 18 10 10 10 6.973474244755357 14.340054396158195 0.0 3 0.985008565854492 10.066922463155791 65256.0 42.22852362832298 0.0 - - - - - - - 322.7142857142857 130 7 GM2A GM2 ganglioside activator 1571 201 C20140606_SFK034_02 C20140606_SFK034_02 TB456600.[MT7]-TSAAYLPEDFIR.3y6_1.heavy 509.604 / 776.394 98617.0 39.562599182128906 44 14 10 10 10 3.017208370044828 33.14321973676424 0.0 3 0.946053063277788 5.289406789846031 98617.0 196.5133589236923 0.0 - - - - - - - 328.0 197 6 IRAK2 interleukin-1 receptor-associated kinase 2 1573 201 C20140606_SFK034_02 C20140606_SFK034_02 TB456600.[MT7]-TSAAYLPEDFIR.3b5_1.heavy 509.604 / 638.327 86986.0 39.562599182128906 44 14 10 10 10 3.017208370044828 33.14321973676424 0.0 3 0.946053063277788 5.289406789846031 86986.0 74.76027223582211 0.0 - - - - - - - 311.6 173 5 IRAK2 interleukin-1 receptor-associated kinase 2 1575 201 C20140606_SFK034_02 C20140606_SFK034_02 TB456600.[MT7]-TSAAYLPEDFIR.3y4_1.heavy 509.604 / 550.298 49472.0 39.562599182128906 44 14 10 10 10 3.017208370044828 33.14321973676424 0.0 3 0.946053063277788 5.289406789846031 49472.0 23.94880484971969 0.0 - - - - - - - 491.0 98 2 IRAK2 interleukin-1 receptor-associated kinase 2 1577 201 C20140606_SFK034_02 C20140606_SFK034_02 TB456600.[MT7]-TSAAYLPEDFIR.3y5_1.heavy 509.604 / 679.341 32763.0 39.562599182128906 44 14 10 10 10 3.017208370044828 33.14321973676424 0.0 3 0.946053063277788 5.289406789846031 32763.0 64.26712582771586 0.0 - - - - - - - 795.5714285714286 65 7 IRAK2 interleukin-1 receptor-associated kinase 2 1579 202 C20140606_SFK034_02 C20140606_SFK034_02 TB556074.[MT7]-AVAGHLTR.2y5_1.heavy 484.792 / 583.331 23085.0 17.788700103759766 38 18 4 10 6 4.61207258586396 21.68222597070584 0.0 5 0.9895005549666364 12.033680496960677 23085.0 42.19382911392405 1.0 - - - - - - - 710.875 86 8 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1581 202 C20140606_SFK034_02 C20140606_SFK034_02 TB556074.[MT7]-AVAGHLTR.2y6_1.heavy 484.792 / 654.368 33486.0 17.788700103759766 38 18 4 10 6 4.61207258586396 21.68222597070584 0.0 5 0.9895005549666364 12.033680496960677 33486.0 26.48390559975492 1.0 - - - - - - - 486.0 124 1 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1583 202 C20140606_SFK034_02 C20140606_SFK034_02 TB556074.[MT7]-AVAGHLTR.2b5_1.heavy 484.792 / 580.332 11130.0 17.788700103759766 38 18 4 10 6 4.61207258586396 21.68222597070584 0.0 5 0.9895005549666364 12.033680496960677 11130.0 15.59596921261532 3.0 - - - - - - - 279.4375 45 16 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1585 202 C20140606_SFK034_02 C20140606_SFK034_02 TB556074.[MT7]-AVAGHLTR.2y7_1.heavy 484.792 / 753.437 36742.0 17.788700103759766 38 18 4 10 6 4.61207258586396 21.68222597070584 0.0 5 0.9895005549666364 12.033680496960677 36742.0 151.4178555587583 0.0 - - - - - - - 263.5263157894737 73 19 NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1587 203 C20140606_SFK034_02 C20140606_SFK034_02 TB404038.[MT7]-FLDGDELTLADC[CAM]NLLPK[MT7].2b8_1.heavy 1111.58 / 1035.51 7802.0 44.4109001159668 46 16 10 10 10 4.579065190668188 21.838518526399877 0.0 3 0.9675600223443874 6.8334655465644225 7802.0 21.186304173996483 0.0 - - - - - - - 718.7777777777778 15 9 CLIC5;CLIC6 chloride intracellular channel 5;chloride intracellular channel 6 1589 203 C20140606_SFK034_02 C20140606_SFK034_02 TB404038.[MT7]-FLDGDELTLADC[CAM]NLLPK[MT7].2b6_1.heavy 1111.58 / 821.38 8309.0 44.4109001159668 46 16 10 10 10 4.579065190668188 21.838518526399877 0.0 3 0.9675600223443874 6.8334655465644225 8309.0 23.32499410921828 0.0 - - - - - - - 210.0 16 16 CLIC5;CLIC6 chloride intracellular channel 5;chloride intracellular channel 6 1591 203 C20140606_SFK034_02 C20140606_SFK034_02 TB404038.[MT7]-FLDGDELTLADC[CAM]NLLPK[MT7].2b5_1.heavy 1111.58 / 692.337 13511.0 44.4109001159668 46 16 10 10 10 4.579065190668188 21.838518526399877 0.0 3 0.9675600223443874 6.8334655465644225 13511.0 38.643451270419355 0.0 - - - - - - - 289.5 27 16 CLIC5;CLIC6 chloride intracellular channel 5;chloride intracellular channel 6 1593 203 C20140606_SFK034_02 C20140606_SFK034_02 TB404038.[MT7]-FLDGDELTLADC[CAM]NLLPK[MT7].2b9_1.heavy 1111.58 / 1148.6 5518.0 44.4109001159668 46 16 10 10 10 4.579065190668188 21.838518526399877 0.0 3 0.9675600223443874 6.8334655465644225 5518.0 16.756498430643788 0.0 - - - - - - - 661.2857142857143 11 14 CLIC5;CLIC6 chloride intracellular channel 5;chloride intracellular channel 6 1595 204 C20140606_SFK034_02 C20140606_SFK034_02 TB456333.[MT7]-EDSALR.2y4_1.heavy 417.726 / 446.272 51531.0 17.490100860595703 46 16 10 10 10 2.4984765685405255 32.09236132713442 0.0 3 0.9643437521766379 6.516217739755234 51531.0 73.22181707408039 0.0 - - - - - - - 1779.0 103 7 GLDN gliomedin 1597 204 C20140606_SFK034_02 C20140606_SFK034_02 TB456333.[MT7]-EDSALR.2y5_1.heavy 417.726 / 561.299 49667.0 17.490100860595703 46 16 10 10 10 2.4984765685405255 32.09236132713442 0.0 3 0.9643437521766379 6.516217739755234 49667.0 20.54805470638666 0.0 - - - - - - - 1373.0 99 3 GLDN gliomedin 1599 204 C20140606_SFK034_02 C20140606_SFK034_02 TB456333.[MT7]-EDSALR.2b4_1.heavy 417.726 / 547.248 53541.0 17.490100860595703 46 16 10 10 10 2.4984765685405255 32.09236132713442 0.0 3 0.9643437521766379 6.516217739755234 53541.0 59.4236349016564 0.0 - - - - - - - 1324.0 107 6 GLDN gliomedin 1601 204 C20140606_SFK034_02 C20140606_SFK034_02 TB456333.[MT7]-EDSALR.2b5_1.heavy 417.726 / 660.332 25888.0 17.490100860595703 46 16 10 10 10 2.4984765685405255 32.09236132713442 0.0 3 0.9643437521766379 6.516217739755234 25888.0 28.81113345760577 1.0 - - - - - - - 845.75 71 4 GLDN gliomedin 1603 205 C20140606_SFK034_02 C20140606_SFK034_02 TB456601.[MT7]-AEDEQEEGQPVR.2y5_1.heavy 765.861 / 556.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - IRAK2 interleukin-1 receptor-associated kinase 2 1605 205 C20140606_SFK034_02 C20140606_SFK034_02 TB456601.[MT7]-AEDEQEEGQPVR.2b4_1.heavy 765.861 / 589.259 N/A N/A - - - - - - - - - 0.0 - - - - - - - IRAK2 interleukin-1 receptor-associated kinase 2 1607 205 C20140606_SFK034_02 C20140606_SFK034_02 TB456601.[MT7]-AEDEQEEGQPVR.2y9_1.heavy 765.861 / 1071.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - IRAK2 interleukin-1 receptor-associated kinase 2 1609 205 C20140606_SFK034_02 C20140606_SFK034_02 TB456601.[MT7]-AEDEQEEGQPVR.2y10_1.heavy 765.861 / 1186.53 N/A N/A - - - - - - - - - 0.0 - - - - - - - IRAK2 interleukin-1 receptor-associated kinase 2 1611 206 C20140606_SFK034_02 C20140606_SFK034_02 TB456604.[MT7]-EVPLNTIIFMGR.2y8_1.heavy 767.433 / 951.508 9691.0 44.869150161743164 46 20 10 6 10 11.437011331649973 8.743542967669105 0.034297943115234375 3 0.9958617364892247 19.178004510619 9691.0 12.83009708737864 0.0 - - - - - - - 638.0 19 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1613 206 C20140606_SFK034_02 C20140606_SFK034_02 TB456604.[MT7]-EVPLNTIIFMGR.2b4_1.heavy 767.433 / 583.357 4971.0 44.869150161743164 46 20 10 6 10 11.437011331649973 8.743542967669105 0.034297943115234375 3 0.9958617364892247 19.178004510619 4971.0 6.1944536366819545 1.0 - - - - - - - 1186.5714285714287 37 7 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1615 206 C20140606_SFK034_02 C20140606_SFK034_02 TB456604.[MT7]-EVPLNTIIFMGR.2y9_1.heavy 767.433 / 1064.59 7992.0 44.869150161743164 46 20 10 6 10 11.437011331649973 8.743542967669105 0.034297943115234375 3 0.9958617364892247 19.178004510619 7992.0 14.482391193603403 0.0 - - - - - - - 666.8 15 10 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1617 206 C20140606_SFK034_02 C20140606_SFK034_02 TB456604.[MT7]-EVPLNTIIFMGR.2y10_1.heavy 767.433 / 1161.64 79667.0 44.869150161743164 46 20 10 6 10 11.437011331649973 8.743542967669105 0.034297943115234375 3 0.9958617364892247 19.178004510619 79667.0 159.0595280787046 0.0 - - - - - - - 672.6153846153846 159 13 SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1619 207 C20140606_SFK034_02 C20140606_SFK034_02 TB456336.[MT7]-GLSSALR.2y5_1.heavy 424.26 / 533.304 28619.0 25.454050064086914 39 16 10 5 8 2.545814175410783 27.616586953251613 0.043701171875 4 0.9617168871373779 6.2872887702625535 28619.0 14.138706798131812 0.0 - - - - - - - 874.6666666666666 57 3 GLDN gliomedin 1621 207 C20140606_SFK034_02 C20140606_SFK034_02 TB456336.[MT7]-GLSSALR.2b4_1.heavy 424.26 / 489.279 18041.0 25.454050064086914 39 16 10 5 8 2.545814175410783 27.616586953251613 0.043701171875 4 0.9617168871373779 6.2872887702625535 18041.0 11.395503439649781 0.0 - - - - - - - 1230.0 36 1 GLDN gliomedin 1623 207 C20140606_SFK034_02 C20140606_SFK034_02 TB456336.[MT7]-GLSSALR.2y6_1.heavy 424.26 / 646.388 30587.0 25.454050064086914 39 16 10 5 8 2.545814175410783 27.616586953251613 0.043701171875 4 0.9617168871373779 6.2872887702625535 30587.0 37.447498804399814 1.0 - - - - - - - 792.6666666666666 64 9 GLDN gliomedin 1625 207 C20140606_SFK034_02 C20140606_SFK034_02 TB456336.[MT7]-GLSSALR.2b5_1.heavy 424.26 / 560.316 44856.0 25.454050064086914 39 16 10 5 8 2.545814175410783 27.616586953251613 0.043701171875 4 0.9617168871373779 6.2872887702625535 44856.0 13.136295364306708 0.0 - - - - - - - 738.0 89 1 GLDN gliomedin 1627 208 C20140606_SFK034_02 C20140606_SFK034_02 TB556071.[MT7]-VSGLYQR.2y5_1.heavy 483.778 / 636.346 28980.0 24.345199584960938 50 20 10 10 10 80.72650889878902 1.2387504595965515 0.0 3 0.9999690941718716 221.9939090547545 28980.0 37.87929840681248 0.0 - - - - - - - 1762.2 57 10 DMGDH dimethylglycine dehydrogenase 1629 208 C20140606_SFK034_02 C20140606_SFK034_02 TB556071.[MT7]-VSGLYQR.2b4_1.heavy 483.778 / 501.315 43918.0 24.345199584960938 50 20 10 10 10 80.72650889878902 1.2387504595965515 0.0 3 0.9999690941718716 221.9939090547545 43918.0 34.70229237856112 0.0 - - - - - - - 1349.4 87 5 DMGDH dimethylglycine dehydrogenase 1631 208 C20140606_SFK034_02 C20140606_SFK034_02 TB556071.[MT7]-VSGLYQR.2y6_1.heavy 483.778 / 723.378 154884.0 24.345199584960938 50 20 10 10 10 80.72650889878902 1.2387504595965515 0.0 3 0.9999690941718716 221.9939090547545 154884.0 102.77557539673808 0.0 - - - - - - - 395.75 309 4 DMGDH dimethylglycine dehydrogenase 1633 208 C20140606_SFK034_02 C20140606_SFK034_02 TB556071.[MT7]-VSGLYQR.2b5_1.heavy 483.778 / 664.379 14800.0 24.345199584960938 50 20 10 10 10 80.72650889878902 1.2387504595965515 0.0 3 0.9999690941718716 221.9939090547545 14800.0 8.271074688023841 2.0 - - - - - - - 459.0 54 3 DMGDH dimethylglycine dehydrogenase 1635 209 C20140606_SFK034_02 C20140606_SFK034_02 TB559714.[MT7]-TPPYLQLQVTEK[MT7].3b6_1.heavy 568.997 / 844.469 67400.0 35.7947998046875 50 20 10 10 10 6.6373065592419005 15.066352459004364 0.0 3 0.9904098497635784 12.592210453111536 67400.0 100.53564593301437 0.0 - - - - - - - 313.25 134 4 LAMA5 laminin, alpha 5 1637 209 C20140606_SFK034_02 C20140606_SFK034_02 TB559714.[MT7]-TPPYLQLQVTEK[MT7].3y3_1.heavy 568.997 / 521.305 195513.0 35.7947998046875 50 20 10 10 10 6.6373065592419005 15.066352459004364 0.0 3 0.9904098497635784 12.592210453111536 195513.0 109.20283546431273 0.0 - - - - - - - 522.0 391 1 LAMA5 laminin, alpha 5 1639 209 C20140606_SFK034_02 C20140606_SFK034_02 TB559714.[MT7]-TPPYLQLQVTEK[MT7].3b4_1.heavy 568.997 / 603.326 186631.0 35.7947998046875 50 20 10 10 10 6.6373065592419005 15.066352459004364 0.0 3 0.9904098497635784 12.592210453111536 186631.0 134.14183519686898 0.0 - - - - - - - 1097.0 373 2 LAMA5 laminin, alpha 5 1641 209 C20140606_SFK034_02 C20140606_SFK034_02 TB559714.[MT7]-TPPYLQLQVTEK[MT7].3y4_1.heavy 568.997 / 620.374 132084.0 35.7947998046875 50 20 10 10 10 6.6373065592419005 15.066352459004364 0.0 3 0.9904098497635784 12.592210453111536 132084.0 76.26045228016766 0.0 - - - - - - - 418.0 264 1 LAMA5 laminin, alpha 5 1643 210 C20140606_SFK034_02 C20140606_SFK034_02 TB559712.[MT7]-FEFGQETSQTLK[MT7].3b6_1.heavy 568.301 / 882.411 47896.0 33.437801361083984 44 14 10 10 10 1.980243815737059 41.4665157036134 0.0 3 0.9415314007829525 5.078809472170898 47896.0 65.50181064101682 0.0 - - - - - - - 277.57142857142856 95 7 GLDN gliomedin 1645 210 C20140606_SFK034_02 C20140606_SFK034_02 TB559712.[MT7]-FEFGQETSQTLK[MT7].3y3_1.heavy 568.301 / 505.347 146431.0 33.437801361083984 44 14 10 10 10 1.980243815737059 41.4665157036134 0.0 3 0.9415314007829525 5.078809472170898 146431.0 70.60331043380333 0.0 - - - - - - - 857.0 292 2 GLDN gliomedin 1647 210 C20140606_SFK034_02 C20140606_SFK034_02 TB559712.[MT7]-FEFGQETSQTLK[MT7].3b4_1.heavy 568.301 / 625.31 60927.0 33.437801361083984 44 14 10 10 10 1.980243815737059 41.4665157036134 0.0 3 0.9415314007829525 5.078809472170898 60927.0 88.44217851628557 0.0 - - - - - - - 400.0 121 2 GLDN gliomedin 1649 210 C20140606_SFK034_02 C20140606_SFK034_02 TB559712.[MT7]-FEFGQETSQTLK[MT7].3b5_1.heavy 568.301 / 753.369 77960.0 33.437801361083984 44 14 10 10 10 1.980243815737059 41.4665157036134 0.0 3 0.9415314007829525 5.078809472170898 77960.0 78.56049268560761 0.0 - - - - - - - 365.6 155 5 GLDN gliomedin 1651 211 C20140606_SFK034_02 C20140606_SFK034_02 TB456710.[MT7]-SEFVVPDLELPSWLTTGNYR.3b4_1.heavy 823.092 / 607.321 218833.0 51.35049819946289 43 13 10 10 10 2.539012716336215 27.17989058995647 0.0 3 0.9280303610940482 4.572439570529158 218833.0 152.41977424569467 0.0 - - - - - - - 735.6666666666666 437 12 GM2A GM2 ganglioside activator 1653 211 C20140606_SFK034_02 C20140606_SFK034_02 TB456710.[MT7]-SEFVVPDLELPSWLTTGNYR.3b5_1.heavy 823.092 / 706.389 235944.0 51.35049819946289 43 13 10 10 10 2.539012716336215 27.17989058995647 0.0 3 0.9280303610940482 4.572439570529158 235944.0 71.72220653565664 0.0 - - - - - - - 761.0666666666667 471 15 GM2A GM2 ganglioside activator 1655 211 C20140606_SFK034_02 C20140606_SFK034_02 TB456710.[MT7]-SEFVVPDLELPSWLTTGNYR.3b3_1.heavy 823.092 / 508.252 89700.0 51.35049819946289 43 13 10 10 10 2.539012716336215 27.17989058995647 0.0 3 0.9280303610940482 4.572439570529158 89700.0 116.73266800994767 0.0 - - - - - - - 642.0 179 13 GM2A GM2 ganglioside activator 1657 211 C20140606_SFK034_02 C20140606_SFK034_02 TB456710.[MT7]-SEFVVPDLELPSWLTTGNYR.3y10_1.heavy 823.092 / 1194.59 153731.0 51.35049819946289 43 13 10 10 10 2.539012716336215 27.17989058995647 0.0 3 0.9280303610940482 4.572439570529158 153731.0 122.21256445927231 0.0 - - - - - - - 1138.2857142857142 307 7 GM2A GM2 ganglioside activator 1659 212 C20140606_SFK034_02 C20140606_SFK034_02 TB560231.[MT7]-ATADIQQLLSWESLK[MT7].3y6_1.heavy 664.373 / 893.485 7739.0 46.123600006103516 42 16 10 6 10 2.158095596892342 38.099572373827606 0.0391998291015625 3 0.9656356563999936 6.6382980217401295 7739.0 13.42850214897654 0.0 - - - - - - - 219.42857142857142 15 14 FAM75D1 family with sequence similarity 75, member D1 1661 212 C20140606_SFK034_02 C20140606_SFK034_02 TB560231.[MT7]-ATADIQQLLSWESLK[MT7].3b6_1.heavy 664.373 / 744.401 5117.0 46.123600006103516 42 16 10 6 10 2.158095596892342 38.099572373827606 0.0391998291015625 3 0.9656356563999936 6.6382980217401295 5117.0 6.759673295454545 0.0 - - - - - - - 625.5555555555555 10 9 FAM75D1 family with sequence similarity 75, member D1 1663 212 C20140606_SFK034_02 C20140606_SFK034_02 TB560231.[MT7]-ATADIQQLLSWESLK[MT7].3b4_1.heavy 664.373 / 503.258 13879.0 46.123600006103516 42 16 10 6 10 2.158095596892342 38.099572373827606 0.0391998291015625 3 0.9656356563999936 6.6382980217401295 13879.0 15.848829226759342 0.0 - - - - - - - 1215.0 27 8 FAM75D1 family with sequence similarity 75, member D1 1665 212 C20140606_SFK034_02 C20140606_SFK034_02 TB560231.[MT7]-ATADIQQLLSWESLK[MT7].3b5_1.heavy 664.373 / 616.342 5948.0 46.123600006103516 42 16 10 6 10 2.158095596892342 38.099572373827606 0.0391998291015625 3 0.9656356563999936 6.6382980217401295 5948.0 3.3303587856485737 1.0 - - - - - - - 674.6363636363636 11 11 FAM75D1 family with sequence similarity 75, member D1 1667 213 C20140606_SFK034_02 C20140606_SFK034_02 TB555837.[MT7]-VMEEIR.2y4_1.heavy 460.753 / 546.288 26217.0 26.31060028076172 44 14 10 10 10 2.209982900703049 45.249218882276224 0.0 3 0.9459642851203451 5.285019988013334 26217.0 10.473355000046197 0.0 - - - - - - - 754.0 52 4 NFYC nuclear transcription factor Y, gamma 1669 213 C20140606_SFK034_02 C20140606_SFK034_02 TB555837.[MT7]-VMEEIR.2b3_1.heavy 460.753 / 504.261 60727.0 26.31060028076172 44 14 10 10 10 2.209982900703049 45.249218882276224 0.0 3 0.9459642851203451 5.285019988013334 60727.0 36.30227832120164 0.0 - - - - - - - 1214.5 121 2 NFYC nuclear transcription factor Y, gamma 1671 213 C20140606_SFK034_02 C20140606_SFK034_02 TB555837.[MT7]-VMEEIR.2y5_1.heavy 460.753 / 677.329 170874.0 26.31060028076172 44 14 10 10 10 2.209982900703049 45.249218882276224 0.0 3 0.9459642851203451 5.285019988013334 170874.0 232.1358892812994 0.0 - - - - - - - 1591.4285714285713 341 7 NFYC nuclear transcription factor Y, gamma 1673 213 C20140606_SFK034_02 C20140606_SFK034_02 TB555837.[MT7]-VMEEIR.2b4_1.heavy 460.753 / 633.303 168110.0 26.31060028076172 44 14 10 10 10 2.209982900703049 45.249218882276224 0.0 3 0.9459642851203451 5.285019988013334 168110.0 126.66682555671863 0.0 - - - - - - - 503.0 336 2 NFYC nuclear transcription factor Y, gamma 1675 214 C20140606_SFK034_02 C20140606_SFK034_02 TB559472.[MT7]-FQHLQAWETVR.3y7_1.heavy 520.28 / 889.453 42859.0 33.262298583984375 50 20 10 10 10 7.6355174031156015 13.096689421360749 0.0 3 0.9930811516756359 14.828415443261328 42859.0 62.68554744208163 0.0 - - - - - - - 242.77777777777777 85 9 NPHP3 nephronophthisis 3 (adolescent) 1677 214 C20140606_SFK034_02 C20140606_SFK034_02 TB559472.[MT7]-FQHLQAWETVR.3y6_1.heavy 520.28 / 761.394 70436.0 33.262298583984375 50 20 10 10 10 7.6355174031156015 13.096689421360749 0.0 3 0.9930811516756359 14.828415443261328 70436.0 344.414328820116 0.0 - - - - - - - 313.6363636363636 140 11 NPHP3 nephronophthisis 3 (adolescent) 1679 214 C20140606_SFK034_02 C20140606_SFK034_02 TB559472.[MT7]-FQHLQAWETVR.3b3_1.heavy 520.28 / 557.295 102954.0 33.262298583984375 50 20 10 10 10 7.6355174031156015 13.096689421360749 0.0 3 0.9930811516756359 14.828415443261328 102954.0 61.64111473147222 0.0 - - - - - - - 746.5 205 2 NPHP3 nephronophthisis 3 (adolescent) 1681 214 C20140606_SFK034_02 C20140606_SFK034_02 TB559472.[MT7]-FQHLQAWETVR.3y5_1.heavy 520.28 / 690.357 59060.0 33.262298583984375 50 20 10 10 10 7.6355174031156015 13.096689421360749 0.0 3 0.9930811516756359 14.828415443261328 59060.0 43.13696414178607 0.0 - - - - - - - 842.3333333333334 118 3 NPHP3 nephronophthisis 3 (adolescent) 1683 215 C20140606_SFK034_02 C20140606_SFK034_02 TB456388.[MT7]-ENAEQSR.2y5_1.heavy 489.242 / 590.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1685 215 C20140606_SFK034_02 C20140606_SFK034_02 TB456388.[MT7]-ENAEQSR.2b4_1.heavy 489.242 / 588.275 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1687 215 C20140606_SFK034_02 C20140606_SFK034_02 TB456388.[MT7]-ENAEQSR.2y6_1.heavy 489.242 / 704.332 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1689 215 C20140606_SFK034_02 C20140606_SFK034_02 TB456388.[MT7]-ENAEQSR.2b5_1.heavy 489.242 / 716.333 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1691 216 C20140606_SFK034_02 C20140606_SFK034_02 TB559576.[MT7]-GTTADTSELEALK[MT7].3b6_1.heavy 541.961 / 691.338 28827.0 31.40679931640625 44 14 10 10 10 1.5255465290747643 45.61745740838423 0.0 3 0.9366543411887509 4.877354093483056 28827.0 43.81196035242291 0.0 - - - - - - - 397.0 57 2 FMN1 formin 1 1693 216 C20140606_SFK034_02 C20140606_SFK034_02 TB559576.[MT7]-GTTADTSELEALK[MT7].3b5_1.heavy 541.961 / 590.29 93405.0 31.40679931640625 44 14 10 10 10 1.5255465290747643 45.61745740838423 0.0 3 0.9366543411887509 4.877354093483056 93405.0 55.939189772825436 0.0 - - - - - - - 340.5 186 2 FMN1 formin 1 1695 216 C20140606_SFK034_02 C20140606_SFK034_02 TB559576.[MT7]-GTTADTSELEALK[MT7].3y4_1.heavy 541.961 / 604.379 134036.0 31.40679931640625 44 14 10 10 10 1.5255465290747643 45.61745740838423 0.0 3 0.9366543411887509 4.877354093483056 134036.0 54.792429984834264 0.0 - - - - - - - 1361.5 268 4 FMN1 formin 1 1697 216 C20140606_SFK034_02 C20140606_SFK034_02 TB559576.[MT7]-GTTADTSELEALK[MT7].3b8_1.heavy 541.961 / 907.412 78992.0 31.40679931640625 44 14 10 10 10 1.5255465290747643 45.61745740838423 0.0 3 0.9366543411887509 4.877354093483056 78992.0 121.13854696345825 0.0 - - - - - - - 259.2857142857143 157 7 FMN1 formin 1 1699 217 C20140606_SFK034_02 C20140606_SFK034_02 TB558469.[MT7]-RVGMVQELLR.3b4_1.heavy 448.935 / 588.341 57402.0 34.21039962768555 46 16 10 10 10 2.7948156751925692 28.55524280116429 0.0 3 0.9687734552455098 6.965683723222872 57402.0 64.60248673159239 0.0 - - - - - - - 330.6666666666667 114 3 C17orf76 chromosome 17 open reading frame 76 1701 217 C20140606_SFK034_02 C20140606_SFK034_02 TB558469.[MT7]-RVGMVQELLR.3b5_1.heavy 448.935 / 687.409 24569.0 34.21039962768555 46 16 10 10 10 2.7948156751925692 28.55524280116429 0.0 3 0.9687734552455098 6.965683723222872 24569.0 45.34569680605972 0.0 - - - - - - - 231.3 49 10 C17orf76 chromosome 17 open reading frame 76 1703 217 C20140606_SFK034_02 C20140606_SFK034_02 TB558469.[MT7]-RVGMVQELLR.3y4_1.heavy 448.935 / 530.33 82302.0 34.21039962768555 46 16 10 10 10 2.7948156751925692 28.55524280116429 0.0 3 0.9687734552455098 6.965683723222872 82302.0 99.4880978334923 0.0 - - - - - - - 441.0 164 1 C17orf76 chromosome 17 open reading frame 76 1705 217 C20140606_SFK034_02 C20140606_SFK034_02 TB558469.[MT7]-RVGMVQELLR.3y5_1.heavy 448.935 / 658.388 57402.0 34.21039962768555 46 16 10 10 10 2.7948156751925692 28.55524280116429 0.0 3 0.9687734552455098 6.965683723222872 57402.0 150.69978334845734 0.0 - - - - - - - 708.2857142857143 114 7 C17orf76 chromosome 17 open reading frame 76 1707 218 C20140606_SFK034_02 C20140606_SFK034_02 TB404025.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNR.3b9_1.heavy 1052.52 / 1014.6 N/A N/A - - - - - - - - - 0.0 - - - - - - - IRAK2 interleukin-1 receptor-associated kinase 2 1709 218 C20140606_SFK034_02 C20140606_SFK034_02 TB404025.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNR.3b10_1.heavy 1052.52 / 1161.66 N/A N/A - - - - - - - - - 0.0 - - - - - - - IRAK2 interleukin-1 receptor-associated kinase 2 1711 218 C20140606_SFK034_02 C20140606_SFK034_02 TB404025.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNR.3b7_1.heavy 1052.52 / 814.479 N/A N/A - - - - - - - - - 0.0 - - - - - - - IRAK2 interleukin-1 receptor-associated kinase 2 1713 218 C20140606_SFK034_02 C20140606_SFK034_02 TB404025.[MT7]-LLSLAGDSLFWSEADVVQATDDFNQNR.3y5_1.heavy 1052.52 / 678.332 N/A N/A - - - - - - - - - 0.0 - - - - - - - IRAK2 interleukin-1 receptor-associated kinase 2 1715 219 C20140606_SFK034_02 C20140606_SFK034_02 TB403831.[MT7]-EWDENLK[MT7].2y4_1.heavy 611.321 / 647.385 20969.0 28.29960060119629 41 15 8 10 8 3.65214483303018 21.71372594936159 0.0 4 0.9589422111703229 6.069701690514828 20969.0 21.02195741657676 0.0 - - - - - - - 1736.857142857143 41 7 CRBN cereblon 1717 219 C20140606_SFK034_02 C20140606_SFK034_02 TB403831.[MT7]-EWDENLK[MT7].2b3_1.heavy 611.321 / 575.258 30749.0 28.29960060119629 41 15 8 10 8 3.65214483303018 21.71372594936159 0.0 4 0.9589422111703229 6.069701690514828 30749.0 13.551517052585272 1.0 - - - - - - - 1498.0 79 2 CRBN cereblon 1719 219 C20140606_SFK034_02 C20140606_SFK034_02 TB403831.[MT7]-EWDENLK[MT7].2y5_1.heavy 611.321 / 762.411 10220.0 28.29960060119629 41 15 8 10 8 3.65214483303018 21.71372594936159 0.0 4 0.9589422111703229 6.069701690514828 10220.0 14.950021689464705 0.0 - - - - - - - 1213.7777777777778 20 9 CRBN cereblon 1721 219 C20140606_SFK034_02 C20140606_SFK034_02 TB403831.[MT7]-EWDENLK[MT7].2y6_1.heavy 611.321 / 948.491 28546.0 28.29960060119629 41 15 8 10 8 3.65214483303018 21.71372594936159 0.0 4 0.9589422111703229 6.069701690514828 28546.0 49.66485099564463 0.0 - - - - - - - 727.0 57 8 CRBN cereblon 1723 220 C20140606_SFK034_02 C20140606_SFK034_02 TB557666.[MT7]-AQEDELVK[MT7].2y5_1.heavy 610.342 / 747.437 2985.0 23.2223326365153 43 18 10 7 8 5.540610629731394 18.048552169212428 0.028699874877929688 4 0.9891297518783532 11.82628790143113 2985.0 0.5100122684333208 3.0 - - - - - - - 253.0952380952381 6 21 FMN1 formin 1 1725 220 C20140606_SFK034_02 C20140606_SFK034_02 TB557666.[MT7]-AQEDELVK[MT7].2b4_1.heavy 610.342 / 588.275 N/A 23.2223326365153 43 18 10 7 8 5.540610629731394 18.048552169212428 0.028699874877929688 4 0.9891297518783532 11.82628790143113 15700.0 8.425835234512128 0.0 - - - - - - - 2259.714285714286 31 7 FMN1 formin 1 1727 220 C20140606_SFK034_02 C20140606_SFK034_02 TB557666.[MT7]-AQEDELVK[MT7].2b6_1.heavy 610.342 / 830.401 3880.0 23.2223326365153 43 18 10 7 8 5.540610629731394 18.048552169212428 0.028699874877929688 4 0.9891297518783532 11.82628790143113 3880.0 22.75977653631285 0.0 - - - - - - - 210.23809523809524 7 21 FMN1 formin 1 1729 220 C20140606_SFK034_02 C20140606_SFK034_02 TB557666.[MT7]-AQEDELVK[MT7].2b5_1.heavy 610.342 / 717.317 4776.0 23.2223326365153 43 18 10 7 8 5.540610629731394 18.048552169212428 0.028699874877929688 4 0.9891297518783532 11.82628790143113 4776.0 18.052033955441146 0.0 - - - - - - - 626.75 9 8 FMN1 formin 1 1731 221 C20140606_SFK034_02 C20140606_SFK034_02 TB456716.[MT7]-LLDK[MT7]PEQFLHELAQIPNFAER.4y5_1.heavy 699.888 / 636.31 14459.0 49.67884922027588 44 18 10 6 10 7.117251319880496 14.050367972909953 0.033397674560546875 3 0.9897290086163701 12.167007220918162 14459.0 28.672588757396447 0.0 - - - - - - - 668.5714285714286 28 14 FMN1 formin 1 1733 221 C20140606_SFK034_02 C20140606_SFK034_02 TB456716.[MT7]-LLDK[MT7]PEQFLHELAQIPNFAER.4b8_2.heavy 699.888 / 630.365 24341.0 49.67884922027588 44 18 10 6 10 7.117251319880496 14.050367972909953 0.033397674560546875 3 0.9897290086163701 12.167007220918162 24341.0 56.47353598014888 0.0 - - - - - - - 642.9090909090909 48 11 FMN1 formin 1 1735 221 C20140606_SFK034_02 C20140606_SFK034_02 TB456716.[MT7]-LLDK[MT7]PEQFLHELAQIPNFAER.4b7_2.heavy 699.888 / 556.831 11338.0 49.67884922027588 44 18 10 6 10 7.117251319880496 14.050367972909953 0.033397674560546875 3 0.9897290086163701 12.167007220918162 11338.0 33.57792307692308 0.0 - - - - - - - 624.0 22 7 FMN1 formin 1 1737 221 C20140606_SFK034_02 C20140606_SFK034_02 TB456716.[MT7]-LLDK[MT7]PEQFLHELAQIPNFAER.4y6_1.heavy 699.888 / 733.363 119938.0 49.67884922027588 44 18 10 6 10 7.117251319880496 14.050367972909953 0.033397674560546875 3 0.9897290086163701 12.167007220918162 119938.0 247.125 0.0 - - - - - - - 699.1111111111111 239 9 FMN1 formin 1 1739 222 C20140606_SFK034_02 C20140606_SFK034_02 TB559477.[MT7]-MISAEAPVLFAK[MT7].3y3_1.heavy 522.305 / 509.32 123946.0 39.89789962768555 44 14 10 10 10 2.347443402053106 33.82417619747884 0.0 3 0.9375809014609112 4.913809277869371 123946.0 73.67412531766523 0.0 - - - - - - - 303.0 247 2 NFYC nuclear transcription factor Y, gamma 1741 222 C20140606_SFK034_02 C20140606_SFK034_02 TB559477.[MT7]-MISAEAPVLFAK[MT7].3b6_1.heavy 522.305 / 747.383 77580.0 39.89789962768555 44 14 10 10 10 2.347443402053106 33.82417619747884 0.0 3 0.9375809014609112 4.913809277869371 77580.0 77.52592952462948 0.0 - - - - - - - 290.6666666666667 155 6 NFYC nuclear transcription factor Y, gamma 1743 222 C20140606_SFK034_02 C20140606_SFK034_02 TB559477.[MT7]-MISAEAPVLFAK[MT7].3b5_1.heavy 522.305 / 676.346 53336.0 39.89789962768555 44 14 10 10 10 2.347443402053106 33.82417619747884 0.0 3 0.9375809014609112 4.913809277869371 53336.0 143.89771260997065 0.0 - - - - - - - 242.7 106 10 NFYC nuclear transcription factor Y, gamma 1745 222 C20140606_SFK034_02 C20140606_SFK034_02 TB559477.[MT7]-MISAEAPVLFAK[MT7].3y4_1.heavy 522.305 / 622.404 65306.0 39.89789962768555 44 14 10 10 10 2.347443402053106 33.82417619747884 0.0 3 0.9375809014609112 4.913809277869371 65306.0 28.55482245438668 0.0 - - - - - - - 767.125 130 8 NFYC nuclear transcription factor Y, gamma 1747 223 C20140606_SFK034_02 C20140606_SFK034_02 TB559478.[MT7]-REEAGTLLQHLR.3b6_1.heavy 522.966 / 788.402 52714.0 29.059149265289307 40 15 9 6 10 3.1113593555092818 32.14029257756102 0.03380012512207031 3 0.9594628268332334 6.108822746947621 52714.0 47.60160745904711 1.0 - - - - - - - 1203.5 105 8 C17orf76 chromosome 17 open reading frame 76 1749 223 C20140606_SFK034_02 C20140606_SFK034_02 TB559478.[MT7]-REEAGTLLQHLR.3y4_1.heavy 522.966 / 553.32 188075.0 29.059149265289307 40 15 9 6 10 3.1113593555092818 32.14029257756102 0.03380012512207031 3 0.9594628268332334 6.108822746947621 188075.0 107.47235269373962 0.0 - - - - - - - 381.0 376 1 C17orf76 chromosome 17 open reading frame 76 1751 223 C20140606_SFK034_02 C20140606_SFK034_02 TB559478.[MT7]-REEAGTLLQHLR.3b7_1.heavy 522.966 / 901.486 38320.0 29.059149265289307 40 15 9 6 10 3.1113593555092818 32.14029257756102 0.03380012512207031 3 0.9594628268332334 6.108822746947621 38320.0 16.180765284627945 2.0 - - - - - - - 2192.0 425 1 C17orf76 chromosome 17 open reading frame 76 1753 223 C20140606_SFK034_02 C20140606_SFK034_02 TB559478.[MT7]-REEAGTLLQHLR.3y5_1.heavy 522.966 / 666.405 114389.0 29.059149265289307 40 15 9 6 10 3.1113593555092818 32.14029257756102 0.03380012512207031 3 0.9594628268332334 6.108822746947621 114389.0 117.87463892700514 0.0 - - - - - - - 750.75 228 8 C17orf76 chromosome 17 open reading frame 76 1755 224 C20140606_SFK034_02 C20140606_SFK034_02 TB403993.[MT7]-FLEQQNQVLQTK[MT7].2b3_1.heavy 882.498 / 534.304 11959.0 31.75309944152832 41 11 10 10 10 1.3908791465887895 57.449323627066576 0.0 3 0.8749194688881158 3.452495791866002 11959.0 84.7970029239766 0.0 - - - - - - - 196.9090909090909 23 11 KRT77;KRT1;KRT2 keratin 77;keratin 1;keratin 2 1757 224 C20140606_SFK034_02 C20140606_SFK034_02 TB403993.[MT7]-FLEQQNQVLQTK[MT7].2y4_1.heavy 882.498 / 633.405 6720.0 31.75309944152832 41 11 10 10 10 1.3908791465887895 57.449323627066576 0.0 3 0.8749194688881158 3.452495791866002 6720.0 8.907917536576178 1.0 - - - - - - - 330.6 18 10 KRT77;KRT1;KRT2 keratin 77;keratin 1;keratin 2 1759 224 C20140606_SFK034_02 C20140606_SFK034_02 TB403993.[MT7]-FLEQQNQVLQTK[MT7].2b4_1.heavy 882.498 / 662.363 6264.0 31.75309944152832 41 11 10 10 10 1.3908791465887895 57.449323627066576 0.0 3 0.8749194688881158 3.452495791866002 6264.0 16.352123979862974 0.0 - - - - - - - 634.1428571428571 12 7 KRT77;KRT1;KRT2 keratin 77;keratin 1;keratin 2 1761 224 C20140606_SFK034_02 C20140606_SFK034_02 TB403993.[MT7]-FLEQQNQVLQTK[MT7].2b6_1.heavy 882.498 / 904.464 1936.0 31.75309944152832 41 11 10 10 10 1.3908791465887895 57.449323627066576 0.0 3 0.8749194688881158 3.452495791866002 1936.0 5.443936731107206 0.0 - - - - - - - 190.0 3 9 KRT77;KRT1;KRT2 keratin 77;keratin 1;keratin 2 1763 225 C20140606_SFK034_02 C20140606_SFK034_02 TB456712.[MT7]-IWHTQLLPGGLQGLILNPIFR.3b6_1.heavy 844.164 / 923.522 125661.0 52.17839813232422 46 16 10 10 10 1.9257929601728652 35.56120127774558 0.0 3 0.9618821405345456 6.300990764284794 125661.0 526.097664542106 0.0 - - - - - - - 304.77777777777777 251 9 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1765 225 C20140606_SFK034_02 C20140606_SFK034_02 TB456712.[MT7]-IWHTQLLPGGLQGLILNPIFR.3y6_1.heavy 844.164 / 759.451 143288.0 52.17839813232422 46 16 10 10 10 1.9257929601728652 35.56120127774558 0.0 3 0.9618821405345456 6.300990764284794 143288.0 329.93947368421055 0.0 - - - - - - - 788.2857142857143 286 7 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1767 225 C20140606_SFK034_02 C20140606_SFK034_02 TB456712.[MT7]-IWHTQLLPGGLQGLILNPIFR.3b7_1.heavy 844.164 / 1036.61 241355.0 52.17839813232422 46 16 10 10 10 1.9257929601728652 35.56120127774558 0.0 3 0.9618821405345456 6.300990764284794 241355.0 439.7346201788677 0.0 - - - - - - - 323.3333333333333 482 3 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1769 225 C20140606_SFK034_02 C20140606_SFK034_02 TB456712.[MT7]-IWHTQLLPGGLQGLILNPIFR.3y9_1.heavy 844.164 / 1042.64 220317.0 52.17839813232422 46 16 10 10 10 1.9257929601728652 35.56120127774558 0.0 3 0.9618821405345456 6.300990764284794 220317.0 440.3303467607974 0.0 - - - - - - - 769.375 440 8 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1771 226 C20140606_SFK034_02 C20140606_SFK034_02 TB403994.[MT7]-FDQFDFLIDIVPR.2b3_1.heavy 884.973 / 535.263 31707.0 53.95154857635498 43 17 10 6 10 3.270328880512287 30.57796437413209 0.034198760986328125 3 0.9749829461405191 7.7863641209931265 31707.0 59.48895551257253 1.0 - - - - - - - 165.62962962962962 63 27 NFYC nuclear transcription factor Y, gamma 1773 226 C20140606_SFK034_02 C20140606_SFK034_02 TB403994.[MT7]-FDQFDFLIDIVPR.2y8_1.heavy 884.973 / 972.588 39844.0 53.95154857635498 43 17 10 6 10 3.270328880512287 30.57796437413209 0.034198760986328125 3 0.9749829461405191 7.7863641209931265 39844.0 121.82858147912694 0.0 - - - - - - - 671.0 79 7 NFYC nuclear transcription factor Y, gamma 1775 226 C20140606_SFK034_02 C20140606_SFK034_02 TB403994.[MT7]-FDQFDFLIDIVPR.2y9_1.heavy 884.973 / 1087.61 32983.0 53.95154857635498 43 17 10 6 10 3.270328880512287 30.57796437413209 0.034198760986328125 3 0.9749829461405191 7.7863641209931265 32983.0 178.87886017892833 0.0 - - - - - - - 745.1428571428571 65 7 NFYC nuclear transcription factor Y, gamma 1777 226 C20140606_SFK034_02 C20140606_SFK034_02 TB403994.[MT7]-FDQFDFLIDIVPR.2b5_1.heavy 884.973 / 797.359 39247.0 53.95154857635498 43 17 10 6 10 3.270328880512287 30.57796437413209 0.034198760986328125 3 0.9749829461405191 7.7863641209931265 39247.0 168.67223273182196 0.0 - - - - - - - 192.4814814814815 78 27 NFYC nuclear transcription factor Y, gamma 1779 227 C20140606_SFK034_02 C20140606_SFK034_02 TB560424.[MT7]-LEEETGQVVGFHQPGSIR.3b4_1.heavy 709.703 / 645.321 87074.0 31.83989906311035 47 17 10 10 10 9.275647873205793 10.780918095097826 0.0 3 0.9707099949112692 7.193443998199736 87074.0 122.55181076305347 0.0 - - - - - - - 1810.2857142857142 174 7 DMGDH dimethylglycine dehydrogenase 1781 227 C20140606_SFK034_02 C20140606_SFK034_02 TB560424.[MT7]-LEEETGQVVGFHQPGSIR.3b7_1.heavy 709.703 / 931.449 230646.0 31.83989906311035 47 17 10 10 10 9.275647873205793 10.780918095097826 0.0 3 0.9707099949112692 7.193443998199736 230646.0 511.0683883216429 0.0 - - - - - - - 319.75 461 8 DMGDH dimethylglycine dehydrogenase 1783 227 C20140606_SFK034_02 C20140606_SFK034_02 TB560424.[MT7]-LEEETGQVVGFHQPGSIR.3y5_1.heavy 709.703 / 529.309 415140.0 31.83989906311035 47 17 10 10 10 9.275647873205793 10.780918095097826 0.0 3 0.9707099949112692 7.193443998199736 415140.0 403.5721322954987 0.0 - - - - - - - 465.0 830 1 DMGDH dimethylglycine dehydrogenase 1785 227 C20140606_SFK034_02 C20140606_SFK034_02 TB560424.[MT7]-LEEETGQVVGFHQPGSIR.3y9_1.heavy 709.703 / 998.517 241225.0 31.83989906311035 47 17 10 10 10 9.275647873205793 10.780918095097826 0.0 3 0.9707099949112692 7.193443998199736 241225.0 392.44622241111955 0.0 - - - - - - - 387.55555555555554 482 9 DMGDH dimethylglycine dehydrogenase 1787 228 C20140606_SFK034_02 C20140606_SFK034_02 TB456720.[MT7]-SLAFAYVPVQLSEVGQQVEVELLGK[MT7].4b7_1.heavy 748.672 / 896.5 3085.0 54.746700286865234 44 14 10 10 10 2.0241525448037336 39.352335119722824 0.0 3 0.9387024116616177 4.9590316675798185 3085.0 24.038961038961038 0.0 - - - - - - - 108.37931034482759 6 29 DMGDH dimethylglycine dehydrogenase 1789 228 C20140606_SFK034_02 C20140606_SFK034_02 TB456720.[MT7]-SLAFAYVPVQLSEVGQQVEVELLGK[MT7].4b4_1.heavy 748.672 / 563.331 2164.0 54.746700286865234 44 14 10 10 10 2.0241525448037336 39.352335119722824 0.0 3 0.9387024116616177 4.9590316675798185 2164.0 10.468376638133476 0.0 - - - - - - - 150.86666666666667 4 30 DMGDH dimethylglycine dehydrogenase 1791 228 C20140606_SFK034_02 C20140606_SFK034_02 TB456720.[MT7]-SLAFAYVPVQLSEVGQQVEVELLGK[MT7].4b5_1.heavy 748.672 / 634.368 10312.0 54.746700286865234 44 14 10 10 10 2.0241525448037336 39.352335119722824 0.0 3 0.9387024116616177 4.9590316675798185 10312.0 77.13040650406505 0.0 - - - - - - - 154.0 20 27 DMGDH dimethylglycine dehydrogenase 1793 228 C20140606_SFK034_02 C20140606_SFK034_02 TB456720.[MT7]-SLAFAYVPVQLSEVGQQVEVELLGK[MT7].4b6_1.heavy 748.672 / 797.431 2716.0 54.746700286865234 44 14 10 10 10 2.0241525448037336 39.352335119722824 0.0 3 0.9387024116616177 4.9590316675798185 2716.0 0.0 0.0 - - - - - - - 98.5 5 26 DMGDH dimethylglycine dehydrogenase 1795 229 C20140606_SFK034_02 C20140606_SFK034_02 TB403826.[MT7]-AWSQEGPHR.2y4_1.heavy 606.306 / 466.252 1629.0 19.76026725769043 39 20 8 7 4 8.179380064063118 12.22586543439392 0.027099609375 9 0.9925245840536933 14.26506558050128 1629.0 -0.3592334676661585 8.0 - - - - - - - 1273.125 4 8 LAMA5 laminin, alpha 5 1797 229 C20140606_SFK034_02 C20140606_SFK034_02 TB403826.[MT7]-AWSQEGPHR.2y8_1.heavy 606.306 / 996.465 2263.0 19.76026725769043 39 20 8 7 4 8.179380064063118 12.22586543439392 0.027099609375 9 0.9925245840536933 14.26506558050128 2263.0 -0.4340697484940814 2.0 - - - - - - - 197.8421052631579 5 19 LAMA5 laminin, alpha 5 1799 229 C20140606_SFK034_02 C20140606_SFK034_02 TB403826.[MT7]-AWSQEGPHR.2y6_1.heavy 606.306 / 723.353 724.0 19.76026725769043 39 20 8 7 4 8.179380064063118 12.22586543439392 0.027099609375 9 0.9925245840536933 14.26506558050128 724.0 1.9411152757591983 6.0 - - - - - - - 0.0 1 0 LAMA5 laminin, alpha 5 1801 229 C20140606_SFK034_02 C20140606_SFK034_02 TB403826.[MT7]-AWSQEGPHR.2y7_1.heavy 606.306 / 810.385 N/A 19.76026725769043 39 20 8 7 4 8.179380064063118 12.22586543439392 0.027099609375 9 0.9925245840536933 14.26506558050128 0.0 0.0 50.0 - - - - - - - 0.0 1 0 LAMA5 laminin, alpha 5 1803 230 C20140606_SFK034_02 C20140606_SFK034_02 TB403828.[MT7]-EDQC[CAM]SYK[MT7].2y4_1.heavy 609.289 / 701.341 1345.0 17.132699966430664 47 17 10 10 10 2.4552091176609747 32.418301104208375 0.0 3 0.9784695027460258 8.395624976534059 1345.0 2.8020833333333335 0.0 - - - - - - - 194.28571428571428 2 21 CRBN cereblon 1805 230 C20140606_SFK034_02 C20140606_SFK034_02 TB403828.[MT7]-EDQC[CAM]SYK[MT7].2y5_1.heavy 609.289 / 829.399 2786.0 17.132699966430664 47 17 10 10 10 2.4552091176609747 32.418301104208375 0.0 3 0.9784695027460258 8.395624976534059 2786.0 19.037666666666667 0.0 - - - - - - - 186.0 5 16 CRBN cereblon 1807 230 C20140606_SFK034_02 C20140606_SFK034_02 TB403828.[MT7]-EDQC[CAM]SYK[MT7].2y3_1.heavy 609.289 / 541.31 1970.0 17.132699966430664 47 17 10 10 10 2.4552091176609747 32.418301104208375 0.0 3 0.9784695027460258 8.395624976534059 1970.0 6.314102564102564 0.0 - - - - - - - 264.0 3 20 CRBN cereblon 1809 230 C20140606_SFK034_02 C20140606_SFK034_02 TB403828.[MT7]-EDQC[CAM]SYK[MT7].2y6_1.heavy 609.289 / 944.426 3315.0 17.132699966430664 47 17 10 10 10 2.4552091176609747 32.418301104208375 0.0 3 0.9784695027460258 8.395624976534059 3315.0 64.52410714285715 0.0 - - - - - - - 144.0 6 12 CRBN cereblon 1811 231 C20140606_SFK034_02 C20140606_SFK034_02 TB456377.[MT7]-VDLQAK[MT7].2b3_1.heavy 481.3 / 472.289 56363.0 23.37364959716797 44 17 10 7 10 4.2317537606419515 23.630864567325425 0.0298004150390625 3 0.9764975699997505 8.034367920376571 56363.0 12.22544472940514 0.0 - - - - - - - 3614.0 112 1 KRT1 keratin 1 1813 231 C20140606_SFK034_02 C20140606_SFK034_02 TB456377.[MT7]-VDLQAK[MT7].2y4_1.heavy 481.3 / 603.395 61816.0 23.37364959716797 44 17 10 7 10 4.2317537606419515 23.630864567325425 0.0298004150390625 3 0.9764975699997505 8.034367920376571 61816.0 48.942269369543695 0.0 - - - - - - - 1218.6666666666667 123 9 KRT1 keratin 1 1815 231 C20140606_SFK034_02 C20140606_SFK034_02 TB456377.[MT7]-VDLQAK[MT7].2y5_1.heavy 481.3 / 718.422 68156.0 23.37364959716797 44 17 10 7 10 4.2317537606419515 23.630864567325425 0.0298004150390625 3 0.9764975699997505 8.034367920376571 68156.0 64.47625172420008 0.0 - - - - - - - 1304.2857142857142 136 7 KRT1 keratin 1 1817 231 C20140606_SFK034_02 C20140606_SFK034_02 TB456377.[MT7]-VDLQAK[MT7].2b4_1.heavy 481.3 / 600.347 24600.0 23.37364959716797 44 17 10 7 10 4.2317537606419515 23.630864567325425 0.0298004150390625 3 0.9764975699997505 8.034367920376571 24600.0 17.25463815457844 0.0 - - - - - - - 1236.2 49 10 KRT1 keratin 1 1819 232 C20140606_SFK034_02 C20140606_SFK034_02 TB403843.[MT7]-SC[CAM]PDGADEK[MT7].2y8_1.heavy 633.797 / 1035.45 N/A N/A - - - - - - - - - 0.0 - - - - - - - LRP3 low density lipoprotein receptor-related protein 3 1821 232 C20140606_SFK034_02 C20140606_SFK034_02 TB403843.[MT7]-SC[CAM]PDGADEK[MT7].2y5_1.heavy 633.797 / 663.343 N/A N/A - - - - - - - - - 0.0 - - - - - - - LRP3 low density lipoprotein receptor-related protein 3 1823 232 C20140606_SFK034_02 C20140606_SFK034_02 TB403843.[MT7]-SC[CAM]PDGADEK[MT7].2y3_1.heavy 633.797 / 535.284 N/A N/A - - - - - - - - - 0.0 - - - - - - - LRP3 low density lipoprotein receptor-related protein 3 1825 232 C20140606_SFK034_02 C20140606_SFK034_02 TB403843.[MT7]-SC[CAM]PDGADEK[MT7].2y7_1.heavy 633.797 / 875.423 N/A N/A - - - - - - - - - 0.0 - - - - - - - LRP3 low density lipoprotein receptor-related protein 3 1827 233 C20140606_SFK034_02 C20140606_SFK034_02 TB558706.[MT7]-THNLEPYFESFINNLR.3y7_1.heavy 713.364 / 863.473 18240.0 46.95690155029297 44 18 10 6 10 6.081889663989135 16.442258167243633 0.0391998291015625 3 0.9851457975032383 10.113433850404455 18240.0 48.18293275722387 0.0 - - - - - - - 404.6666666666667 36 6 KRT1 keratin 1 1829 233 C20140606_SFK034_02 C20140606_SFK034_02 TB558706.[MT7]-THNLEPYFESFINNLR.3b5_1.heavy 713.364 / 739.385 27641.0 46.95690155029297 44 18 10 6 10 6.081889663989135 16.442258167243633 0.0391998291015625 3 0.9851457975032383 10.113433850404455 27641.0 54.11769967171707 0.0 - - - - - - - 299.0 55 5 KRT1 keratin 1 1831 233 C20140606_SFK034_02 C20140606_SFK034_02 TB558706.[MT7]-THNLEPYFESFINNLR.3y8_1.heavy 713.364 / 992.516 16373.0 46.95690155029297 44 18 10 6 10 6.081889663989135 16.442258167243633 0.0391998291015625 3 0.9851457975032383 10.113433850404455 16373.0 46.37024817518248 0.0 - - - - - - - 334.875 32 8 KRT1 keratin 1 1833 233 C20140606_SFK034_02 C20140606_SFK034_02 TB558706.[MT7]-THNLEPYFESFINNLR.3y9_1.heavy 713.364 / 1139.58 9587.0 46.95690155029297 44 18 10 6 10 6.081889663989135 16.442258167243633 0.0391998291015625 3 0.9851457975032383 10.113433850404455 9587.0 10.774696117365925 1.0 - - - - - - - 785.875 19 8 KRT1 keratin 1 1835 234 C20140606_SFK034_02 C20140606_SFK034_02 TB326626.[MT7]-IWHTQLLPGGLQGLILNPIFR.4y4_1.heavy 633.375 / 532.324 87295.0 52.15904998779297 41 15 10 6 10 5.7892938461170695 17.273263831144256 0.0386962890625 3 0.9594536184467535 6.108124269861667 87295.0 204.75729586644223 0.0 - - - - - - - 804.8571428571429 174 7 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1837 234 C20140606_SFK034_02 C20140606_SFK034_02 TB326626.[MT7]-IWHTQLLPGGLQGLILNPIFR.4b7_1.heavy 633.375 / 1036.61 76442.0 52.15904998779297 41 15 10 6 10 5.7892938461170695 17.273263831144256 0.0386962890625 3 0.9594536184467535 6.108124269861667 76442.0 313.5637434235608 0.0 - - - - - - - 263.75 152 12 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1839 234 C20140606_SFK034_02 C20140606_SFK034_02 TB326626.[MT7]-IWHTQLLPGGLQGLILNPIFR.4y6_1.heavy 633.375 / 759.451 102561.0 52.15904998779297 41 15 10 6 10 5.7892938461170695 17.273263831144256 0.0386962890625 3 0.9594536184467535 6.108124269861667 102561.0 298.55209375375375 0.0 - - - - - - - 262.3333333333333 205 9 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1841 234 C20140606_SFK034_02 C20140606_SFK034_02 TB326626.[MT7]-IWHTQLLPGGLQGLILNPIFR.4b6_1.heavy 633.375 / 923.522 39970.0 52.15904998779297 41 15 10 6 10 5.7892938461170695 17.273263831144256 0.0386962890625 3 0.9594536184467535 6.108124269861667 39970.0 296.27841742664555 0.0 - - - - - - - 188.42857142857142 79 14 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1843 235 C20140606_SFK034_02 C20140606_SFK034_02 TB404010.[MT7]-NLVDPITHDLIISLAR.2y9_1.heavy 967.563 / 1037.61 7282.0 46.02595043182373 34 8 10 6 10 1.9669753830268084 50.839477129662214 0.037403106689453125 3 0.7893953677905855 2.6405459305452705 7282.0 14.580924026286265 0.0 - - - - - - - 647.0 14 7 C17orf76 chromosome 17 open reading frame 76 1845 235 C20140606_SFK034_02 C20140606_SFK034_02 TB404010.[MT7]-NLVDPITHDLIISLAR.2b4_1.heavy 967.563 / 586.332 70736.0 46.02595043182373 34 8 10 6 10 1.9669753830268084 50.839477129662214 0.037403106689453125 3 0.7893953677905855 2.6405459305452705 70736.0 240.92643051771117 0.0 - - - - - - - 280.5833333333333 141 12 C17orf76 chromosome 17 open reading frame 76 1847 235 C20140606_SFK034_02 C20140606_SFK034_02 TB404010.[MT7]-NLVDPITHDLIISLAR.2y10_1.heavy 967.563 / 1138.66 6119.0 46.02595043182373 34 8 10 6 10 1.9669753830268084 50.839477129662214 0.037403106689453125 3 0.7893953677905855 2.6405459305452705 6119.0 20.63793412191792 0.0 - - - - - - - 284.07142857142856 12 14 C17orf76 chromosome 17 open reading frame 76 1849 235 C20140606_SFK034_02 C20140606_SFK034_02 TB404010.[MT7]-NLVDPITHDLIISLAR.2y7_1.heavy 967.563 / 785.524 5385.0 46.02595043182373 34 8 10 6 10 1.9669753830268084 50.839477129662214 0.037403106689453125 3 0.7893953677905855 2.6405459305452705 5385.0 10.512116933788949 0.0 - - - - - - - 664.2857142857143 10 7 C17orf76 chromosome 17 open reading frame 76 1851 236 C20140606_SFK034_02 C20140606_SFK034_02 TB403986.[MT7]-AWSDDTSQLGPDK[MT7].2y4_1.heavy 854.425 / 560.316 15454.0 28.245850563049316 42 16 10 6 10 2.8471576096352584 35.12274826710796 0.03610038757324219 3 0.9632698166644149 6.419666526092781 15454.0 36.06603861590194 0.0 - - - - - - - 234.11111111111111 30 9 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1853 236 C20140606_SFK034_02 C20140606_SFK034_02 TB403986.[MT7]-AWSDDTSQLGPDK[MT7].2y9_1.heavy 854.425 / 1104.57 6586.0 28.245850563049316 42 16 10 6 10 2.8471576096352584 35.12274826710796 0.03610038757324219 3 0.9632698166644149 6.419666526092781 6586.0 12.638504361353409 0.0 - - - - - - - 667.3 13 10 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1855 236 C20140606_SFK034_02 C20140606_SFK034_02 TB403986.[MT7]-AWSDDTSQLGPDK[MT7].2y3_1.heavy 854.425 / 503.295 5708.0 28.245850563049316 42 16 10 6 10 2.8471576096352584 35.12274826710796 0.03610038757324219 3 0.9632698166644149 6.419666526092781 5708.0 5.75789865903767 0.0 - - - - - - - 208.5 11 8 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1857 236 C20140606_SFK034_02 C20140606_SFK034_02 TB403986.[MT7]-AWSDDTSQLGPDK[MT7].2b5_1.heavy 854.425 / 719.312 7025.0 28.245850563049316 42 16 10 6 10 2.8471576096352584 35.12274826710796 0.03610038757324219 3 0.9632698166644149 6.419666526092781 7025.0 32.84441930981374 0.0 - - - - - - - 216.6 14 15 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 1859 237 C20140606_SFK034_02 C20140606_SFK034_02 TB456472.[MT7]-TNWFEPVGSEYK[MT7].3b5_1.heavy 582.298 / 822.39 38855.0 37.4536018371582 45 17 10 10 8 2.367380985556006 33.870573238235416 0.0 4 0.970702777065131 7.192553459536468 38855.0 69.66133562742931 0.0 - - - - - - - 725.0 77 12 DMGDH dimethylglycine dehydrogenase 1861 237 C20140606_SFK034_02 C20140606_SFK034_02 TB456472.[MT7]-TNWFEPVGSEYK[MT7].3y4_1.heavy 582.298 / 670.353 8699.0 37.4536018371582 45 17 10 10 8 2.367380985556006 33.870573238235416 0.0 4 0.970702777065131 7.192553459536468 8699.0 9.425732260892723 0.0 - - - - - - - 743.6153846153846 17 13 DMGDH dimethylglycine dehydrogenase 1863 237 C20140606_SFK034_02 C20140606_SFK034_02 TB456472.[MT7]-TNWFEPVGSEYK[MT7].3b3_1.heavy 582.298 / 546.279 21844.0 37.4536018371582 45 17 10 10 8 2.367380985556006 33.870573238235416 0.0 4 0.970702777065131 7.192553459536468 21844.0 10.822925496091967 1.0 - - - - - - - 2235.0 53 8 DMGDH dimethylglycine dehydrogenase 1865 237 C20140606_SFK034_02 C20140606_SFK034_02 TB456472.[MT7]-TNWFEPVGSEYK[MT7].3y5_1.heavy 582.298 / 727.374 34409.0 37.4536018371582 45 17 10 10 8 2.367380985556006 33.870573238235416 0.0 4 0.970702777065131 7.192553459536468 34409.0 26.949274750544742 0.0 - - - - - - - 387.0 68 1 DMGDH dimethylglycine dehydrogenase 1867 238 C20140606_SFK034_02 C20140606_SFK034_02 TB326497.[MT7]-TQSDGIQQAK[MT7].2y8_1.heavy 682.375 / 990.534 8851.0 17.972000122070312 44 14 10 10 10 4.267426353323275 18.42704317491734 0.0 3 0.944669041666885 5.222219843280471 8851.0 127.11542553191491 0.0 - - - - - - - 123.375 17 16 CRBN cereblon 1869 238 C20140606_SFK034_02 C20140606_SFK034_02 TB326497.[MT7]-TQSDGIQQAK[MT7].2b4_1.heavy 682.375 / 576.275 19398.0 17.972000122070312 44 14 10 10 10 4.267426353323275 18.42704317491734 0.0 3 0.944669041666885 5.222219843280471 19398.0 62.2295593913241 0.0 - - - - - - - 638.8571428571429 38 7 CRBN cereblon 1871 238 C20140606_SFK034_02 C20140606_SFK034_02 TB326497.[MT7]-TQSDGIQQAK[MT7].2y6_1.heavy 682.375 / 788.475 14831.0 17.972000122070312 44 14 10 10 10 4.267426353323275 18.42704317491734 0.0 3 0.944669041666885 5.222219843280471 14831.0 133.95232978723405 0.0 - - - - - - - 194.85714285714286 29 14 CRBN cereblon 1873 238 C20140606_SFK034_02 C20140606_SFK034_02 TB326497.[MT7]-TQSDGIQQAK[MT7].2b5_1.heavy 682.375 / 633.296 3390.0 17.972000122070312 44 14 10 10 10 4.267426353323275 18.42704317491734 0.0 3 0.944669041666885 5.222219843280471 3390.0 5.3999999999999995 0.0 - - - - - - - 591.8571428571429 6 7 CRBN cereblon 1875 239 C20140606_SFK034_02 C20140606_SFK034_02 TB558472.[MT7]-VTETFGTWIR.2b8_1.heavy 677.368 / 1066.53 10349.0 39.69049835205078 50 20 10 10 10 20.10771098131848 4.973216498531695 0.0 3 0.9994929998709025 54.80749894205669 10349.0 16.50094762266187 0.0 - - - - - - - 762.0833333333334 20 12 GLDN gliomedin 1877 239 C20140606_SFK034_02 C20140606_SFK034_02 TB558472.[MT7]-VTETFGTWIR.2y8_1.heavy 677.368 / 1009.51 20618.0 39.69049835205078 50 20 10 10 10 20.10771098131848 4.973216498531695 0.0 3 0.9994929998709025 54.80749894205669 20618.0 43.434894539352555 0.0 - - - - - - - 704.2222222222222 41 9 GLDN gliomedin 1879 239 C20140606_SFK034_02 C20140606_SFK034_02 TB558472.[MT7]-VTETFGTWIR.2y5_1.heavy 677.368 / 632.352 15804.0 39.69049835205078 50 20 10 10 10 20.10771098131848 4.973216498531695 0.0 3 0.9994929998709025 54.80749894205669 15804.0 8.275737093095584 0.0 - - - - - - - 2258.0 31 7 GLDN gliomedin 1881 239 C20140606_SFK034_02 C20140606_SFK034_02 TB558472.[MT7]-VTETFGTWIR.2y9_1.heavy 677.368 / 1110.56 80948.0 39.69049835205078 50 20 10 10 10 20.10771098131848 4.973216498531695 0.0 3 0.9994929998709025 54.80749894205669 80948.0 135.1373578302712 0.0 - - - - - - - 256.6 161 5 GLDN gliomedin 1883 240 C20140606_SFK034_02 C20140606_SFK034_02 TB456479.[MT7]-LQGQGGSDPLPWPQR.3y7_1.heavy 593.98 / 893.499 13626.0 35.223501205444336 46 20 10 6 10 9.723432324730023 10.284434205981535 0.038799285888671875 3 0.9915242353931158 13.395708871311983 13626.0 19.342902208201895 1.0 - - - - - - - 664.0 31 7 IRAK2 interleukin-1 receptor-associated kinase 2 1885 240 C20140606_SFK034_02 C20140606_SFK034_02 TB456479.[MT7]-LQGQGGSDPLPWPQR.3b4_1.heavy 593.98 / 571.332 22076.0 35.223501205444336 46 20 10 6 10 9.723432324730023 10.284434205981535 0.038799285888671875 3 0.9915242353931158 13.395708871311983 22076.0 6.201625123605504 2.0 - - - - - - - 1162.0 44 1 IRAK2 interleukin-1 receptor-associated kinase 2 1887 240 C20140606_SFK034_02 C20140606_SFK034_02 TB456479.[MT7]-LQGQGGSDPLPWPQR.3b8_1.heavy 593.98 / 887.434 54505.0 35.223501205444336 46 20 10 6 10 9.723432324730023 10.284434205981535 0.038799285888671875 3 0.9915242353931158 13.395708871311983 54505.0 67.26689576415664 0.0 - - - - - - - 739.3333333333334 109 6 IRAK2 interleukin-1 receptor-associated kinase 2 1889 240 C20140606_SFK034_02 C20140606_SFK034_02 TB456479.[MT7]-LQGQGGSDPLPWPQR.3y5_1.heavy 593.98 / 683.362 125170.0 35.223501205444336 46 20 10 6 10 9.723432324730023 10.284434205981535 0.038799285888671875 3 0.9915242353931158 13.395708871311983 125170.0 124.95357010589187 0.0 - - - - - - - 739.0 250 1 IRAK2 interleukin-1 receptor-associated kinase 2 1891 241 C20140606_SFK034_02 C20140606_SFK034_02 TB557340.[MT7]-DFSTSIPK[MT7].2y4_1.heavy 591.834 / 588.384 N/A 27.974000930786133 34 16 0 10 8 2.1665569433920306 36.76750107508704 0.0 4 0.9654420829115524 6.619571807040436 8974.0 8.49643355635615 8.0 - - - - - - - 755.3333333333334 95 6 IRAK2 interleukin-1 receptor-associated kinase 2 1893 241 C20140606_SFK034_02 C20140606_SFK034_02 TB557340.[MT7]-DFSTSIPK[MT7].2b4_1.heavy 591.834 / 595.284 6436.0 27.974000930786133 34 16 0 10 8 2.1665569433920306 36.76750107508704 0.0 4 0.9654420829115524 6.619571807040436 6436.0 7.759464544874879 0.0 - - - - - - - 815.6363636363636 12 11 IRAK2 interleukin-1 receptor-associated kinase 2 1895 241 C20140606_SFK034_02 C20140606_SFK034_02 TB557340.[MT7]-DFSTSIPK[MT7].2b5_1.heavy 591.834 / 682.316 8611.0 27.974000930786133 34 16 0 10 8 2.1665569433920306 36.76750107508704 0.0 4 0.9654420829115524 6.619571807040436 8611.0 21.04943092318299 1.0 - - - - - - - 741.4545454545455 19 11 IRAK2 interleukin-1 receptor-associated kinase 2 1897 241 C20140606_SFK034_02 C20140606_SFK034_02 TB557340.[MT7]-DFSTSIPK[MT7].2y7_1.heavy 591.834 / 923.532 8158.0 27.974000930786133 34 16 0 10 8 2.1665569433920306 36.76750107508704 0.0 4 0.9654420829115524 6.619571807040436 8158.0 35.12117912561213 0.0 - - - - - - - 704.8888888888889 16 9 IRAK2 interleukin-1 receptor-associated kinase 2 1899 242 C20140606_SFK034_02 C20140606_SFK034_02 TB557341.[MT7]-TAIGHDRK[MT7].2y5_1.heavy 593.351 / 756.423 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1901 242 C20140606_SFK034_02 C20140606_SFK034_02 TB557341.[MT7]-TAIGHDRK[MT7].2b6_1.heavy 593.351 / 739.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1903 242 C20140606_SFK034_02 C20140606_SFK034_02 TB557341.[MT7]-TAIGHDRK[MT7].2y6_1.heavy 593.351 / 869.507 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1905 242 C20140606_SFK034_02 C20140606_SFK034_02 TB557341.[MT7]-TAIGHDRK[MT7].2y7_1.heavy 593.351 / 940.544 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1907 243 C20140606_SFK034_02 C20140606_SFK034_02 TB403983.[MT7]-TPPYLQLQVTEK[MT7].2y5_1.heavy 852.992 / 748.432 6164.0 35.80484962463379 35 10 10 5 10 2.3172594216355487 43.154425899116134 0.04019927978515625 3 0.8375791429943766 3.019812304934526 6164.0 5.100847469361802 1.0 - - - - - - - 826.2222222222222 12 9 LAMA5 laminin, alpha 5 1909 243 C20140606_SFK034_02 C20140606_SFK034_02 TB403983.[MT7]-TPPYLQLQVTEK[MT7].2y3_1.heavy 852.992 / 521.305 10370.0 35.80484962463379 35 10 10 5 10 2.3172594216355487 43.154425899116134 0.04019927978515625 3 0.8375791429943766 3.019812304934526 10370.0 16.236756782255185 1.0 - - - - - - - 706.6666666666666 21 9 LAMA5 laminin, alpha 5 1911 243 C20140606_SFK034_02 C20140606_SFK034_02 TB403983.[MT7]-TPPYLQLQVTEK[MT7].2y6_1.heavy 852.992 / 861.516 8609.0 35.80484962463379 35 10 10 5 10 2.3172594216355487 43.154425899116134 0.04019927978515625 3 0.8375791429943766 3.019812304934526 8609.0 18.33122483509648 1.0 - - - - - - - 713.0 17 7 LAMA5 laminin, alpha 5 1913 243 C20140606_SFK034_02 C20140606_SFK034_02 TB403983.[MT7]-TPPYLQLQVTEK[MT7].2y11_2.heavy 852.992 / 730.417 161915.0 35.80484962463379 35 10 10 5 10 2.3172594216355487 43.154425899116134 0.04019927978515625 3 0.8375791429943766 3.019812304934526 161915.0 311.61743309002435 0.0 - - - - - - - 171.5 323 4 LAMA5 laminin, alpha 5 1915 244 C20140606_SFK034_02 C20140606_SFK034_02 TB456722.[MT7]-DIQQAIFNVDDSVVDLETLAALYENR.3b6_1.heavy 1032.53 / 813.459 2838.0 54.746700286865234 41 11 10 10 10 2.9620768979630463 33.76009585327368 0.0 3 0.8635119543726297 3.3017708033873303 2838.0 16.70691988451822 0.0 - - - - - - - 132.06896551724137 5 29 FMN1 formin 1 1917 244 C20140606_SFK034_02 C20140606_SFK034_02 TB456722.[MT7]-DIQQAIFNVDDSVVDLETLAALYENR.3b4_1.heavy 1032.53 / 629.338 1697.0 54.746700286865234 41 11 10 10 10 2.9620768979630463 33.76009585327368 0.0 3 0.8635119543726297 3.3017708033873303 1697.0 7.97248322147651 0.0 - - - - - - - 115.20689655172414 3 29 FMN1 formin 1 1919 244 C20140606_SFK034_02 C20140606_SFK034_02 TB456722.[MT7]-DIQQAIFNVDDSVVDLETLAALYENR.3b5_1.heavy 1032.53 / 700.375 1127.0 54.746700286865234 41 11 10 10 10 2.9620768979630463 33.76009585327368 0.0 3 0.8635119543726297 3.3017708033873303 1127.0 13.498828804048848 0.0 - - - - - - - 146.56666666666666 2 30 FMN1 formin 1 1921 244 C20140606_SFK034_02 C20140606_SFK034_02 TB456722.[MT7]-DIQQAIFNVDDSVVDLETLAALYENR.3b8_1.heavy 1032.53 / 1074.57 1385.0 54.746700286865234 41 11 10 10 10 2.9620768979630463 33.76009585327368 0.0 3 0.8635119543726297 3.3017708033873303 1385.0 3.3876274989800077 0.0 - - - - - - - 161.3846153846154 2 26 FMN1 formin 1 1923 245 C20140606_SFK034_02 C20140606_SFK034_02 TB558473.[MT7]-AQYEDIAQK[MT7].3y3_1.heavy 451.913 / 490.311 195098.0 24.4596004486084 42 14 10 10 8 1.714732103845232 37.1316538601362 0.0 4 0.9362467660509151 4.861569530616165 195098.0 94.62241414173842 0.0 - - - - - - - 1131.0 390 4 KRT1 keratin 1 1925 245 C20140606_SFK034_02 C20140606_SFK034_02 TB558473.[MT7]-AQYEDIAQK[MT7].3b4_1.heavy 451.913 / 636.311 42022.0 24.4596004486084 42 14 10 10 8 1.714732103845232 37.1316538601362 0.0 4 0.9362467660509151 4.861569530616165 42022.0 62.23156911815845 0.0 - - - - - - - 1194.125 84 8 KRT1 keratin 1 1927 245 C20140606_SFK034_02 C20140606_SFK034_02 TB558473.[MT7]-AQYEDIAQK[MT7].3b5_1.heavy 451.913 / 751.338 188346.0 24.4596004486084 42 14 10 10 8 1.714732103845232 37.1316538601362 0.0 4 0.9362467660509151 4.861569530616165 188346.0 511.97323613449737 0.0 - - - - - - - 672.6363636363636 376 11 KRT1 keratin 1 1929 245 C20140606_SFK034_02 C20140606_SFK034_02 TB558473.[MT7]-AQYEDIAQK[MT7].3b3_1.heavy 451.913 / 507.268 55096.0 24.4596004486084 42 14 10 10 8 1.714732103845232 37.1316538601362 0.0 4 0.9362467660509151 4.861569530616165 55096.0 46.7078384195694 1.0 - - - - - - - 1754.857142857143 229 7 KRT1 keratin 1